UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 20-F

 

¨REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR

xANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 20132016

 

OR

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ____________ to _______________

 

OR

¨SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of event requiring this shell company report. . . . . .. . . . .. . .

 

Commission file number000-20181

 

 

 

 

SAPIENS INTERNATIONAL CORPORATION N.V.

(Exact name of Registrant as specified in its charter)

 

Curaçao

(Jurisdiction of incorporation or organization)

 

Landhuis JoonchiAzrieli Center

Kaya Richard J. Beaujon z/n26 Harukmim St.

P.O. Box 837

CuraçaoHolon, 5885800 Israel

(Address of principal executive offices)

 

Roni Giladi, Chief Financial Officer

Tel: +972-3-790-2000

Fax+972-3-790 2942

Azrieli Center

26 Harukmim St.

Holon, 5885800 Israel

(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)

 

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of Class: Name of each exchange on which registered:
Common Shares, par value € 0.01 per share NASDAQ Capital Market

 

Securities registered or to be registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act:None

 

 

 

Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report

 

As of December 31, 2013,2016, the issuer had 46,014,982 49,035,951Common Shares, par value € 0.01 per share, outstanding.outstanding (which excludes 2,328,296 Common Shares held in treasury).

 

Indicate by check mark if the registrant is well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

 

Yes¨                 Nox

 

If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

 

Yes¨                 Nox

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yesx                 No¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

 

Yesx                 No¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer.filer or an emerging growth company. See definition of “accelerated filer” and “large accelerated filer” in Rule 12b-2 of the Exchange Act.

 

¨ Large Accelerated Filerx Accelerated Filer¨Non-Accelerated Filer

Large accelerated filer:¨Accelerated filer:x

Non-accelerated filer:¨Emerging growth company¨

If an emerging growth company that prepares its financial statements in accordance with US GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act¨

 

Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:

xU.S. GAAP¨International Financial Reporting Standards as issued
by the International Accounting Standards Board
¨Other

U.S. GAAP¨ International Financial Reporting Standards as issued¨ Other

by the International Accounting Standards Board

 

If “Other” has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow:

 

Item 17¨                  Item 18¨

 

If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes¨                 Nox

 

TABLE OF CONTENTS

 

  Page
Introduction 1
PART I 1
Item 1Identity of Directors, Senior Management and Advisers1
Item 2Offer Statistics and Expected Timetable21
Item 3Key Information2
Item 4Information on the Company1817
Item 4AUnresolved Staff Comments3735
Item 5Operating and Financial Review and Prospects3735
Item 6Directors, Senior Management and Employees6059
Item 7Major Shareholders and Related Party Transactions7165
Item 8Financial Information7467
Item 9The Offer and Listing7568
Item 10Additional Information7770
Item 11Quantitative and Qualitative Disclosures About Market Risk10083
Item 12Description of Securities Other Than Equity Securities10183
PART II 101
PART II84
Item 13Defaults, Dividend Arrearages and Delinquencies10184
Item 14Material Modifications to the Rights of Security Holders and Use of Proceeds10184
Item 15Controls and Procedures10184
Item 16[Reserved]10284
Item 16AAudit Committee Financial Expert10285
Item 16BCode of Ethics10285
Item 16CPrincipal Accountant Fees and Services10285
Item 16DExemptions from the Listing Standards for Audit Committees10385
Item 16EPurchases of Equity Securities by the Issuer and Affiliated Purchasers10385
Item 16FChange in Registrant'sRegistrant’s Certifying Accountant10386
Item 16GCorporate Governance10386
Item 16HMine Safety Disclosures10487
PART III 104
PART III87
Item 17Financial Statements10487
Item 18Financial Statements10487
Item 19Exhibits10588
Signature 107
Signature89

 

 

INTRODUCTION

 

Definitions

 

In this annual report, unless the context otherwise requires:

 

·references to “Sapiens,” the “Company,” the “Registrant,” “our company,” “us,” “we” and “our” refer to Sapiens International Corporation N.V., a Curaçao company, and its consolidated subsidiaries;

References to “Sapiens,” the “Company,” the “Registrant,” “us,” “we” and “our” refer to Sapiens International Corporation N.V., a Curaçao company, and its consolidated subsidiaries.

·references to “our shares,” “Common Shares” and similar expressions refer to Sapiens’ Common Shares, par value € 0.01 per share;

·references to “Insseco” refer to Insseco Sp. Z O.O., a Poland-based software and services provider for the insurance market that Sapiens acquired in the third quarter of 2015;

References to “our shares,” “Common Shares” and similar expressions refer to the Registrant’s Common Shares, par value € 0.01 per share.

·references to “StoneRiver” refer to StoneRiver, Inc., a Denver, Colorado- based provider of technology solutions and services to the insurance industry that Sapiens acquired in the first quarter of 2017;

·references to “dollars”, “U.S. dollars”, “U.S. $” and “$” are to United States Dollars;

References to “dollars”, “US dollars” or “$” are to United States Dollars.

·references to “Euro” or “€”are to the Euro, the official currency of the Eurozone in the European Union;

·references to “shekels” and “NIS” are to New Israeli Shekels, the Israeli currency;

References to “GBP” are to Great British Pound.

·references to the “Articles” are to our Amended Articles of Association, as currently in effect;

·references to the “Securities Act” are to the Securities Act of 1933, as amended;

References to “NIS” are to New Israeli Shekels, the Israeli currency.

·references to the “Exchange Act” are to the Securities Exchange Act of 1934, as amended;

·references to “NASDAQ” are to the NASDAQ Stock Market; 

·references to the “TASE” are to the Tel Aviv Stock Exchange; and

·references to the “SEC” are to the United States Securities and Exchange Commission.

 

Cautionary StatementNote Regarding Forward-Looking Statements

 

Certain matters discussed in this annual report are forward-looking statements within the meaning of Section 27A of the Securities Act, of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs and assumptions as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed in Item 3 – “Key Information” under the caption “Risk Factors” and cautionary statements appearing elsewhere in this annual report in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements.

 

We undertake no obligation publicly to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed in this annual report might not occur.

 

PART I

Item 1.          Identity of Directors, Senior Management and Advisers

Item 1.Identity of Directors, Senior Management and Advisers

 

Not applicable.

 

Item 2.          Offer Statistics and Expected Timetable

Item 2.Offer Statistics and Expected Timetable

 

Not applicable.

 

Item 3.          Key Information

1

 

A.           Selected Financial Data.

Item 3.Key Information

A.Selected Financial Data.

 

The following tables summarize certain selected consolidated financial data for the periods and as of the dates indicated. We derived the statement of operations financial data for the years ended December 31, 2011, 20122014, 2015 and 20132016 and the balance sheet data as of December 31, 20122015 and 20132016 from our audited consolidated financial statements included elsewhere in this annual report. The selected consolidated statement of operationsincome financial data for the years ended December 31, 20092012 and 20102013 and the balance sheet data as of December 31, 2009, 20102012, 2013 and 20112014 are derived from our audited financial statements not included in this annual report. Our historical consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles, (“or U.S. GAAP”)GAAP, and presented in U.S. dollars. You should read the information presented below in conjunction with those statements.

The summary consolidated balance sheet data as of December 31, 2014, as derived from our audited consolidated balance sheet as of that date that appears elsewhere herein, reflects the carrying amounts combination between Sapiens and Insseco as of that date, consistent with the pooling of interest accounting method that we accorded to our acquisition of Insseco. Also consistent with that accounting method, our consolidated statements of income data for the year ended December 31, 2015 includes the revenues and expenses of Insseco for the entire year (although the acquisition was actually consummated on August 18, 2015).See also Note 1(d)(2) to our consolidated financial statements contained elsewhere in this annual report.

 

The information presented below is qualified by the more detailed historical consolidated financial statements, the notes thereto and the discussion under “Operating and Financial Review and Prospects” included elsewhere in this annual report.

 

Selected Financial Data: Year Ended December 31,
  (In thousands, except per share data)
  2009 2010 2011 2012 2013
           
Revenues $45,695  $52,235  $69,927  $113,909  $135,377 
Cost of revenues  26,571   29,921   40,067   66,459   84,971 
Gross profit  19,124   22,314   29,860   47,450   50,406 
Operating Expenses:                    
Research and development, net  2,735   3,293   5,008   10,169   11,846 
Selling, marketing, general and administrative  11,048   12,310   18,113   25,236   26,677 
Acquisition-related and restructuring costs  -   -   1,115   -   - 
Total operating expenses  13,783   15,603   24,236   35,405   38,523 
Operating income  5,341   6,711   5,624   12,045   11,883 
Financial income (expenses), net  (880)  (364)  104   193   520 
Income before taxes on income  4,461   6,347   5,728   12,238   12,403 
Taxes on income (benefit)  260   177   (230)  435   811 
                     
Net income  4,201   6,170   5,958   11,803   11,592 
                     
Attributable to non-controlling interest  -   18   61   23   (12)
                     
Net income attributable to Sapiens  4,201   6,152   5,897   11,780   11,604 
                     
Basic net earnings per share attributable to Sapiens' shareholders $0.19  $0.28  $0.21  $0.29  $0.29 
Diluted net earnings per share attributable to Sapiens' shareholders $0.19  $0.28  $0.19  $0.28  $0.27 
Weighted average number of shares used in computing basic net earnings per share  21,573   21,583   28,460   39,953   40,024 
Weighted average number of shares used in computing diluted net earnings per share  21,574   22,181   30,764   41,671   42,316 
  At December 31,
Balance Sheet Data: 2009 2010 2011 2012 2013
  (In thousands)
           
Cash and cash equivalents $11,172  $16,182  $21,460  $29,050  $70,313 
Working capital  925   4,868   7,736   18,723   62,835 
Total assets  48,731   58,719   153,468   162,584   222,428 
Accrued severance pay(1)  3,895   4,446   10,711   11,645   12,615 
Other long-term liabilities  34   299   617   803   1,712 
Capital stock(2) (3)  132,821   133,418   208,464   210,594   245,205 
Total equity $26,415  $34,118  $110,247  $118,439  $170,408 
Selected Financial Data: Year Ended December 31, 
  (In thousands, except per share data) 
Statement of Income Data: 2012  2013  2014  2015(1)  2016 
                
Revenues $113,909  $135,377  $157,450  $185,636  $216,190 
Cost of revenues  66,459   84,971   99,095   111,192   130,402 
Gross profit  47,450   50,406   58,355   74,444   85,788 
Operating Expenses:                    
Research and development  10,169   11,846   11,352   10,235   16,488 
Selling, marketing, general and administrative  25,236   26,677   32,097   39,859   44,460 
Total operating expenses  35,405   38,523   43,449   50,094   60,948 
Operating income  12,045   11,883   14,906   24,350   24,840 
Financial income, net  193   520   124   163   533 
Income before taxes on income  12,238   12,403   15,030   24,513   25,373 
Taxes on income  (435)  (811)  (454)  (4,213)  (5,772)
                     
Net income  11,803   11,592   14,576   20,300   19,601 
                     
Attributed to non-controlling interest  23   (12)  131   59   (43)
Attributed to redeemable non-controlling interest  -   -   (18)  1   (134)
Adjustment to redeemable non-controlling interest  -   -   -   224   442 
                     
Net income attributable to Sapiens  11,780   11,604   14,463   20,016   19,336 
                     
Basic net earnings per share attributable to Sapiens’ shareholders $0.29  $0.29  $0.31  $0.42  $0.40 
Diluted net earnings per share attributable to Sapiens’ shareholders $0.28  $0.27  $0.30  $0.41  $0.40 
Weighted average number of shares used in computing basic net earnings per share  39,953   40,024   47,210   48,121   48,947 
Weighted average number of shares used in computing diluted net earnings per share  41,671   42,316   48,637   49,327   49,780 

 

2

  At December 31, 
    
Balance Sheet Data: 2012  2013  2014(1)  2015  2016 
  (In thousands) 
       
Cash and cash equivalents $29,050  $70,313  $47,400  $54,351  $60,908 
Marketable securities  -   -   33,098   39,651   35,448 
Working capital  18,723   63,516   43,663   51,342   72,453 
Total assets  162,584   222,428   233,210   242,271   257,851 
Capital stock(2)  210,594   245,205   249,938   234,658   227,463 
Total equity $118,439  $170,408  $178,293   181,809   194,391 

(1)Accrued severance pay relates to accrued severance obligations mainly to our Israeli employeesAs indicated above, the balance sheet data as required under Israeli labor law. We are legally required to pay severance upon certain circumstances, primarily upon termination of employment by our company, retirement or deathDecember 31, 2014 and the statement of income data for the respective employee. Our obligation for our Israeli employees is fully provided for by monthly depositsyear ended December 31, 2015 reflect the carrying amounts combination between Sapiens and Insseco as of December 31, 2014 and as of January 1, 2015, respectively, consistent with insurance policies and by provisionthe pooling of interest accounting method in accordance with Israeli Severance Pay Law (For more details – refer to Note 2respect of our consolidated financial statements included elsewhere herein.acquisition of Insseco.

 

(2)In November 2012, we repurchased 2 million of our outstanding ordinary shares for total consideration of $7 million.

 

On January 15, 2013, April 22, 2015 and March 31, 2016, our Board of Directors determined, subject to shareholder approval, to declare and pay one-time cash interim dividends of $0.15, $0.15 and $0.20 per Common Share (or $5.8 million, $7.2 million and $10.0 million, in the aggregate, respectively), which were paid on February 22, 2013, June 1, 2015 and June 1, 2016, respectively.

OnNovember 19, 2013, we consummated an underwritten follow-on public offering of 5,650,000 of our Common Shares, plus an additional 847,400 Common Shares to cover over-allotments, pursuant to an underwriting agreement with Barclays Capital Inc., as representative of certain underwriters.

(3)B.On November 19, 2013, we consummated an underwritten follow-on public offering of 5,650,000 of our Common Shares, plus an additional 847,400 Common Shares to cover over-allotments, pursuant to an underwriting agreement with Barclays Capital Inc., as representative of certain underwriters.Capitalization and Indebtedness.

B.           Capitalization and Indebtedness.

Not applicable.

C.           Reasons for the Offer and Use of Proceeds.

 

Not applicable.

 

C.Reasons for the Offer and Use of Proceeds.

D.           Risk Factors.

Not applicable.

D.Risk Factors.

 

We operate globally in a dynamic and rapidly changing environment that involves numerous risks and uncertainties. The following section lists some, but not all, of those risks and uncertainties that may have a material adverse effect on our business, financial position, results of operations or cash flows.

 

3

Risks Relating to Our Business, Our Industry and our Financing Activities

 

Our development cycles are lengthy, we may not have the resources available to complete development of new, enhanced or modified solutions and we may incur significant expenses before we generate revenues, if any, from our solutions.

 

Because our solutions are complex and require rigorous testing, development cycles can be lengthy, taking us up to two years to develop and introduce new, enhanced or modified solutions. Moreover, development projects can be technically challenging and expensive. The nature of these development cycles may cause us to experience delays between the time we incur expenses associated with research and development and the time we generate revenues, if any, from such expenses. We may also not have sufficient funds or other resources to make the required investments in product development. Furthermore, we may invest substantial resources in the development of solutions that do not achieve market acceptance or commercial success. We may also not have sufficient funds or other resources to make the required investments in product development. Even where we succeed in our sales efforts and obtain new orders from customers, the complexity involved in delivering our solutions to such customers makes it more difficult for us to consummate delivery in a timely manner and to recognize revenue and maximize profitability. Failure to deliver our solutions in a timely manner could result in order cancellations, damage our reputations and require us to indemnify our customers. Any of these risks relating to our lengthy and expensive development cycle could have a material adverse effect on our business, financial conditions and results of operations.

Our sales cycle is variable and often lengthy, depends upon many factors outside our control, and could causerequires us to expend significant time and resources prior to earninggenerating associated revenues.

 

The typical sales cycle for our solutions and services is lengthy and unpredictable, requires pre-purchase evaluation by a significant number of persons in our customers’ organizations, and often involves a significant operational decision by our customers. Our sales efforts involve educating our customers and industry analysts and consultants about the use and benefits of our solutions, including the technical capabilities of our solutions and the efficiencies achievable by organizations deploying our solutions. Customers typically undertake a significant evaluation process, which frequently involves not only our solutions, but also those of our competitors and can result in a lengthy sales cycle. Our sales cycle for new customers is typically six to eighteen months and can extend even longer in some cases. We spend substantial time, effort and money in our sales efforts without any assurance that such efforts will produce any sales.

Investment in highly skilled research and development and customer support personnel is critical to our ability to develop and enhance our solutions and support our customers, but an increase in such investment may reduce our profitability.

 

As a provider of software solutions that rely upon technological advancements, we rely heavily on our research and development activities to remain competitive. We consequently depend in large part on the ability to attract, train, motivate and retain highly skilled information technology professionals for our research and development team, particularly individuals with knowledge and experience in the insurance industry. Because our software solutions are highly complex and are generally used by our customers to perform critical business functions, we also depend heavily on other skilled technology professionals.professionals to provide ongoing support to our customers. Skilled technology professionals are often in high demand and short supply. If we are unable to hire or retain qualified research and development personnel and other technology professionals to develop, implement and modify our solutions, we may be unable to meet the needs of our customers. Even if we succeed in retaining the necessary skilled personnel and in our research and development and customer support efforts, our investments in our personnel and product development efforts increase our costs of operations and thereby reduce our profitability, unless accompanied by increased revenues. Given the highly competitive industry in which we operate, we may not succeed in increasing our revenues in line with our increasing investments in our personnel and research and development efforts.

 

Furthermore, if we seek to expand the marketing and offering of our products into new territories, that requiresit would require the retention of new, additional skilled personnel with knowledge of the particular market and applicable regulatory regime. Such skilled personnel may not be available at a reasonable cost relative to the additional revenues that we expect to recognizegenerate in those territories, or may not be available at all.

 

4

If existing customers are not satisfied with our solutions and services and either do not make subsequent purchases from us andor do not continue using such solutions and services, or if our relationships with our largest customers are impaired, our revenue could be negatively affected.

 

Our existing customers are a key asset, and weWe depend heavily on repeat product and service revenues from our base of existing customers. Five of our customers accounted for, 33%in the aggregate, 32% and 30%34% of our revenues in the years ended December 31, 20122015 and 2013,2016, respectively. If our existing customers are not satisfied with our solutions and services, they may not enter into new project contracts with us or continue using our technologies. A significant decline in our revenue stream from existing customers would have a material adverse effect on our business, results of operations and financial condition.

The implementation of our M&A growth strategy, which requires the integration of our multiple acquired companies, including, most recently, StoneRiver, MaxPro, 4Sight, Insseco and IBEXI Solutions Private Limited, and their respective businesses, operations and employees with our own, involves significant risks, and the failure to integrate successfully may adversely affect our future results.

In the past six years we have completed eight acquisitions. Most recently, in 2017, we have acquired StoneRiver, after having acquired Maximum Processing Inc, or MaxPro, and 4Sight Business Intelligence, or 4Sight, in 2016, and IBEXI Solutions Private Limited, or IBEXI, and Insseco in 2015. These acquisitions are part of our integrated M&A growth strategy, which is centered on three key factors: growing our customer base, expanding geographically and adding complementary solutions to our portfolio— all while we seek to ensure our continued high quality of services and product delivery. Any failure to successfully integrate the business, operations and employees of our acquired companies, or to otherwise realize the anticipated benefits of these acquisitions, could harm our results of operations. Our ability to realize these benefits will depend on the timely integration and consolidation of organizations, operations, facilities, procedures, policies and technologies, and the harmonization of differences in the business cultures between these companies and their personnel. Integration of these businesses will be complex and time-consuming, will involve additional expense and could disrupt our business and divert management’s attention from ongoing business concerns. The challenges involved in integrating IBEXI, Insseco, MaxPro, 4Sight and StoneRiver include:

·preserving customer, supplier and other important relationships;

·integrating financial forecasting and controls, procedures and reporting cycles;

·combining and integrating information technology, or IT, systems; and

·integrating employees and related HR systems and benefits, maintaining employee morale and retaining key employees.

The benefits we expect to realize from these acquisitions are, necessarily, based on projections and assumptions about the combined businesses of our company, IBEXI, Insseco, MaxPro, 4Sight and StoneRiver, and assume, among other things, the successful integration of IBEXI, Insseco, MaxPro, 4Sight and StoneRiver into our business and operations.The acquisition of StoneRiver, in particular, is expected to significantly expand our presence and scale in the North American insurance industry, and to help us further accelerate our growing market footprint in the U.S. P&C space. Our projections and assumptions concerning our acquisitions may be inaccurate, however, and we may not successfully integrate the acquired companies and our operations in a timely manner, or at all. We may also be exposed to unexpected contingencies or liabilities of the acquired companies. If we do not realize the anticipated benefits of these transactions, our growth strategy and future profitability could be adversely affected.

5

Failure to manage our rapid growth effectively could harm our business.

We have recently experienced, and expect to continue to experience, rapid growth in our number of employees and in our international operations that has placed, and will continue to place, a significant strain on our operational and financial resources and our personnel. To manage our anticipated future growth effectively, we must continue to maintain and may need to enhance our information technology infrastructure, financial and accounting systems and controls and manage expanded operations and employees in geographically distributed locations. We also must attract, train and retain a significant number of additional qualified sales and marketing personnel, professional services personnel, software engineers, technical personnel and management personnel. Our failure to manage our rapid growth effectively could have a material adverse effect on our business, results of operations and financial condition. Our growth could require significant capital expenditures and may divert financial resources from other projects, such as the development of new services or product enhancements. For example, since it may take as long as six months to hire and train a new member of our professional services staff, we make decisions regarding the size of our professional services staff based upon our expectations with respect to customer demand for our products and services. If these expectations are incorrect, and we increase the size of our professional services organization without experiencing an increase in sales of our products and services, we will experience reductions in our gross and operating margins and net income. If we are unable to effectively manage our growth, our expenses may increase more than expected, our revenues could decline or grow more slowly than expected and we may be unable to implement our business strategy. We also intend to continue to expand into additional international markets which, if not technologically or commercially successful, could harm our financial condition and prospects.

We may be liable to our clients for damages caused by a violation of intellectual property rights, the disclosure of other confidential information, including personally identifiable information, system failures, errors or unsatisfactory performance of services, and our insurance policies may not be sufficient to cover these damages.

We often have access to, and are required to collect and store, sensitive or confidential client information, including personally identifiable information. Some of our client agreements do not limit our potential liability for breaches of confidentiality, infringement indemnity and certain other matters. Furthermore, breaches of confidentiality may entitle the aggrieved party to equitable remedies, including injunctive relief. If any person, including any of our employees and subcontractors, penetrates our network security or misappropriates sensitive or confidential client information, including personally identifiable information, we could be subject to significant liability from our clients or from our clients’ customers for breaching contractual confidentiality provisions or privacy laws. Despite measures we take to protect the intellectual property and other confidential information or personally identifiable information of our clients, unauthorized parties, including our employees and subcontractors, may attempt to misappropriate certain intellectual property rights that are proprietary to our clients or otherwise breach our clients’ confidences. Unauthorized disclosure of sensitive or confidential client information, including personally identifiable information, or a violation of intellectual property rights, whether through employee misconduct, breach of our computer systems, systems failure or otherwise, may subject us to liabilities, damage our reputation and cause us to lose clients.

 

Many of our contracts involve projects that are critical to the operations of our clients’ businesses and provide benefits to our clients that may be difficult to quantify. Any failure in a client’s system or any breach of security could result in a claim for substantial damages against us, regardless of our responsibility for such failure. Furthermore, any errors by our employees in the performance of services for a client, or poor execution of such services, could result in a client terminating our engagement and seeking damages from us.

 

In addition, while we have taken steps to protect the confidential information that we have access to, including confidential information we may obtain through usage of our cloud-based services, our security measures may be breached. If a cyber-attack or other security incident were to result in unauthorized access to or modification of our customers’ data or our own data or our IT systems or in disruption of the services we provide to our customers, or if our products or services are perceived as having security vulnerabilities, we could suffer significant damage to our business and reputation.

Although we attempt to limit our contractual liability for consequential damages in rendering our services, these limitations on liability may not apply in all circumstances, may be unenforceable in some cases, or may be insufficient to protect us from liability for damages. There may be instances when liabilities for damages are greater than the insurance coverage we hold and we will have to internalize those losses, damages and liabilities not covered by our insurance.

 

6

Changes in privacy regulations may impose additional costs and liabilities on us, limit our use of information, and adversely affect our business.

Personal privacy has become a significant issue in the United States, Europe, and many other countries where we operate. Many government agencies and industry regulators continue to impose new restrictions and modify existing requirements about the collection, use, and disclosure of personal information. Changes to laws or regulations affecting privacy and security may impose additional liability and costs on us and may limit our use of such information in providing our services to customers. If we were required to change our business activities, revise or eliminate services or products, or implement burdensome compliance measures, our business and results of operations may be harmed. Additionally, we may be subject to regulatory enforcement actions resulting in fines, penalties, and potential litigation if we fail to comply with applicable privacy laws and regulations.

Errors or defects in our software solutions could inevitably arise and would harm our profitability and our reputation with customers, and could even give rise to liability claims against us.

 

The quality of our solutions, including new, modified or enhanced versions thereof, is critical to our success. Since our software solutions are complex, they may contain errors that cannot be detected at any point in their testing phase. While we continually test our solutions for errors or defects and work with customers to identify and correct them, errors in our technology may be found in the future. Testing for errors or defects is complicated because it is difficult to simulate the breadth of operating systems, user applications and computing environments that our customers use and our solutions themselves are increasingly complex. Errors or defects in our technology have resulted in terminated work orders and could result in delayed or lost revenue, diversion of development resources and increased services, termination of work orders, damage to our brand and warranty and insurance costs in the future. In addition, time-consuming implementations may also increase the number of services personnel we must allocate to each customer, thereby increasing our costs and adversely affecting our business, results of operations and financial condition.

In addition, since our customers rely on our solutions to operate, monitor and improve the performance of their business processes, they are sensitive to potential disruptions that may be caused by the use of, or any defects in, our software. As a result, we may be subject to claims for damages related to software errors in the future. Liability claims could require us to spend significant time and money in litigation or to pay significant damages. Regardless of whether we prevail, diversion of key employees’ time and attention from our business, the incurrence of substantial expenses and potential damage to our reputation might result. While the terms of our sales contracts typically limit our exposure to potential liability claims and we carry errors and omissions insurance against such claims, there can be no assurance that such insurance will continue to be available on acceptable terms, if at all, or that such insurance will provide us with adequate protection against any such claims. A significant liability claim against us could have a material adverse effect on our business, results of operations and financial position.

Failure to meet customer expectations with respect to the implementation and use of our solutions could result in negative publicity, reduced sales and diversion of resources.

 

We generally provide our customers with upfront estimates regarding the duration, budget and costs associated with the implementation of our products. Implementation of our solutions is complex and meeting the anticipated duration, budget and costs often depend on factors relating to our customers or their other vendors. We may not meet the upfront estimates and expectations of our customers for the implementation of our solutions or the provision of our services as a result of factors within our control such as issues or limitations with our solutions, or factors beyond our control such as issues related to our system integrator partners or our customers'customers’ IT employees.

 

If we fail to meet upfront estimates and the expectations of our customers for the implementation of our solutions, our reputation could be harmed, which could adversely affect our ability to attract new customers and sell additional solutions and services to existing customers.

 

Our business involves long-term, large projects, some of which are fixed-price projects that involve uncertainties, such as estimated project costs and profit margins, and which can therefore adversely affect our results of operations.

 

Our business is characterized by relatively large projects or engagements that can have a significant impact on our total revenue and cost of revenue from quarter to quarter. A high percentage of our expenses, particularly employee compensation, are relatively fixed. Therefore, a variation in the timing of the initiation, progress or completion of projects or engagements can cause significant variations in operating results from quarter to quarter.

7

 

This is particularly the case on fixed-price contracts. Some of our solutions and services are sold as fixed-price projects with delivery requirements spanning more than one year. As our projects can be highly complex, we may not be able to accurately estimate our actual costs of completing a fixed-price project. If our actual cost-to-completion of these projects exceeds significantly the estimated costs, we could experience a loss on the related contracts, which would have a material adverse effect on our results of operations, financial position and cash flow.

 

Similarly, delays in executing client contracts (whether fixed price or not) may affect our revenue and cause our operating results to vary widely. Our solutions are delivered over periods of time ranging from several months to a few years. Payment terms are generally based on periodic payments or on the achievement of milestones. Any delays in payment or in the achievement of milestones may have a material adverse effect on our results of operations, financial position or cash flows.

The market for software solutions and related services is highly competitive.

 

The market for software solutions and related services and for business solutions for the insurance and financial services industry in particular, is highly competitive. Many of our smaller competitors have been acquired by larger competitors, which provides such smaller competitors with greater resources and potentially a larger client base for which they can develop solutions. Our customers or potential customers may prefer suppliers that are larger than us, are better known in the market or that have a greater global reach. In addition, we and some of our competitors have developed systems to allow customers to outsource their core systems to external providers (known as BPO). We are seeking to partner with BPO providers, but there can be no assurance that such BPO providers will adopt our solutions rather than those of our competitors. Determinations by current and potential customers to use BPO providers that do not use our solutions may result in the loss of such customers and limit our ability to gain new customers.

 

Consolidation in the insurance industry in which some of our clients operate also increases competitiveness for us by reducing the number of potential clients for whose business we and our competitors compete. The high level of continuity with which insurance and other financial services clients remain with their providers of software-related services also increases general competitiveness by tying clients to their service providers and thereby shrinking the market of potential clients.

Incorrect or improper use of our products or our failure to properly train customers on how to implement or utilize our products could result in customer dissatisfaction and negatively affect our business, results of operations, financial condition and growth prospects.

 

Our products are complex and are deployed in a wide variety of network environments. The proper use of our solutions requires training of the customer. If our solutions are not used correctly or as intended, inadequate performance may result. Additionally, our customers or third-party partners may incorrectly implement or use our solutions. Our solutions may also be intentionally misused or abused by customers or their employees or third parties who are able to access or use our solutions. Similarly, our solutions are sometimes installed or maintained by customers or third parties with smaller or less qualified IT departments, potentially resulting in sub-optimal installation and, consequently, performance that is less than the level anticipated by the customer. Because our customers rely on our software, services and maintenance support to manage a wide range of operations, the incorrect or improper use of our solutions, our failure to properly train customers on how to efficiently and effectively use our solutions, or our failure to properly provide implementation or maintenance services to our customers has resulted in terminated work orders and may result in termination of work orders, negative publicity or legal claims against us in the future. Also, as we continue to expand our customer base, any failure by us to properly provide these services will likely result in lost opportunities for follow-on sales of our software and services.

In addition, if there is substantial turnover of customer personnel responsible for implementation and use of our products, or if customer personnel are not well trained in the use of our products, customers may defer the deployment of our products, may deploy them in a more limited manner than originally anticipated or may not deploy them at all. Further, if there is substantial turnover of the customer personnel responsible for implementation and use of our products, our ability to make additional sales may be substantially limited.

 

8

Assertions by third parties of infringement or other violation by us of their intellectual property rights could result in significant costs and substantially harm our business and results of operations.

 

The software industry is characterized by the existence of a large number of patents and frequent claims and related litigation regarding patents and other intellectual property rights. In particular, leading companies in the software industry own large numbers of patents, copyrights, trademarks and trade secrets, which they may use to assert claims against us. From time to time, third parties, including certain of these leading companies, may assert patent, copyright, trademark or other intellectual property claims against us, our customers and partners, and those from whom we license technology and intellectual property.

Although we believe that our products and services do not infringe upon the intellectual property rights of third parties, we cannot assure you that third parties will not assert infringement or misappropriation claims against us with respect to current or future products or services, or that any such assertions will not require us to enter into royalty arrangements or result in costly litigation, or result in us being unable to use certain intellectual property. We cannot assure you that we are not infringing or otherwise violating any third party intellectual property rights. Infringement assertions from third parties may involve patent holding companies or other patent owners who have no relevant product revenues, and therefore our own issued and pending patents may provide little or no deterrence to these patent owners in bringing intellectual property rights claims against us.

 

Any intellectual property infringement or misappropriation claim or assertion against us, our customers or partners, and those from whom we license technology and intellectual property could have a material adverse effect on our business, financial condition, reputation and competitive position regardless of the validity or outcome. If we are forced to defend against any infringement or misappropriation claims, whether they are with or without merit, are settled out of court, or are determined in our favor, we may be required to expend significant time and financial resources on the defense of such claims. Furthermore, an adverse outcome of a dispute may require us to pay damages, potentially including treble damages and attorneys’ fees, if we are found to have willfully infringed on a party’s intellectual property; cease making, licensing or using our products or services that are alleged to infringe or misappropriate the intellectual property of others; expend additional development resources to redesign our products or services; enter into potentially unfavorable royalty or license agreements in order to obtain the right to use necessary technologies or works; and to indemnify our partners, customers, and other third parties. Royalty or licensing agreements, if required or desirable, may be unavailable on terms acceptable to us, or at all, and may require significant royalty payments and other expenditures. Any of these events could seriously harm our business, results of operations and financial condition. In addition, any lawsuits regarding intellectual property rights, regardless of their success, could be expensive to resolve and divert the time and attention of our management and technical personnel.

Although we apply measures to protect our intellectual property rights and our source code, there can be no assurance that the measures that we employ to do so will be successful.

 

In accordance with industry practice, since we have no registered patents on our software solution technologies, we rely on a combination of contractual provisions and intellectual property law to protect our proprietary technology. We believe that due to the dynamic nature of the computer and software industries, copyright protection is less significant than factors such as the knowledge and experience of our management and personnel, the frequency of product enhancements and the timeliness and quality of our support services. We seek to protect the source code of our products as trade secret information and as unpublished copyright works. We also rely on security and copy protection features in our proprietary software. We distribute our products under software license agreements that grant customers a personal, non-transferable license to use our products and contain terms and conditions prohibiting the unauthorized reproduction or transfer of our products. In addition, while we attempt to protect trade secrets and other proprietary information through non-disclosure agreements with employees, consultants and distributors, not all of our employees have signed invention assignment agreements. Although we intend to protect our rights vigorously, there can be no assurance that these measures will be successful. Our failure to protect our rights, or the improper use of our products by others without licensing them from us could have a material adverse effect on our results of operations and financial condition.

 

9

We and our customers rely on technology and intellectual property of third parties, the loss of which could limit the functionality of our products and disrupt our business.

 

We use technology and intellectual property licensed from unaffiliated third parties in certain of our products, and we may license additional third-party technology and intellectual property in the future. Any errors or defects in this third-party technology and intellectual property could result in errors that could harm our brand and business. In addition, licensed technology and intellectual property may not continue to be available on commercially reasonable terms, or at all. The loss of the right to license and distribute this third party technology could limit the functionality of our products and might require us to redesign our products.

 

Further, although we believe that there are currently adequate replacements for the third-party technology and intellectual property we presently use and distribute, the loss of our right to use any of this technology and intellectual property could result in delays in producing or delivering affected products until equivalent technology or intellectual property is identified, licensed or otherwise procured, and integrated. Our business would be disrupted if any technology and intellectual property we license from others or functional equivalents of this software were either no longer available to us or no longer offered to us on commercially reasonable terms. In either case, we would be required either to attempt to redesign our products to function with technology and intellectual property available from other parties or to develop these components ourselves, which would result in increased costs and could result in delays in product sales and the release of new product offerings. Alternatively, we might be forced to limit the features available in affected products. Any of these results could harm our business and impact our results of operations.

We could be required to provide the source code of our products to our customers.

Some of our customers have the right to require the source code of our products to be deposited into a source code escrow. Under certain circumstances, our source code could be released to our customers. The conditions triggering the release of our source code vary by customer. A release of our source code would give our customers access to our trade secrets and other proprietary and confidential information which could harm our business, results of operations and financial condition.

Significant disruptions of our information technology systems or breaches of our data security could adversely affect our business.

A significant invasion, interruption, destruction or breakdown of our information technology systems and/or infrastructure by persons with authorized or unauthorized access could negatively impact our business and operations. We could also experience business interruption, information theft and/or reputational damage from cyber attacks, which may compromise our systems and lead to data leakage either internally or at our third party providers. Our systems have been, and are expected to continue to be, the target of malware and other cyber attacks. Although we have invested in measures to reduce these risks, we cannot assure you that these measures will be successful in preventing compromise and/or disruption of our information technology systems and related data.

Catastrophes may adversely impact the P&C insurance industry, preventing us from expanding or maintaining our existing customer base and increasing our revenues.

Our customers include P&C insurance carriers that have experienced, and will likely experience in the future, catastrophe losses that adversely impact their businesses. Catastrophes can be caused by various events, including, amongst others, hurricanes, tsunamis, floods, windstorms, earthquakes, hail, tornados, explosions, severe weather and fires. Moreover, acts of terrorism or war could cause disruptions in our or our customers’ businesses or the economy as a whole. The risks associated with natural disasters and catastrophes are inherently unpredictable, and it is difficult to predict the timing of such events or estimate the amount of loss they will generate. In the event a future catastrophe adversely impacts our current or potential customers, we may be prevented from maintaining and expanding our customer base and from increasing our revenues because such events may cause customers to postpone purchases of new products and professional service engagements or discontinue projects.

 

10

There may be consolidation in the P&C insurance industry, which could reduce the use of our products and services and adversely affect our revenues.

 

Mergers or consolidations among our customers could reduce the number of our customers and potential customers. This could adversely affect our revenues even if these events do not reduce the aggregate number of customers or the activities of the consolidated entities. If our customers merge with or are acquired by other entities that are not our customers, or that use fewer of our products and services, they may discontinue or reduce their use of our products and services. Any of these developments could materially and adversely affect our results of operations and cash flows.

Some of our services and technologies may use “open source” software, which may restrict how we use or distribute our services or require that we release the source code of certain products subject to those licenses.

Some of our services and technologies may incorporate software licensed under so-called “open source” licenses, including, but not limited to, the GNU General Public License and the GNU Lesser General Public License. In addition to risks related to license requirements, usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or controls on origin of the software. Additionally, open source licenses typically require that source code subject to the license be made available to the public and that any modifications or derivative works to open source software continue to be licensed under open source licenses. These open source licenses typically mandate that proprietary software, when combined in specific ways with open source software, become subject to the open source license. If we combine our proprietary software with open source software, we could be required to release the source code of our proprietary software.

 

We take steps to ensure that our proprietary software is not combined with, and does not incorporate, open source software in ways that would require our proprietary software to be subject to an open source license. However, few courts have interpreted open source licenses, and the manner in which these licenses may be interpreted and enforced is therefore subject to some uncertainty. Additionally, we rely on multiple software programmers to design our proprietary technologies, and although we take steps to prevent our programmers from including open source software in the technologies and software code that they design, write and modify, we do not exercise complete control over the development efforts of our programmers and we cannot be certain that our programmers have not incorporated open source software into our proprietary products and technologies or that they will not do so in the future. In the event that portions of our proprietary technology are determined to be subject to an open source license, we could be required to publicly release the affected portions of our source code, re-engineer all or a portion of our technologies, or otherwise be limited in the licensing of our technologies, each of which could reduce or eliminate the value of our services and technologies and materially and adversely affect our business, results of operations and prospects.

 

FailureOur indebtedness is subject to managea floating interest rate and subjects us to debt service obligations that could have an adverseeffect on our rapid growth effectivelycontinuing liquidity and manage our headquarters transition could harm our business.financial condition.

 

We have recently experienced,The repayment of the principal amount of the bank debt that we incurred in connection with our acquisition of StoneRiver, which was initially $40 million, is subject to the terms of the credit agreement that we entered into with the lender, HSBC Bank USA, National Association. The interest rate payable on the loan is LIBOR plus 1.85%. Until repayment of the bank debt, we are subject to certain financial covenants. Our ability to make due payment of principal and expect to continue to experience, rapid growth in our number of employeesinterest and in our international operations that has placed, and will continue to place, a significant strain on our operational and financial resources and our personnel. To manage our anticipated future growth effectively, we must continue to maintain and may need to enhance our information technology infrastructure,comply with the financial and accounting systemsother covenants under the credit agreement is subject to the risk factors described herein, and controls and manage expanded operations and employees in geographically distributed locations. We also must attract, train and retain a significant number of additional qualified sales and marketing personnel, professional services personnel, software engineers, technical personnel and management personnel. Ourany failure to manage our rapid growth effectivelycomply with the covenants could have a materialan adverse effect on our business, resultsliquidity and operations. This debt requires us to dedicate a portion of operations and financial condition. Our growthour cash flow to debt service, could require significantimpair our ability to obtain additional financing for capital expenditures or other purposes, could hinder our ability to adjust rapidly to changing market conditions and may divert financial resources from other projects, such ascompetitive pressures, and could make us more vulnerable in the developmentevent of new servicesa downturn in our business or product enhancements.deterioration of general economic conditions. For example,further information concerning our indebtedness, see “Liquidity and Capital Resources” in Item 5 below and “HSBC Term Loan Credit Agreement” in Item 10.C below. Additionally, since it may take as long as six monthsour debt is subject to hire and train a new memberfloating rate of our professional services staff, we make decisions regarding the size of our professional services staff based upon our expectations with respect to customer demand for our products and services. If these expectations are incorrect, and we increase the size of our professional services organization without experiencinginterest, an increase in sales of our products and services, we will experience reductions in our gross and operating margins and net income. Furthermore, we have recently completed the relocation of our corporate headquarters within Israel, having moved from Ness Ziona to Holon in July 2013. We have incurred additional costs in connection with this relocation and our new headquarters lease. If we are unable to effectively manage our growth, our expenses may increase more than expected, our revenuesLIBOR could decline or grow more slowly than expected and we may be unable to implement our business strategy. We also intend to continue to expand into additional international markets which, if not technologically or commercially successful, could harm our financial condition and prospects.adversely affect us.

11

Risks Relating to Our International Operations

Our international sales and operations subject us to additional risks that can adversely affect our business, results of operations and financial condition.

 

We sell our products and services to customers located outside North America, and we are continuing to expand our international operations as part of our growth strategy. In fiscal years 20122015 and 2013, 69%2016, 67% and 67%66%, respectively, of our revenues were derived from outside of North America. Our current international operations and our plans to further expand our international operations subject us to a variety of risks, including:

 

·increased exposure to fluctuations in foreign currency exchange rates;

·
complexity in our tax planning, and increased exposure to changes in tax regulations in various jurisdictions in which we operate, which could adversely affect our operating results and frustrate our ability to conduct effective tax planning;   
increased management, travel, infrastructure and legal compliance costs associated with having multiple international operations;

·
longer payment cycles and difficulties in enforcing contracts and collecting accounts receivable;

·
the need to localize our products and licensing programs for international customers;

·
lack of familiarity with and unexpected changes in foreign regulatory requirements;

·
the burdens of complying with a wide variety of foreign laws and legal standards;

·
compliance with the U.S. Foreign Corrupt Practices Act of 1977, as amended, or FCPA, particularly in emerging market countries;

·
import and export license requirements, tariffs, taxes and other trade barriers;

·
increased financial accounting and reporting burdens and complexities;

·
weaker protection of intellectual property rights in some countries;

·
multiple and possibly overlapping tax regimes; and

·
political, social and economic instability abroad, terrorist attacks and security concerns in general.

 

As we continue to expand our business globally, our success will depend, in large part, on our ability to anticipate and effectively manage these and other risks associated with our international operations. Any of these risks could harm our international operations and reduce our international sales, adversely affecting our business, results of operations, financial condition and growth prospects.

 

International operations in the insurance industry, in which a significant portion of our business is concentrated, is accompanied by additional costs related to adaptation to specific territories.

As we seek to expand the marketing and offering of our products into new territories, because insurance regulations vary by legal jurisdiction, the investment required to adapt our solutions to the legal and language requirements of such territories may prevent or delay us from effectively expanding into such territories. Such adaptation process requires the retention of new, additional skilled personnel with knowledge of the particular market and applicable regulatory regime. Such skilled personnel may not be available at a reasonable cost relative to the additional revenues that we expect to recognize in those territories, or may not be available at all.

 

Our international operations expose us to risks associated with fluctuations in foreign currency exchange rates that could adversely affect our business.

 

Most of our revenues are derived from international operations that are conducted in local currencies, mainly inincluding US dollars, but also in GBP, EURO, and New Israeli Shekels, or NIS. Our primary economic environment currency isNIS, Japanese Yen, or JPY, Indian rupee, or INR and Polish zloty, or PLN. In 2015 and 2016, our revenues were approximately 36% and 37%, respectively, in US dollars, with the US dollar and therefore our functional currency isremainder in the US dollar.other currencies.

 

12

Fluctuations in

Because exchange rates between the NIS, GBP, Euro, JPY, INR and the PLN against the US dollar fluctuate continuously, exchange rate fluctuations and other currencies which we and our subsidiaries use, especially the NIS, maylarger periodic devaluations could negatively affect our earnings. A significant portion of our expenses, including researchrevenue and development, personnel and facilities-related expenses, are incurred in Israel, in NIS. Consequently, we are particularly exposed to the risk of appreciation of the NIS in relation to the US dollar. This appreciation would cause an increase in our expenses as recorded in our US dollar denominated financial statements even if the expenses denominated in local currencies remains unchanged. In addition, our level of revenues and profits may be adversely affected by exchange rate fluctuations.profitability.

 

In certain locations, we engage in currency-hedging transactions intended to reduce the effect of fluctuations in foreign currency exchange rates on our financial position and results of operations. However, there can be no assurance that any such hedging transactions will materially reduce the effect of fluctuation in foreign currency exchange rates on such results. In addition, if for any reason exchange or price controls or other restrictions on the conversion of foreign currencies were imposed, our financial position and results of operations could be adversely affected.

 

The tax benefits that will beare available to our Israeli subsidiaries will require us to continue to meet various conditions and may be terminated or reduced in the future, which could increase our costs and taxes.

 

Some of our Israeli subsidiaries have been granted “Approved Enterprise” and “Benefited Enterprise” status, which provide certain benefits, including tax exemptions and reduced tax rates under the Israeli Law for the Encouragement of Capital Investments, 1959, referred to as the Investment Law. Income not eligible for Approved Enterprise and Benefited Enterprise benefits is taxed at the regular ratescorporate tax rate (25% in 20132016, 24% in 2017 and 26.5%23% in 2014)2018 and thereafter).

 

In the event of distribution of dividends from said tax-exempt income, the amount distributed will be subject to corporate tax at the rate ordinarilythat would have otherwise been applicable toon the Approved/Benefited Enterprise'sEnterprise’s income. Tax-exempt income generated under the Approved/Benefited Enterprise program will be subject to taxes upon dividend distribution (which includes the repurchase of the Company's shares) or liquidation. The benefits period under the Investment Law has yet to commence.

The entitlement to the above benefits (once they commence) is conditional upon the fulfillment of the conditions stipulated by the Investment Law and applicable regulations. Should the Israeli subsidiaries fail to meet such requirements, in the future, income attributable to the Approved Enterprise and Benefited Enterprise programs could be subject to the statutory Israeli corporate tax rate and they may be required to refund a portion of the tax benefits already received with respect to such programs.

 

Risks Related to an Investment in our Common Shares

 

There is limited trading volume for our common shares, which reduces liquidity for our shareholders, and may furthermore cause the stockshare price to be volatile, all of which may lead to losses by investors.

 

There has historically been limited trading volume forin our common shares, both on the NASDAQ Capital Market and the TASE. While recently there has been some improvement, the trading volume hasis still not reached the level that enables shareholders to freely sell their shareslimited, which results in substantial quantities on an ongoing basis and thereby readily achievereduced liquidity for their investment.our shareholders. As a further result of the limited volume, our common shares have experienced significant market price volatility in the past and may experience significant market price and volume fluctuations in the future, in response to factors such as announcements of developments related to our business, announcements by competitors, quarterly fluctuations in our financial results and general conditions in the industry in which we compete.

 

We are a foreign private issuer under the rules and regulations of the SEC and are therefore exempt from a number of rules under the Exchange Act and are permitted to file less information with the SEC than a domestic U.S. reporting company, which reduces the level and amount of disclosure that you receive.

 

As a foreign private issuer under the Exchange Act, we are exempt from certain rules under the Exchange Act, including the proxy rules, which impose certain disclosure and procedural requirements for proxy solicitations. Moreover, we are not required to file periodic reports and financial statements with the Securities and Exchange Commission, or the SEC as frequently or as promptly as domestic U.S. companies with securities registered under the Exchange Act; and are not required to comply with Regulation FD, which imposes certain restrictions on the selective disclosure of material information. In addition, our officers, directors and principal shareholders are exempt from the reporting and “short-swing” profit recovery provisions of Section 16 of the Exchange Act and the rules under the Exchange Act with respect to their purchases and sales of our common shares. Accordingly, you receive less information about our company than you would receive about a domestic U.S. company, and are afforded less protection under the U.S. federal securities laws than you would be afforded in holding securities of a domestic U.S. company.

13

As a foreign private issuer, we are also permitted, and have begun, to follow certain home country corporate governance practices instead of those otherwise required under the Listing Rules of the NASDAQ Stock Market for domestic U.S. issuers. We have informed NASDAQ that we follow home country practice in CuracaoCuraçao with regard to, among other things, composition of our boardBoard of directorsDirectors (whereby a majority of the members of our boardBoard of directorsDirectors need not be “independent directors,” as is generally required for domestic U.S. issuers), director nomination procedure and approval of compensation of officers. In addition, we have opted to follow home country law instead of the Listing Rules of the NASDAQ Stock Market that require that a listed company obtain shareholder approval for certain dilutive events, such as the establishment or amendment of certain equity-based compensation plans, an issuance that will result in a change of control of the company,Company, certain transactions other than a public offering involving issuances of a 20% or greater interest in the company,Company, and certain acquisitions of the stock or assets of another company. Following our home country governance practices as opposed to the requirements that would otherwise apply to a United States company listed on the NASDAQ Capital Market may provide our shareholders with less protection than they would have as stockholders of a domestic U.S. company.

 

Our controlling shareholder, Formula Systems (1985) Ltd., beneficially owns approximately 48.9% of our outstanding Common Shares and therefore asserts a controlling influence over matters requiring shareholder approval, which could delay or prevent a change of control that may benefit our public shareholders.

Formula Systems (1985) Ltd.beneficially owns approximately 48.9% of our outstanding Common Shares. As a result, it exercises a controlling influence over our operations and business strategy and has sufficient voting power to control the outcome of various matters requiring shareholder approval. These matters may include:

the composition of our board of directors, which has the authority to direct our business and to appoint and remove our officers;

approving or rejecting a merger, consolidation or other business combination;

raising future capital; and

amending our Articles, which govern the rights attached to our Common Shares.

This concentration of ownership of our Common Shares could delay or prevent proxy contests, mergers, tender offers, open-market purchase programs or other purchases of our Common Shares that might otherwise give you the opportunity to realize a premium over the then-prevailing market price of our Common Shares. This concentration of ownership may also adversely affect our share price.

Risks Related to Our Israeli Operations and Our Status as a Curaçao Company

The Israeli government grants that weour Israeli subsidiary has received require us to meet several conditions and restrict our ability to manufacture and engineer products and transfer know-how developed using such grants outside of Israel and require us to satisfy specified conditions.

We haveOne of our Israeli subsidiaries received grants in the past from the government of Israel through the National Technological Innovation Authority, or the Innovation Authority (formerly operating as Office of the Chief Scientist of the Ministry of Economy of the State of Israel, or the OCS,OCS), for the financing of a portion of ourits research and development expenditures in Israel. When know-howIsrael with respect to our legacy technology. In consideration for receiving grants from the OCS, we are obligated to pay the Innovation Authority royalties from the revenues generated from the sale of products (and related services) developed (in whole or in part) using the OCS funds, in an amount that is up to 100% to 150% of the aggregate amount of the total grants that we received from the OCS, plus annual interest for grants received after January 1, 1999. We must fully and originally own any intellectual property developed using the OCS grants and any right derived therefrom unless transfer thereof is approved in accordance with the provisions of the Israeli Encouragement of Research, Development and Technological Innovation Law, 5744-1984, or the Innovation Law (formerly known as the Encouragement of Industrial Research and Development Law, 5744-1984, or the R&D Law, as well asResearch Law), and related regulations.

14

When a company develops know-how, technology or products using grants provided by the Innovation Authority, the terms of these grants and the Innovation Law restrict the transfer of such know-how, and the transfer of manufacturing or manufacturing rights of such products, technologies or know-how outside of Israel. Even after the repayment of such grants in full, we will remain subject to the restrictions set forth under the Innovation Law, including:

·Transfer of know-how outside of Israel. Any transfer of the know-how that was developed with the funding of the Innovation Authority, outside of Israel, requires prior approval of the Innovation Authority, and the payment of a redemption fee.

·Local manufacturing obligation. The terms of the grants under the Innovation Law require that the manufacturing of products resulting from Innovation Authority-funded programs be carried out in Israel, unless a prior written approval of the Innovation Authority is obtained (except for a transfer of up to 10% of the production rights, for which a notification to the Innovation Authority is sufficient).

·Certain reporting obligations. We, as any recipient of a grant or a benefit under the Innovation Law, are required to file reports on the progress of activities for which the grant was provided as well as on our revenues from know-how and products funded by the Innovation Authority. In addition, we are required to notify the Innovation Authority of certain events detailed in the Innovation Law.

Therefore, if aspects of our technologies are deemed to have been developed with OCS funding, the discretionary approval of an OCS committee would be required for any transfer to third parties outside of Israel of know-how or manufacturing or manufacturing rights related to those aspects of such technologies. We may not receive those approvals. Furthermore, the OCS may impose certain conditions on any arrangement under which it permits us to transfer technology or development out of Israel.

The transfer of OCS-supported technology or know-how outside of Israel requires pre-approval bymay involve the OCS which may at its sole discretion grant such approval and impose certain conditions, including requirement of payment of a transfer fee (referred to insignificant amounts, depending upon the law as the “Base Amount”) calculated according to the formula provided in the R&D Law which takes into account the consideration for such know-how paid to us in the transaction in which the technology is transferred. In addition, any decreasevalue of the percentagetransferred technology or know-how, the amount of manufacturing performed in Israel, as originally declared inOCS support, the application to the OCS, requires us to notify, or to obtain the approvaltime of completion of the OCSOCS-supported research project and may result in increased royalty payments to the OCS as well as increase total amount to be paid to the OCS. These restrictions may impair our ability to enter into agreements for those products or technologies without the approval of the OCS. We cannot be certain that any approval of the OCS will be obtained on terms that are acceptable to us, or at all.other factors. Furthermore, in the event that we undertake a transaction involving the transfer to a non-Israeli entity of technology developed with OCS funding pursuant to a merger or similar transaction, the consideration available to our shareholders in a transaction involving the transfer outside of Israel of technology or know-how developed with OCS funding (such as a merger or similar transaction) may be reduced by theany amounts that we are required to pay to the OCS. Any approval, if given,

We received grants from the OCS prior to an extensive amendment to the Research Law that came into effect as of January 1, 2016, or the Amendment, which may also affect the terms of existing grants. The Amendment provides for an interim transition period (which has not yet expired), after which time our grants will generally be subject to additional financial obligations. Failureterms of the Amendment. Under the Research Law, as amended by the Amendment, the Authority is provided with a power to comply withmodify the requirements underterms of existing grants. Such changes, if introduced by the R&D LawAuthority in the future, may subject us to mandatory repayment of grants received by us (together with interest and penalties), as well as expose us to criminal proceedings.impact the terms governing our grants.

We are not subject to the supervision of the Central Bank of Curaçao and Sint Maarten, so our shareholders are not protected by any regulatory inspections in Curacao.Curaçao.

 

We are not an entity subject to any regulatory supervision in Curaçao by the Central Bank of Curaçao and Sint Maarten. As a result, shareholders are not protected by any regulatory supervision or inspections by any regulatory agency in Curaçao, and we are not required to observe any restrictions in respect of its conduct, save asexcept to the extent disclosed in this prospectus supplementour annual report or our Amended Articles of Association.Articles.

 

We have been granted an exemption under the Foreign Exchange Regulations Curaçao and Sint Maarten enacted by the Central Bank of Curaçao and Sint Maarten (referred to as the FX Regulations). As a result of this exemption, we are exempted from certain conditions, regulations and provisions stemming from the FX Regulations relating to, among other things, capital transactions with non-residents of Curaçao (including dividend payments) and license fees on payments to non-residents of Curaçao. The exemption has been granted subject to our compliance with certain conditions, and the Central Bank of Curaçao and Sint Maarten can revoke the exemption should we no longer comply with one or more of those conditions. Those conditions include that none of our activities may take place in Curaçao or Sint Maarten, that we may not offer goods and services to residents of Curaçao or Sint Maarten, that we may not participate in Curaçao and Sint Maarten resident companies and that we may not extend loans to residents of Curaçao or Sint Maarten. Furthermore, residents of Curaçao or Sint Maarten may not be holders of our Common Shares.

15

The rights of shareholders under CuracaoCuraçao law differ from those under U.S. law, and you may have fewer protections as a shareholder.

Our corporate affairs are governed by our Amended Articles, of Association, the Civil Code of Curaçao and the civil law of Curaçao. The rights of shareholders to take legal action against our directors, actions by minority shareholders and the fiduciary responsibilities of our directors under Curaçao law are to a large extent governed by the Civil Code of Curaçao, the civil law of Curaçao and applicable case law. The rights of shareholders and the fiduciary responsibilities of our directors under Curaçao law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the U.S. In particular, Curaçao has a less developed body of securities laws as compared to the U.S., and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. In addition, Curaçao law does not make a distinctiongenerally distinguish between public and private companies, and some of the protections and safeguards (such as statutory pre-emption rights, saveexcept to the extent that they are expressly provided for in the Amended Articles of Association)Articles) that investors may expect to find in relation to a public company are not provided for under Curaçao law. As a result of all of the above, holders of our common sharesCommon Shares may have more difficulty in protecting their interests in the face of actions taken by our management, directors or major shareholders than they would as shareholders of a U.S. company.

 

Shareholders in CuracaoCuraçao companies may not be able to initiate shareholder derivative actions, thereby depriving a shareholder of the ability to protect its interests.

 

While caseDerivative actions are not permitted in Curaçao. Under Curaçao law, does exist in The Kingdom of The Netherlands for derivative actionsonly the Company may bring a civil action against a person who is liable to be brought in certain circumstances, shareholdersa Curaçao public limited liability company. Shareholders in Curaçao companies may not have standing to initiate a shareholder derivative action in a federal court of the U.S. The circumstances in which any such action may be brought, and the procedures and defenses that may be available in respect to any such action, may result in the rights of shareholders of a Curaçao company being more limited than those of shareholders of a company organized in the U.S. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The Curaçao courts are also unlikely to: (i) recognize or enforce against us judgments of courts in the U.S. based on certain civil liability provisions of U.S. securities law; or (ii) to impose liabilities against us, in original actions brought in Curaçao, based on certain civil liability provisions of U.S. securities laws that are penal in nature. There is no statutory recognition in Curaçao of judgments obtained in the U.S., although the courts of Curaçao will in certain circumstances recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits.

The laws of CuracaoCuraçao provide little protection for minority shareholders, so minority shareholders will have little or no recourse if the shareholders are dissatisfied with the conduct of our affairs.

 

Under the laws of Curaçao, there is little statutory protection offor minority shareholders other than the provisions of the Civil Code dealing withof Curaçao, which provides for shareholder remedies. Minority shareholders of a Curaçao company may commence legal proceedings against the company in which they hold shares on the following grounds:

 

tort (onrechtmatige daad). A- a tortious act may arise if a company makes certain promises to the shareholders, the shareholders could expect a certain attitude from the company according to rules of “reasonableness and fairness”fairness,” and the company does not comply therewith;
breach of contract- assuming there is any specific contract between the minority shareholders and the company; and
nullification of resolutions- if a resolution is approved in violation of the provisions of Curacao law or the articles of association as to how the decision needs to be taken, or in violation of rules, or in case a resolution to amend the articles adversely affects the legal position of a person involved in the company (such as a minority shareholder), provided such person has a serious interest, the resolution can be nullified.

16

Under Curaçao law, shareholders who satisfy certain threshold requirements can initiate inquiry proceedings with the joint Court of Justice of Aruba, Curaçao, Sint Maarten, Bonaire, Sint Eustatius and Saba. Such inquiry proceedings can relate to the policy of the company and its business as well as to the (deficient) functioning of the company as such. The Court of Justice will only order an inquiry if it finds that well-founded reasons exist to doubt the soundness of the policies of the company or the conduct of its business. This is not restricted to the policies of the governing bodies of the company (for example, the board) but can also pertain to acts or omissions of the general meeting of shareholders. During the proceedings, the Court of Justice may impose immediate provisional measures, such as a temporary amendment to the articles of association of the company; or

breach of contract assuming there is any specific contract between the minority shareholderscompany and the company.
appointment of interim board members.

 

In addition to the above, there are alternative claims under Curaçao law available for minority shareholders who seek relief for alleged wrongful acts by a company, its directors or the majority shareholders, such as contesting the corporate resolutions of a company and requesting the majority shareholders to purchase the stake of the minority shareholders (uitkoopuittreding). However, these alternative possibilities are very cumbersome and time-consuming.time-consuming and may not be instituted in respect of shares which are traded at a stock exchange.

 

Curacao law makes it more difficult for us to enter into a change of control transaction in which we are acquired and you are paid a premium on the shares that you hold in our company.

Our status as a Curacao company makes it more challenging (compared to Israel and various US states) to consummate a change of control transaction in which our company is acquired and our shareholders benefit economically via the payment of a premium on their shares relative to the then-current market price. Under Curacao law, there is no legal basis for a reverse triangular merger, a commonly-utilized transaction structure for the acquisition of publicly traded companies such as ours, in which shareholders receive cash. Curacao law allows for the acquisition of a publicly traded company such as ours for cash through a tender offer, provided that the offeror acquires at least 95% of the company's issued and outstanding share capital (which 95% threshold may be reduced under certain circumstances to 90% or 80% in case of a pre-wired asset sale), following which the offeror can purchase the remaining shares subject to court approval and possibly the exercise of certain dissenters' rights. Since Curacao law does not permit a cash merger and due to the challenges in obtaining such level of acceptance of the tender offer, a potential buyer might need to use different structures to acquire our company, e.g. migrating the company to another jurisdiction that allows for a cash merger as a means to acquire publicly traded companies; however, such process may be very time-consuming and could therefore prevent such a transaction from occurring. An additional option under Curacao law is a sale of assets, which is likely to be generally less efficient to our shareholders from a tax perspective.  Each of the foregoing limitations or disadvantages of effecting an acquisition of our company or its assets in which shareholders realize a premium could furthermore adversely impact the market price of our shares in an ongoing manner.   

ITEMItem 4.INFORMATION ON THE COMPANYInformation on the Company

 

A.History and Development of the Company.

 

Corporate Details

 

Our legal and commercial name is Sapiens International Corporation N.V., and we were incorporated and registered in Curaçao on April 6, 1990. We are a public limited liability company and operate under the provisions of the Curaçao Commercial Code. In addition, we are registered as an Israeli company for tax purposes only. Our registered officeprincipal place of business is located at Landhuis Joonchi, Kaya Richard J. Beaujon z/n, Curaçao,Azrieli Center, 26 Harokmim Street, Holon, 5885800, Israel, and our telephone number in Curaçaothere is + 5999-736-6277. United International Trust N.V.+972-3-790-2000. Sapiens Americas Corporation is the Company’sour agent in Curaçao and serves as a member of our Board of Directors.the United States. Our World Wide Web address is www.sapiens.com. The information contained on the web site is not a part of this annual report. Except as described immediately below,elsewhere in this annual report, we have not had any important events in the development of our business since January 1, 2013.

Underwritten Follow-On Offering2016.

 

17

On November 19, 2013, we consummated an underwritten follow-on public offering of 5,650,000 of our Common Shares, plus an additional 847,400 Common Shares to cover over-allotments, pursuant to an underwriting agreement with Barclays Capital Inc., as representative of certain underwriters. The shares (including the over-allotment shares) were sold at a price to the public of $6.25 per share, from which we realized net proceeds of approximately $37.8 million. The shares sold in the offering were listed for trading on the NASDAQ Capital Market and the TASE.

Capital Expenditures and Divestitures since January 1, 20112014

 

On August 21, 2011,In the third quarter of 2014, we acquired FIS Software Ltd. (“FIS”)Knowledge Partners International LLC, or KPI, and the assets of The Decision Model, or TDM, for total consideration of $49.7 million, which was comprised of $6.75$2.1 million in cash 10,016,875and 57,000 ordinary shares of Sapiens Decision, our Common Sharessubsidiary which holds all of the interests in KPI (representing 3% of Sapiens Decision’s issued and warrantsoutstanding ordinary shares immediately prior to purchase 1,000,000 of our Common Shares.closing). In addition, on Augustone of the shareholders of KPI received 88,500 restricted shares of Sapiens Decision (of which 29,500 vested during each of the years ended December 31, 2011 we acquired IDIT I.D.I. Technologies Ltd. (“IDIT”)2015 and 2016) plus $450,000 in cash, subject to certain performance criteria. The agreements for total consideration of $31.4 million, which was comprised of 7,483,125 of our Common Shares. The aggregatethe foregoing acquisitions included, among other things, certain put and call options relating to the Sapiens Decision shares issued upon completionconsummation of the foregoing transactions constituted, immediatelytransaction and certain other benefits payable upon such completion, 44.2%the occurrence of certain conditions. For further information, please see Note 1(d) to our issuedconsolidated financial statements included in Item 18 of this annual report.

In the second quarter of 2015, we acquired IBEXI Solutions Private Limited, or IBEXI, an India-based provider of insurance solutions and outstanding share capital. Options toservices, which services 18 insurers in both the P&C and L&P markets throughout Southeast Asia. The total purchase shares of FIS and IDIT were replacedprice in this acquisition was approximately $4.8 million, which we paid in cash at the closing, with optionsand which is subject to purchase an aggregateadjustment based on certain future criteria. For further information, please see Note 1(b) to our consolidated financial statements included in Item 18 of 1,938,844this annual report.

In the third quarter of 2015, we acquired Insseco, a Poland-based software and services provider for the insurance market, from Asseco Poland S.A., or Asseco, the indirect controlling shareholder of our Common Shares.company, which helped us to establish a strong presence in the Polish insurance market. We paid approximately $9.1 million in cash for Insseco, subject to upwards adjustment based on its achieving future revenue goals. For further information, please see Note 1(b) to our consolidated financial statements included in Item 18 of this annual report.

In the third quarter of 2016, we acquiredMaximum Processing Inc., or MaxPro,a privately-held company headquartered in Bradenton, Florida, with offices in Garner, North Carolina. MaxPro is the provider of the Stingray System, a P&C insurance administration suite targeted towards the tier 4-5 U.S. market, as well as managing general agents, or MGAs, third-party administrators, or TPAs, and insurance brokers. We paid $4.3 million in cash for this acquisition (including $1.5 million that we placed in escrow at the closing). The seller also has the right to receive performance based payments of up to $2.6 million relating to achievements of revenue and profitability goals over three years (2016, 2017, 2018), which are also subject to continued employment. For further information, please see Note 1(b) to our consolidated financial statements included in Item 18 of this annual report.

In the third quarter of 2016, we acquired4Sight Business Intelligence Inc., or 4Sight, a provider of business intelligence reports that is based in Austin, Texas. 4Sight offers insurance-specific business intelligence, or BI, solutions, including 4SightBI, a P&C-specific, off-the-shelf business intelligence (BI) product. We paid $330,000 in cash for this acquisition. In addition, the seller of 4Sight may receive additional performance-based payments of up to $2.6 million relating to achievements of revenue and profitability goals over three years (2016, 2017, 2018), which are also subject to continued employment. For further information, please see Note 1(b) to our consolidated financial statements included in Item 18 of this annual report.

In the first quarter of 2017, we acquired StoneRiver, a Denver, Colorado-based provider of a wide range of technology solutions and services to insurance carriers, agents, and broker-dealers, whose product groups encompass front-office, policy, claim, rating, underwriting, billing, and reinsurance solutions for all major business lines. The acquisition will enable us to expand the range of solutions and services that we offer in North America. We paid approximately $100 million in cash, subject to certain adjustments based on working capital, transaction expenses, unpaid debt and certain litigation matters. For further information, please see Note 17(a) to our consolidated financial statements included in Item 18 of this annual report.

 

Our principal capital expenditures during the last three years related mainly to the purchase of computer equipment and software for use by our subsidiaries. TheseOur capital expenditures totaled approximately $0.5$1.5 million in 2011, $1.32014, $2.8 million in 20122015 and $4.1$4.7 million in 2013 (including lease improvements.2016.

18

 

B.Business Overview.

We are a leading global provider of software solutions for the insurance industry, with an emerging focus ona growing presence in the broader financial services sector.We offer coresector. Our extensive expertise in the insurance industry is reflected in our innovative software suites, solutions and services for Propertyproviders of property & Casualty/General Insurancecasualty/general insurance (P&C), and Life, Annuities, & Pensionslife, annuities and pension (L&P) providers, allowing theminsurance. Our offerings enable our customers to effectively manage their core business functions, including policy administration, claims management and billing functions. billing.

We also providesupply core record-keeping software solutions for Retirement Servicesretirement services and a complete offering for reinsurance providers. In addition,Additionally, we offer a variety of other technology-based solutionsdecision management platform that enable organizationsenables our customers to quickly deploy business logic and comply with policies and regulations across their organizations. organizations and our digital suite facilitates an end-to-end, holistic and seamless digital experience for agents, customers and assorted insurance personnel.

Our solutions, enablewhich possess modern, modular architecture and are digital-ready, empower customers to respond to evolving market needs and regulatory changes, while improving the efficiency of their core operations, thereby increasingoperations. These enhancements increase revenues and reducingreduce costs.

Our offering is comprised primarily of:

 

Software Solutions

Our software solutions portfolio is comprised of:

·Software solutions for the Insurance industry with emerging focus on the broader financial services sector, and

·Global Services including project delivery and implementation of our solutions.

Software solutions

·Sapiens L&P for Life, Pension, Annuity Pension and Retirement Solutions– comprehensive software solutions for the management of a diversified rangesrange of products for Life, Annuity, Saving, Pensionslife, pension, annuity and Retirement. Portfolioretirement. Our portfolio includes Sapiens ALIS, TOPAZ,Sapiens INSIGHT, Sapiens Retirement and Sapiens Closed Books.

·Sapiens P&C for Property and Casualty/General Insurance -Solutions – a comprehensive software suite of solutions supporting a broad range of business lines, including personal, lines, commercial lines and specialty lines, as well as a solution for the management of reinsurance contracts. PortfolioOur portfolio includes Sapiens IDIT and Sapiens Reinsurance.

·Sapiens DECISION – a disruptive technology that allows large organizations to centrally manage the business logic, for better governance, control and reusability of the logic.
·TechnologySapiens DECISION – an enterprise-scale platform that enables institutions to centrally author, store and manage all organizational business logic. Organizations of all types – including banks, mortgage institutions and insurers – use it to track, verify and ensure that every decision is based on the most up-to-date rules and policies. 
·Sapiens Digital Suite–a digital transformation solution comprised of five integral offerings: advanced analytics, a portal for consumers and agents, personalized video capabilities, a customer engagement platform and cloud offerings and services. Together they offer an end-to-end, holistic and seamless digital experience for agents, customers and assorted insurance personnel.
·Technology-Based Solutions - In addition, we offer tailored made– tailor-made solutions (unrelated to the insurance or financial services)services market) based on our eMerge platform.platform, which provides end-to-end, modular business solutions, ensuring rapid time to market.

 

Services

Our services modernize and automate processes for insurance providers and financial institutions around the globe, helping to create greater organizational efficiencies, reduce costs and provide a better end user experience.

Our services include:

·Project delivery and implementation services, backed by our methodologies and best practices, for our Software Solutions portfolio.

·We offerBusiness and technical consulting related to our customers support and maintenance for the software. Our maintenance plan covers bug fixes and new releases.products
·Project and program management
·Training
·User acceptance testing
·Migration
·Maintenance
·Ongoing support
·Hosting and managed services
·Product upgrades
·Business transformation services

19

Built on a solid foundation of insurance domain expertise, proven technology and a history of successful deployments, our organization assists clients in identifying and eliminating IT barriers to achieve business objectives.

 

For more information about our software solutions and services, please see “Sapiens’ Software SolutionsSolutions” and Services please read“Sapiens’ Global Services” below in this Item 4B.section.

 

Our Marketplace and its Needs

 

Our Target Markets

 

We operate in a large market undergoing significant transformation. According to a research report published by Celent, a research and consulting firm (IT Spending in Insurance, — Aa Global Perspective, March 2013)2016, by Jamie Macregor, Juan Mazzini, Karen Monks and KyongSun Kong, published on April 27, 2016), global IT spending by insurance companies is expected to grow from $140.2$184.9 billion in 20132016 to $154.5$195.5 billion in 2015.2017 and $208 billion in 2018. In particular, such IT spending on external software and IT services, willwhich was expected to total approximately $57.0$81 billion in 2013, and2016, is expected to increase to $63.7$87 billion by 2015, representing2017, reflecting a 6% compound annual7.3% growth rate from 2013 to 2015. Of these amounts, werate.

We believe that our current total addressable market for core insurance software solutions is approximately $25.0$30 billion, and that it willwhich we expect to grow as a result of theinsurance carriers’ and financial institutions’ need for insurance carriers and other financial institutions to spend on modern software solutions from external providers to rectifyaddress the operational challenges presented by the inefficiency of their legacy policy administrationcore systems. SuchLegacy systems includepossess technical and functional limitations that have an adverseadversely impact on thecarriers’ ability of carriers to swiftly launch new, innovative products in line withthat satisfy their customers’ changing needs and preferences. These legacy systems also slowBy slowing down carriers’ business and geographic expansion, and lead tolegacy systems create operational inefficiencies whichthat are translated into increased business risk and financial costs. Furthermore, our

Our customers are operating in a dynamic and changing regulatory environment. Often thesetheir legacy systems simply do not support new regulatory requirements and put carriers at risk of non compliance.non-compliance. We believe these challenges will cause an acceleratingaccelerate the shift from spending on legacy systems to new vendor software solutions, and athe shift from reliance on in-house development to external vendors such as ourselves.vendors.

 

There is also a strong trend of shifting attention to the end-customer experience and activities, with a focus on digital operations. Many insurers are currently unable to provide the type of quality digital experience that their customers are already enjoying across most other verticals and customer satisfaction is only one of the many recognized benefits of going digital. This can only be supported via increased usage of data for decision-making, risk analysis, customer evaluation and rating, which requires a streamlined data flow and easy access to information from multiple sources.

The Life, Insurance, Annuities, Savings, PensionsPension, Annuity and Retirement (“L&P”) MarketMarkets

 

L&PLife, pension, annuity and retirement providers offer their customers a wide range of products for long-term savings, protection, pension and insurance toinsurance. They assist policyholders inwith financial planning through life insurance, retirement, pensionspension, medical and investment products. L&PTheir products can be classified ininto several areas, primarily Investmentinvestment and Savingssavings, risk and protection, pension and health-related products. These products Risk and Protection products, and Pension products – and can exist both as individual-targeted productsbe targeted to individuals, as well as group-relatedgroup- and employer-related products. Some L&P providers as well as otherinsurance and financial services providers also offer retirement services products, particularly management of, and recordkeeping for, defined contribution retirement plans.

Retirement services offer Employer- related Defined Contributionemployer-related, defined contribution plans whichthat are the primary and fastest-growing retirement savings vehicles in the U.S., holdingincluding nearly one-third of overall retirement assets. Financial Servicesservices companies such as including insurance companies, Mutual Funds, Banksmutual funds, banks and TPAs,third-party administrators (TPAs) provide recordkeeping services for employer-related plans. Many recordkeepingRecordkeeping service providers commonly use legacy or in-house software solutions to manage their books.

 

20

The Property & Casualty/General Insurance (“P&C”) Market

 

P&CProperty and casualty insurance (also– also known as non-life insurance, or General Insurance / “GI”)general insurance (GI) – protects policyholders against a range of losses on items of value. P&C insurance includes the Personalpersonal segment (insurance, which is insurance coverage for individuals, includingwith products such as motor, home, personal property and travel)travel; thecommercial segment, the Commercial segment (coveringcovering aspects of commercial activity, such as commercial property, car fleet,fleets and professional liability)liability; andspecialty lines, and Specialty Lines (coveringcovering unique domains, such as marine, art and credit insurance).insurance.

 

Reinsurance is insurance that is purchased by an insurance company (“ceded reinsurance”) from another insurance company (“assumed reinsurance”) as a means of risk management. The reinsurer and the insurer enter into a reinsurance agreement (referred to as “contract” or “treaty”), which details the conditions upon which the reinsurer would pay the insurer'sinsurer’s losses. The reinsurer is paid a reinsurance premium by the insurer and the insurer issues insurance policies to its own policyholders. The insurer must maintain an accurate system of recordrecords to track hisits reinsurance contracts and treaties, to avoid claims leakage.

 

The Financial Services Market for Decision Management

 

LargeIncreasing competition, regulatory burden, customer experience expectations, the proliferation of digital and product innovation requirements are necessitating a shift in thinking and approach across the financial organizations –retail banking, investment banking, mortgage bankingservices market. By replacing conventional policy and others –process management with the growing discipline known as “decision management,” financial institutions are bridging the gap between business and IT by enabling business users to rapidly frame requirements in formal business models that can be easily understood by all heavily rely on huge amounts of data. This data is used for their ongoing operations, and serves the decision management process.stakeholders.

 

The decision management processprocesses in financial services has an impact onaffects overall corporate performance, vis-à-visincluding its impact on customers competitors and in response to regulatory requirements.competitors. Decision management systems are a key performance component of every financial services organization, as they help the organization define, avoid and hedge and financial risk.

 

Increasing competition, regulatory burden and product innovation requirements are necessitating a shift in thinking and approach across the financial services market.  Sapiens DECISION remains focused on expandingNeeds of our market presence in the mortgage, retail and investment banking sectors, where the scale and complexity of operations requires enterprise-grade technology that can easily be adapted as polices and business strategies rapidly evolve. 

In a recent Gartner report (“Find the Best Approach to Decision Management”, Published: 26 February 2014 by analyst(s): W. Roy Schulte, Teresa Jones, Lisa Kart), Gartner has identified that Business Decision Management solutions are the next revolution in complex organization management, and are required to align the Business Rules Management (BRM) systems and Business Process Management (BPM) systems. Where business logic is complex, regulated and re-used, it must be managed in a central repository and treated as an asset.Target Markets

 

This market is now gaining traction. Gartner analysts state that “Decision management improves the intelligence of business operations by enabling fast, consistent and precise fact-based decisions. The vast increase in the amount of available data, and the decreasing cost of computers, memory, mobile devices, sensors and communication networks, have given enterprises the opportunity to greatly improve their operational effectiveness and efficiency.”

Our Target Markets Needs

Large financial organizations need tomust constantly invest in their IT systems in order to respond to several key market drivers, including:drivers.

They require the ability to:

 

-·Improve end-customer experience throughSatisfy today’s sophisticated, tech-savvy and demanding customers – who expect the type of instant, personalized service they enjoy via Facebook or Amazon – via digitalization and innovative initiatives - The customers of the financial organizations expect better experience as they become more sophisticated, technology-savvy, and mobileinitiatives.

-·Provide innovative business models, based on technology capabilities and digital operation (such as a portal, a web-based acquisition process, advanced analytics, customer engagement platforms and the usage of data sources such as wearables, the Internet of Things (IoT) and robo-advice.
·Respond to heavy regulations - –complex and evolving regulatory standards, such as Solvency II, Dodd-Frank Basel, and MISMOlegislation, DGPR, etc.

-·Support internal customers’ growth & operations - Reduceand operations. This includes reducing the time to market of new products, expandexpanding into new geographies, reduce costreducing costs and improve operationsstreamlining operations.

 

Specific Needs of the Insurance &and Retirement Services Market Specific NeedsMarkets

The insurance market is a large, complex and highly regulated environment. Insurance carriers operate in a highly competitivesuper-competitive and quickly evolving market, and thewhich necessitates differentiating their value proposition of the carrier must be better identified. In addition, thepropositions. Additionally, carriers operate under a rigid regulatory regime and are required to comply with market regulations.that demands fast compliance.

In order to

To efficiently manage their operations, insurance carriers require IT platforms that enable rapid introduction of changes via configurable, user-driven activities, integrateintegration with other internal and external systems, control and audit theauditing of internal employeesemployees’ work, support multi-channelfor omni-channel distribution and provide clear visibility ofinto the carrier’s business operations.operations, through streamlining and intelligent usage of data.

 

21

We believe that many insurance

Insurance carriers are experiencing substantial operational challenges due to the inefficiency of their legacy policy administration systems. Suchsystems and their lack of digitalization. These legacy systems, which include both technical and functional limitations, have acuteacutely impact on thecarriers’ ability of the carriers to face thecope with growing challenges, ofsuch as the rapidly-changing insurance marketplace aroundneed for innovation, the shift of power to the consumer, and the dynamic and constantly changing regulatory environment.

 

We believe that the following are key factors thatconsiderations for insurance carriers take into consideration when considering an upgrade ofthey think about upgrading their legacy systems:

·            Dynamic business environment with constantly changing regulationsMany insurance carriers still use outdated legacy systems that are costly and time-consuming to modify or upgrade. This has prevented insurance carriers from innovating and growing. Carriers who use legacy systems may find that it is difficult for them to modify existing products, introduce new products and reach untapped market segments. Varied and frequently changing global regulatory requirements require specialized data and business rules, which makes change implementation particularly challenging.

·            Change in end-consumers’ behavior and the shift of power to consumers Insurance carriers must adapt rapidly to the shifting needs and behaviors of consumers, including the types and terms of insurance products offered, and how consumers access information. Insurance carriers require systems with new technologies are:integration capability and support for multi-channel distribution, so they can reach their clients’ customers and partners using multiple methods, including social media, across devices.

-Dynamic business environment with ever-changing regulation- In today’s dynamic and highly competitive environment, insurance carriers are constantly seeking new competitive advantages and differentiators. Accordingly, there is a clear need for a flexible core system that supports rapid implementation of changes. Many insurance carriers still use outdated legacy systems that are costly and time-consuming to modify or upgrade. This has prevented insurance carriers from innovating and growing, including by modifying current products, introducing new products and reaching new market segments. Varied and frequently changing regulatory requirements throughout the world require specialized data and business rules, which makes implementation of changes particularly challenging.

-Change in end-consumers’ behavior and shift of power to consumers - Insurance carriers must adapt rapidly to the shifting needs and behaviors of consumers, including the types and terms of insurance products offered and how consumers can access information to compare insurance products. Consequently, insurance carriers require systems with integration capability and support of multi-channel distribution to allow them to reach their consumers customers and partners in a variety of means.

-A need to improve operational efficiency and reduce Total Cost of Ownership (TCO) - We believe that a majority of insurance carriers are still using inefficient and outdated processes which lack automation of operation, workflow and efficient process management. These processes tend to be inefficient and have high error rates. Additionally, the ongoing maintenance of these legacy systems is expensive and technically difficult. A specialized IT staff with the requisite skills and experience needed to maintain these systems is difficult to find or replace. Insurers seek systems that are modern, automated, efficient and easy to maintain and which can enable a decrease of costs in the long run.

-Increasing global and multi-national operation – more and more insurers are accelerating their growth initiatives through global acquisitions. These insurers in turn are seeking sole providers who can deliver solutions that can be used across markets, combining the support of local regulatory requirements and specific customer needs while driving a generic corporate business approach and strategy across the globe, reducing costs and overhead.

 

·            A need to improve operational efficiency and reduce total cost of ownershipWe believe that a majority of insurance carriers are still using inefficient and outdated processes that do not automate operations and workflows, and thus don’t offer efficient process management. Many of these processes may have high error rates. Additionally, the ongoing maintenance of legacy systems is expensive and technically difficult. A specialized IT staff with the requisite skills and experience needed to maintain these systems is difficult to find or replace. Insurers seek systems that are modern, digital, automated, efficient and easy to maintain, and can lower costs over the long term.

·            Increasing global and multi-national operation – A rising number of insurers are accelerating their growth initiatives through global acquisitions. These insurers seek sole providers who can deliver solutions that will be used across markets, combining the support of local regulatory requirements and specific customer needs, while driving a generic corporate business approach and strategy across the globe, reducing costs and overhead.

·            Going digital Digitalization holds significant potential for financial services institutions and insurers, but only if they manage to efficiently digitalize their operations, support multi-channel distribution and ensure that agents and customers are able to access real-time, accurate data at any time and from anywhere – including tablets and other mobile devices.

Business Decision Management Market Needs

Many large organizations, particularly in the financial services market, must adhere to growing regulation, andcomply with complex regulations. They operate in a highly competitive marketmarkets that requiresrequire quick responses. Business logic drives most of the financial services transactions and is the very backbone of an organization'sorganization’s policies and strategies, and its ability to successfully operate in this market.operate.

 

To support that, theoperate efficiently, business owners must assume ownership onof the business logic be ableand possess the ability to define and modify it,it; standardize it; and makereuse it consistent and reusable across the organization. Today, the business logic is defined by the business owners and compliance officers, but the IT departments aretranslate the ones to translate those requirements into code. This process raises several key challenges: the result does not always accurately reflect the business requirements; the new requirements might conflict with, or override, previous requirements; and the wholeentire process is not fully audited. These gaps often create an inefficient and risk-exposed organization.

 

23
22 

 

Sapiens’ Software Solutions

Overview

 

We are a leading global provider of software solutions for the insurance industry with an emerging focus ona growing presence in the broader financial services sector, with the abilitysector. By enabling our customers to digitize and be more agile in the face of new and changing business environments, we help them take advantage of powerful current trends – such as the Internet of Things, social media, ride sharing, customer engagement, robo-advice, etc. – while simultaneously reducing IT costs.

 

We offer our insurance customers a range of packagepackaged software solutions that are:

-·Comprehensive and function-rich, supporting generic insurance standards, regulationregulations and processes by providing field provenfield-proven functionality and best practices.

-·Customizable,to easily match our customers’ specific business requirements and expandable/requirements. Our flexible architecture allowingand configurable structure allows quick functionality augmentation that permits use of our platform to be used across different markets, unique business requirements and regulatory regimes, usingutilizing our knowledge ofand extensive insurance best practices.

-·Based on model-drivenService-oriented architecture (SOA) based,(incorporating “Service Oriented Architecture - SOA”) and engineered to provide easy integration to any external application under any technology, allowing streamlined secure processing, whileconnectivity to all satellite applications and enhancing the digital experience and omni-channel distribution (while maintaining total platform independence and system reliability.reliability).

-·Digital, revealing their history and anticipating their future needs, while facilitating easy communication across preferred interaction channels and devices.
·Component-based and scalable,allowing our customers to deploy the solutions in a phased and modular approach, reducing risk and destructionharm to the business, while supporting the growth plans and cost efficiency of the organization.

 

Our packagepackaged software solutions enable, for our customers:

enable:

-·Rapid deployment of new insurance products, by providingvia configurable software, and offering the opportunity to achievewhich creates a competitive advantage in all of the P&C and L&Pinsurance markets by arriving to the market early with new products.we serve.

-·Improvement of operational efficiency and reduction of risk, by providing full automation of insurance process automation, with configurable workflow,workflows, audit and control, streamlined insurance practices and easysimple integration and maintenance.

-·Reduction of overhead for ITmaintenance through easy-to-integrate solutions with flexible and modern architecture, resulting in lower costs for ongoing maintenance, modifications, additions and integration.
·Enhanced omni-channel distribution and focus on the customers,throughevent-driven architecture, a proactive client management approach, rapid access to all levels of data and a holistic view of clients and distributors.
·Various deployment models, from an on-premise deployment approach, to cloud and hosted solutions.
·Support of digitalization, whichholds massive potential for insurers and financial services institutions, if they manage to efficiently digitalize their operations, support omni-channel distribution and ensure that agents and customers are able to access real-time, accurate data at any time and from anywhere – including tablets and mobile devices.

Sapiens Life, Pension & Annuity Solutions

 

Sapiens L&P (ALIS)ALIS for Life, Pension and Annuities

 

Sapiens L&P (ALIS)ALIS is a comprehensive L&P software solution for individual and group insurance products. Sapiens L&PIt provides comprehensive support for the complete policy lifecycle of all life insurance products from quotation and illustrations, throughillustrations; to underwriting, billing and servicing, and up to theservicing; through claims management and exit processing.

 

Sapiens L&PALIS supports a wide range of insurance product lines across multiple territories, including:

·Individual and Group Life, Investment & Savingsgroup life, investment and savings
·Individual and Group Protectiongroup protection, and Risk Productsrisk products
·Individual and Group Pension
·Group Life and Protection Productsgroup pension
·Annuity Productsproducts
·Hybrid Productsproducts

 

23

Sapiens L&PALIS is a modular system and itsthat includes all the functional components include all the components necessary for L&P insurers to manage their business. Sapiens L&P allows insuranceInsurance carriers tocan manage their entire core business on a single platform and to integrate Sapiens L&PALIS with other systems for the completion of a specific activity or domain.

 

Sapiens L&PALIS integrates all of the following functions into one solution:

·QuotationSales, quotation and Illustrationillustration
·New Businessbusiness
·Underwriting
·Policy Servicingservicing
·Billing, , Collectioncollection and Payments Managementpayment management
·Claims Processingprocessing
·Agency and Commission
·Document Managementcommission
·CRM and Customer Managementcustomer management
·Workflow and diary
·Compliance and Calculationcalculation engine
·Insurance product manufacturing

 

On top of the functional modules, Sapiens ALIS provides a set of digital capabilities to its customers, including an advanced analytics solution, a consumer and agent portal, personalized video capabilities and a customer engagement platform These capabilities increase customer touch-points and generate actionable insights. Sapiens has partnered with Microsoft Azure to offer its Sapiens ALIS policy administration system and accompanying services over private and public clouds. 

Sapiens L&P (Retirement Services)Retirement Services

 

Leveraging assets we have built from our Sapiens L&P (ALIS),ALIS offering, we have developed Sapiens Recordkeeping for Retirement, Services: a modern, end-to-end, packaged software solution that manages record-keeping for record-keeping management for Defined Contribution Recordkeepingdefined-contribution recordkeeping providers.

 

Sapiens Recordkeeping solution offersRetirement Services Platform is a completenext-generation, defined contribution platform that enables recordkeepers to secure and retain profitable plans by offering the efficiency, flexibility and end-to-end support of the recordkeeping functionality, based on a modular deployment structure, allowing flexibility on using specific modules, which seamlessly integrates with our customers’ preferred systems/modules.governance required for success in today’s market. Designed by leading industry experts, Sapiens Recordkeeping for Retirement Services supports the fulla wide range of Defined Contribution retirement products, including, but not limitedplan types – 401(k), 403(b) and 457 – from micro to 401(k), ESOP and Profit Sharing,mega plans, and the associated plan variations, including ERISA, Non-ERISA, Safe Harbor, Taft Hartley and others.

Sapiens L&P (Closed Books)Closed Books

Sapiens Closed Books is a solution for life and pension insurance companies that enables them to efficiently and more effectively administer policies and claims relating to their legacy portfolio and closed books of business where products(products that are no longer open to new business.business, but must still be administered).

 

An industry leading and proven system, Sapiens Closed Books was designed to deliver solutions to legacy portfolio challenges, while significantly cutting the costs that are commonly associated with legacy platforms. Sapiens Closed Books provides a full, end-to-end legacy portfolio-focused system that is capable of dealing with missing data, old legislation and a wide range of product types.

The Sapiens Closed Books model ensures that benefits are realized in a controlled and low risk manner, via best practices and proven industry experience.

24

Sapiens L&P (TOPAZ)INSIGHT

Sapiens L&P (TOPAZ)INSIGHT is offered uniquely in the Israeli market,Israel, enabling L&P carriers in Israellife and pension insurance providers to handle a wide range of L&P activities and regulations that are unique to the Israeli market.

 

Sapiens Property & Casualty/General Insurance Solutions

 

Sapiens P&C (IDIT)IDIT

Sapiens P&C (IDIT)IDIT is a component basedcomponent-based software solution, addressing the specific needs of general insurance carriers for traditional insurance, direct insurance, bancassurance and brokers markets, primarily in EuropeEMEA and Asia-Pacific.

 

Sapiens P&CIt supports a broad range of general, personal and commercial lines of business, including:

-·Personal linese.g. motor, personal property & homeowners,and homeowner, yacht, travel, medical insurance, liability, professional indemnity, etc.
-·Commercial lines e.g. fleet insurance, marine, cargo, engineering, real estate and commercial building, small and large commercial risks, etc.
-·Specialty linese.g.agriculture, credit insurance, or art insurance, etc.

 

Sapiens P&CIDIT integrates multiple front office and back office processes, including insurance product design, the quote and buy process, policy administration, underwriting, call center, and remote users and partners, backed by fully secured internet-based capabilities.

 

Sapiens P&C providesBy providing a full set of components, to supportSapiens IDIT supports insurance carriers’ core operations lifecycle from inception to renewal, and claims, including:claims. This includes:

·Policy Administrationadministration
·Claims Managementmanagement
·Billing and Collectioncollection

 

The solutionSapiens IDIT includes modular software components that can be customized to match specific insurance business requirements, while providing pre-configured functionality, including:

·Product Factoryfactory
·Policy Administrationadministration
·Billing and Collectioncollection
·Claims Managementmanagement
·Customer Relationship Management (CRM)
·Intermediary Managementmanagement
·Workflow Managementmanagement
·Technical Accountingaccounting
·Document Managementmanagement

On top of the functional modules, Sapiens IDIT provides a set of digital solutions and services to its customers, including an advanced analytics solution, a consumer and agent portal, personalized video capabilities and cloud offerings and services. These capabilities accelerate and automate responses, and reduce costs.

Sapiens Stingray

Sapiens Stingray is a modular browser-based, property and casualty policy administration solution for Policy (quoting, rating, issuance), Billing, Claims and Reinsurance administration. Sapiens Stingray includes complete customer and agent portals as well as an imaging system. Additionally, Stingray has statistical bureau reporting, DMV, Credit Card, General Ledger, Comparative Raters, CLUE, Business Intelligence, reporting and many other third party insurance related interfaces.

25

 

Sapiens Reinsurance

Sapiens Reinsurance enables P&C/General Insurance carriersis a comprehensive business and brokersaccounting solution designed to handlesupport the entire range of reinsurance contracts and activities, both ceded and assumed, for all lines of their P&C/Generalbusiness. This software product provides both insurers and reinsurers superior handling of all reinsurance activities and in-depth accounting functionality on a single platform, with full financial control and auditing support.platform. By incorporating in-depth, fully automated functions readily adaptable to each company'sadapted conveniently for its customers’ business procedures, Sapiens Reinsurance provides flexible and full financial control of theits customers’ reinsurance practice,processes, including full support for all auditing requirements and regulatory reporting.statutory compliance.

 

Sapiens Reinsurance providesoffers end-to-end processing, including:

·SetupSet-up and definition of the reinsurance program
·Import of premium and claims transactions
·Automatic allocation of premiumscomprehensive transaction processing for both cession and claims to reinsuranceassumed contracts
·ProductionAutomated production of all periodic statements, &billings, bordereaux and accounts to reinsurance participantsfor all parties – reinsurers, brokers and ceding companies
·All-inclusive financial accounting module for current accounts management, P&L and balance sheet figures, and comprehensive support for general ledger accounts
·Complete audit trail and tracking capability of all activities, transactions and business processes

 

Sapiens P&C (Insight)Insight

Sapiens Insight for P&C is a software solution used by P&C carriers that workworks on IBM System z (mainframe) and System i platforms. Insight for P&C has been customized to meet the particularspecific business demands at the insurer level and the regulatory needs at the state level.

Sapiens Digital Suite

Sapiens INTELLIGENCE

Sapiens INTELLIGENCE is a modular, highly innovative business intelligence solution specifically designed for the insurance market. Based on the advanced technology of SAP’s analytics platform, Sapiens INTELLIGENCE is an important component of the industry-leading Sapiens’ portfolio and is comprised of two integral elements: SmartStore and InfoMaster.

SmartStore is a centralized data hub for all insurance reporting and analytics. It gathers data from Sapiens’ operational repository and intelligently transforms it into an insurance-domain set of business logical models, specifically designed for complex and in-depth analytics.

InfoMaster is Sapiens’ set of analytical applications, offering a wide range of data visualization and analysis capabilities through reporting, dashboards and data discovery. Incorporating Sapiens’ best practices and three decades of leading experience, Sapiens InfoMaster helps insurers achieve greater efficiency and begin reaping the benefits of analytics immediately.

Sapiens PORTAL

The Sapiens PORTAL is pre-integrated with Sapiens ALIS and Sapiens IDIT. In addition to enjoying the myriad benefits provided by Sapiens ALIS and Sapiens IDIT, insurers can deploy a portal that will transform their online sales, customer and agent experience.

The Sapiens PORTAL was specifically designed to address insurers’ needs, guided by Sapiens’ three decades of industry experience. Two key segments are addressed by the Sapiens PORTAL:

The PORTAL for Consumers is a direct-to-consumer application that enables customers to buy policies, view the status of their policies and accounts, issue claims and conduct many other transactions that save insurers time and reduce costs. Insurers can leverage their investment by offering customers a unique, real-time customer experience tailored to today’s digital natives.

The PORTAL for Agents empowers the agent with full lifecycle enablement, including the ability to manage their pipeline, sell policies to their consumers and provide top-level customer service in real time. They can also obtain a holistic view of their business performance overall and benefit from full access to all their remunerations, payments, commission transactions and statements. Equipping agents with self-service tools that make their lives easier and help them better serve their customers will increase agent efficiency and satisfaction.

26

Sapiens Business Decision Management Solutions

 

Sapiens DECISION

Sapiens DECISION is an innovative business decision software solution which allows business professionals - with no IT skills - to design, simulate, implement, change, analyze, and visualize business logic that drives financial operations and compliance in a business-friendly format and environment.

 

Sapiens DECISION is a business decision management solution that consistently enforces business logic across all enterprise applications. Organizations use it to track, verify and ensure that every decision is based on the most up-to-date rules and policies. The solution is powered by The Decision ModelModel®, a widely adopted decision management methodology, for which we license underown a long term license fromnumber of patents.

Organizations are undergoing a paradigm shift in the Knowledge Partners International LLC. When implementedway they approach change, by replacing conventional policy and process management with Sapiens DECISION, ita growing discipline called “decision management.” Decision management bridges the gap between business and IT, by enabling business users to rapidly frame requirements in formal business models that can resolvebe easily understood by all stakeholders. This ensures that the disparate nature of thebusiness logic across the organization to provide a central repository for enterprise management ofis complete, internally consistent and accurate, and does not replicate existing logic. It allows a single representation of the logic across the organization and treats it as an enterprise asset.



Sapiens DECISION allows the reusability and governance of business logic across all business divisions and software applications, using any rules engine or business process management system, and integrating seamlessly with the BRM or BPM system that the organization has in place.

Some of the key benefits for organizations that use Sapiens DECISION are:

-·ImprovedReduced risk management, by having a single versionassessing the impact of the organization'sany change (competitive, strategy, regulatory, etc.) and allowing users to simply and quickly design new and sustainable models to meet evolving business logic, managed in a central repository and applied across the organization.requirements.
-·Better corporate governanceLimited costs and complexity, through a secured authorization process forby centralizing the introductiondevelopment and dissemination of newinstitutional business logic, or changes to existing logic and full audit trail for traceability.which improves efficiency.
-·QuickImproved visibility and easy deploymenttrue governance, by putting business users in full control of new or changedinstitutional business logic for products, services and regulations in a single, centralized repository using business-like language.enabling them to trace every policy and rule back to its motivation and documentation.
-·EmpowermentEstablishment of a “single point of truth,” by providing business people, who can create, change and validate allIT users a centralized business logic themselves.
-Improved efficiency, through the ability to re-use business logic across multiple applications.
-Testing and validating capabilities, by allowing all changes to be validated before being deployed in the system to avoid disruption and conflicts.repository.

 

We are currently focusing on the development and marketing of Sapiens DECISION in the financial services market in North America and WestWestern Europe, and we are building best practices to be used mostlyprimarily by mortgage, banking, retail banking and investment banking.

banking where the scale and complexity of operations requires enterprise-grade technology that can easily be adapted as policies and business strategies rapidly evolve. We also intend to develop and market Sapiens DECISION for the insurance industry and leverage our industry knowledge and close relationships with our existing customers and partners.

Technology Based Solutions:Technology-Based Solutions

 

Sapiens eMerge

Sapiens eMerge is a rules-based, model-driven architecture that enables the creation of tailor-made, mission-critical core enterprise applications with little or no coding. Our technology is intended to allow customers to meet complex and unique requirements using a robust development platform. For example, we perform proxy porting for our customers in an efficient, cost effective manner with Sapiens eMerge.

27

 

Sapiens’ Global Services

Sapiens provides implementation

Our services modernize and integration servicesautomate processes for insurance providers and financial institutions around the globe, helping to help our customers fully realize benefit from our software solutions. Somecreate greater organizational efficiencies, reduce costs and provide a better end-user experience. Built on a solid foundation of the key advantagesinsurance domain expertise, proven technology and a heritage of our professional services are outlined below:successful deployments, we assist clients in identifying and eliminating IT barriers to achieve business objectives. Benefits include:

 

-·Project Delivery Experiencedelivery experience. – more than 30 years of field-proven project delivery of core system solutions, based on best practices and accumulated experience.

-·System Integrationintegration: Using our know-how to – we help our customers deploy modern solutions, while expertly integrating these solutions with their legacy environmentenvironments that must be supported.
-·Global Presencepresence: Insurance – insurance and technology domain experts are available worldwide to provide bandwidth of global professional services.

 

Our implementation teams assist customers in building implementation plans, integrating our software solutions with their existing systems, and deploying specific requirements unique to each customer and installation.

 

We also partner with several leading system integration and consulting firms to achieve scalable, cost-effective implementations for our customers. We have developed an efficient, repeatable methodology that is closely aligned with the unique capabilities of our solutions.

Most of our clients in whose sites we have deployed our solutions, elect to enter into an ongoing maintenance and support contract with us. The term of such a contract is usually twelve months and is renewed every year. A maintenance contract entitles the customer to technology upgrades (when made generally available) and technical support. In addition, we offer introductory and advanced classes and training programs available at our offices and at customer sites.

Our service teams havepossess strong technology skills and industry expertise. The level of service and business understanding they provide contributes to the long term success of our customers. This helps us develop strategic relationships with our customers, enhances information exchange and deepens our understanding of the needs of companies within the industry.

 

WeThrough our service teams, we provide a wide scope of services and consultancy around our core solutions, both in the stage of the initial project implementation stage, as well as on-goingongoing additional services. Many of our customers also use our services and expertise on an on-going basis to assist them with various aspects of daily maintenance, on-goingongoing system administration and additionsthe addition of new enhancements to the solutions - and are considering Sapiens as a strategic partner for such services.solution enhancements.

 

Such services include, among others:

include:

·Adding new Lineslines of Businessbusiness and functional coverage to existing solutions running in production

·On-goingOngoing support services for managing and administering the solutions

·Creating new functionalities per specific requirements of our customers

·Assisting to addwith compliance for new regulations and legal requirements

In addition, most of our clients elect to enter into an ongoing maintenance and support contract with us. The terms of such a contract are usually twelve months and are renewed every year. A maintenance contract entitles the customer to technology upgrades (when made generally available) and technical support. We also offer introductory and advanced classes and training programs available at our offices and customer sites.

We partner with several system integration and consulting firms to achieve scalable, cost-effective implementations for our customers. We have developed an efficient, repeatable methodology that is closely aligned with the unique capabilities of our solutions.

Our Strengths

 

Comprehensive suite of core solutions.suitesof high-end, crucial solutions for insurance. We offer end-to-end solutions for both the P&C and L&P&P/L&A markets, supporting allmost sub-segments of these markets and the complete lifecycle of product lines .lines. Our software supports and enables our customers’ most fundamentalcore insurance business processes throughout the full lifecycle of administration within an organization, including policy administration, billing and claims. Ourclaims, which we believe is a unique offering among software solution providers. In addition, our solutions for the Retirement Servicesretirement market provides modern record keeping solutionsupport core record-keeping for retirement services providers, which areis fundamental to their operations. Our business decision management solution is a unique offeringBuilt for the design, management,global and governance of the business logic behindmulti-national operations, and complianceour solutions are used in a wide variety of organizations.international regulatory, language and currency environments. Our digital suite is pre-integrated with Sapiens IDIT and Sapiens ALIS.

 

Innovative productssolutions with leading functionality and technology. Our solutions include integrated, flexible, configurable, scalable and reliable suites of productsare based on advanced, modern architectures whichthat are specifically designed forto satisfy our customers’ needs. In addition,These solutions are integrated, modular and component-based, and include scalable product suites supporting various lines of business. By using our solutions, are highly compatible with other software solutions our customers may use. We allow carriers tocan support new sales channels, including mobile and social, reduce time to market for new product launches, and lower total cost of ownership, and support global operations. We have significant investmentownership. Additionally, we significantly invest in research and development to ensure that our products employ new technology, and are compatible with the needs of our clients.clients and are easy to use. As a result, our products are highly regardedmaintain a leadership position, as recognized by leadingtop industry analysts, such as Celent and Ovum, for their levels of both technology and functionality.

 

28

One-stop-shop across products and services. In addition to our market-leading products across P&C and L&P, we possess consulting and implementation capabilities, which we use to customize our products and design the solution that best meets our customers’ requirements. We believe that our customers do business with us not only because of our leading products, but also due to our complementary service offerings, which enhance our products and enable clients to maximize the value derived from our solutions. We believe that this approach lowers the risks for our clients, as they transition to a new system, and at the same time provides them with the functionality they desire. For example, we consult with each of our customers to determine their specific needs and then enhance our core solution and customize the appropriate interfaces. Through these interactions and experiences, we foster long-term relationships with our customers, which provide opportunities to deliver a wide range of our products and services as requirements change over time.

Strong, diverse and stable customer base. We currently haveserve more than 130200 customers globally, including some of the world’s largest global insurance carriers and financial institutions. Our customer base is well diversified across the P&C, L&Pinsurance providers, including life, pensions and annuities; property and casualty insurers; and retirement services segments.providers. We believehave been able to successfully maintain these customers due to our broad product portfolio geared toward addressing the needs of these industries. In addition, our business decision management solutions areplatform is applicable across the financial services industry, including a wide range of financial institutions, and offeroffers an opportunity for further diversification. Wediversification in other markets. Geographically, we derived 33%34.4%, 58%21.7%, 16.4%, 13.5% and 9%14.0% of our revenuesrevenue from North America, the Americas,United Kingdom, the rest of Europe, Israel and the Asia-Pacific region, respectively, in the year ended December 31, 20132016, and 31%33.0%, 58%22.9%, 17.7%, 15.3% and 11% from those respective regions,11.0%, respectively, in the year ended December 31, 2012.2015.

Long-term relationships with customers.Our products are at the core of our customers’ businesses, which ensures that our customers continue to use and co-invest in our products, providing us with long-term relationships that result in revenue stability. Installing a new core system is a major undertaking for insurance carriers whichthat involves extended pre-production work and entails a complexcomprehensive integration and implementation effort. Our products are at the coreeffort that is offered as part of our customers’ businesses, and our customers are therefore committed to our products, providing us with long-term relationships that result in revenue stability.services. Many of our customer relationships have been in place for more than 10 years and we have benefited from recurring revenues as customers request support, upgrades and enhancements for our systems. In addition, we benefit from these relationships, due to our ability to market complementary solutions to our loyal customer base.

 

Portfolio is recognizedProven management team. Our management team has extensive experience in the insurance and financial services industries and we have been able to achieve our business and development objectives to date. Management has also been successful in retaining key personnel from the companies we acquired,enabling us to benefit from their experience and knowledge of the acquired products and technology. Our management team possesses a variety of skills in product development, business development, sales, marketing, technology and finance, as market leader.During 2013,well as a unique knowledge of the financial services industry. We have maximized contributions from our products were recognized as market leaders in their space, as follows:hard working, talented and innovative employees.

-Sapiens P&C (IDIT) recognized as a market leader in Europe
Report Name: Ovum Decision Matrix: Selecting a P&C Insurance Policy Administration Platform – Europe, 2013–14; Publication Date: 17 Oct 2013; Author: Charles Juniper

-Sapiens P&C (IDIT) won XCelent Award for best functionality and technology in EMEA
Report Name: EMEA Policy Administration Systems General Insurance, P&C ABCD Vendor View; Publication Date: January, 2014; Author: Craig Beattie

-Sapiens P&C (IDIT) won XCelent Award for best functionality in APAC
Report Name: Asia-Pacific Policy Administration Systems Property & Casualty ABCD Vendor View; Publication Date: January, 2014; Author: Wenli YuanSapiens L&P (ALIS) won XCelent Award for best functionality in North America
Report Name: North American Policy Administration Systems 2013, Life, Annuities, and Health ABCD Vendor View; Publication Date: November 2013; Author: Karen Monks and Chuck Johnston
-Sapiens L&P (ALIS) won XCelent Award for best functionality in EMEA
Report Name: EMEA Policy Administration Systems 2013, Life, Annuities, Pensions, and Health ABCD Vendor View; Publication Date: November 2013; Author: Jamie Macgregor and Nicolas Michellod

 

Our Strategy

 

Our visionLeveraging our offerings, geographic presence and experienced management team, our goal is to become a leadingfurther expand our presence in the markets in which we operate and further enhance our leadership in the global provider of innovative software solutions for the insurance industry, with an emerging focusmarket. Our growth strategy is solidly based on the broader financial services sector.both existing and new customers, and will include mergers and acquisitions, when applicable, to accelerate our growth. We plan to achieve our goals by focusing on the following principles:

 

GrowthContinue to innovate and extend the leadership of our product offerings. Due to past investments, we have become a leader in revenues within existing markets (new and existing customers) - we intendproviding software offerings to the insurance industry. We plan to continue to operateinvest in research and development to enhance our software platform solutions and to ensure they remain leading products, in terms of functionality and technology. We believe our focus on innovation, combined with our industry expertise, will enable us to improve our existing marketsofferings and allow us to produce new solutions for the benefit of our customers and partners.

29

Leverage our global footprint to offer our complete solutions suite.We intend to broaden our existing offering of solutions to enhance our presence in the geographies in which we have present and referenced customers and to increase our customer base in such markets. In addition, we intend to strengthen our recurring revenue model by providing additional solutions, support, maintenance, assistance, and implementation services to our existing customer base, leveraging our comprehensive and diversified product suite.

Growth with existing products into new markets - we plan to grow our business by offering our existing portfolio in new markets.currently operate. In particular, we believe that there is considerable opportunity to commence and grow sales of our P&C product suite in additional European countries, as well as the United States and Canada, and also to expand the customer base for Sapiens DECISIONmarket reach of our business decision management platform into Europe and the Asia Pacific region. Additionally, we plan to market our current suite of solutions to other countries in Europe.Europe in order to continue to generate revenue on existing products in new geographies.

 

Maintain InnovationMergers and technology leadership -Acquisitions.Our M&A approach facilitates our growth strategy. We seek to identify new growth markets to penetrate via acquisition of local offices and customer bases. In addition, we aim to enhance our product portfolio with complementary solutions that will help our customers excel. We believe that our acquisition of local customer bases and expertise will accelerate our market penetration in growth geographies. We plan to take advantage of our recent acquisition of StoneRiver to strengthen our presence in North America, expand our product portfolio and accelerate our footprint in the U.S. Property & Casualty market.

Capture adjacencies and new opportunities.In order to maximize the value of our current offerings and leverage our long-term relationships with customers, we plan to continuefeature and promote our digital suite to enhance our presence in the insurance market. To date, our core insurance software solutions to ensure they remain leading products in termsaccount for approximately 80% of functionality andour business, while our technology to meet the market demand.platforms account for approximately 20% of our business. We believe our plan to remain vertically focused, while concentrating on our customers’ ancillary needs, will strengthen our customer relationships. Additionally, we plan to focus on innovationpenetrating the financial services market with our business decision management platform to aid financial services organizations in the management, design and our industry expertise will enable ussimulation of the business logic behind operations. Our business decision management platform can be geared toward compliance in a wide variety of organizations to further improve our existing product offering as well as to produce new software solutions for the benefit of our customersfacilitate streamlined and partners. We will continue to leverage the insights and best practices drawn from our customer base as well as to invest in research and development.efficient regulatory compliance.

 

Growth through acquisitions -Invest in sales and marketing. as partWe plan to strengthen our sales and marketing teams by working with and training sales professionals with experience in the insurance industry, or with connections to new or existing customers, enhancing market-awareness of our growth strategy, we have made three acquisitions over the past few years. We will continue to seekbrand and evaluate opportunities to grow through acquisitions of companies with complementary software solutions, related intellectual property or customer base. As various companies in our industry offer differentiated solutions sold to different customers, we believe we may encounter opportunities to acquire companies or technologies that can be meaningfully synergistic with our solutions. We will balance investment in such acquisitions with returnbelieve that the strength of our core solutions, the experience of our sales and marketing team, and our established and growing customer base create a significant opportunity to investorsprovide new and allocatecomplementary solutions that address the ongoing needs of our capital resources accordingly.customers.

Competitive Landscape

We operate in two main markets – insurance and the broader financial services sector – with different competitive landscapes.

 

The market for core software solutions for the insurance industry is highly competitive and characterized by rapidly changing technologies, evolving industry standards and customer requirements, and frequent innovations.

 

The market for business decision management is a relatively new and innovative market, and as such it is toostill early to accurately identify competition.

 

Competitive Landscape for our Insurance Software Solutions

 

Our competitors in the insurance software solutions market differ from us based on the size, geography and linelines of business in which we operate.business. Some of our competitors offer a full suite, andwhile others offer only one module; some operate in specific (domestic) geographies, while others operate on a global basis; and theirbasis. And delivery model willmodels vary, with some competitors keeping delivery in-house, or using IT Outsourcingoutsourcing (ITO) or business process outsourcing (BPO).

 

The insurance software solutions market is highly competitive and demanding. Maintaining a leading-edgeleading position is challenging, for several reasons:because it requires:

-·Development of new core insurance solutions, requireswhich necessitates a heavy R&D investmentsinvestment and an in-depth knowledge of complex insurance environments.environments

30

·Technology innovation, to attract new customers
-Innovation in technology is mandatory to gain new customers.
-·A global presence and the ability to support global insurance operations
-·RegulatorySatisfaction of regulatory requirements, which can be burdensome and require specific IT solutions.solutions
-·Continued support and development of the solutions requiresentails a critical mass of customers that support an on-goingongoing R&D investment.investment
-·Know-how of insurance system requirements and an ability to bridge between new systems and legacy technologies must be maintained in many cases

 

The complex requirements of this market create a high barrier to entrance ofentry for new players. As for existing players, these requirements have led to a marked increase in M&A transactions in the insurance software solutions sector, since small, local vendors have not been able to sustain growth without continuing to fund their R&D departments and follow the globalization trend of their customers.

 

We believe we are well positionedwell-positioned to leverage our modern solutions, customer base and global presence to compete in this market and meet its challenges. In addition, our accumulated experience and expert teams allow us to provide a comprehensive response to the IT challenges of this market.

 

SomeDifferent types of competitors are:

include:

-·Global software providers with their own IP.
-·Local/domestic software vendors with their own IP, operating in a designated geographic market and/or within a designated segment of the insurance industry.
-·BPO providers who offer end-to-end outsourcing of insurance carriers business, including core software administration (although BPO providers want to buy comprehensive software platforms to serve as part of the BPO proposition from vendors and may seek to purchase our solutions for this purpose).
-·Internal IT departments, whichwho often prefer to develop solutions in-house.

 

We differentiate ourselves from our competitors throughvia the following key factors:

·We offer innovative and modern software solutions, with rich functionality and advanced, intuitive user interfaces.
·We use model-driven architecture that allows rapid deployment of the system, while reducing total cost of ownership.
·Our solutions are built using an architecture that allows customers to implement the full solution or components, and readily integrate the solution or individual components into their existing IT landscape.
·We recognize technology trends and invest in adjusting our solutions to meet this rapid pace.
·We are able to fund R&D investmentsinvestment and maintain the competitive advantage of our products because ofdue to our large and growing customer base and our financial stabilitystability.
·Our delivery methodology is based on extensive insurance industry experience and cooperation with large insurance companies globally.
·We leverage our proven track record of successful delivery to help our customers deploy our modern solutions, while integrating with their legacy environment that(that must remain supported.supported).

 

Competitive Landscape for Business Decision Management Solutions

Sapiens DECISION is a pioneer in this innovative, disruptive market landscape. Since the introduction to the market of our innovative approach to enterprise architecture to the market, we have identified only a small number of potential competitors.

 

We differentiate ourselves from our potential competitors through the following key factors:

-·We believe that Sapiens DECISION is the only solution that offers a true separation of the business logic in a decision management system for large enterprises and that is currently generally available and already in production.
-·Sapiens DECISION is unique in its proven ability to support complex environments, with full audit trail and governance that is key incrucial for large financial services organizations.
-·Our track record of delivering complex, mission-critical solutions, which helps usWe understand complex environments where DECISION is key.deployed due to our experience delivering complex, mission-critical solutions

31

Geographical Scope of Our Operations

For a breakdown of the geographical regions in which our revenues are generated and the relative amounts of such revenues over the course of the last three fiscal years, please see “Item 5—Operating and Financial Review and Prospects—A. Operating Results—Revenue by geographical region” below in this annual report.

 

Sales &and Marketing

 

Our main sales channel is direct sales, with a small (yet growing) portion of partner sales. Our sales team is located atdispersed across our regional offices in North America, the United Kingdom, Belgium, France, Israel, Australia, India, Poland and Japan. The direct sales force is geared to large organizations within the Insurance Industryinsurance and the financial services industry.

 

In 2013,2016, we expandedcontinued to significantly invest in our investment in sales and marketing to new customers. We intend to further expand our sales and marketing efforts intarget regions North America, UK and Europe as we enhance and our local offices with sales, presale,presales, domain expert,experts and marketing teamspersonnel. We anticipate that our sales team will leverage the vicinitytheir proximity to the customers and prospective clients to drive more business, and brand awareness.offer our services across our target markets.

 

In addition, in 2013 we expanded our account management teams. Our have account managers who arewere focused on building ongoing relationships with existing customers during the past year, to maintain a high level of customer satisfaction and identify up-selling opportunities within these organizations. We believe that a high level of post-contract customer support is important to our continued success. In addition, we employ a team of technical specialists who provide a full range of maintenance and support services to our customers to help them fully exploit the capabilities of our solutions.

 

As part of our sales process, we typically sell a package whichthat includes license, implementation, customization and integration services, and training services. All of our clients for whom we have deployed our solutions elect to enter into an ongoing maintenance and support contract with us.

We aim to expand our distribution model to include more channel partners and system integrators, but we intend to maintain the direct sales model as our prime distribution channel.

 

We attend major industry trade shows to improve our visibility and our market recognition. Additionally, we host client conferences such as our annual Sapiens Client Conference, which took place in Gouvieux, France in October 2015 and in North Atlanta, U.S. in September 2016that are intended to strengthen our relationshiprelationships with our existing customer base. We continue investing in our web presence, using the internetwe created a new blog channel in 2014 (“Sapiens Spotlight”) and social media networks.totally refreshed and redesigned our website. We also invest in tightening our working relationshiprelationships and advisory services within the global industry-analyst community.

 

We work together with standards providers such as ACORD, MISMO and MISMO,SPARK to further enrich our offeringofferings and provide our customers with a comprehensive and innovative solutionsolutions that addressesaddress the entire breadth of their business needs.

Intellectual Property

 

We rely on a combination of contractual provisions and intellectual property law to protect our proprietary technology. We believe that due to the dynamic nature of the computer and software industries, copyright protection is less significant than factors such as the knowledge and experience of our management and personnel, the frequency of product enhancements and the timeliness and quality of our support services.

 

We seek to protect the source code of our products as trade secret information and as an unpublished copyright work, although in some cases, we agree to place our source code into escrow. We also rely on security and copy protection features in our proprietary software. We distribute our products under software license agreements whichthat grant customers a personal, non-transferable license to use our products and contain terms and conditions prohibiting the unauthorized reproduction or transfer of our products. In addition, we attempt to protect trade secrets and other proprietary information through agreements with employees, consultants and distributors. As of today, we do not hold any patents.

32

 

Our trademark rights include rights associated with our use of our trademarks, and rights obtained by registration of our trademarks. Our use and registration of our trademarks do not ensure that we have superior rights to others that may have registered or used identical or related marks on related goods or services. We have registrations for the mark “Sapiens” in USA, Benelux, Germany, Italy Switzerland and Israel, the name “RapidSure” in the USAU.S. and Canada, and the names ALIS, E-ALIS, CORE-ALIS and certain other related marks, as well as the ALIS design in the USA and Israel. The initial terms of protection for our registered trademarks range from 10 to 20 years and are renewable thereafter.

 

We have entered into a long term teaming agreement with Knowledge Partners International LLC (“In the third quarter of 2014, we acquired KPI”) and a long term license agreement with the Decision Model Licensing LLC, pursuant to which we were granted the right to integrateassets of The Decision Model, or TDM, which included certain intellectual property rights, including a patent held by TDM and a patent application for The Event Model, or TEM. Both TDM and TEM relate to decision management methodology which is patented inthat was invented by Larry Goldberg and Barbara Von Halle (in the US,case of TEM, IBM was a co-inventor as partwell). See “Item 4.A. History and Development of the Company– Capital Expenditures and Divestitures since January 1, 2014” and “Item 4.B. Business Overview— Sapiens DECISION solution, subject to payment of royalties on our Sapiens DECISION license revenues.Business Decision Management Solutions” for further information.

 

Regulatory Impact

 

The global financial services industry is heavily subject to significant government regulation, which is constantly changing. Financial services companies must comply with regulations, such as the Sarbanes-Oxley Act, Solvency II, Retail Distribution Review (known as RDR) in the United Kingdom, the Dodd-Frank Act and other directives regarding transparency. In addition, many individual countries have increased supervision over financial services operating in their market.

 

For example, regulators in Europe regulators have been very active, motivated by past financial crises and the need for pension restructuring. Distribution of policies is being optimized with the increasing use of Bank Assurance (selling of insurance through a bank’s established distribution channels), supermarkets and kiosks (insurance stands). Increased activitysuch as that occurring in Europe would generally tend to have a positive impact on the demand for our software solutions and services; nevertheless,services. Nevertheless, insurers are cautiously approaching spending increases, and while many companies have not taken proactive steps to replace their software solutions in recent years, many of them are now looking for innovative, modern replacements to meet the regulatory changes.

For further information, please see Item 5.D below, “Trend Information.”

 

C.Organizational Structure.

 

Sapiens International Corporation N.V. (“, or Sapiens N.V.”), is the parent company of the Sapiens group of companies. Our significant subsidiaries are as follows:

 

Sapiens International Corporation B.V. (“, or Sapiens B.V.”): incorporated in the Netherlands and 100% owned by Sapiens N.V.

 

Unless otherwise indicated, the other significant subsidiaries of Sapiens listed below are 100% owned by Sapiens B.V.:

Sapiens Israel Software Systems Ltd.: incorporated in Israel


Sapiens Technologies (1982) Ltd.: incorporated in Israel


Sapiens Americas Corporation: incorporated in New York, US

SapiensU.S.
Sapiens North America Inc.: incorporated in Ontario, Canada.

Sapiens (UK) Limited: incorporated in England


Sapiens France S.A.S.: incorporated in France


Sapiens Deutschland GmbH: incorporated in Germany

(owned 100% by Sapiens Technologies (1982) Ltd.)
Sapiens Japan Co.: incorporated in Japan and 90% owned by Sapiens B.V.

Sapiens Software Solution (IDIT) Ltd. (“, or Sapiens IDIT”):IDIT: incorporated in Israel (owned 100% by Sapiens Technologies (1982) Ltd.)

33

IDIT Europe N.V.: incorporated in Belgium (owned 100% by Sapiens IDIT)

IDIT APAC PTY. Limited: incorporated in NSW, Australia (owned 100% by Sapiens IDIT)

Sapiens (Singapore) Insurance Solution.: incorporated in Singapore (owned 100% by Sapiens IDIT)

 

Sapiens Software Solution (Life and Pension) Ltd. (“, or Sapiens L&P”) :&P: incorporated in Israel (owned 100% by Sapiens Technologies (1982) Ltd.)

Sapiens (UK) Insurance Software Solutions Limited: incorporated in the UK (owned 100% by Sapiens L&P))

Sapiens NA Insurance Solutions Inc.: incorporated in Delaware, US (owned 100% by Sapiens L&P)

Formula Insurance Solutions (FIS) France: incorporated in France (owned 100% by Sapiens (UK) Insurance Software Solutions Limited)

FIS- AU Pty Limited: incorporated in Australia (owned 100% by Sapiens (UK) Insurance Software Solutions Limited.)

Neuralmatic Ltd.: incorporated in Israel (owned 66% by Sapiens L&P)

Sapiens Software Solutions (Decision) Ltd., or Sapiens Decision (owned 95.7% by Sapiens Technologies (1982) Ltd.)

Sapiens Decision NA Inc. (owned 100% by Sapiens Decision)

Knowledge Partners International LLC, or KPI (owned 100% by Sapiens Decision NA Inc.)

Sapiens (UK) Decision Limited (owned 100% by KPI)

Ibexi Solutions Private Limited: incorporated in India (owned 95% by Sapiens Technologies (1982) Ltd)

Ibexi Solutions Pte Limited: incorporated in Singapore (owned 100% by Ibexi Solutions Private Limited)

Ibexi Solutions FZE: incorporated in Dubai (owned 100% by Ibexi Solutions Private Limited)

Sapiens Software Solutions (Poland) Sp. z o.o. (formerly Insseco Sp. z o.o.): incorporated in Poland (owned 100% by Sapiens Technologies (1982) Ltd)

Maximum Processing Inc., incorporated in Florida (owned 100% bySapiens Americas Corporation)

4Sight Business Intelligence Inc., incorporated in Texas(owned 100% bySapiens Americas Corporation)

StoneRiver, Inc, incorporated in Delaware (owned 100% by Sapiens Americas Corporation)

Sapiens Software Solutions (Denmark ApS): incorporated in Denmark (owned 100% by Sapiens (UK Insurance Software Solutions Limited))

Sapiens Software Solutions Instanbul: incorporated in Turkey (owned 100% by Sapiens Technologies (1982) Ltd.)

Sapiens SA PTY Ltd.: incorporated in South Africa (owned 100% by Sapiens (UK Insurance Software Solutions Limited))

 

We are a member of the Formula Systems (1985) Ltd., or Formula, Group (NASDAQ: FORTY and TASE: FORT).

Formula is a holding and managing company of (currently) three publicly traded companies whichthat provide IT solutions worldwide, developing and implementing innovative, proprietary software, services and solutions, turnkey projects and outsourcing services, as well as software distribution and support.

As

Based on information provided to the Company by Formula, Formula held 23,954,094 of April 1, 2014, based on the last amendment to its Schedule 13D, filed on May 6, 2013, in which it reported ownership of 22,369,035our Common Shares, and based onor approximately 48.9% of our 46,881,450 outstanding Common Shares as of AprilMarch 1, 2014, Formula beneficially owned approximately 47.7% of our outstanding Common Shares.2017. As of AprilMarch 1, 2014,2017, Asseco beneficially owned 46.4%46.3% of the outstanding share capital of Formula.

 

Based on the foregoing beneficial ownership by each of Formula and Asseco, each of Formula and Asseco may be deemed to directly or indirectly (as appropriate) control us.

 

34

D.Property, Plants and Equipment.

 

We lease office space, constituting our primary office locations, in the following countries: Israel, the United States, Canada, the United Kingdom, Belgium, Japan, India and Japan.Poland. The lease terms for the spaces that we currently occupy are generally five to eleven years. In Israel, basedBased on our current occupancy, we lease approximately 101,000(except for owned real property indicated below) the following amount of office space in the following locations, which constitute our primary locations:

·Israel – approximately 135,100 square feet;
·United States – approximately 20,300 square feet*;
·Canada – approximately 1,400 square feet;
·United Kingdom – approximately 21,400 square feet;
·Japan – approximately 6,400 square feet;
·India – approximately 45,400 square feet;
·Poland – approximately 27,200 square feet; and
·China – approximately 1,200 square feet.

* 10,243 square feet of such office space;space in the United States approximately 9,100 square feet; in Canada, approximately 8,900 square feet; in the United Kingdom, approximately 14,200 square feet, in Belgium, approximately 3,400 square feet and in Japan, approximately 4,400 square feet. In 2013,constitutes owned real property.

Our Israeli offices house our rent costs totaled $3.4 million, in the aggregate, for all of our leased offices. Our corporate headquarters, are located in Israel andas well as our core research and development activities are performedactivities. As of December 31, 2016, the lease at our offices across Israel. In July 2013 we consolidated all of our operations in Israel and moved to our new location in Azrieli Center in Holon. The lease at thatIsraeli facility is for a termtermof in excess of 11seven remaining years and we have an option to extend the term for an additional five years. In 2016, our rent costs totaled $6.3 million, in the aggregate, for all of our leased offices (which does not include office space leased by StoneRiver in the United States, since it was acquired after December 31, 2016). We believe that our existing facilities are adequate for our current needs.

 

ITEMItem 4A.UNRESOLVED STAFF COMMENTS

 

Not applicable.

 

ITEM 5.OPERATING AND FINANCIAL REVIEW AND PROSPECTS

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and the notes thereto included elsewhere herein. Our financial statements have been prepared in accordance with U.S. GAAP. This discussion contains forward-looking statements that are subject to known and unknown risks and uncertainties. As a result of many factors, such as those set forth under Item 3.D “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the Introduction to this annual report,our actual results may differ materially from those anticipated in these forward-looking statements.

 

Overview

 

We are a leading global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector.Wesector. We offer core software solutions for Life, Pension & Annuities (L&P) and Property & Casualty/General Insurance (P&C), and Life, Annuities, & Pensions (L&P) providers, allowing them to manage policy administration, claims management and billing functions. We also provide record-keeping software solutions for Retirement Services providers. In addition, we offer a variety of other technology-based solutions that enable organizations to deploy business logic and comply with policies and regulations across their organizations. Our solutions enable customers to respond to evolving market needs and regulatory changes, while improving the efficiency of their core operations, thereby increasing revenues and reducing costs.

We derive our revenues principally from the sale, implementation, maintenance and support of our solutions and from the provision ofproviding consulting and other services related to our products. Revenues are comprised primarily of revenues from services, including systems integration and implementation and product maintenance and support, and from licenses of our products.

 

We also generate revenues from other customers unrelated to the financial services industry, which use our legacy solution based on e-Merge software. For these customers, except for the difference in the target industry, revenues are recognized from the compositionsale of revenues described inpackage-based software solutions that include the preceding paragraph (that is,grant of a license to use our product, implementation and customization services related to the product sold and maintenance and support services and licenses) is applicable as well.follow similar methods of project delivery. See “Critical Accounting Policies and Estimates” below for a discussion of how we account for our revenues and their associated costs.

35

Key Business Metrics

We use certain key financial metrics to evaluate and manage our business and that we believe are useful for investors, including select GAAP and non-GAAP metrics. These metrics include, most prominently, our operating cash flow.

Operating Cash Flows

We monitor our cash flows from operating activities, or operating cash flows, as a key measure of our overall business performance, enabling us to analyze our financial performance without the effects of certain non-cash items such as depreciation and amortization and stock-based compensation expenses. Additionally, operating cash flows take into account the impact of changes in deferred revenue, which reflects the receipt of cash payment for products and services before they are recognized as revenue. Our operating cash flows are impacted by changes in deferred revenue and collections of accounts receivable. As a result, our operating cash flows may fluctuate significantly on a quarterly basis.

Our operating cash flows were $21.6 million, $40.4 million and $26.0 million for the years ended December 31, 2014, 2015 and 2016, respectively. For a further discussion of our operating cash flows, see “Item 5.B. Liquidity and Capital ResourcesCash Flows from Operating Activities” below in this annual report.

A.Operating Results.

GAAP Results of Operations

The following tables set forth certain data from our results of operations for the years ended December 31, 2014, 2015 and 2016, as well as such data as a percentage of our revenues for those years. The data has been derived from our audited consolidated financial statements included in this annual report. The operating results for the below years should not be considered indicative of results for any future period. This information should be read in conjunction with the audited consolidated financial statements and notes thereto included in this annual report.

Statement of Income Data
(U.S. dollars, in thousands, except share and per share data)

  Year ended
December 31,
 
  2014  2015  2016 
Revenues  157,450   185,636   216,190 
Cost of revenues  99,095   111,192   130,402 
Gross profit  58,355   74,444   85,788 
Operating expenses:            
Research and development  11,352   10,235   16,488 
Selling, marketing, general and administrative  32,097   39,859   44,460 
Total operating expenses  43,449   50,094   60,948 
Operating income  14,906   24,350   24,840 
Financial income, net  124   163   533 
Income before taxes on income  15,030   24,513   25,373 
Taxes on income  (454)  (4,213)  (5,772)
Net income  14,576   20,300   19,601 
Attributed to non-controlling interests  131   59   (43)
Attributed to redeemable non-controlling interest  (18)  1   (134)
Adjustment to redeemable non-controlling interest  -   224   442 
Net income attributable to Sapiens’ shareholders $14,463   20,016   19,336 

36

Statement of Income Data as a Percentage of Revenues
    
  Year ended
December 31,
 
  2014  2015  2016 
Revenues  100%  100%  100%
Cost of revenues  62.9%  59.9%  60.3%
Gross profit  37.1%  40.1%  39.7%
Operating expenses:            
Research and development  7.2%  5.5%  7.6%
Selling, marketing, general and administrative  20.4%  21.5%  20.6%
Total operating expenses  27.6%  27.0%  28.2%
Operating income  9.5%  13.1%  11.5%
Financial income, net  0.1%  0.1%  0.2%
Income before taxes on income  9.6%  13.2%  11.7%
Taxes on income  0.3%  2.3%  2.7%
Net income  9.3%  10.9%  9.0%
Attributed to non-controlling interests  0.1%  0.0%  0.0%
Attributed to redeemable non-controlling interest  0.0%  0.0%  0.0%
Adjustment to redeemable non-controlling interest  0.0%  0.1%  0.1%
Net income attributable to Sapiens’ shareholders  9.2%  10.8%  8.9%

Comparison of the years ended December 31, 2015 and 2016

Revenues

Please refer to “Critical Accounting Policies and Estimatesbelow in this Item 5.A for a description of our accounting policies related to revenue recognition.

Our overall revenues increased by $30.6 million, or 16.5%, to $216.2 million for the year ended December 31, 2016 from $185.6 million for the year ended December 31, 2015, as shown in the table below:

  Year ended
December 31,
2015
  Year-over-year
change
  Year ended
December 31,
2016
 
($ in thousands) $185,636   16.5% $216,190 

Revenues are derived primarily from implementation of our solutions and post-implementation services such as ongoing support and maintenance and professional services as part of an overall solution that we offer to our customers. The increase in revenues for the year ended December 31, 2016 is attributed to organic growth of approximately $38.0 million, primarily due to implementation and professional services generated from existing and new customers, which were offset in part, in an amount of $4.6 million, due to the devaluation of foreign currencies (in which revenues were received) relative to the U.S. dollar. The increase was furthermore due to $3.5 million of revenues attributable to MaxPro and 4Sight, the results of which were included in our consolidated results for the first time for the year ended December 31, 2016.

37

Revenues by geographical region

The dollar amount and percentage share of our revenues attributable to each of the geographical regions in which we conduct our operations for the year ended December 31, 2015 and 2016, respectively, as well as the percentage change between such periods, were as follows:

  Year ended December 31,
2015
  Year-over-  

Year ended December 31,
2016

 
($ in thousands) Revenues  Percentage  year change  Revenues  Percentage 
Geographical region               
                
North America* $61,332   33.0%  21.4% $74,455   34.4%
United Kingdom  42,580   22.9%  10.1%  46,892   21.7%
Rest of Europe  32,897   17.7%  8.0%  35,535   16.4%
Israel  28,315   15.3%  2.7%  29,085   13.5%
Asia Pacific  20,512   11.0%  47.3%  30,223   14.0%
                     
Total $185,636   100%  16.5% $216,190   100%

*Revenue amounts for North America that are shown in the above table consist of revenues from the United States, except for approximately $0.5 million and $0.9 million of revenues generated in Canada in the years ended December 31, 2015 and 2016, respectively.

Our revenues in North America increased by $13.1 million, or 21.4%, to $74.5 million for the year ended December 31, 2016 from $61.3 million for the year ended December 31, 2015, reflectingan increase of $9.6 million in revenues from existing and new customers, as well as an increase of $3.5 million of revenues attributable to MaxPro and 4Sight, the results of which were included in our consolidated results for the first time for the year ended December 31, 2016.

Our revenues in the United Kingdom increased by $4.3 million, or 10.1%, to $46.9 million in the year ended December 31, 2016 from $42.6 million in the year ended December 31, 2015. The increase was attributable to an increase of $10.52 million in revenues from our existing and new customers, offset by $6.2 million due to devaluation of the GBP relative to the U.S. dollar resulting from the decision of United Kingdom to exit the European Union.

Our revenues in the Rest of Europe increased by $2.6 million, or 8.0%, to $35.5 million in the year ended December 31, 2016 from $32.9 million in the year ended December 31, 2015. The increase was attributable to an increase in revenues from our existing and new customers.

Our revenues in Israel increased by $0.8 million, or 2.7%, to $29.1 million in the year ended December 31, 2016 from $28.3 million in the year ended December 31, 2015.

Our revenues in Asia Pacific, or APAC, increased by $9.7 million, or 47.3%, to $30.2 million in the year ended December 31, 2016 from $20.5 million in the year ended December 31, 2015. The increase was attributable to an increase of $7.7 million in revenues from our existing and new customers in Japan, as well as an increase of $2.0 million due to the appreciation of foreign currencies (primarily the Japanese yen) relative to the U.S. dollar.

38

Cost of Revenues

Our cost of revenues for the years ended December 31, 2015 and 2016, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those years, are provided in the below table:

($ in thousands) Year ended
December 31,
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Cost of revenues $111,192   17.3% $130,402 
Cost of revenues as a percentage of revenues  59.9%      60.3%

Our cost of revenues increased by $19.2 million, or 17.3%, to $130.4 million for the year ended December 31, 2016, ascompared to $111.2million for the year ended December 31, 2015. Cost of revenues increased as a percentage of our revenues during the year ended December 31, 2016, to 60.3% as compared to 59.9% during the year ended December 31, 2015. The increase in absolute cost of revenues was related to the increase in revenues during the year ended December 31, 2016 relative to the year ended December 31, 2015, including due to the inclusion of MaxPro and 4Sight in our consolidated results for the first time for the year ended December 31, 2016. The level of our cost of revenues as a percentage of our revenues remained relatively stable in 2016. Certain projects in certain non-central locations that are not part of our core insurance business had a lower degree of profitability, which contributed to the slight increase in our cost of revenues as a percentage of our revenues. In addition, the appreciation of the New Israeli Shekel relative to the U.S. dollar also increased our cost of revenues as a percentage of our revenues as recorded in U.S. dollars for the year ended December 31, 2016.

Gross profit

Our gross profit for the years ended December 31, 2015 and 2016, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those periods, are provided in the below table:

($ in thousands) Year ended
December 31,
2015
  Year over-
year
change
  Year ended
December 31,
2016
 
Gross profit $74,444   15.2% $85,788 
Gross profit as a percentage of revenues  40.1%      39.7%

Our gross profit increased by $11.4 million, or 15.2%, to $85.8 million for the year ended December 31, 2016, as compared to $74.4 million for theyear ended December 31, 2015. This increase was primarily attributable to the absolute increase in our revenues by $30.6 million for the year ended December 31, 2016 compared to theyear ended December 31, 2015. The decrease in gross profit as a percentage of revenues for the year ended December 31, 2016 was due to the factors described above with respect to the increase in our cost of revenues as a percentage of revenues.

Operating expenses

The amount of each category of operating expense for the years ended December 31, 2015 and 2016, respectively, as well as the percentage change in each such expense category between such periods, and the percentage of our revenues constituted by our total operating expenses in each such period, is provided in the below table:

($ in thousands) Year ended
December 31,
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Research and development, net $10,235   61.1% $16,488 
Selling, marketing, general and administrative  39,859   11.5%  44,460 
Total operating expenses $50,094   21.7% $60,948 
Percentage of total revenues  27.0%      28.2%

39

Research and development expenses, net increased by 61.1% for the year ended December 31, 2016 compared to theyear ended December 31, 2015.This increase was attributable to our greater level of investment in research and development activities in support of the expansion of our offering of solutions in the year ended December 31, 2016, including due to the inclusion of MaxPro and 4Sight in our consolidated results for the first time for the year ended December 31, 2016. Our gross research anddevelopment expenses (before capitalization of eligible software development costs) for the year ended December 31, 2016 totaled $22.0 million compared to $16.2 million in the year ended December 31, 2015. Such increase of 35.8% was attributable to the same factor related to the increase in our net research and development expenses.Capitalization of software development costs accounted for $5.5 million of our research and development expenses, net for the year ended December 31, 2016 compared to $6.0 million in the year ended December 31, 2015, constituting a non-material change from one such year to the other.

Selling, marketing, general and administrative, or SMG&A, expenses were $44.5 million for the year ended December 31, 2016 compared to $39.9 million in theyear ended December 31, 2015.The increase was attributable to a greater investment in our sales and marketing organizations team and our increased marketing expenses to support our brands and expand sales opportunities, including due to the inclusion of MaxPro and 4Sight in our consolidated results for the first time for the year ended December 31, 2016, which was evidenced by the 16.5% increase in our revenues in the year ended December 31, 2016. As a percentage of total revenues, our SMG&A decreased from 21.5% in the year ended December 31, 2015 to 20.6% for the year ended December 31, 2016, constituting a non-material change from one such period to the other.

Operating income

Operating income and operating income as a percentage of total revenues for the years ended December 31, 2015 and 2016, respectively, as well as the percentage change in operating income between such periods, were as follows:

($ in thousands) Year ended
December 31, 
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Operating income $24,350   2.0% $24,840 
Percentage of total revenues  13.1%      11.5%

The increase in our operating income during the year ended December 31, 2016 relative to theyear ended

December 31, 2015 as an absolute amount, and the decrease in operating income as a percentage of our revenues, as reflected in the above table, were attributable to the various gross profit and operating expenses trends described above.

Financial income, net

The amount of our financial income, net, for the years ended December 31, 2015 and 2016, respectively, and the percentage of our revenues for those respective periods constituted by such amounts, as well as the percentage change in such amounts between such periods, were as follows:

($ in thousands) Year ended
December 31,
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Financial income, net $163   227.0% $533 
Percentage of total revenues  0.1%      0.2%

40

Financial income, net, was $0.5 million for the year ended December 31, 2016 compared to financial income of $0.2 million in theyear ended December 31, 2015.

We engage in economic hedging in order to help protect against fluctuation in foreign currency exchange rates. Instruments that we use to manage currency exchange risks may include foreign currency forward contracts. The purpose of our foreign currency hedging activities is to reduce our exposure, from the perspective of our profitability, to the risks that arise from the adverse impact that exchange rates bear on our revenues and expenses that are denominated in non-U.S. currencies. These instruments are used selectively to manage risks, but there can be no assurance that we will be fully protected against material foreign currency fluctuations. We do not use these instruments for speculative or trading purposes.

Taxes on income

Taxes on income, both as a dollar value and as a percentage of income before taxes on income, for the years ended December 31, 2015 and 2016, respectively, as well as the percentage change in the amount of taxes on income between such periods, were as follows:

($ in thousands) Year ended
December 31,
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Taxes on income $4,213   37.0% $5,772 
As a percentage of income before taxes on income  17.2%      22.7%

The increase in our expense from taxes on income was primarily attributable to an increase in our taxable income in Israel, the United States, APAC and other jurisdictions in which we operate. In addition, during the year ended December 31, 2016, certain of our subsidiaries in Israel and the UK became subject to tax liability following the utilization of tax benefits in previous years.

Our effective income tax rate varies from period to period as a result of the various jurisdictions in which we operate, as each jurisdiction has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We do not recognize certain of the deferred tax assets relating to the net operating losses of certain of our subsidiaries worldwide due to the uncertainty of the realization of such tax benefits in the foreseeable future.

Net income attributable to Sapiens shareholders

The amount of net income attributable to Sapiens shareholders and such amount as a percentage of revenues for the years ended December 31, 2015 and 2016, respectively, as well as the percentage change in net income attributable to Sapiens shareholders between such periods, were as follows:

($ in thousands) Year ended
December 31,
2015
  Year-over-
year
change
  Year ended
December 31,
2016
 
Net income attributable to Sapiens shareholders $20,016   (3.4)% $19,336 
Percentage of total revenues  10.8%      8.9%

41

As a percentage of total revenues, our net income attributable to Sapiens shareholders decreased from 10.8% in the year ended December 31, 2015 to 8.9% for the year ended December 31, 2016, reflecting the cumulative effect of all of the above-described line items from our statements of income.

Comparison of the years ended December 31, 2014 and 2015

Revenues

Please refer to “Critical Accounting Policies and Estimatesbelow in this Item 5.A for a description of our accounting policies related to revenue recognition.

Our overall revenues increased by $28.2 million, or 17.9%, to $185.6 million for the year ended December 31, 2015 from $157.4 million for the year ended December 31, 2014, as shown in the table below.

  Year ended
December 31,
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
($ in thousands)  157,450   17.9%  185,636 

Revenues are derived primarily from implementation of our solutions and post-implementation services such as ongoing support and maintenance and professional services as part of an overall solution that we offer to our customers. The increase in revenues for the year ended December 31, 2015 is attributed to organic growth of approximately $25.6 million, primarily due to implementation and professional services generated from existing and new customers, which were offset in part, in an amount of $11.6 million, due to the devaluation of foreign currencies (in which revenues were received) relative to the U.S. dollar. The increase was furthermore due to $14.2 million of revenues attributable to Ibexi and Insseco, the results of which were included in our consolidated results for the first time for the year ended December 31, 2015 (in the case of Insseco, for the full year ended December 31, 2015, due to the pooling of interest accounting treatment accorded to the acquisition of Insseco).

Revenues by geographical region

The dollar amount and percentage share of our revenues attributable to each of the geographical regions in which we conduct our operations for the year ended December 31, 2014 and 2015, respectively, as well as the percentage change between such periods, were as follows:

  

Year ended

December 31, 2014

  Year-over-  

Year ended

December 31, 2015

 
($ in thousands) Revenues  Percentage  year change  Revenues  Percentage 
Geographical region               
                
North America* $49,585   31.5%  23.7% $61,332   33.0%
United Kingdom  34,961   22.2%  21.8%  42,580   22.9%
Rest of Europe  28,351   18.0%  16.0%  32,897   17.7%
Israel  28,821   18.3%  (1.8)%  28,315   15.3%
Asia Pacific  15,732   10.0%  30.4%  20,512   11.0%
                     
Total $157,450   100%  17.9% $185,636   100%

*Revenue amounts for North America that are shown in the above table consist of revenues from the United States, except for approximately $0.6 million and $0.5 million of revenues generated in Canada in the years ended December 31, 2014 and 2015, respectively.

42

Our revenues in North America increased by $11.7 million, or 23.7%, to $61.3 million for the year ended December 31, 2015 from $49.6 million for the year ended December 31, 2014, due toan increase in revenues from our existing and new customers.

Our revenues in the United Kingdom increased by $7.6 million, or 21.8%, to $42.6 million in the year ended December 31, 2015 from $35.0 million in the year ended December 31, 2014. The increase was attributable to an increase in revenues from our existing and new customers.

Our revenues in the Rest of Europe increased by $4.5 million, or 16.0%, to $32.9 million in the year ended December 31, 2015 from $28.4 million in the year ended December 31, 2014. The increase was attributable, in primary part to an increase of $10.5 million due to the consolidation of Insseco’s results with our results for the year ended December 31, 2015, as described above, offset, in part, by a decrease of $5.8 million in our other revenues related to our various products.

Our revenues in Israel decreased by $0.5 million, or 1.8%, to $28.3 million in the year ended December 31, 2015 from $28.8 million in the year ended December 31, 2014.

Our revenues in Asia Pacific, or APAC, increased by $4.8 million, or 30.4%, to $20.5 million in the year ended December 31, 2015 from $15.7 million in the year ended December 31, 2014. The increase was attributable primarily to an increase of $3.5 million of revenues attributable to Ibexi, the results of which were included in our consolidated results for the first time for the year ended December 31, 2015.

Cost of Revenues

Our cost of revenues for the years ended December 31, 2014 and 2015, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those years, are provided in the below table:

($ in thousands) Year ended
December 31,
2014
  Year-over-
year
change
  Year ended 
December 31,
2015
 
Cost of revenues $99,095   12.2% $111,192 
Cost of revenues as a percentage of revenues  62.9%      59.9%

Our cost of revenues increased by $12.1 million, or 12.2%, to $111.2 million for the year ended December 31, 2015, ascompared to $99.1 million for the year ended December 31, 2014. Cost of revenues decreased as a percentage of our revenues during the year ended December 31, 2015, to 59.9% as compared to 62.9% during the year ended December 31, 2014. The increase in absolute cost of revenues was related to the increase in revenues during the year ended December 31, 2015 relative to the year ended December 31, 2014, including an increase in cost of revenues of $9.8 million related to the increase of $14.2 million of revenues due to the acquisitions of, and consolidation in our financial results of, Insseco and Ibexi, in the aggregate, for the year ended December 31, 2015 (in the case of Insseco, for the full year ended December 31, 2015, due to the pooling of interest accounting treatment accorded to the acquisition of Insseco). The decrease in the cost of revenues as a percentage of our revenues during the year ended December 31, 2015 was primarily attributable to our efficiency program that we initiated at the end of 2014, which included, among other factors, hiring of employees in replacement of subcontractors, as well as, recruitment of offshore employees who bore a lower cost to us. In addition, the erosion in the value of the New Israeli Shekel relative to the U.S. dollar reduced our cost of revenues as recorded in U.S. dollars.

43

Gross profit

Our gross profit for the years ended December 31, 2014 and 2015, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those periods, are provided in the below table:

($ in thousands) Year ended
December 31,
2014
  Year over-
year
change
  Year ended 
December 31,
2015
 
Gross profit $58,355   27.6% $74,444 
Gross profit as a percentage of revenues  37.1%      40.1%

Our gross profit increased by $16.0 million, or 27.6%, to $74.4 million for the year ended December 31, 2015, as compared to $58.4 million for theyear ended December 31, 2014. This increase was primarily attributable to the absolute increase in our revenues by $28.2 million for the year ended December 31, 2015 compared to theyear ended December 31, 2014. The increase in gross profit as a percentage of revenues for the year ended December 31, 2015 was due to the factors described above with respect to the decrease in our cost of revenues as a percentage of revenues.

Operating expenses

The amount of each category of operating expense for the years ended December 31, 2014 and 2015, respectively, as well as the percentage change in each such expense category between such periods, and the percentage of our revenues constituted by our total operating expenses in each such period, is provided in the below table:

($ in thousands) Year ended 
December 31, 
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
Research and development, net $11,352   (9.8)% $10,235 
Selling, marketing, general and administrative  32,097   24.2%  39,859 
Total operating expenses $43,449   15.3% $50,094 
Percentage of total revenues  27.6%      27.0%

Research and development expenses, net decreased by 9.8% for the year ended December 31, 2015 compared to theyear ended December 31, 2014. Such decrease was primarily attributable toerosion in the value of the New Israeli Shekel relative to the U.S. dollar, which reduced our research and development expenses (consisting primarily of salaries of research and development employees) as recorded in U.S. dollars, as a majority of our research and development employees are based in Israel. This decrease was also attributable to a shift in the utilization of our research and development employees for project delivery activities to support the growing demand for our products and services in the year ended December 31, 2015. Our gross research anddevelopment expenses for the year ended December 31, 2015 totaled $16.2 million compared to $17.5 million in the year ended December 31, 2014. Such decrease of 6.8% was attributable to the same factors related to the decrease in our net research and development expenses.Capitalization of software development costs accounted for $6.0 million of our research and development expenses net for the year ended December 31, 2015 compared to $6.1 million in the corresponding period of 2014, constituting a non-material change from one such period to the other.

Selling, marketing, general and administrative, or SMG&A, expenses were $39.9 million for the year ended December 31, 2015 compared to $32.1 in theyear ended December 31, 2014.The increase was attributable to a greater investment in our sales and marketing organizations team and our increased marketing expenses to support our brands and expand sales opportunities. In addition, the increase in SMG&A was attributable, in an amount of $2.9 million, to the inclusion of the SMG&A of Insseco and Ibexi, in the aggregate, in our consolidated SMG&A for the first time during the year endedDecember 31, 2015, due to the acquisitions of Insseco and Ibexi, as described above(in the case of Insseco, for the full year ended December 31, 2015, due to the pooling of interest accounting treatment accorded to the acquisition of Insseco). As a percentage of total revenues, our SMG&A increased from 20.4% in the year ended December 31, 2014 to 21.5% for the year ended December 31, 2015, constituting a non-material change from one such period to the other.

44

Operating income

Operating income and operating income as a percentage of total revenues for the years ended December 31, 2014 and 2015, respectively, as well as the percentage change in operating income between such periods, were as follows:

($ in thousands) Year ended
December 31,
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
Operating income $14,906   63.4% $24,350 
Percentage of total revenues  9.5%      13.1%

The increase in our operating income during the year ended December 31, 2015 relative to theyear ended December 31, 2014, both as an absolute amount and as a percentage of our revenues, as reflected in the above table, was attributable to the various gross profit and operating expenses trends described above.

Financial income, net

The amount of our financial income, net, for the years ended December 31, 2014 and 2015, respectively, and the percentage of our revenues for those respective periods constituted by such amounts, as well as the percentage change in such amounts between such periods, were as follows:

($ in thousands) Year ended
December 31,
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
Financial income, net $124   31.5% $163 
Percentage of total revenues  0.1%      0.1%

Financial income, net, were $0.2 million for the year ended December 31, 2015 compared to financial income of $0.1 million in theyear ended December 31, 2014.

We engage in economic hedging in order to help protect against fluctuation in foreign currency exchange rates. Instruments that we use to manage currency exchange risks may include foreign currency forward contracts. The purpose of our foreign currency hedging activities is to protect our company from the risk that the eventual dollar cash flows from our international activities will be adversely affected by changes in the exchange rates. These instruments are used selectively to manage risks, but there can be no assurance that we will be fully protected against material foreign currency fluctuations. We do not use these instruments for speculative or trading purposes.

Taxes on income

Taxes on income, both as a dollar value and as a percentage of income before taxes on income, for the years ended December 31, 2014 and 2015, respectively, as well as the percentage change in the amount of taxes on income between such periods, were as follows:

($ in thousands) Year ended
December 31,
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
Taxes on income $454   828.0% $4,213 
As a percentage of income before taxes on income  3.0%      17.2%

The increase in our expense from taxes on income was primarily attributable to an increase in our taxable income in Israel, the United States, APAC and other jurisdictions in which we operate. In addition, during the year ended December 31, 2014, we had in place a valuation allowance on one of our subsidiaries’ accumulated tax losses. By the end of 2014, we had a deferred tax asset with respect to those losses, which was subsequently utilized during the year ended December 31, 2015.

45

Our effective income tax rate varies from period to period as a result of the various jurisdictions in which we operate, as each jurisdiction has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We do not recognize certain of the deferred tax assets relating to the net operating losses of certain of our subsidiaries worldwide due to the uncertainty of the realization of such tax benefits in the foreseeable future.

Net income attributable to Sapiens shareholders

The amount of net income attributable to Sapiens shareholders and such amount as a percentage of revenues for the years ended December 31, 2014 and 2015, respectively, as well as the percentage change in net income attributable to Sapiens shareholders between such periods, were as follows:

($ in thousands) Year ended
December 31,
2014
  Year-over-
year
change
  Year ended
December 31,
2015
 
Net income attributable to Sapiens shareholders $14,463   38.4% $20,016 
Percentage of total revenues  9.2%      10.8%

As a percentage of total revenues, our net income attributable to Sapiens shareholders increased from 9.2% in the year ended December 31, 2014 to 10.8% for the year ended December 31, 2015, reflecting the cumulative effect of all of the above-described line items from our statements of income.

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with U.S. GAAP. The preparation of our financial statements required us to make estimations and judgments that affect the reporting amounts of assets, liabilities, revenues and expenses and related disclosure of contingent assets and liabilities within the reporting period. We have based our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis of making judgments about the values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. More detailed descriptions of these policies are provided in Note 2 to our consolidated financial statements included under Item 18 of this annual report.

 

We believe that the following critical accounting policies affect the estimates and judgments that we made in preparing our consolidated financial statements:

 

·Revenue Recognition

 

·Marketable Securities

·Business CombinationCombinations

 

·Goodwill, long lived assets and other identifiable intangible assets

 

·Taxes on Income

46

 

Revenue Recognition

 

We generate revenues from sales of software licenses which normally include significant implementation services that are considered essential to the functionality of the software license. In addition, we generate revenues from post implementation consulting services and maintenance services.

Sales of software licenses are recognized when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, and collectability is probable. We consider all arrangements with payment terms extending beyond six months from the delivery of the elements, not to be fixed or determinable. If the fee is not fixed or determinable, revenue is recognized as payments become due from the customer, provided that all other revenue recognition criteria have been met.

 

We usually sell our software licenses as part of an overall solution offered to a customer that combines the sale of software licenses which normally include significant implementation and that is considered essential to the functionality of the license. We account for the services (either fixed price or T&M -Time and Materials) together with the software under contract accounting using the percentage-of-completion method in accordance with Accounting Standards Codification, or ASC, 605-35, “Construction-Type and Production-Type Contracts”. The percentage of completion method is used when the required services are quantifiable, based on the estimated number of labor hoursdirect costs necessary to complete the project, and under that method revenues are recognized using labor hoursactual project direct costs incurred as the measure of progress towards completion. The revenues recognized are limited to revenues derived from our enforceable right to receive payment for services that we provide in accordance with our contract with our customer.

 

The use of the percentage-of-completion method for revenue recognition requires the use of various estimates, including among others, the extent of progress towards completion, contract completion costs and contract revenue. Profit to be recognized is dependent upon the accuracy of estimated progress, achievement of milestones and other incentives and other cost estimates. Such estimates are dependent upon various judgments we make with respect to those factors, and some are difficult to accurately determine until the project is significantly underway. Progress is evaluated each reporting period. We recognize adjustments to profitability on contracts utilizing the percentage-of-completion method on a cumulative basis, when such adjustments are identified. We have a history of making reasonably dependable estimates of the extent of progress towards completion, contract revenue and contract completion costs on our long-term contracts. However, due to uncertainties inherent in the estimation process, it is possible that actual completion costs may vary from estimates.

 

If our actual results turn out to be materially different tothan our estimates, or we do not manage the project properly within the projected periods of time or satisfy our obligations under the contract, project margins may be significantly and negatively affected, which may result in losses on existing contracts. Any such reductions in margins or contract losses in a large, fixed-price contract may have a material adverse impact on our results of operations.operations.

 

In accordance with Accounting Standards Codification, or ASC, 985-605, we establishedthe Company establishes Vendor Specific Objective Evidence, or VSOE, of fair value of maintenance services (PCS) based on the Bell-Shaped approach and determined VSOE for PCS, based on the price charged when the element is sold separately (that is, the actual renewal rate). Our process for establishing VSOE of fair value of PCS is through performance of VSOE compliance test which is an analysis of the entire population of PCS renewal activity for its installed base of customers.

 

Provisions for estimated losses on contracts in progress are made in the period in which they are first determined, in the amount of the estimated loss on the entire contact. Provisions for estimated losses are presented in accrued expenses and other liabilities.

 

In addition, we derive a significant portion of our revenues from post implementation consulting services provided on a time and materials, or T&M, basis, which are recognized as services are performed.

 

Maintenance revenue is recognized ratably over the term of the related maintenance agreement.

 

Deferred revenues and customer advances include unearned amounts received under maintenance and support agreements and amounts received from customers, for which revenues have not yet been recognized.

 

We perform ongoing credit evaluations on our customers. Under certain circumstances, we may require prepayment. An allowance for doubtful accounts is determined with respect to those amounts that we determine to be doubtful of collection. Provisions for doubtful accounts were recorded in general and administrative expenses.

47

Marketable Securities

We account for all our investments in debt securities in accordance with ASC 320, “Investments - Debt and Equity Securities”. We classify all debt securities as “available-for-sale”. All of our investments in available-for-sale securities are reported at fair value. Unrealized gains and losses are comprised of the difference between fair value and the amortized cost of such securities and are recognized, net of tax, in accumulated other comprehensive income (loss).

The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in “financial income, net”.

We recognize an impairment charge when a decline in the fair value of our investments in debt securities below the cost basis of such securities is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and our intent to sell, including whether it is more likely than not that we will be required to sell the investment before recovery of cost basis. For securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in “net gain on sale of marketable securities previously impaired” in the statements of income and is limited to the amount related to credit losses, while impairment related to other factors is recognized in other comprehensive income.

Business CombinationCombinations

 

According to ASC 805 “Business Combination” we are required to allocate the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values. In allocating the purchase price of acquired companies to the tangible and intangible assets acquired and liabilities assumed, we developed the required assumptions underlying the valuation work. Critical estimates in developing such assumptions underlying the valuing of certain of the intangible assets include but are not limited to: future expected cash flows from customer contracts, acquired developed technologies and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, utilizing a market participant approach, but which are inherently uncertain and unpredictable. Assumptions may be incomplete or inaccurate, and unanticipated events and circumstances may occur. We were assisted by third party valuators in applying the required economic models (such as income approach), in order to estimate the fair value of assets acquired and liabilities assumed in our business combination transaction.transactions.

For the year ended December 31, 2015, we implemented the pooling of interest accounting method with respect to our acquisition of Insseco.We applied the pooling of interest accounting method with respect to this acquisition because we and Insseco were under common control. Thus, our balance sheet as of December 31, 2014 was adjusted to reflect the carrying amounts combination between our company and Insseco.

 

Goodwill, long lived assets and other identifiable intangible assets

 

Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350,” Intangibles—Intangibles - Goodwill and Other”, goodwill is subject to an annual impairment test or more frequently if impairment indicators are present. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. Previously, we operated in two reporting units: Sapiens and IDIT. Following a reorganization in 2013, our Sapiens reporting unit was divided into three reporting units: Sapiens, FIS and Decision. The goodwill was allocated based on the relative fair value of these three reporting units. As a result of this reorganization, we now operatecompany operates in a total of four reporting units: Sapiens, FIS,Emerge, L&P, Decision and IDIT.P&C.

 

In September 2011,We applied the FASB issued ASU 2011-08, which amended the rulesprovisions of ASC 350 for testing goodwill for impairment.our annual impairment test. Under the new rules,provisions, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If after assessing the totality of events or circumstances, an entity determines it isqualitative assessment does not result in a more likely than not that the fair valueindication of impairment, no further impairment testing is required.

We performed a reporting unit is less than its carrying amount, then performing the two-step impairment test is unnecessary.

In 2011, we adopted the provisions of ASU 2011-08 for our annual impairment test inqualitative assessment during the fourth quarter of each year. This analysis determinedof 2014, 2015 and 2016 and concluded that no indicatorsthe qualitative assessment did not result in a more likely than not indication of impairment, existed primarily because (1) our market capitalization has consistently exceeded our book value by a sufficient margin, (2) our overall financial performance has been stable since the acquisition, and, (3) forecasts of operating income and cash flows appear sufficient to support the book values of the net assets of each reporting unit.therefore, no further impairment testing was required.

48

 

Nevertheless, it is possible that our determination that goodwill for a reporting unit is not impaired could change in the future if current economic conditions deteriorate or remain difficult for an extended period of time. We continue to monitor the relationship between our market capitalization and book value, as well as the ability of our reporting units to deliver current and income and cash flows sufficient to support the book values of the net assets of their respective businesses.

 

As of December 31, 2013,2016, we had a total of $30.0$28.4 million of intangible assets, , primarily comprised of which $20.8 million were attributable to capitalized software development costs, and the remainder of which were acquired as well as core technology and customer relationship mainly from the acquisitionspart of IDIT and FIS in August 2011.our prior acquisitions.

 

In accordance with ASC 360, “Property, Plant and Equipment”, or ASC 360, our long-lived assets are reviewed for impairment annually and whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. In measuring the recoverability of assets, we are required to make estimates and judgments in assessing our forecast and cash flows and compare that with the carrying amount of the assets. Additional significant estimates used by management in the methodologies used to assess the recoverability of our long-lived assets include estimates of future cash-flows, future short-term and long-term growth rates, market acceptance of products and services, and other judgmental assumptions, which are also affected by factors detailed in our Risk Factors section in this annual report (see Item 3, “Key“Item 3.D. Key Information – Risk Factors”). If these estimates or the related assumptions change in the future, we may be required to record impairment charges for our long-lived assets.

 

We evaluate our intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of such assets may not be recoverable, in accordance with ASC 360 (as described above). In evaluating potential impairment of these assets, we specifically consider whether any indicators of impairment are present, including, but not limited to whether there:

 

·has been a significant adverse change in the business climate that affects the value of an asset;

·has been a significant change in the extent or manner in which an asset is used; and/or

 

·is an expectation that the asset will be sold or disposed of before the end of its originally estimated useful life.

 

If indicators of impairment are present, we compare the estimated undiscounted cash flows that the specific asset is expected to generate to its carrying value. These estimates involve significant subjectivity. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the asset exceeds its fair value.

 

Our policy for capitalized software costs determines the timing of our recognition of certain development costs. Software development costs incurred from the point of reaching technological feasibility until the time of general product release are capitalized. We define technological feasibility as the completion of a detailed program design. The determination of technological feasibility requires the exercise of judgment by our management. Since we sell our products in a market that is subject to rapid technological changes, new product development and changing customer needs, changes in circumstances and estimations may significantly affect the timing and the amounts of software development costs capitalized and thus our financial condition and results of operations.

 

Capitalized software development costs are amortized commencing with general product release by the straight-line method over the estimated useful life of the software product (between 3-7five to seven years). We assess the recoverability of this intangible asset on a regular basis by determining whether the amortization of the asset over its remaining life can be recovered through undiscounted future operating cash flows from the specific software product sold.

 

49

Taxes on Income

 

We account for income taxes in accordance with ASC 740 “Income Taxes”., or ASC 740. ASC 740 prescribes the use of the asset and liability method, whereby deferred tax assets and liability account balances are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Future realization of our deferred tax assets ultimately depends on the existence of sufficient taxable income within the available carryback or carryforward periods. Sources of taxable income include future reversals of existing taxable temporary differences, future taxable income, taxable income in prior carryback years and tax planning strategies. We record a valuation allowance to reduce our deferred tax assets to an amount we believe is more likely than not to be realized. Changes in our valuation allowance impact income tax expense in the period of adjustment. Our deferred tax valuation allowances require significant judgment and uncertainties, including assumptions about future taxable income that are based on historical and projected information.

ASC 740 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740, a company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. We assess our income tax positions and record tax benefits based upon management’s evaluation of the facts, circumstances, and information available at the reporting date. For those tax positions where it is more-likely-than-not that a tax benefit will be sustained, we record the largest amount of tax benefit with a greater than 50 percent likelihood of being realized upon ultimate settlement with a taxing authority having full knowledge of all relevant information. For those income tax positions where it is not more-likely-than-not that a tax benefit will be sustained, no tax benefit is recognized in the financial statements. We classify liabilities for uncertain tax positions as non-current liabilities unless the uncertainty is expected to be resolved within one year. We classify interest as financial expenses and penalties as selling, marketing, general and administration expenses.

 

As a global company, we use significant judgment to calculate and provide for income taxes in each of the tax jurisdictions in which we operate. In the ordinary course of our business, there are transactions and calculations undertaken whose ultimate tax outcome cannot be certain. Some of these uncertainties arise as a consequence of transfer pricing for transactions with our subsidiaries and tax credit estimates. In addition, the calculation of acquired tax attributes and the associated limitations are complex and although our income tax reserves are based on our best knowledge, we may be subject to unexpected audits by tax authorities in the various countries where we have subsidiaries, which may result in material adjustments to the reserves established in our consolidated financial statements and have a material adverse effect on our results of operations. We estimate our exposure to unfavorable outcomes related to these uncertainties and estimate the probability for such outcomes.

 

Although we believe our estimates are reasonable, no assurance can be given that the final tax outcome will not be different from what is reflected in our historical income tax provisions, returns, and accruals. Such differences, or changes in estimates relating to potential differences, could have a material impact on our income tax provision and operating results in the period in which such a determination is made.

Recent Accounting Pronouncements

 

In July 2013,May 2014, the FinancialFASB issued Accounting Standards Board, orUpdate No. 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date.  The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. We currently anticipate adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). We preliminarily anticipate adopting the standard using the modified retrospective method. However, we are continuing to evaluate the impact of the standard on our consolidated financial statements and related disclosures and the adoption method is subject to change.

50

In February 2016, the FASB issued ASU 2016-02, “Leases” (Topic 842), whereby, lessees will be required to recognize for all leases at the commencement date a lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that requires thatrepresents the lessee’s right to use, or control the use of, a nonrecognized tax benefit bespecified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. A modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. This net presentation is required unless a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date or the tax law of the jurisdiction doesmust be applied. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Companies may not apply a full retrospective transition approach. ASU 2016-02 is effective for annual and interim periods beginning after December 15, 2018. Early application is permitted. We are evaluating the entity does not intendpotential impact of this pronouncement.

In March 2016, the FASB issued ASU 2016-09, which provides for improvements to use, the deferred tax asset to settle any additional income tax that would result from the disallowance of the unrecognized tax benefit. This guidanceemployee share-based payment accounting. ASU 2016-09 is effective for fiscal yearyears, and interim periods within those years, beginning after December 15, 2013, with early adoption permitted.2016. ASU 2016-09 simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. We believedo not expect that the adoption of this standardnew guidance will not have a material impact on our consolidated financial statements.

 

In March 2013,April 2016, the FASB issued furtherASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-10”), which clarifies the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendments do not change the core principle of the guidance on accounting for the release of a cumulative translation adjustment into net income when a parent company either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets and provides guidance for the acquisition in stages of a controlling interest in a foreign entity. ThisTopic 606. The new guidance is effective for fiscal yearsannual periods beginning after December 15, 2013,2017, including interim periods within those annual periods, which will be our interim period beginning January 1, 2018. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods with that reporting period. We are evaluating the impact of this standard.

In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. This guidance will be effective for us in the first quarter of 2018 and early adoption is permitted. We believeare still evaluating the effect that the adoption of this standardguidance will not have a material impact on our consolidated financial statements.

In February 2013, the FASB issued ASU No. 2013-02, “Reporting of Amounts Reclassified out of Accumulated Other Comprehensive Income.” Under ASU 2013-02, an entity is required to provide information about the amounts reclassified out of Accumulated Other Comprehensive Income, or AOCI, by component. In addition, an entity is required to present, either on the face of the financial statements or in the notes, significant amounts reclassified out of AOCI by the respective line items of net income, but only if the amount reclassified is required to be reclassified in its entirety in the same reporting period. For amounts that are not required to be reclassified in their entirety to net income, an entity is required to cross-reference to other disclosures that provide additional details about those amounts. ASU 2013-02 does not change the current requirements for reporting net income or other comprehensive income in the financial statements. ASU 2013-02 is effective for our company on January 1, 2013. Since this standard only impacts presentation and disclosure requirements, its adoption did not have a material impact on our consolidated results of operations or financial condition.

A.          Operating Results.The following tables set forth certain data from our results of operations for the years ended December 31, 2012 and 2013, as well as such data as a percentage of our revenues for those years. The data has been derived from our audited consolidated financial statements included in this annual report. The operating results for the below years should not be considered indicative of results for any future period. This information should be read in conjunction with the audited consolidated financial statements and notes thereto included in this annual report.related disclosures.

 

Statement of Income Data
(U.S. dollars, in thousands, except share and per share data)

  Year ended
December 31,
 
  2012  2013 
Revenues $113,909  $135,377 
Cost of revenues  66,459   84,971 
Gross profit  47,450   50,406 
Operating expenses:        
Research and development, net  10,169   11,846 
Selling, marketing, general and administrative  25,236   26,677 
Total operating expenses  35,405   38,523 
Operating income  12,045   11,883 
Financial income, net  193   520 
Income before taxes on income  12,238   12,403 
Taxes on income  (435)  (811)
Net income  11,803   11,592 
Attributable to non-controlling interests  23   (12)
Net income attributable to Sapiens' shareholders $11,780  $11,604 

44

Statement of Income Data as a Percentage of Revenues

  Year ended
December 31,
 
  2012  2013 
Revenues  100.0%  100.0%
Cost of revenues  58.3%  62.8%
Gross profit  41.7%  37.2%
Operating expenses:        
Research and development, net  8.9%  8.8%
Selling, marketing, general and administrative  22.2%  19.7%
Total operating expenses  31.1%  28.5%
Operating income  10.6%  8.8%
Financial income, net  0.1%  0.4%
Income before taxes on income  10.7%  9.2%
Taxes on income  0.3%  0.6%
Net income  10.4%  8.6%
Attributable to non-controlling interests  0.1%  0.0%
Net income attributable to Sapiens' shareholders  10.3%  8.6%

Comparison of the Years ended December 31, 2012 and 2013

Revenues

Our overall revenues increased by $21.5 million, or 18.8%, to $135.4 million for the year ended December 31, 2013 from $113.9 million in the year ended December 31, 2012. This growth in revenues was generated from an increase of $5.1 million in sales of licenses of our software solutions and an increase of $16.3 million in revenues from project delivery and implementation services, support and maintenance services and other post implementation professional services.

A breakdown of our overall revenues into license and services revenues for the years ended December 31, 2012 and 2013, the percentage those respective categories of revenues constituted out of our total revenues in those years, and the percentage change for each such category of revenues from 2012 to 2013, are provided in the below table:

  Year ended December
31, 2012
  Year-over-
year
  Year ended December 31,
2013
 
  Revenues  Percentage  change  Revenues  Percentage 
Revenue category ($ in thousands) 
License $10,025   8.8%  49.8% $15,164   11.2%
Services  103,884   91.2%  15.7%  120,213   88.8%
Total $113,909   100%  18.8% $135,377   100%

License revenues are primarily comprised of revenues that we realize from a perpetual license and also from term based software licenses as part of an overall solution that we offer to our customers and sales of upgrades to our software. License revenues in 2013 increased by $5.1 million, or 51.3%, to $15.2 million, of which 52.1%, or $2.7 million, was attributable to increase in sales of licenses as part of implementation of new projects and progress in our implementation of ongoing projects in North America.

Service revenues are comprised of implementation services related to our solutions and post-implementation services such as ongoing support and maintenance, and professional services.

Revenues from services in 2013 increased by $16.3 million, or 15.7%, to $120.2 million, of which 71%, or $11.7 million, was attributable to an increase in services revenues from new implementation projects and progress in our implementation of ongoing projects in Europe (including the United Kingdom).

Revenues by geographical region

The dollar amount and percentage share of our revenues attributable to each of the geographical regions in which we conduct our operations for the years ended December 31, 2012 and 2013, respectively, as well as the percentage change between such years, were as follows:

  Year ended December
31, 2012
  Year-over-
year
  Year ended December 31,
2013
 
($ in thousands) Revenues  Percentage  change  Revenues  Percentage 
Geographical region                    
North America* $35,519   31%  25% $44,237   33%
United Kingdom  26,630   24%  17%  31,115   23%
Rest of Europe  16,140   14%  54%  24,862   18%
Israel  23,100   20%  -   23,009   17%
Asia Pacific  12,520   11%  (3)%  12,154   9%
Total $113,909   100%  19% $135,377   100%

*Revenue amounts for North America that are shown in the above table consist of revenues from the United States, except for approximately $1.9 million and $1.1 million of revenues generated in Canada in the years ended December 31, 2012 and 2013, respectively.

Our revenues in North America increased by $8.7 million, or 25%, to $44.2 million in the year ended December 31, 2013 from $35.5 millionin the year ended December 31, 2012. An increase of $6.0 million or, 69% was attributable to increase in services revenues related to our various products in North America.

Our revenues in the United Kingdom increased by $4.5 million, or 17%, to $31.1 million in the year ended December 31, 2013 from $26.6 millionin the year ended December 31, 2012. The vast majority of the increase—96%, or $4.3 million—was attributable to an increase in services revenues related to our various productsinthe United Kingdom.

Our revenues in the Rest of Europe increased by $8.7 million, or 54%, to $24.9 million in the year ended December 31 2013 from $16.1 millionin the year ended December 31, 2012. 89% of such increase, or $7.7 million was attributable to an increase in services revenues related to our various products inthe Rest of Europe.

Our revenues in Asia Pacific, or APAC, decreased by 3%, year over year, in the year ended December 31 2013, representing a non-material change.

We expect our revenues to continue to increase in 2014 from ongoing projects and from new projects we expect to begin in 2014. In particular, we anticipate that significant sources of growth in our revenues will be (i) recurring revenues from existing clients and (ii) sales in North America and Europe.

Cost of revenues

Our cost of revenues for the years ended December 31, 2012 and 2013, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those years, are provided in the below table:

($ in thousands) Year ended 
December
31, 2012
  Year-over-
year
change
  Year ended 
December 31,
2013
 
Cost of revenues $66,459   27.9% $84,971 
Cost of revenues as a percentage of revenues  58.3%      62.8%

Our cost of revenues increased by $18.5 million, or 27.9%, to $85.0 million for the year ended December 31, 2013, ascompared to $66.5 million in the year ended December 31, 2012. Cost of revenues also increased as a percentage of our revenues in the year ended December 31, 2013, to 62.8%, as compared to 58.3% during the year ended December 31, 2012.

Cost of revenues was comprised of salaries and other personnel-related expenses of software consultants and engineers of $68.5 million, or 80.6% of our total costs of revenues in 2013, compared to $53.0 million, or 79.8% of our total cost of revenues in 2012. The increase in salaries and other personnel-related expenses of $15.5 million (both in absolute terms and as a percentage of revenues) was attributable to our hiring more employees and subcontractors to support the increasing demands for our products. Trips and travels totaled $5.8 million, or 6.8%, of our total cost of revenues in 2013, compared to $3.5 million, or 5.3%, in 2012. Amortization of capitalized software development costs and other intangible assets was $5.4 million, or 6.3%, of our total cost of revenues in 2013 compared to $4.6 million, or 6.9%, of our total cost of revenues, in 2012.

Gross profit

Our gross profit for the years ended December 31, 2012 and 2013, respectively (both in absolute terms and as a percentage of our overall revenues), as well as the percentage change between those years, are provided in the below table:

($ in thousands) Year ended
December 31,
2012
  Year-over-
year
change
  Year ended
December 31,
2013
 
Gross profit $47,450   6.2% $50,406 
Gross profit as a percentage of revenues  41.7%      37.2%

Our gross profit increased by $3.0 million, or 6.2%, to $50.4 million for the year ended December 31, 2013, as compared to $47.5 millionin the year ended December 31, 2012. The decrease in gross profit as a percentage of revenues for the year ended December 31, 2013 was primarily due to our implementation of projects in that year that had a higher cost of revenues, and, consequently, a lower gross margin. Please see the information under “Cost of revenues” above for details concerning the components of, and changes in (from 2012 to 2013), cost of revenues.

Notwithstanding the decrease in gross profit margin for the year ended December 31, 2013 relative to the prior year, we expect our gross profit to continue to increase in line with the increase in our revenues, and we do not anticipate significant changes in our cost of revenues that would adversely impact or improve our gross margins or our gross profit.

Operating expenses

The amount of each category of operating expense for the years ended December 31, 2012 and 2013, respectively, as well as the percentage change in each such expense category between such years, and the percentage of our revenues constituted by our total operating expenses in each such year, is provided in the below table:

($ in thousands) Year
ended
December 31,
2012
  Year-
over-
year
change
  Year ended
December
31, 2013
 
Research and development, net $10,169   16.5% $11,846 
Selling, marketing, general and administrative  25,236   5.7%  26,677 
Total operating expenses $35,405   8.8% $38,523 
Percentage of total revenues  31.1%      28.5%

Research and Development, net

Research and development, or R&D, expenses, net increased by 16.5% for the year ended December 31, 2013 compared tothe year ended December 31, 2012. Such increase was attributable to increased research and development aimed at expediting and deepening our product development efforts as part of our growth strategy. Our gross research and development expenses for the year ended December 31, 2013 totaled $17.2 million compared to $13.6 million in 2012. Such increase of 26.6% is in line with our efforts to support our future growth and support demand for product enhancements and future products.Capitalization of software development costs accounted for $5.4 million of our net research and development expenses for the year ended December 31, 2013, compared to $3.4 millionin the year ended December 31, 2012,reflecting an intensification of our research and development efforts. As a percentage of total revenues, our net research and development expenses constituted 8.9% and 8.8% for the years ended December 31, 2012 and 2013, respectively.

Research and development expenses, gross, included salaries and other personnel-related expenses of software consultants and engineers in amounts of $15.1 million, or 87.4% of the gross R&D expenses, in 2013, compared to $12.5 million, or 92.1% in 2012.Research and development expenses, gross, also includedcapitalized software development costs in 2013 and 2012, in the respective amounts described in the preceding paragraph. Gross R&D expenses were equal to 12.7% of our revenue in 2013 compared to 12% in 2012.

Selling, Marketing, General and Administrative expenses

Selling, Marketing, General and Administrative expenses, or SG&A expenses, increased by 5.7% for the year ended December 31, 2013 compared to the year ended December 31, 2012. As a percentage of total revenues, our SG&A decreased to 19.7% from 22.2%, resulting from our continuing integration activities that are aimed at optimizing our management and administration teams following our acquisitions of IDIT and FIS on August 31, 2011, which have increased the efficiency of our SG&A related activities each year thereafter. SG&A expenses include costs of salaries of sales, marketing, management and administrative employees, office expenses, communications expenses, expenses related to external consultants and other expenses. Salaries and other personnel-related expenses were $14.8 million in each of 2013 and 2012, or 55.5% and 58.5%, of SG&A expenses in those respective years. Trips and travels were $1.8 million, or 6.7%, of SG&A expenses in 2013, compared to $ 1.9 million, or 7.4%, of SG&A expenses in 2012.

We expect to increase our selling and marketing expenses in line with our strategic goal of increasing our presence and the market awareness of our brand by intensifying our marketing efforts and adding distribution channels. While we intend to continue to invest in our selling and marketing efforts, we do not expect the rate of spending for selling and marketing to increase materially as a percentage of our revenues (and this actually decreased as a percentage of our revenues in 2013).

Operating income

Operating income and operating income as a percentage of total revenues for the years ended December 31, 2012 and 2013, respectively, as well as the percentage change in operating income between such years, were as follows:

($ in thousands) Year ended
December
31, 2012
  Year-over-
year
change
  Year
ended
December
31, 2013
 
Operating income $12,045   (1.3%) $11,883 
Percentage of total revenues  10.6%      8.8%

Our operating income was $11.9 million in 2013 compared to $12.0 in 2012. Operating income, as a percentage of revenues, decreased by 1.3% in 2013 compare to 2012, due to the increase in our cost of revenues and our research and development expenses during the year ended December 31, 2013 (as described above), which more than offset the 18.8% increase in our revenues during 2013. In particular, this reflected our implementation of certain projects with higher cost of revenues in 2013.

Financial income, net

The amount of our financial income, net, for the years ended December 31, 2012 and 2013, respectively, and the percentage of our revenues for those respective years constituted by such amounts, as well as the percentage change in such amounts between such years, were as follows:

($ in thousands) Year ended
December
31, 2013
  Year-over-
year
change
  Year
ended
December
31, 2013
 
Financial income, net $193   169.4% $520 
Percentage of total revenues  0.1%      0.4%

Financial income, net, was $0.6 million for year ended December 31, 2013 compared to $0.2 million in the year ended December 31, 2012. This change was attributable to the effects of changes in currency exchange rates.

We engage in economic hedging in order to help protect against fluctuation in foreign currency exchange rates. Instruments that we use to manage currency exchange risks may include foreign currency forward contracts. The purpose of our foreign currency hedging activities is to protect our company from the risk that the eventual dollar cash flows from our international activities will be adversely affected by changes in the exchange rates. These instruments are used selectively to manage risks, but there can be no assurance that we will be fully protected against material foreign currency fluctuations. We do not use these instruments for speculative or trading purposes.

Taxes on income

Taxes on income, both as a stand-alone number and as a percentage of income before taxes on income, for the years ended December 31, 2012 and 2013, respectively, as well as the percentage change in the amount of taxes on income between such years, were as follows:

($ in thousands) Year ended
December
31, 2012
  Year-over-
year
change
  Year
ended
December
31, 2013
 
Taxes on income $435   86.4% $811 
As a percentage of income before taxes on income  3.6%      6.5%

The increase in our expense from taxes on income resulted from an increase in our income in the United States, United Kingdom and other jurisdictions in which we operate, as well as an increase in our deferred tax expenses associated with utilizing a portion of our net operating losses.

Our provision for taxes on income relates to operations in jurisdictions other than Curaçao. Our effective income tax rate varies from year to year as a result of the various jurisdictions in which we operate, as each jurisdiction has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We do not recognize certain of the deferred tax assets relating to the net operating losses of certain of our subsidiaries worldwide due to the uncertainty of the realization of such tax benefits in the foreseeable future. During 2013, there were no major changes in our valuation allowance.

Net income attributable to Sapiens shareholders

The amount of net income attributable to Sapiens shareholders and such amount as a percentage of revenues for the years ended December 31, 2012 and 2013, respectively, as well as the percentage change in net income attributable to Sapiens shareholders between such years, were as follows:

($ in thousands) Year ended
December
31, 2012
  Year-over-
year
change
  Year ended
December
31, 2013
 
Net income attributable to Sapiens shareholders $11,780   (1.5%) $11,604 
Percentage of total revenues  10.3%      8.6%

As a percentage of total revenues, our net income attributable to Sapiens shareholders decreased from 10.3% in the year ended December 31, 2012 to 8.6% for the year ended December 31, 2013, reflecting the cumulative effect of all of the above described line items from our statements of income.

Comparison of theYears ended December 31, 2011 and 2012

Revenues

Our revenues for the years ended December 31, 2011 and 2012, as well as the percentage change between such years, are provided in the below table:

($ in thousands) Year Ended
December
31, 2011
  Year-over-
Year
change
  Year Ended
December
31, 2012
 
Revenues $69.9   62.9% $113.9 

Total revenues increased to $113.9 million in 2012 from $69.9 million in 2011. This increase of $44 million, or 63%, was primarily due to the inclusion of a full year of revenues of the businesses we acquired in August 2011 compared to approximately four months of revenues from those businesses in 2011, and a net increase of $16.2 million in new and ongoing implementation projects, primarily in North America and Europe, in 2012 compared to our pro forma revenue in 2011 assuming that we acquired the new businesses on January 1, 2011.

Revenues by geographical region

The dollar amount and percentage share of our revenues attributable to each of the geographical regions in which we conduct our operations for the years ended December 31, 2011 and 2012, respectively, as well as the percentage change between such years, were as follows:

  Year ended December
31, 2011
  Year-over-
year
  Year ended December 31, 
2012
 
($ in thousands) Revenues  Percentage  change  Revenues  Percentage 
Geographical region                    
North America $20,889   30%  70% $35,519   31%
United Kingdom  14,672   21%  81%  26,630   24%
Rest of Europe  4,870   7%  231%  16,140   14%
Israel  21,470   31%  8%  23,100   20%
Asia Pacific  8,026   11%  56%  12,520   11%
Total $69,927   100%  63% $113,909   100%

Our revenues in North America increased by a total of $14.7 million to $35.6 million in 2012 from $20.9 million in 2011, primarily due to an increase in new and ongoing implementation of Life, Pension and Annuity solutions and the inclusion of a full year of revenues of the businesses we acquired in August 2011 compared to approximately four months of revenues from those businesses in 2011.

Our revenues in Europe, including the United Kingdom, increased by a total of $23.2 million to $42.8 million in 2012 from $19.5 million in 2011 primarily due to the inclusion of a full year of revenues of the businesses we acquired in August 2011 compared to approximately four months of revenues from those businesses in 2011 and an increase in new and ongoing implementation projects in 2012 compared to 2011.

Our revenues in Asia Pacific increased by a total of $4.5 million to $12.5 million in 2012 from $8 million in 2011 primarily due to the inclusion of a full year of revenues of the businesses we acquired in August 2011 compared to approximately four months of revenues from those businesses in 2011 and due to recovery of our offices in Japan from the 2011 crisis.

We expect our revenue to continue to increase in 2013 from ongoing projects and from new projects we expect to begin in 2013.

Cost of Revenues and Gross Profit

Our cost of revenues for the years ended December 31, 2012 and 2011, respectively, as well as the percentage change between those years, are provided in the below table:

($ in thousands) Year ended 
December 31, 
2011
  Year-over-
year
change
  Year ended 
December 31, 
2012
 
Cost of revenues $40,067   65.9% $66,459 
Cost of revenues as a percentage of revenues  57.3%      58.3%

Cost of revenues increased to $66.5 million in 2012 from $40.1 million in 2011. This increase of $26.4 million or 66% was due primarily to an increase in costs of revenues from the inclusion of a full year of costs of revenues of the businesses we acquired in August 2011 compared to approximately four months of costs of revenues from those businesses in 2011 and the increase in new and ongoing implementation projects in 2012 compared to 2011. Cost of revenues was comprised of salaries and other personnel-related expenses of software consultants and engineers of $53 million, or 80% of our total costs of revenues in 2012 compared to $31.6 million, or 79% of our total cost of revenues in 2011. Amortization of capitalized software development costs was $3.8 million, or 6% of our total costs of revenues, in 2012 compared to $4.5 million, or 11% of our total costs of revenues, in 2011.

Our gross profit in 2012 increased by 59% to $47.4 million from $29.9 million in 2011. The gross profit margin in 2012 decreased to 42% compared to 43% at 2011, primarily due to the increase in revenue from implementation of projects in 2012 which has a lower gross margin.

We expect our cost of revenues to continue to increase in line with the increase in revenues.

Operating expenses

The amount of each category of operating expense for the years ended December 31, 2011 and 2012, respectively, as well as the percentage change in each such expense category between such years, and the percentage of our revenues constituted by our total operating expenses in each such year, is provided in the below table:

($ in thousands) Year
ended 
December
31, 
2012
  Year-
over-
year
change
  Year ended
December
31, 2013
 
Research and development, net $5,008   103.1% $10,169 
Selling, marketing, general and administrative  18,113   39.3%  25,236 
Acquisitions-related and restructuring costs  1,115   -   - 
Total operating expenses $24,236   46.1% $35,405 
Percentage of total revenues  34.7%      31.1%

Research and Development, net

Research and development (“R&D”) costs are mainly comprised of labor costs, reduced by capitalization of software development costs.

Research and development costs, net, increased 103% to $10.2 million in 2012 compared to $5 million in 2011. Gross R&D expenses were $13.6 million in 2012 compared to $9.7 million in 2011. This increase of $3.9 million or 40% was due to increased R&D expenses resulting from the inclusion of a full year of R&D expenses related to the businesses we acquired in August 2011 compared to approximately four months of R&D expenses from those businesses in 2011 and increased R&D spending for development of our solutions including our DECISION solution. Salaries and other personnel-related expenses of software consultants and engineers costs comprised 92% of the gross R&D expenses. Capitalization of software development costs were $3.5 million in 2012 compared to $4.7 million in 2011. Gross R&D expenses were equal to 12% of our revenue in 2012 compare to 14% in 2011.

Selling, Marketing, General and Administrative expenses

Selling, Marketing, General and Administrative expenses (“SG&A expenses”) include costs of salaries of sales, marketing, management and administrative employees, office expenses, communications, external consultants and other expenses.

SG&A expenses increased to $25.2 million in 2012 from $18.1 million in 2011. This increase of $7.1 million, or 39%, was primarily due to increased headcount in our global sales team, marketing and management and administration and the inclusion of a full year of SG&A expenses related to the businesses we acquired in August 2011 compared to approximately four months of SG&A expenses from those businesses in 2011 offset by post-merger integration activities to optimize our management and administration teams. Salaries and other personnel-related expenses were $14.8 million, or 58% of SG&A expenses, in 2012 compared to $9.9 million or 54% of SG&A expenses, in 2011. The increase in salary and other personnel related expenses resulted primarily from the inclusion of a full year of salary and personnel related expenses and the addition of new sales and marketing personnel. SG&A expenses were equal to 22% and 26% of revenue in 2012 and 2011, respectively.

Acquisition-related and restructuring costs

There were no such costs in 2012. In 2011, acquisition-related and restructuring costs were $1.1 million and consisted of $0.5 million of restructuring charges relating primarily to our post-merger integration and $0.6 million of other transaction-related costs including legal, due diligence, accounting and other costs, all in connection with our acquisition of IDIT and FIS.

54

Financial income (expenses), net

The amount of our financial income, net, for the years ended December 31, 2011 and 2012, respectively, and the percentage of our revenues for those respective years constituted by such amounts, as well as the percentage change in such amounts between such years, were as follows:

($ in thousands) Year ended
December
31, 2011
  Year-over-
year
change
  Year
ended
December
31, 2012
 
Financial income, net $104   85.6% $193 
Percentage of total revenues  0.1%      0.3%

Financial income, net, was $0.2 million in 2012 compared to $0.1 million in 2011. This change was primarily due to the effect of changes in currency rates.

Taxes on Income

Taxes on income, both as a stand-alone number and as a percentage of income before taxes on income, for the years ended December 31, 2011 and 2012, respectively, as well as the percentage change in the amount of taxes on income between such years, were as follows:

($ in thousands) Year ended
December
31, 2011
  Year-over-
year
change
  Year
ended
December
31, 2012
 
Taxes on income (tax benefits) $(230)  189.1% $435 
As a percentage of income before taxes on income  (4.0%)      6.5%

Taxes on income in 2012 were $0.4 million compared to tax benefit of $0.2 million in 2011. This change resulted from increase of current tax expenses in the amount of $0.3 million and the decrease of net deferred tax income in the amount of $0.3 million.

Our provision for taxes on income relates to operations in jurisdictions other than Curaçao. The effective income tax rate varies from period to period as a result of the various jurisdictions in which we operate and where each one has its own system of taxation (not only with respect to the nominal rate, but also with respect to the allowance of deductions, credits and other benefits). We record a valuation allowance if we believe that it is more likely than not that the deferred income taxes regarding the loss carry forwards and other temporary differences, on which a valuation allowance has been provided, will not be realized in the foreseeable future. We did not recognize certain of the deferred tax assets relating to the net operating losses of our subsidiaries worldwide due to the uncertainty of the realization of such tax benefits in the foreseeable future.

55

Net Income attributable to Sapiens shareholders

The amount of net income attributable to Sapiens shareholders and such amount as a percentage of revenues for the years ended December 31, 2011 and 2012, respectively, as well as the percentage change in net income attributable to Sapiens shareholders between such years, were as follows:

($ in thousands) Year ended
December
31, 2011
  Year-over-
year
change
  Year
ended
December
31, 2012
 
Net income attributable to Sapiens shareholders $5,897   99.8  $11,780 
Percentage of total revenues  8.4%      10.3%

Net income attributable to Sapiens shareholders increased to $11.8 million in 2012 from $5.9 million in 2011. The increase of $5.9 million, or 100%, was due to a $6.4 million increase in operating income in 2012, from $5.6 million in 2011 to $12.0 million in 2012, which was driven by operational synergy and improved profitability of the acquired companies in 2012 and the increase in revenues from the sales and implementation of our solutions to our customers. The increase in operating income was offset by an increase in tax expenses of $0.6 million.

Impact of Tax Policies and Programs on our Operating Results

 

For a description of the taxIsraeli Tax Considerations and Government Programs

Tax regulations that have a material impact on our operating results,business, particularly in Israel where we have our headquarters please see “Item 10. Additional Information—E. Taxation—and due to our election to be treated as an Israeli resident corporation for tax purposes. The following summary describes the current tax structure applicable to companies in Israel, with special reference to its effect on us.

General Corporate Tax ConsiderationsStructure

Generally, Israeli companies are subject to corporate tax on their taxable income. In 2016, the corporate tax rate was 25% (in 2017 the corporate tax rate is 24% and Government Programs”as of 2018 the corporate tax rate will be 23%). However, the effective tax rate payable by a company that derives income from an Approved Enterprise or a Preferred Enterprise, as further discussed below, may be considerably lower. See “Law for the Encouragement of Capital Investments” in this Item 5.A below. In addition, Israeli companies are currently subject to regular corporate tax rate on their capital gains.

51

Besides being subject to the general corporate tax rules in Israel, certain of our Israeli subsidiaries have also, from time to time, applied for and received certain grants and tax benefits from, and participate in, programs sponsored by the Government of Israel, as described below.

Law for the Encouragement of Industry (Taxes), 1969

The Law for the Encouragement of Industry (Taxes), 5729-1969, or the Industry Encouragement Law, provides several tax benefits for an “Industrial Company”. Pursuant to the Industry Encouragement Law, a company qualifies as an Industrial Company if it is an Israeli resident company which was incorporated in Israel and at least 90% of its income in any tax year (other than income from certain government loans) is generated from an “Industrial Enterprise” that it owns and located in Israel. An “Industrial Enterprise” is defined as an enterprise whose major activity, in a given tax year, is industrial production.

An Industrial Company is entitled to certain tax benefits, including:

§Deduction of the cost of the purchases of patents, or the right to use a patent or know-how used for the development or promotion of the Industrial Enterprise, over an eight year period commencing on the year in which such rights were first exercised;

§The right to elect, under certain conditions, to file a consolidated tax return together with Israeli Industrial Companies controlled by it; and

§Accelerated depreciation rates on equipment and buildings.

Eligibility for benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any governmental authority.

We believe that certain of our Israeli subsidiaries currently qualify as Industrial Companies within the definition under the Industry Encouragement Law. We cannot assure you that we will continue to qualify as Industrial Companies or that the benefits described above will be available in the future.

Law for the Encouragement of Capital Investments, 5719-1959

The Law for the Encouragement of Capital Investments, 5719-1959, or the Investment Law, provides certain incentives for capital investments in a production facility (or other eligible assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as an Approved Enterprise, a Preferred Enterprise or a Preferred Enterprise, is entitled to benefits as discussed below. These benefits may include cash grants from the Israeli government and tax benefits, based upon, among other things, the geographic location in Israel of the facility in which the investment is made. In order to qualify for these incentives, an Approved Enterprise, a Preferred Enterprise or a Preferred Enterprise is required to comply with the requirements of the Investment Law.

The Investment Law has been amended several times over the recent years, with the three most significant changes effective as of April 1, 2005 (referred to as the 2005 Amendment), as of January 1, 2011 (referred to as the 2011 Amendment) and as of January 1, 2017 (referred to as the 2017 Amendment). Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force but any benefits granted subsequently are subject to the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced new benefits instead of the benefits granted in accordance with the provisions of the Investment Law prior to the 2011 Amendment. However, companies entitled to benefits under the Investment Law as in effect up to January 1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and elect the benefits of the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.

52

Tax benefits for Approved Enterprises approved before April 1, 2005

Under the Investment Law prior to the 2005 Amendment, a company that wished to receive benefits on its investment program that is implemented in accordance with the provisions of the Investment Law (referred to as an Approved Enterprise), had to receive an approval from the Israeli Authority for Investments and Development of the Industry and Economy (referred to as the Investment Center). Each certificate of approval for an Approved Enterprise relates to a specific investment program, delineated both by the financial scope of the investment, including sources of funds, and by the physical characteristics of the facility or other assets.

An Approved Enterprise may elect to forego any entitlement to the cash grants otherwise available under the Investment Law and, instead, participate in an alternative benefits program. Under the alternative benefits program, a company’s undistributed income derived from an Approved Enterprise will be exempt from corporate tax for a period of between two and ten years from the first year of taxable income, depending on the geographic location within Israel of the Approved Enterprise, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year, as detailed below. The benefits period under Approved Enterprise status is limited to 12 years from the year in which the production commenced (as determined by the Investment Center), or 14 years from the year of receipt of the approval as an Approved Enterprise, whichever ends earlier. If a company has more than one Approved Enterprise program or if only a portion of its capital investments are approved, its effective tax rate is the result of a weighted combination of the applicable rates. The tax benefits available under any certificate of approval relate only to taxable income attributable to the specific program and are contingent upon meeting the criteria set out in the certificate of approval. Income derived from activity that is not integral to the activity of the Approved Enterprise will not enjoy tax benefits.

A company that has an Approved Enterprise program is eligible for further tax benefits, if it qualifies as a Foreign Investors’ Company, or FIC. An FIC eligible for benefits is essentially a company with a level of foreign investment, as defined in the Investment Law, of more than 25%. The level of foreign investment is measured as the percentage of rights in the company (in terms of shares, rights to profits, voting and appointment of directors), and of combined share and loan capital, that are owned, directly or indirectly, by persons who are not residents of Israel. The determination as to whether or not a company qualifies as an FIC is made on an annual report.basis. An FIC that has an Approved Enterprise program will be eligible for an extension of the period during which it is entitled to tax benefits under its Approved Enterprise status (so that the benefits period may be up to ten years) and for further tax benefits if the level of foreign investment is 49% or more. If a company that has an Approved Enterprise program is a wholly owned subsidiary of another company, then the percentage of foreign investment is determined based on the percentage of foreign investment in the parent company.

The corporate tax rates and related levels of foreign investments with respect to an FIC that has an Approved Enterprise program are set forth in the following table:

Percentage of non-Israeli ownershipCorporate Tax Rate
Over 25% but less than 49%25%
49% or more but less than 74%20%
74% or more but less than 90%15%
90% or more10%

A company that has elected to participate in the alternative benefits program and that subsequently pays a dividend out of the income derived from the portion of its facilities that have been granted Approved Enterprise status during the tax exemption period will be subject to tax in respect of the amount of dividend distributed (grossed up to reflect such pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate that would have been otherwise applicable if such income had not been tax-exempted under the alternative benefits program. This rate generally ranges from 10% to 25%, depending on the level of foreign investment in the company in each year as explained above.

53

In addition, dividends paid out of income attributed to an Approved Enterprise (or out of dividends received from a company whose income is attributed to an Approved Enterprise) are generally subject to withholding tax at the rate of 15%, or at a lower rate provided under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). The 15% tax rate is limited to dividends and distributions out of income derived during the benefits period and actually paid at any time up to 12 years thereafter. After this period, the withholding tax is applied at a rate of up to 30%, or at a lower rate under an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). In the case of an FIC, the 12-year limitation on reduced withholding tax on dividends does not apply.

The Investment Law also provides that an Approved Enterprise is entitled to accelerated depreciation on its property and equipment that are included in an approved investment program in the first five years of using the equipment. This benefit is an incentive granted by the Israeli government regardless of whether the alternative benefits program is elected.

The benefits available to an Approved Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations and the criteria in the specific certificate of approval with respect thereto, as described above. If a company does not meet these conditions, it would be required to refund the amount of tax benefits, adjusted to the Israeli consumer price index and interest, or other monetary penalty.

Under the terms of the Approved Enterprise program, income that is attributable to one of our Israeli subsidiaries has been exempted from income tax for a period of two years commencing in 2014.

Tax benefits under the 2011 Amendment that became effective on January 1, 2011

The 2011 Amendment canceled the availability of the benefits granted in accordance with the provisions of the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a “Preferred Company” through its Preferred Enterprise (as such terms are defined in the Investment Law) as of January 1, 2011. A Preferred Company is defined as either (i) a company incorporated in Israel which is not wholly owned by a governmental entity or (ii) a limited partnership that (a) was registered under the Israeli Partnerships Ordinance and (b) all of its limited partners are companies incorporated in Israel, but not all of them are governmental entities; which has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its preferred income attributed to its Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a certain development zone, in which case the rate will be 10%. Such corporate tax rate was reduced to 12.5% and 7%, respectively, in 2013 and was increased to 16% and 9%, respectively, in 2014 until 2016. Pursuant to the 2017 Amendment, in 2017 and thereafter, the corporate tax rate for a Preferred Enterprise that is located in a specified development zone was decreased to 7.5%, while the reduced corporate tax rate for other development zones remains 16%. Income derived by a Preferred Company from a ‘Special Preferred Enterprise’ (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or 5% if the Special Preferred Enterprise is located in a certain development zone. As of January 1, 2017, the definition for ‘Special Preferred Enterprise’ includes less stringent conditions.

Dividends paid out of preferred income attributed to a Preferred Enterprise or to a Special Preferred Enterprise are generally subject to withholding tax at source at the rate of 20% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% or such lower rate as may be provided in an applicable tax treaty will apply). In 2017 to 2019, dividends paid out of preferred income attributed to a Special Preferred Enterprise, directly to a foreign parent company, are subject to withholding tax at source at the rate of 5% (temporary provisions).

54

The 2011 Amendment also provided transitional provisions to address companies already enjoying current benefits under the Investment Law. These transitional provisions provide, among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011: (i) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, which chose to receive grants, before the 2011 Amendment became effective, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, and subject to certain conditions; and (ii) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, that had participated in an alternative benefits program, before the 2011 Amendment became effective, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, provided that certain conditions are met. As of December 31, 2015, some of our Israeli subsidiaries had filed a request to apply the new benefits under the 2011 Amendment.

New Tax benefits under the 2017 Amendment that became effective on January 1, 2017

The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017, subject to the publication of regulations expected to be released before March 31, 2017. The 2017 Amendment provides new tax benefits for two types of “Technology Enterprises”, as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.

The 2017 Amendment provides that a technology company satisfying certain conditions will qualify as a “Preferred Technology Enterprise” and will thereby enjoy a reduced corporate tax rate of 12% on income that qualifies as “Preferred Technology Income”, as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technology Enterprise located in development zone A. In addition, a Preferred Technology Company will enjoy a reduced corporate tax rate of 12% on capital gain derived from the sale of certain “Benefited Intangible Assets” (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017 for at least NIS 200 million, and the sale receives prior approval from the National Authority for Technological Innovation (referred to as NATI).

The 2017 Amendment further provides that a technology company satisfying certain conditions will qualify as a “Special Preferred Technology Enterprise” and will thereby enjoy a reduced corporate tax rate of 6% on “Preferred Technology Income” regardless of the company’s geographic location within Israel. In addition, a Special Preferred Technology Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain “Benefited Intangible Assets” to a related foreign company if the Benefited Intangible Assets were either developed by an Israeli company or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from NATI. A Special Preferred Technology Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million will be eligible for these benefits for at least ten years, subject to certain approvals as specified in the Investment Law.

Dividends distributed by a Preferred Technology Enterprise or a Special Preferred Technology Enterprise, paid out of Preferred Technology Income, are subject to withholding tax at source at the rate of 20%, and if distributed to a foreign company and other conditions are met, the withholding tax rate will be 4%.

We are examining the impact of the 2017 Amendment and the degree to which we will qualify as a Preferred Technology Enterprise or Special Preferred Technology Enterprise, and the amount of Preferred Technology Income that we may have, or other benefits that we may receive, from the 2017 Amendment.

Tax Benefits for Research and Development

Israeli tax law allows, under certain conditions, a tax deduction for research and development expenditures, including capital expenditures, for the year in which they are incurred.  Such expenditures must relate to scientific research and development projects, and must be approved by the relevant Israeli government ministry, determined by the field of research.  Furthermore, the research and development must be for the promotion of the company’s business and carried out by or on behalf of the company seeking such tax deduction.  However, the amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects.  Expenditures not so approved by the relevant Israeli government ministry, but otherwise qualifying for deduction, are deductible over a three-year period.

55

 

B.Liquidity and Capital Resources.Resources

 

To date, we have substantially satisfied our capital and liquidity needs through cash flows from operations.operations and sales of our equity securities.

 

Cash flows provided by operations were $18.8$40.4 million and $17.3$26.0 million during the years ended December 31, 20122015 and 2013,2016, respectively. We used $4.9$18.9 million and $9.7$8.3 million of cash in investing activities during the years ended December 31, 20122015 and 2013,2016, respectively. OurCash flows used by financing activities also had an impact on our cash resources in each ofwere $14.2 million and $11.2 million during the years ended December 31, 20122015 and 2013, as we paid out a cash dividend amounting to $5.8 million, in the aggregate, in 2012, and we issued and sold shares in a public offering, which raised $37.8 million of cash, in 2013.2016, respectively. As of December 31, 20122015 and 2013,2016, we had $29.0$94.0 million and $70.3$96.4 million, respectively, of cash, cash equivalents and investments in marketable securities, and $18.7$51.3 million and $62.8$72.5 million, respectively, of working capital.

We expect that we will continue to generate positive cash flows from operations on an annual basis, although this may fluctuate significantly on a quarterly basis. As such, weWe believe that based on our current operating forecast, the combination of existing working capital and expected cash and cash equivalents and sources of liquidityflows from operations will be sufficient to fundfinance our ongoing operations for at least the next 12twelve months.

Our future capital requirements will depend on many factors, including the rate of growth of our revenues, the expansion of our sales and marketing activities and the timing and extent of our spending to support our research and development efforts and expansion into other markets. We may determine to distribute dividends to our shareholders. See “Item 8. Financial Information - Dividend Policy”. We may also seek to invest in, or acquire complementary businesses, applications or technologies. To the extent that existing cash and cash equivalents, investments in marketable securities and cash from operations are insufficient to fund our future activities, we may need to raise additional funds through public or private equity or debt financing. Additional funds may not be available on terms favorable to us or at all.

 

In connection with our acquisition of StoneRiver, in the first quarter of 2017, we(via our wholly-owned subsidiary, Sapiens Americas Corporation) obtained $40 million of secured debt financing from HSBCBank USA, National Association pursuant to a credit agreement, as described in “Item 10. Additional Information—C. Material Contracts—HSBC Term Loan Credit Agreement” below.Under the credit agreement with HSBC, we are subject to affirmative covenants and negative covenants, which include, without limitation, restrictions on indebtedness, liens, investments, and certain dispositions with respect to the property secured by the lien of HSBC. The credit agreement also contains customary events of default that entitle the lender to cause any or all of our company's indebtedness to become immediately due and payable and to foreclose on the lien, and includes customary grace periods before certain events are deemed events of default.

Cash Flows

 

The following table summarizestables summarize the sources and uses of our cash in the years ended December 31, 20122015 and 2013:2016:

 

 Year ended December 31,  Year ended December 31, 
 2012  2013  2015  2016 
 (in thousands US$)  (in thousands US$) 
Net cash provided by operating activities $18,792  $17,266  $40,440  $26,039 
Net cash used in investing activities  (4,859)  (9,731)  (18,853)  (8,317)
Net cash provided by (used in) financing activities  (5,983)  33,521 
Net cash used in financing activities  (14,177)  (11,233)
        

 

NetOperating Activities

We recorded positive cash flows from operating activities of $40.4 million and $26.0 million during the years ended December 31, 2015 and 2016, respectively. This decrease in cash flows provided by operating activities was $17.3 million in 2013, compared with net cash provided by operating activities of $18.8 million in 2012. The decreasefor the year ended December 31, 2016 relative to the year ended December 31, 2015 resulted primarily resulted from a slight decrease in net income (from $11.8of $0.7 million, from $20.3 million to $11.6$19.6 million, from 2012which was due to 2013), as adjusted for the following non-cash income statement items and changesfactors described above. The decrease in assets:cash flows was furthermore attributable to an increase in trade receivables of $6.7$5.4 million in 2013 compareaccounts receivable during the year ended December 31, 2016, as compared to a more modest increasedecrease of $1.6$1.9 million in 2012, andaccounts receivable during the prior year, which year-over-year difference contributed $7.3 million, in the aggregate, to the decrease in operating cash flow during 2016. Another contributing factor was an increase in other operating assets during 2016 relative to the prior year, from an increase of $2.3$1.2 million in 2013 compared to aan increase of $3.3 million, thereby contributing an aggregate of $2.1 million towards the decrease of $0.2 millionoperating cash flows in 2012. These factors were offset, in part, by an increase in deferred revenues and customer advances of $2.5 million in 2013 compared to a decrease of $2.4 million in 2012, and an increase in deferred tax assets of $1.1 million in 2013 compared to a decrease of $0.2 million in 2012.the year ended December 31, 2016.

56

Investing Activities

 

Net cash used in investing activities was $9.7decreased to $8.3 million for the year ended December 31, 2016 compared to $18.9 million in 2013,the year ended December 31, 2015, primarily due to a decrease in purchases of marketable securities and increase in sales of marketable securities in the year ended December 31, 2016 relative to the previous year. In 2016, we received $4.9 million of cash, net, from sales (net of purchases) of marketable securities, compared to $4.9$6.2 million used in the purchases of marketable securities (net of sales) in the year ended December 31, 2015, constituting an overall difference of $11.1 million between the two years. The decrease in cash used for investing activities in the year ended December 31, 2016 was offset, in part, by an increase in use of cash, for the acquisition of businesses during 2016, which increased to $4.4 million, compared to $2.9 million in 2012. The increase of $4.8 million primarily resulted from2015. An additional offsetting factor to the decrease in cash used for investing activities was an increase in use of $2.8cash, to an amount of $4.7 million, in our investments for the purchase of property and equipment in 2013during the year ended December 31, 2016, compared to 2012. This increase primarily related to leasehold improvements associated with our having moved into our new headquarters building$2.8 million in Israel in 2013. Our capitalized software development costs also increased in 2013, by $1.9 million compared to 2012.2015.

Net cash provided by

Financing Activities

Our financing activities was $33.5 million in 2013, compared to net cash used in financing activities of $6.0 million in 2012. The change resulted primarily from the net cash provided by our issuance and sale of Common Shares in our public offering in 2013, which raised $37.8$11.2 million of cash whichduring the year ended December 31, 2016, as compared to using $14.2 millionof cash in the year ended December 31, 2015. Cash use in the year ended December 31, 2016 was primarily attributable to a cash dividend in a total amount of approximately $9.8 million, as compared to a cash dividend in a total amount of approximately $7.2 million and the distribution of $8.5 million to our ultimate parent company for a business acquisition under common control (that is, for the acquisition of Insseco, as described in Item 3.A, “Selected Financial Data”, above) in the year ended December 31, 2015. Cash used for financing activities during each of the years ended December 31, 2015 andDecember 31,2016 was partially offset by our use of $5.8$1.6 million and $0.9 million, respectively, of cash in the aggregate, for the payment of a dividend in 2013. In 2012, our primary use of cash for financing activities was cash used for our repurchase of shares, which used an aggregate of $7.0 million of cash.provided by stock option exercises during each reported period.

 

C.Research and Development, Patents and Licenses, etc.

 

See the captionscaption titled “Research and Development, net”Development” insectionpart A. “Operating Results” of this Item 5 above for a description of our R&D policies and amounts expended thereon during the last two fiscal years.

 

D.Trend Information

 

There are various sales and marketing trends that influence our business. Accordingbusiness.According to a research report published by Celent, a research and advisoryconsulting firm, CELENT(Report Name: IT(IT Spending in Insurance, - Aa Global Perspective; Publication Date: March 18 2013; Author:Perspective, 2016, by Jamie Macregor, Juan Mazzini, Karen Monks Catherine Stagg-Macey, Wenli Yuan)and KyongSun Kong, published on April 27, 2016), global IT spending inby insurance companies is expected to grow to $147.3from $184.9 billion in 2014 and2016 to $154.5$208 billion in 2015. This spending relates to the target market for Sapiens' software solutions2017 and related services.

CELENT$208.1 billion in 2018. Celent also projectsprojected that IT spending in North America will climbwould rise to US$58.5$86 billion in 2015, a CAGR2017, annual growth of 4.6%8.5% from 2013 to 2015.2016. IT spending in Europe willwould grow to $59 billion in 2017, at a rate of 1.9% from 2016. Asia-Pacific was expected to climb to US$53.0$36 billion in 2015, a CAGR of 0.9% from 2013 to 2015 and that IT spending in the Asia Pacific region is expected to grow to a relatively modest rate (3.7% CAGR). Spending in this region will grow to US$31.1 billion in 2015.2017 at 5.9% annual growth.

 

According to CELENT,Celent, IT spending in external software and services, which is the market we address, was expected to grow from an estimated $81 billion in 2016, is expected to growincrease to approximately $59.9$87 billion by 2014 and $63.7 billion by 2015. CELENT2017, a 7.3% growth rate. Celent reports that growththe significant increase in external software and services is driven both by pure growth in IT spending, butand also from the shift ofin IT spending from internal to external providers like Sapiens.(such as our company). This is due to the move from in-house, home-grown solutions to packaged solutions, as IT departments recognize the value of buying software solutions from specialized vendors, rather than developing internal solutions that are harddifficult to maintain and do not have the advantage of significant R&D investments at the rate that is invested by outside vendors.investment.

 

In the insurance software industry, according to CELENT (Trackinga report by Gartner in 2016 (Modernizing Insurance Core Systems Primer for 2016, published January 21, 2016), legacy modernization remains one of the Progress in Global Insurance report, January 2013), over 50% of insurers are progressing with core system replacement, which could result in an increase in insurers looking to modernize their IT systems.

We believe we are well positioned to leverage our innovative software solutions, advanced technologies, customer base and global presence to address this market trend. Our rich portfolio of core software solutionstop projects for P&C and L&P products backedLife insurers.

57

According to Gartner, over 60% of Life and P&C chief information officers, or CIOs, indicate that legacy modernization is extremely or very important. This strategic roadmap will provide CIOs with insight into how requirements from insurers, solution capabilities and the vendor landscape for legacy modernization will evolve during the next few years (The Report: 2016 Strategic Roadmap for Insurance Legacy Modernization, published on August 16, 2016 by analyst(s): Richard Thomas Natale and Juergen Weiss).

According to Gartner, there is great variation in business priorities among insurers around the yearsglobe. However, what is clear is that the direction of accumulated experiencebusiness and expert teams allow us to provide a comprehensive responsetechnology are inextricably intertwined. According to the IT challenges of this market.2017 Gartner CIO Survey, insurance CIOs identify their top three strategic organizational priorities in 2016 and 2017 as digital business, customer focus and growth (or increasing market share).

The global insurance industry is evolving in a number of areas, and insurance carriers require support from their software and their IT service providers to keep up. The primary areas of evolution include:

 

·Tighter competition

 

·Tougher regulationsregulation

 

·Customer Sophisticationsophistication

 

·Globalization and M&Aconsolidation

 

With the growing need for insurance, as people accumulate more property and live longer, the insurance industry has become more competitive. The competition for the customer’scustomers’ business requires insurers to improve customer experience, be faster to market with new products and offer innovative channels, such as social media and mobile. Innovative technology infrastructure is necessary to support these business initiatives.

 

In addition, insurers are faced with the increasing significance of regulatory changes to protect the policyholder in many markets, particularly large insurers whichthat are considered important to the stability of the world economic system. Many insurers are integrating enterprise risk management as a standard operating procedure, while spreading ownership of risk throughout the strategic decision-making process.

 

As customers become more sophisticated, the support of innovative products and distribution channels is mandatory. Insurers are identifying growth opportunities by attracting new customers and retaining current customers by seeking to reinvent the customer experience and provide quote and policy information to their customers as theyupon request.

 

AccordingWith today’s strong trend of shifting attention to Gartner (Finding the Best Approachend-customer experience and activities, there is an increasing focus on digital operations to Decision Management,February 26, 2014), decision management improvessupport the intelligenceincreasing usage of business operations by enabling fast, consistentthe Internet for sales, recommendations and precise fact-based decisions. The vast increase ingeneral communication. This affects the amount of available data,carriers’ needs to innovate their product proposition through a flexible and modern solution. Another substantial trend is the decreasing cost of computers, memory, mobile devices, sensors and communication networks, have given enterprises the opportunity to greatly improve their operational effectiveness and efficiency. However, they need decision management to help them deal with the volumeincreasing usage of data for decision-making, risk analysis, customers’ evaluation and rating, which requires streamlined data flow and easy access to information from multiple sources.

Increased global competition, the complexityneed to improve distribution channels and provide an enhanced customer experience, and efforts to expand into new countries and markets have required heavy investments from insurers, resulting in a trend towards consolidation. This has mainly included consolidation of computation in some modern decision-making scenarios.applications, databases, development tools, hardware and data centers.

 

E.Off-Balance Sheet Arrangements

 

We have not engaged in nor been a party to any off-balance sheet transactions.

 

58

F.Contractual Obligations

 

The following table sets forth information on our short-term and long-term contractual obligations as at December 31, 2013 (in thousands of dollars).2016.

  Payments due by period 
  Total  Less than 1
year
  1 to 3
years
  3 to 5
years
  Over 5
years
 
                
Accrued severance pay, net(1) $1,387              $1,387 
Operating leases $17,304  $2,718  $5,644  $5,114  $3,828 
Liability to the OCS(2) $269  $269             
Total Contractual Cash Obligations $18,961  $2,987  $5,644  $5,114  $5,216 
Uncertain Income Tax Position(3) $652                 

  Payments due by period 
  Total  Less than 1
year
  1 to 3
years
  3 to 5 years  Over 5 years 
  (in thousands) 
Accrued severance pay, net(1) $899   -   -   -  $899 
Operating leases  11,618   4,050   6,400   1,168   - 
Liability to the OCS(2)  259   -   -   -   259 
Contingent payment obligations - acquisitions(3)  3,035   1,676   231   1,128   - 
Total Contractual Cash Obligations $15,881  $5,726  $6,631  $2,296  $1,158 

 

(1)Accrued severance pay relates to accrued severance obligations mainly to our Israeli employees as required under Israeli labor law.  We are legally required to pay severance upon certain circumstances, primarily upon termination of employment by our company, retirement or death of the respective employee.  Our liability for all of our Israeli employees is fully provided for by monthly deposits with insurance policies and by an accrual.

(2)Does not include contingent liabilities to the OCSInnovation Authority of approximately $7.6$7.1 million as described in Note 9(a)10(a) to our consolidated financial statements contained elsewhere in this report.
(3)See Note 10(i) of our consolidated financial statements contained elsewhere in this annual report, as of December 31, 2013. Due to the uncertainties related to those tax matters, we are currently unable to make a reasonably reliable estimate of when cash settlement with a relevant tax authority will occur.report.

  

(3)

Contingent payment obligations for our acquisitions do not include contingent payments in an amount of up to $7.8 million, in the aggregate, that are subject to continued employment by the potential recipients thereof.

The total amount of unrecognized tax benefits for uncertain tax positions was $2.5 million as of December 31, 2016. Payment of these obligations would result from settlements with taxing authorities. Due to the uncertainties related to those tax matters, we are currently unable to make a reasonably reliable estimate of when cash settlement with a relevant tax authority will occur. See Note 11(i) to our consolidated financial statements contained elsewhere in this annual report, as of December 31, 2016.

ITEM 6.Directors, Senior Management and Employees

 

A.Directors and Senior Management

 

The following table and below biographies set forth certain information regarding the current executive officers and directors of the Company as of February 25, 2014.2016.

 

Name Age Position
Guy Bernstein 4649 Chairman of the Board of Directors
Roni Al Dor 5356 President, Chief Executive Officer and Director
Naamit Salomon 5053 Director
Yacov Elinav (1) 6972 Director
Uzi Netanel (1) 7881 Director
Eyal Ben Chlouche (1) 5255 Director
United International Trust N.V. (2)   Director
Roni Giladi 4346 Chief Financial Officer

 

(1)Member of Audit Committee
(2)United International Trust N.V. or UIT, is a corporate body organized under the laws of Curaçao. Mr. Gregory Elias exercises decision making authority for UIT. The Articles of Incorporation of the Company provide that a corporate body may be a member of the Board of Directors.

 

6059

 

Guy Bernstein has served as a director of the Company since January 1, 2007 and was appointed Chairman of the Board of Directors on November 12, 2009. Mr. Bernstein has served as the chief executive officer of Formula, Systems, our parent company, since January 2008.  From December 2006 to November 2010, Mr. Bernstein served as a director and the chief executive officer of Emblaze Ltd. or Emblaze, our former controlling shareholder. From April 2004 to December 2006, Mr. Bernstein served as the chief financial officer of Emblaze. He also served as a director of Emblaze from April 2004 until November 2010. Prior to joining Emblaze, Mr. Bernstein served as Chief Financial and Operations Officer of Magic Software, Enterprises Ltd. (“Magic”) (NASDAQ: MGIC), a position he held since 1999. Mr. Bernstein joined Magic Software from Kost Forer Gabbay & Kasierer, a member of EY Global, where he acted as senior manager from 1994 to 1997. Mr. Bernstein also serves as Chief Executive Officer of Magic Software and Chairman of the Board of Matrix IT Ltd. Mr. Bernstein is a Certified Licensed Public Accountant and holds a BA in Accounting and Economics from Tel Aviv University.

 

Roni Al Dor joined the Company as President and Chief Executive Officer in November 2005 and has served as a director of the Company since November 2005. Prior to joining the Company, Mr. Al Dor was one of the two founders of TTI Team Telecom International Ltd. (“, or TTI,”), a global supplier of operations support systems to communications service providers and from August 1996 until 2004, Mr. Al Dor served as President of TTI. Prior to that, Mr. Al Dor served as TTI’s Co-President from November 1995 until August 1996 and its Vice President from September 1992 to November 1995. During his service in the Israeli Air Force, Mr. Al Dor worked on projects relating to computerization in aircrafts. Mr. Al Dor is a graduate of the military computer college of the Israeli Air Force, studied computer science and management at Bar Ilan University and attended the Israel Management Center for Business Administration.

 

Eyal Ben-Chlouchehas served as a director of the Company since August 15, 2008, Mr. Ben-Chlouche served as the Commissioner of Capital Market Insurance and Savings at the Israeli Ministry of Finance from 2002 through 2005, where he was responsible for implementation of fundamental reforms in pension savings. Prior to that, he served as a Deputy Commissioner of Capital Market Insurance and Savings and as a Senior Foreign Exchange and Investment Manager in the Foreign Exchange Department of the Bank of Israel.  He also served as an Investment Officer in the Foreign Exchange Department of the Bank of England, in London. Mr. Ben-Chlouche served as Chairman of the Board of Directors of the Shahar Group, Chairman of the Advisory Board of Directors of the Shekel Group until the end of 2007 and serves as a director of Matrix IT Ltd. and Migdal Holding Ltd. Mr. Ben-Chlouche also serves on the Board of Directors of several other private companies. Mr. Ben-Chlouche also serves as Chairman of the Advisory Board of the Caesarea Center for Capital Markets and Risk Management. In 2005, Mr. Ben-Chlouche served as a member of the Bachar Committee on Capital Market Reform in Israel. Mr. Ben-Chlouche is an independent director.

Naamit Salomon has served as a director of the Company since September 2003. She held the position of Chief Financial Officer of Formula from August 1997 until December 2009. Since January 2010 Ms. Salomon has served as a partner in an investment company. Ms. Salomon also serves as a director of Magic. From 1990 through August 1997, Ms. Salomon was a controller of two large, privately held companies in the Formula Group. Ms. Salomon holds a BA in economics and business administration from Ben Gurion University and an LL.M. from the Bar-Ilan University.

 

61

Yacov Elinav has served as a director of the Company since March 2005. For over 30 years, Mr. Elinav served in various positions at Bank Hapoalim B.M., which is listed on the London and Tel Aviv Stock Exchanges, including over 10 years as a member of the Board of Management, responsible for subsidiary and related companies.  From 1992 through 2006, Mr. Elinav served as Chairman of the Board of Directors of Diur B.P. Ltd., the real estate subsidiary of Bank Hapoalim. From August 2004 until 2009, Mr. Elinav has served as Chairman of the Board of Directors of DS Securities and Investments, Ltd. From August 2004 through 2008, Mr. Elinav served as Chairman of the Board of Directors of DS Provident Funds Ltd., and hasfrom 2010 until August 2015, served as Chairman of the Board of Directors of Golden Pages Ltd. from 2010 to the present time.Ltd.. Mr. Elinav also serves on the Board of Directors of several other public and private companies. Mr. Elinav is an independent director.

 

Uzi Netanel has served has a director of the Company since March 2005.He has served as chairman of the Board of Directors of Maccabi Enterprise Development & Management Ltd., and as Chairman of Maccabi Group Holdings Ltd. from 2005 through 2011.From 2004 through 2007, Mr. Netanel served as Chairman of Board of Directors of M.L.L SoftwearSoftware & Computers, and from 2000 through 2011 served as a director of Bazan and Carmel Olephine. FromOlephine.From 2001 through 2003, Mr. Netanel served as partner in the FIMI Opportunity Fund.From 1993 through 2001, he served as Active Chairman of Israel Discount Capital Markets and Investments Ltd.From 1997 to 1999, Mr. Netanel served as Chairman of Poliziv Plastics Company (1998) Ltd.Mr.Ltd.From 2005 through 2014, he served as director of Maman Group and from 2012 through 2014, he served as director of Gadot Biochemicals. Mr. Netanel also serves on the Board of Directors of The Maman Group, Acme Trading, Scope Metals Ltd. (external director), Gadot Biochemicals,  Assuta Health Centers, and Maccabi Health Services.Mr. Netanel is an independent director.

 

60

United International Trust N.V. (“UIT”), or UIT, is a corporate body organizedduly established under the laws of the (former) Netherlands Antillies and validly existing under the laws of the Netherlands Antilles.Curaçao.  It, or one of its predecessor entities, has provided the Company with corporate-related services since April 1990, including serving as the Company'sCompany’s transfer agent and registrar, maintaining the corporate-related records of the Company, and filing various corporate documents and the annual corporate tax return with the governmental authorities in the Netherlands Antilles.  In January 1, 2007, UIT was established by former shareholders of Intertrust (Curacao)(Curaçao) N.V., including Mr. Elias, which subsequently operated under the names of MeesPierson Intertrust (Curacao)(Curaçao) N.V. and Fortis Intertrust (Curacao)(Curaçao) N.V.   Between 2005 and June 2009, Mr. Elias acted as a Supervisory Board Member of Banco di Caribe and currently acts as Of Counsel thereto. Mr. Elias also serves as special counsel to the Government of Curaçao, in international finance / tax matters. He holds board positions in several organizations of a social, economic, (e)-commercial and charitable nature. He was knighted Companion of the Order of Orange-Nassau in March 2011 for his numerous contributions to charity and community projects over the past 30 years. MrMr. Elias holds two Masters degrees in Law from the University of Amsterdam, the Netherlands.

62

 

Roni Giladi joined the Company as Chief Financial Officer in July 2007. Prior to joining the Company, Mr. Giladi served as the Director of Finance at Emblaze from January 2007. Prior to joining Emblaze, Mr. Giladi served as Chief Financial Officer of RichFX, from August 2003 until November 2006, after serving as Corporate Controller from June 2002. Prior to RichFX, Mr. Giladi worked at EY Israel, from 1997-2002, as a manager in the high-tech practice group. From July 2007 until July 2010, Mr. Giladi served as a directorboard member of MediRisk Solutions Ltd., as the nominee of the Company. Mr. Giladi is Certified Licensed Public Accountant and holds a BA in Business Management and Accounting from the College of Management in Israel.

The Board of Directors must have a minimum of three, and may have a maximum of 24, directors. Directors of the Company are appointed by our General Meeting of Shareholders and hold office until the expiration of the term of their appointment by our General Meeting of Shareholders, or until they resign or are suspended or dismissed by the General Meeting of Shareholders. The Board of Directors may appoint up to four directors in addition to the directors elected by the General Meeting of Shareholders, subject to the maximum number of directors permitted, and any such appointment shall be effective until the next General Meeting of Shareholders. The Board of Directors may fill any vacancies on the Board of Directors, whether as a result of the resignation or dismissal of a director, or as a result of a decision of the Board of Directors to expand the Board of Directors.

 

Our executive officers are appointed by, and serve at the discretion of, our Board of Directors.

 

Our Chairman, Guy Bernstein, serves as the Chief Executive Officer of Formula.Formula and as a director of Asseco. In addition, Ms. Salomon, another Board member of ours, who served as an executive officer of Formula until December 2009, is a member of the Board of Directors of our affiliate Magic Software Enterprises Ltd. Formula directly owns (as of AprilMarch 1, 2014)2017) approximately 47.7%48.9% of our currently outstanding Common Shares, and since November 2010, Asseco holds a controlling interest in Formula (46.4%(46.3% of the outstanding share capital of Formula as of AprilMarch 1, 2014)2017).

 

B.Compensation of Directors and Officers

 

The aggregate amount of compensation paid by us, or accrued by us, during the fiscal year ended December 31, 2013 with respect to such year, tofor all directors and executive officers as a group for services in all capacities with respect to the fiscal year ended December 31, 2016 was $1.4$1.7 million. ThisIn addition to the foregoing amount, doeswe also set aside or accrued for our directors and executive officers with respect to the fiscal year ended December 31, 2016 $60,000 for pension, retirement severance, vacation accrual and similar benefits of the Company. These compensation amounts do not include amounts expended by us for automobiles made available to our officers or expenses (including business travel and professional and business association dues) reimbursed to such officers. The aggregate amount set aside or accrued by us during our fiscal year ended December 31, 2013 to provide pension, retirement severance, vacation accrual and similar benefits for directors and executive officers of the Company was $83,000. The foregoing amounts also exclude the value of stock option grants to our directors and officers pursuant to our 1992 Stock Option and Incentive Plan, our 2003 Share Option Plan, our 2005 Special Incentive Share Option Plan and our 2011 Share Incentive Plan, which areis described below.

61

 

We have employment agreements with our officers.  We in the ordinary course of our business,also enter into confidentiality agreements with our personnel and have entered into non-competition and confidentiality agreements with our officers and high-level technical personnel.personnel, in each case in the ordinary course of business.  We do not maintain key person life insurance on any of our executive officers.

63

 

Board Fees and Expenses

 

We reimburse all members of our Board of Directors for reasonable out-of-pocket expenses incurred in connection with their attendance at meetings of the Board of Directors or committee meetings.its committees.

 

We grantpay a fee of approximately $26,600 to each of our independent directors a fee(except to Formula, to which we pay approximately $23,200 in respect of the service of its Chief Executive Officer, Guy Bernstein, as our Chairman of the Board), for attending or participating in meetings of the Board of Directors meetings and committee meetings,its committees, and for participating in Board action taken via unanimous written consents.

We pay theconsent. Such fees to our independent directors according toare set in accordance with the rates paid to outside directors“external directors” under the Israeli Companies Law 5759-1999, even though5759-1999. Although we are not an Israeli company and are not subject to the Israeli Companies Law, (as we deem thecertain standards of suchthat body of law (including compensation to Board members) relevant to a company such as ours that has a substantial percentage of Israeli operations and Israeli employees).

In 2005, we grantedemployees. United International Trust N.V., which also qualifies as an independent director, instead receives a fee of $1,200 for director services and an additional annual amount for consulting and related services that it provides to two of our independent directors options to purchase 4,000 Common Shares annually. The options were granted at an exercise price equal to the fair market value of the Company’s Common Shares on the date of grant. The term of the options was set at 10 years and the options become exercisable in four equal, annual installments, beginning with the first anniversary of the grant date.

In 2010, we granted to three of our independent directors and another director options to purchase 15,000 Common Shares each. The options were granted at an exercise price equal to the fair market value of the Company’s Common Shares on the date of grant. The term of the options was 6 years and the options become exercisable in four equal, annual installments, beginning with the first anniversary of the grant date.us.

 

Stock Option and Incentive Plans

 

Prior Incentive Plans

In 1992, 2003 and 2005, our Board of Directors adopted (and our shareholders subsequently approved) our 1992 Stock Option and Incentive Plan, 2003 Share Option Plan, and 2005 Special Incentive ShareStock Option Plan, respectively, collectively referred to as our Prior Incentive Plans. These plans were administered by our Compensation Committee. Upon the approval of our 2011 Share Incentive Plan (as described below), our Board of Directors determined that no further awards would be granted under the Prior Incentive Plans. Furthermore, the exercise period for all remaining outstanding options under the Prior Incentive Plans terminated in September 2015. Consequently, there are no remaining awards outstanding under any of the Prior Incentive Plans.

 

2011 Share Incentive Plan

In 1992,2011, in connection with our acquisition of IDIT and FIS, our Board of Directors and shareholders approved the 1992 Stock Option andadopted our 2011 Share Incentive Plan, (the “1992 Stock Plan”)or the 2011 Plan, pursuant to which our employees, directors, officers, directorsconsultants, advisors, suppliers, business partners, customers and employeesany other person or entity whose services are considered valuable are eligible to receive awardsoptions, restricted shares, restricted share units and other share-based awards. The number of stock options and restricted stock. In February 2003,Common Shares available under the Board of Directors authorized the extension of the 1992 Stock2011 Plan until April 2012 and our shareholders approved that extension. In 2003, our Board of Directors and shareholders approved the 2003 Share Option Plan (the “2003 Option Plan”), pursuant to which our officers, directors, employees, consultants `and contractors are eligible to receive awards of stock options. In the following description, the 1992 Stock Plan and 2003 Option Plan will be referred to together as the “Prior Incentive Plans” and each may be referred to individually as a “Prior Incentive Plan.”was set at 4,000,000.

 

Options granted under the 1992 Stock2011 Plan may be “incentive stock options” (“ISOs”),ISOs or NQSOs within the meaning of sectionSection 422 of the Internal Revenue CodeCode. In the case of 1986, as amended (the “Code”), or non-qualified stockIsraeli grantees, we intend that options (“non-Qualified Stock Options”). Restricted stock may be granted in addition to or in lieu of any other award granted under the 1992 Stock Plan. Option grants under the 2003 Option Plan are intended to comply with, and benefit from, applicable tax laws and regulations in Israel. We are also eligible to grant restricted stock, restricted share units and other share-based compensation in addition to or in lieu of any other award under the 2011 Plan.

Each of the Prior Incentive Plans

The 2011 Plan is administered by the Compensation Committee of our Board of Directors (the “Committee”).Committee. Subject to the provisions of each Incentivethe 2011 Plan, the Compensation Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Compensation Committee also determines the terms, provisions, and kind of consideration payable (if any), with respect to awards. The Compensation Committee has discretionary authority to interpret the Incentive Plans2011 Plan and to adopt rules and regulationspractices related thereto. In determining the persons to whom awards shall be granted and the number of shares covered by each award, the Compensation Committee takes into account the contributiontheir present and potential contributions to the management, growth and/or profitability of the businesssuccess of the Company by the respective persons and such other factors as the Compensation Committee shall deem relevant includingin connection with accomplishing the length of employmentpurpose of the respective persons, the nature of their responsibilities to the Company, and their flexibility with regard to location of their employment and other employment-related factors.2011 Plan.

 

62

An

Under the 2011 Plan, an option may be granted on such terms and conditions as the Compensation Committee may approve, and generally may be exercised for a period of up to 106 years from the date of grant. In 2008, certain grants were limited to an exercise period of 6 years. Options granted under the Prior Incentive Plans2011 Plan become exercisable in four equal, annual installments, beginning with the first anniversary of the date of the grant, or pursuant to such other schedule as the Compensation Committee may provide in the option agreement. The exercise price of such options generally will be not less than 100% of the fair market value per share of the Common Shares at the date of the grant. In the case of ISOs, certain limitations will apply with respect to the aggregate value of option shares which can become exercisable for the first time during any one calendar year, and certain additional limitations will apply to “Ten Percent Stockholders”Shareholders” (as defined in the 1992 Stock2011 Plan). The Compensation Committee may provide for the payment of the optionexercise price in cash, by delivery of other Common Shares having a fair market value equal to such option exercise price, by a combination thereof or by any method in accordance with the terms of the option agreements. The Incentive Plans containexercise price for each outstanding option to purchase one Common Share granted under the 2011 Plan is subject to reduction by the per share amount of any dividend that we declare from time to time while the option is outstanding. The 2011 Plan contains special rules governing the time of exercise ofperiod during which options may be exercised in the case of death, disability, or other termination of employment. Options are not transferable except by will or pursuant to applicable laws of descent and distribution upon death of the employee.an employee, unless otherwise approved by our Board of Directors.

 

The 1992 Stock2011 Plan also provides for the granting of restricted stockshare awards, which are awards of Common Shares that may not be disposed of, except by will or the laws of descent and distribution, for such period as the Compensation Committee determines (the “restricted period”)(which we refer to as the restricted period). The Compensation Committee may also impose such other conditions and restrictions on the shares as it deems appropriate, including the satisfaction of performance criteria. The Compensation Committee may provide that such restrictions will lapse with respect to specified percentages of the awarded shares on successive anniversaries of the date of the award. During the restricted period, the grantee is entitled to receive dividends with respect to, and to vote the shares awarded to him or her. If, during the restricted period, the grantee’s continuous employment with the Company terminates for any reason, any shares remaining subject to restrictions will be forfeited. The Committee has the authority to cancel any or all outstanding restrictions prior to the end of the restricted period, including cancellation of restrictions in connection with certain types of termination of employment.

In 2005, our Board of Directors authorized a new Incentive Stock Option Plan (the “Special Plan”) and our shareholders approved the Special Plan in 2006. The number of Common Shares available for grants pursuant to the Special Plan was set at 2,000,000 shares. The Special Plan is intended to be used solely to attract or retain senior management and/or members of the Board of Directors. Unless otherwise determined by the Committee, options granted pursuant to the Special Plan have an exercise price of $3.00 per share. In addition, shares issued upon exercise are locked up for up to five years following the grant date, and the right to obtain shares is contingent upon the optionee providing services to the Company throughout the entire five year period. In the event of a change of control of the Company, any unvested options will be accelerated.

The Special Plan is administered by the Committee. Subject to the provisions of the Special Plan, the Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Committee also determines the terms and provisions with respect to awards. The Committee has discretionary authority to interpret the Special Plan and to adopt rules and regulations related thereto.

Pursuant to the Special Plan, in November 2005, the Company’s President and Chief Executive Officer was granted options to purchase 1,000,000 Common Shares at an exercise price of $3.00 per share. During 2009, all of the outstanding options under the Special Plan were re-priced. See “Re-pricing of Options” below.

During 2009, under the Prior Incentive Plans and the Special Plan, we granted to our directors and executive officers a total of 57,892 options to purchase Common Shares at an exercise price of $1.50 per Common Share, which options have a term of six years.

During 2010, under the Prior Incentive Plans and the Special Plan, we granted to our directors and executive officers a total of 210,000 options to purchase Common Shares at an exercise price of $1.60 per Common Share, as applicable, which options have a term of six years.

As of December 31, 2013, options to purchase 1,921,471 Common Shares, 1,471,596 of which were held by officers and directors, were outstanding under the Prior Incentive Plans and the Special Plan. As of that date, there were 6,340 shares of restricted stock that the Company had granted to employees and other eligible grantees (none of which were held by current or former officers and directors.

Re-pricing of Options

During 2009, our Board of Directors approved the re-pricing of options outstanding under the Prior Incentive Plans and Special Plan. As a result of the re-pricing, options to purchase 1,985,650 Common Shares at exercise prices ranging from $1.74 to $5.30 per share were converted into, and re-priced as, options to purchase 1,554,627 Common Shares at an exercise price of $1.50 per share. The exercise price of 925,870 of those 1,554,627 options is subject to market conditions (if the market price of our Common Shares were to reach $2.10). In addition, the expiration of the exercise period for all remaining outstanding options was reduced to no later than September 2015.

66

New Incentive Stock Option Plan

Upon the approval of our 2011 Share Incentive Plan, which is described below, our board of directors determined that no further awards would be issued under the Prior Incentive Plans or the Special Plan.

2011 Share Incentive Plan

In 2011, in connection with the acquisition of IDIT and FIS, our board of directors approved our 2011 Share Incentive Plan (the “2011 Plan”) pursuant to which our employees, directors, officers, consultants, advisors, suppliers, business partner, customer and any other person or entity whose services are considered valuable are eligible to receive awards of share options, restricted shares, restricted share units and other share-based awards The number of Common Shares available under the 2011 Plan was set at 4,000,000.

Options granted under the 2011 Plan may be “incentive stock options” (“ISOs”), within the meaning of section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), or non-qualified stock options (“non-Qualified Stock Options”). Restricted shares may be granted in addition to or in lieu of any other award granted under the 2011 Plan. In addition, the Company may grant restricted share units and other share-based compensation. Option grants under the 2011 Plan are intended to comply with, and benefit from, applicable tax laws and regulations in Israel to the extent applicable the recipient of the grant.

The 2011 Plan is administered by the Committee. Subject to the provisions of the 2011 Plan, the Committee determines the type of award, when and to whom awards will be granted and the number of shares covered by each award. The Committee also determines the terms, provisions, and kind of consideration payable (if any), with respect to awards. The Committee has discretionary authority to interpret the 2011 Plan and to adopt rules and regulations related thereto. In determining the persons to whom awards shall be granted and the number of shares covered by each award, the Committee takes into account their present and potential contributions to the success of the Company and such other factors as the Committee shall deem relevant in connection with accomplishing the purpose of the 2011 Plan.

An option may be granted on such terms and conditions as the Committee may approve, and generally may be exercised for a period of up to 6 years from the date of grant. Options granted under the 2011 Plan become exercisable in four equal, annual installments, beginning with the first anniversary of the date of the grant, or pursuant to such other schedule as the Committee may provide in the option agreement. The exercise price of such options generally will be not less than 100% of the fair market value per share of the Common Shares at the date of the grant. In the case of ISOs, certain limitations will apply with respect to the aggregate value of option shares which can become exercisable for the first time during any one calendar year, and certain additional limitations will apply to “Ten Percent Shareholders” (as defined in the 2011 Plan). The Committee may provide for the payment of the option price in cash, by delivery of other Common Shares having a fair market value equal to such option exercise price, by a combination thereof or by any method in accordance with the terms of the option agreements. The Incentive Plans contain special rules governing the time of exercise of options in the case of death, disability, or other termination of employment. Options are not transferable except by will or pursuant to applicable laws of descent and distribution upon death of the employee, unless otherwise approved by the Company’s Board of Directors.

The 2011 Plan also provides for the granting of restricted share awards, which are awards of Common Shares that may not be disposed of, except by will or the laws of descent and distribution, for such period as the Committee determines (the “restricted period”). The Committee may also impose such other conditions and restrictions on the shares as it deems appropriate, including the satisfaction of performance criteria. The Committee may provide that such restrictions will lapse with respect to specified percentages of the awarded shares on successive anniversaries of the date of the award. During the restricted period, the grantee is entitled to receive dividends with respect to, and to vote the shares awarded to him or her. If, during the restricted period, the grantee’s continuous employment with the Company terminates for any reason, any shares remaining subject to restrictions will be forfeited. TheCompensation Committee has the authority to cancel any or all outstanding restrictions prior to the end of the restricted period, including cancellation of restrictions in connection with certain types of termination of employment.

 

The 2011 Plan alsofurthermore provides for the granting of restricted share units, which are awards that are settled by the issuance of a number of Common Shares. The grantee has no rights with respect to such Common Shares until they are actually issued to the grantee. The Compensation Committee may also grant other share-based awards under the 2011 Plan, such as share appreciation rights.

 

UponIn February 2016, our Board of Directors approved the consummationreservation of the acquisition of IDIT and FIS, 1,938,844 share options with a weighted average exercise price of $2.09 were issued under the 2011 Plan to former employees of IDIT and FIS in exchange for the share options which had been granted to them by IDIT and FIS, which were cancelled upon the closing of the acquisition.

During 2011 we granted to the Company’s directors and officers options to purchase 300,000an additional 4,000,000 Common Shares at an exercise price of $3.00 per Common Share, which options have a term of six years.

During 2012 we granted to the Company’s directors and officers options to purchase 60,000 Common Shares, at an exercise price of $3.84 per Common Share, which options have a term of six years.

During 2013 we granted to the Company’s directors and officers options to purchase 100,000 Common Shares, at an exercise price of $6.42 per Common Share, which options have a term of six years.

As of December 31, 2013, options to purchase 1,985,024 Common Shares, 460,000 of which were held by our directors and officers, were outstandingfor issuance under the 2011 Plan. As of December 31, 2013, 772,310 shares2016, 2,137,783 Common Shares were issuable upon the exercise of outstanding options under the 2011 Plan, at a weighted average exercise price of $6.91 per share, of which options to purchase 1,172,950 Common Shares had vested.  818,932 of such Common Shares were issuable upon the exercise of outstanding options held by our directors and executive officers. As of December 31, 2016, 3,900,284 Common Shares were available for future grant under the 2011 Plan.

68

Restricted Share and Option Grants Outside of Our Stock Option and Incentive Plans

During 2016, an additional 29,500 of the 88,500 restricted shares of Sapiens Decision, the Company's majority-owned subsidiary that were granted to one of the former shareholders of KPI in 2014 (as described in note 1d(3) to our consolidated financial statements included in this annual report) vested (in addition to the 29,500 of such 88,500 restricted shares that had vested in 2015), thereby reducing the Company’s percentage ownership of Sapiens Decision from 95.7% to 94.25%. During 2016, Sapiens Decision issued options to certain of its employees to purchase shares of Sapiens Decision.

 

C.Board Practices

 

Members of the Company’sour Board of Directors are elected by a vote at the annual general meeting of shareholders and serve for a term of one year, fromuntil the date of the prior year'sfollowing year’s annual meeting. Directors may serve multiple terms and are elected by a majority of the votes cast at the meeting. The Chief Executive Officer serves until his removal by the Board of Directors or resignation from office. Our non-employee directors do not have agreements with the Company for benefits upon termination of their service as directors.

 

63

Audit Committee

 

The Audit Committee of our Board of Directors is comprised of three independent directors (such independence determination having been made by our Board of Directors, in accordance with the NASDAQ Listing Rules), who were nominated by the Board of Directors: Yacov Elinav, Uzi Netanel and Eyal Ben Chlouche. Mr. Elinav serves as the chairman of the committee. The Board of Directors has determined that Mr. Elinav meets the definition of an audit committee financial expert (as defined in paragraph (b) of Item 16A (b) of Form 20-F promulgated by the SEC). The primary function of the Audit Committee is to assist the Board of Directors in fulfilling its oversight responsibilities by reviewing financial information, internal controls and the audit process. In addition, the Committee is responsible for oversight of the work of our independent auditors. The Committee meets at regularly scheduled quarterly meetings.

 

Compensation Committee

 

The Compensation Committee of our Board of Directors is comprised of twothree directors, nominated by the Board of Directors: Uzi Netanel, Naamit Salomon and Guy Bernstein. Mr. Bernstein serves as the chairman of the committee. The Compensation Committee is responsible for the review and approval of grants of options to our employees and other compensation matters as requested by the Board of Directors from time to time.

NASDAQ Opt OutsOpt-Outs for a Foreign Private Issuer

We are a foreign private issuer within the meaning of NASDAQ Listing Rule 5005(a)(18), since we are governed by the laws of Curaçao and we meet the other criteria set forth for a “foreign private issuer” under Rule 3b-4(c) under the Exchange Act.

 

Pursuant to NASDAQ Listing Rule 5615(a)(3), a foreign private issuer may follow home country practice in lieu of certain provisions of the NASDAQ Listing Rule 5600 series and certain other NASDAQ Listing Rules. Please see Item 16G below (““Item 16G. Corporate Governance”) below for a description of the manner in which we rely upon home country practice in lieu of certain of the NASDAQ Listing Rules. We rely on home country practice with respect to a number of matters for which we would otherwise be exempt under the controlled company exemption described above under “NASDAQ Exemptions for a Controlled Company”

 

D.Employees

 

As of December 31, 2013,2016, we had a total of 9381,928 employees, a 19%22.6% increase fromrelative to the end of 2012.2015.

 

The following table sets forth the number of our employees atas of the end of each of the past three fiscal years, according to their geographic area of employment:regions:

 

Geographic Area Total Number of Employees, in All Categories of Activities 
Geographic Region Total Number of Employees as of December 31, 
 2011 2012 2013  2014  2015  2016 
Israel  464   540   644   676   790   862 
UK and Europe  126   150   191   212   367   445 
North America  71   75   73   88   113   175 
Asia Pacific  37   26   30   41   303   446 
Total Employees  688   791   938   1,017   1,573   1,928 

64

 

E.Share Ownership

 

The number of our Common Shares beneficially owned by each of our directors and executive officers individually, and by our directors and executive officers as a group, as of AprilMarch 1, 2014,2017, is as follows:

 

 Shares Beneficially Owned 
 Shares Beneficially Owned  Number Percent (1) 
 Number Percent (1)      
Roni Al Dor  1,424,781(2)  3.0%  1,124,781(2)  2.3%
                
        
All directors and executive officers as a group (7 persons, including Roni Al Dor)(3) (4)  1,681,596   3.6%
All directors and executive officers as a group(7 persons, including Roni Al-Dor)(3) (4)  2,284,950   4.5%

 

(1)Unless otherwise indicated below, the persons in the above table have sole voting and investment power with respect to all shares shown as beneficially owned by them. The percentages shown are based on 46,881,45049,035,951 Common Shares outstanding (which excludes 2,328,296 Common Shares held in treasury) as of AprilMarch 1, 20142017, plus such number of Common Shares as the indicatedrelevant person or group had the right to receive upon exercise of options whichthat are exercisable within 60 days of AprilMarch 1, 2014.2017.

 

(2)Includes options to purchase 189,504408,932 Common Shares under the Prior Incentive Plans2011 Plan at ana weighted average exercise price of $1.50$5.87 per share expiring no later than September 2015, options to purchase 935,277 Common Shares under the Special Plan at an exercise price of $1.50 per share expiring no later than September 2015 and options to purchase 75,000 Common Shares under the Incentive Plans at an exercise price of $1.60 per share expiring no later than March 2016,May 2021, which are vested or will become vested within 60 days of AprilMarch 1, 2014. In additional Mr. Al Dor has options to purchase 225,000 Common Shares with exercise prices between $1.60 and $3.00 per share which are not vested or becoming vested within 60 days of April 1, 2014).2017. See Item 6 - “Directors, Senior Management and Employees - Compensation of Directors and Officers.Officers.

 

(3)Each of our directors and executive officers who is not separately identified in the above table beneficially owns less than 1% of our outstanding Common Shares (including options to purchase Common Shares held by each such party and whichthat are vested or will become vestedvest within 60 days of AprilMarch 1, 2014)2017) and has therefore not been separately identified.

 

(4)Includes options to purchase 1,681,5961,373,783 Common Shares at exercise prices ranging from $1.35$2.50 to $6.42$9.73 per share, which are vested or will become vested within 60 days of AprilMarch 1, 2014, and none of such options expires before 2015.2017.

 

Item 7.Major Shareholders and Related Party Transactions

 

A.Major Shareholders.

 

The following table sets forth, as of AprilMarch 1, 2014,2017, certain information with respect to the beneficial ownership of the Company’s Common Shares by each person known by the Company to own beneficially more than 5% of the outstanding Common Shares, based on information provided to us by the holders or disclosed in public filings of the shareholders with the Securities and Exchange Commission.

 

We determine beneficial ownership of shares under the rules of Form 20-F promulgated by the SEC and include any Common Shares over which a person possesses sole or shared voting or investment power, or the right to receive the economic benefit of ownership, or for which a person has the right to acquire any such beneficial ownership at any time within 60 days.

 

  Shares Beneficially Owned 
Name and Address  Number   Percent(1) 
Formula Systems (1985) Ltd. (2)
5 HaPlada Street
Or Yehuda 60218, Israel
  22,369,035   47.7%
Yelin Lapidot Holdings Management Ltd. (4)
50 Dizengoff St., Dizengoff Center, Gate 3, Top
Tower, 13th floor, Tel Aviv 64332, Israel
  2,339,878   5.0%
  Shares Beneficially Owned 
Name and Address Number  Percent (1) 
Formula Systems (1985) Ltd.
5 HaPlada Street
Or Yehuda 60218, Israel
  23,954,094(2)  48.9%

 

Unless otherwise indicated below,To the personsbest of our knowledge, the entity listed in the above table havehas sole voting and investment power with respect to all shares shown as beneficially owned by them.it.

65

 

(1)The percentages shown are based on 46,881,45049,035,951 Common Shares outstanding (which excludes 2,328,296 Common Shares held in treasury) as of AprilMarch 1, 2014.2017.

(2)BasedThe number of Common Shares shown as owned by Formula is based on Amendment No. 22information provided to the Schedule 13D filedCompany by Formula on May 6, 2013, which presented ownership as of May 2, 2013. BasedMarch 1, 2017. Also based on information provided to the Company, Asseco beneficially owned, as of AprilMarch 1, 2014, 50.2%2017, 46.3% of the outstanding share capital of Formula. As such, Asseco may be deemed to be the beneficial owner of the aggregate 22,369,03523,954,094 Common Shares held directly by Formula. The address of Asseco is Olchowa 14 35-322 Rzeszow, Poland.

(3)Based on Amendment No. 1 to the Schedule 13G filed by Yelin Lapidot Provident Funds Management Ltd., Yelin Lapidot Mutual Funds Management Ltd., Yair Lapidot and Dov Yelin on February 3, 2014. The Common Shares reported as owned by this shareholder are beneficially owned by provident funds managed by Yelin Lapidot Provident Funds Management Ltd. and mutual funds managed by Yelin Lapidot Mutual Funds Management Ltd. (the “Subsidiaries”), each a wholly-owned subsidiary of Yelin Lapidot Holdings Management Ltd. (“Yelin Lapidot Holdings”). Messrs. Yelin and Lapidot each own 24.38% of the share capital and 25% of the voting rights of Yelin Lapidot Holdings, and are responsible for the day-to-day management of Yelin Lapidot Holdings. The Subsidiaries operate under independent management and make their own independent voting and investment decisions. Any economic interest or beneficial ownership in any of the Common Shares covered by that Schedule 13G is held for the benefit of the members of the provident funds or mutual funds, as the case may be. Each of Messrs. Yelin and Lapidot, Yelin Lapidot Holdings, and the Subsidiaries disclaims beneficial ownership of the Common Shares covered by that Schedule 13G.

 

Significant changes in holdings of major shareholders

 

From time to time, Formula has increased its beneficial shareholding in our Company through market purchases of additional Common Shares. From January 2010 through July 10, 2011, Formula increased its holding of our Common Shares by approximately 1,198,431 additional Common Shares through purchases on the public market and in private transactions. See the Schedule 13D/As filed by Formula with the SEC on July 26, 2010, June 14, 2011and July 13, 2011 with respect to such purchases.

 

On August 21, 2011, KCPS Technology Investments (2006) Ltd. acquired 3,759,806 Common Shares in connection with our acquisitionAs of IDIT and FIS. See the Schedule 13G filed by KCPS Technology Investments (2006) Ltd. (“KCPS”) with the SEC on July 25, 2011 with respect to such acquisition. KCPS has subsequently (during 2013) disposed of the vast majority of those shares and is no longer a 5% beneficial holder of our Common Shares. On August 21, 2011, Kardan acquired shared beneficial ownership of 7,536,243 Common Shares and Formula Vision Technologies (F.V.T.) Ltd. (“FVT”) and Dan Goldstein acquired shared beneficial ownership of 9,638,337 Common Shares. See the Schedule 13D filed by Kardan and other parties with the SEC on July 29, 2011 with respect to such acquisition.

Between July 11, 2011 through August 25, 2011, Formula purchased 356,555 Common Shares in private transactions. See the Schedule 13D/As filed by Formula with the SEC on August 18, 2011 and August 25, 2011 with respect to such purchases. Between September 28, 2011 and November 14, 2011, Formula purchased 1,891,885 Common Shares from FVT. See the Schedule 13D/As filed by Formula with the SEC on October 4, 2011 and November 22, 2011 with respect to such purchases. From December 28, 2011 through January 29, 2012, Formula purchased an aggregate of 2,005,738 Common Shares in private transactions. Of such Common Shares, 1,600,000 were purchased from FVT and Kardan. See the Schedule 13D/A filed by Formula with the SEC on January 31, 2012 with respect to such purchases.

On August 16, 2012, Formula purchased 1,000,000 Common Shares from Kardan in a private transaction. See the Schedule 13D/A filed by Formula with the SEC on August 21, 2012 with respect to such purchase.

Between September 28, 2012 and November 28, 2012, Kardan sold an aggregate of 2,065,733 Common Shares. Of such Common Shares, 2,000,000 were repurchased by the Company from Kardan on November 28, 2012. These transactions resulted in Kardan no longer beneficially owning 5% of our outstanding Common Shares.

From April 11, 2013 through May 2, 2013, Formula purchased an aggregate of 469,000 Common Shares in broker-initiated and private transactions for an aggregate purchase price of US$2,666,000, resulting in its last-reported ownership ofowned 22,369,035 Common Shares, or 57.2% of all outstanding Common Shares. That ownership was diluted down to 47.7% as of April 1, 2014, primarily as a result of our issuance of 6,497,500 Common Shares pursuant to our public offering in November 2013. From August 21, 2014 through September 16, 2014, Formula purchased an aggregate of 736,862 Common Shares in broker-initiated and private transactions for an aggregate purchase price of $5.8 million, following which Formula owned 23,105,897 Common Shares, or 48.5% of all outstanding Common Shares. From September 17, 2014 through December 26, 2014, Formula purchased an aggregate of 808,940 Common Shares in broker-initiated and private transactions, for an aggregate purchase price of $6.1 million, thereby increasing its beneficial ownership percentage back up to 50.2%. That beneficial ownership has been diluted down once again to 48.9% as of March 1, 2017, primarily as a result of various minor issuances of Common Shares that we have made.

 

In October 2013, Yelin Lapidot Holdings Management Ltd. and its affiliates, which were formerly a 5% shareholder of our company, had acquired 2,209,748 of our Common Shares in October 2013, and currently hold 2,339,878then acquired additional shares such that they held 2,625,007 Common Shares as of thosethe end of 2015. They have subsequently sold shares and reduced their holdings to 2,381,426 Common Shares as of December 31, 2016, thereby reducing their ownership of our Common Shares below 5% (based on Amendment No. 14 to the Schedule 13G filed by Yelin Lapidot Provident Funds Management Ltd., Yelin Lapidot Mutual Funds Management Ltd., Yair Lapidot and Dov Yelin on February 3, 2014)8, 2017).

 

Voting rights of major shareholders

 

The major shareholders disclosed above do not have different voting rights than other shareholders with respect to the Common Shares that they hold.

Holders of Recordrecord

 

As Aprilof March 1, 20142017 there were 7565 holders of record of the Company’sour Common Shares, including 5245 holders of record with addresses in the United States who holdheld a total of 44,246,315(out41,372,232 Common Shares (out of which 39,146,975 Common41,363,233Common Shares are held of record by CEDE & Co), representing approximately 94.4%84.4% of our issued and outstanding Common Shares.  The number of record holders in the United States is not representative of the number of beneficial holders, nor is it representative of where such beneficial holders are resident, because many of these Common Shares were held of record by nominees (including CEDE & Co., as nominee for a large number of banks, brokers, institutions and underlying beneficial holders of our Common Shares).In particular, Formula, which held (as of March 1, 2017 (in part as a record holder and in part as an underlying beneficial holder) 23,954,094 Common Shares, representing 48.9% of our issued and outstanding shares, is not a United States company.

 

Control of the Company

 

Based on Formula’s beneficial ownership of 47.1%48.9% of the outstanding Common Shares of the Company (as of AprilMarch 1, 2014)2017), and based on Asseco'sAsseco’s beneficial ownership of 46.4%46.3% of the outstanding share capital of Formula (also as of that date), both Formula and Asseco may be deemed to control the Company. We are unaware of any arrangements the operation of which may at a subsequent date result in a change of control of the Company.

66

B.Related Party Transactions.Transactions

Registration Rights Agreement with Major Shareholders

 

The description of the Registration Rights Agreement set forth in Item 10.C “Material Contracts” is incorporated herein by reference.reference herein.

Fees Paid to Major Shareholder for Board Service of its Affiliate

We paid to our major shareholder, Formula, approximately $23,000 in respect of our share of the director fees of Guy Bernstein, our Chairman, for the year ended December 31, 2016. Mr. Bernstein serves as the Chief Executive Officer of Formula and a director of Asseco. Formula directly owns (as of March 1, 2017) approximately 48.9% of our currently outstanding Common Shares.

Additional Agreements and Transactions with Affiliated Companies of Formula

During the year ended December 31, 2016, we paid to affiliated companies of Formula approximately $6.1 million, in the aggregate, pursuant to services agreements that we have in place with those companies under which we receive services. In 2016, we also purchased from those affiliated companies an aggregate of approximately $1.0 million of hardware and software. Please see Note 13 to our audited consolidated financial statements included in Item 18 of this annual report for further information.

Services Obtained from Asseco

During 2016, Asseco provided back-office services, professional services and fixed assets to our wholly-owned subsidiary, Insseco, in an amount totaling approximately $1.9 million.  Please see Note 13 to our audited consolidated financial statements included in Item 18 of this annual report for further information.

Trade Payables and Receivables

As of December 31, 2016, we had trade payables balances due to, and trade receivables balances due from, our related parties in amounts of approximately $1.3 millionand $1.4 million, respectively.

 

C.Interests of Experts and Counsel.

 

Not applicable.

 

Item 8.Financial Information

 

A.Consolidated Statements and Other Financial Information.

 

Financial Statements

 

See the Consolidated Financial Statements and related notes in Item 18.

 

Export Sales

 

In 2013, 83%2016, 86.5% of our revenues originated from customers located outside of Israel. For information on our revenues breakdown by geographic marketregion for the past three years, see Item 4, “Information5.A, “Operating and Financial Review and Prospects— Operating Results— Comparison of the years ended December 31, 2015 and 2016, and Comparison of the years ended December 31, 2014 and 2015— Revenues by geographical region”.

67

Legal Proceedings

Previously, we entered into a software development project agreement with a significant customer to customize, enhance and implement a new product. We have recently received a letter from that customer, in which the customer alleged that we have materially breached our agreement with the customer. After carefully examining the customer’s allegations, we informed the customer that we have not materially breached any of our obligations under the agreement and that the customer itself has materially breached the agreement. Work on the Company – Business Overview - Geographical Distribution of Revenues.”

Legal Proceedingsproject has been halted due to the dispute. The parties are currently engaged in discussions relating to the foregoing.

 

FromIn addition to the foregoing, from time to time, we are a party to various non-material legal proceedings and claims that arise in the ordinary course of business.

 

Dividend Policy

 

Upon review of our consolidated results of operations, financial condition, cash requirements, future prospects and other factors, on January 15, 2013, April 20, 2015 and March 31, 2016, our Board of Directors determined, subject to shareholder approval, to declare and pay a one-time cash dividendinterim dividends of $0.15, $0.15 and $0.20 per Common Share (or $5.8 million, $7.2 million and $10 million, in the aggregate). aggregate, respectively), which were paid on February 22, 2013 and commencing on June 1, 2015 and June 1, 2016, respectively.

We currentlydo not have noa dividend policy andpolicy. However, our Board of Directors has not yet made a determinationwill determine, on an annual basis, as to whether we will pay a dividend in the Company would payupcoming year. Such determination will be dependent upon our financial condition, recent and prospective results of operations, and cash requirements, among other relevant factors, and will be subject to the requirements of Curaçao law and the Articles. If our company continues to be profitable, our Board of Directors may decide to distribute additional dividends in the future. Any determination in the future to pay dividends will be dependent upon the Company’s financial condition and cash requirements and other factors.as well. For more information about distribution of dividends, the related requirements of Curaçao law and various tax implications, see Item 10, “Additional Information -Information— Memorandum and Articles of Association;” Item 10, “Additional InformationExchange Controls,” and Item 10, “Additional InformationInformation— Taxation.”

B.Significant Changes

 

No significant change, other than as otherwise described in this annual report, has occurred in our operations since the date of our consolidated financial statements included in this annual report.

 

ITEM 9.THE OFFER AND LISTING

 

A.Offer and Listing Details.Details

 

The Company’s Common Shares are quotedlisted on the NASDAQ Capital Market and on the TASE under the symbol “SPNS”.

 

NASDAQ:

 

The table below sets forth the high and low marketclosing prices (in US dollars) for our Common Shares on the NASDAQ Capital Market (i) on an annual basis for the years 20092012 through 2013,2016, and the year 20142017 (through March 31, 2014)14, 2017), and (ii) on a quarterly basis for 2011, 2012, 20132015, 2016 and the first quarter of 2014.2017 (through March 14, 2017):

 

 HIGH  LOW  HIGH  LOW 
     
2009 (Annual)  2.00   0.76 
2010 (Annual )  3.20   1.33 
2011 (Annual)  4.74   2.35 
2012 (Annual)  4.48   3.03   4.33   3.20 
2013 (Annual)  7.88   3.93   7.77   3.99 
2014 (through March 31, 2014)  8.56   6.60 
2014 (Annual)  8.46   6.73 
2015 (Annual)  12.64   6.42 
2016 (Annual)  15.64   9.47 
2017 (through March 14, 2017)  15.45   13.07 
                
2011        
2015        
First Quarter  4.74   2.31   8.33   6.42 
Second Quarter  4.07   2.96   10.38   8.33 
Third Quarter  4.37   2.67   12.64   10.22 
Fourth Quarter  4.20   2.72   11.86   9.71 
2012        
        
2016        
First Quarter  4.33   3.03   12.12   9.47 
Second Quarter  4.48   3.25   12.65   10.99 
Third Quarter  4.07   3.40   14.12   11.74 
Fourth Quarter  4.17   3.16   15.64   12.58 
2013        
First Quarter  5.57   3.93 
Second Quarter  5.97   4.88 
Third Quarter  6.24   5.24 
Fourth Quarter  7.88   5.85 
2014        
First Quarter  8.56   6.60 
        
2017        
First Quarter (through March 14, 2017)  15.45   13.07 

68

The table below sets forth the high and low marketclosing prices (in US dollars) for our Common Shares on the NASDAQ Capital Market on a monthly basis during the most recent six-month period.

 

  HIGH  LOW 
October  2013  6.92   5.85 
November  2013  7.27   6.20 
December  2013  7.88   6.86 
January  2014  7.78   6.63 
February  2014  7.60   6.60 
March 2014  8.56   7.42 

  HIGH  LOW 
September  2016  13.73   12.77 
October  2016  13.63   12.58 
November  2016  14.93   12.93 
December  2016  15.64   14.15 
January  2017  14.94   13.07 
February  2017  15.45   13.47 
March 2017 (through March 14, 2017)  14.44   13.12 

 

The closing price of our Common Shares on the NASDAQ Capital Market on March 31, 2014,14, 2017, being the last practicable date prior to publication of this annual report, was $8.11.$13.12.

 

TASE:

 

Our Common Shares began trading on the TASE effective March 6, 2003. Under current Israeli law, the Company will satisfysatisfies its reporting obligations in Israel by furnishing to the applicable Israeli regulators those reports whichthat the Company is required to file or submit in the United States. The table below sets forth the high and low marketclosing prices, in US dollars, for our Common Shares on the TASE on an annual basis for the years 20092012 through 20132016 and the year 2017 (through March 14, 2017), and on a quarterly basis for the years 20122015 and 2013,2016, and for the first three monthsquarter of 2014.2017 (through March 14, 2017). The conversion from NIS into US dollars for the following two tables is based on the average monthly, quarterly or yearly representative rate of exchange published by the Bank of Israel for the month, quarter or year (as appropriate) in which such high or low closing price per share was recorded).recorded.

 

 HIGH  LOW  HIGH  LOW 
     
2009 (Annual)  2.06   0.92 
2010 (Annual)  3.30   1.30 
2011 (Annual)  4.45   2.34 
2012 (Annual)  4.24   3.05   4.24   3.05 
2013 (Annual)  7.90   4.10   7.90   4.10 
2014 (through March 31, 2014)  8.60   6.75 
2014 (Annual)  8.37   6.66 
2015 (Annual)  12.70   6.48 
2016 (Annual)  15.34   9.20 
2017 (through March 14, 2017)  15.27   12.85 
                
2012        
2015        
First Quarter  4.22   3.04   8.23   6.48 
Second Quarter  4.17   3.16   10.00   8.24 
Third Quarter  3.96   3.49   12.70   10.10 
Fourth Quarter  4.19   3.30   11.91   9.77 
                

2013

        
2016        
First Quarter  5.45   4.10   11.77   9.20 
Second Quarter  5.83   5.08   12.50   11.18 
Third Quarter  6.43   5.21   13.87   11.78 
Fourth Quarter  7.90   6.06   15.34   12.78 
                
2014        
First Quarter  8.60   6.75 
2017        
First Quarter (through March 14, 2017)  15.27   12.85 

69

The table below sets forth the high and low marketclosing prices, in US dollars, for our Common Shares on the TASE during the most recent six-month period:

 

  HIGH  LOW 
October 2013  7.02   6.04 
November 2013  7.24   6.26 
December  2013  7.98   6.92 
January  2014  7.86   6.77 
February  2014  7.52   6.75 
March 2014  8.60   7.55 

  HIGH  LOW 
September 2016  13.81   12.96 
October 2016  13.82   12.78 
November 2016  15.2   12.90 
December  2016  15.34   14.19 
January  2017  15.01   12.85 
February  2017  15.27   13.72 
March 2017 (through March 14, 2017)  14.53   13.05 

 

The closing price of our Common Shares on the TASE on March 31, 2014,14, 2017, being the last practicable date prior to publication of this annual report, was $8.14$13.12 (as converted from NIS based on the average monthlyclosing representative exchange rate foras of March 2014)14, 2017).

 

B.Plan of Distribution.

 

Not applicable.

 

C.Markets.

 

The Company’sOur Common Shares are listed on the NASDAQ Capital Market and on the TASE under the symbol “SPNS”.

 

D.Selling Shareholders.

 

Not applicable.

 

E.Dilution.

 

Not applicable.

 

F.Expenses of the Issue.

 

Not applicable.

 

Item 10.Additional Information

 

A.Share Capital.

 

Not applicable.

B.Memorandum and Articles of Association (the “Articles”).Association.

 

1.          Registration and Purposes.The Company is organized and existing under the laws of Curaçao. Its registered number is 53368.

1.70Registration and Purposes.The Company is organized and existing under the laws of Curaçao. Its registered number is 53368.

 

The objects and purposes of the Company, which are itemized in Article II of theour Amended Articles of Association, may be summarized as follows:

 

·to establish, participate in or have any other interest in business enterprises concerned with the development and commercial operation of software;

 

·to finance directly or indirectly the activities of the Company, its subsidiaries and affiliates;

 

·to borrow and to lend moneys;

 

·to engage in the purchase and sale of securities, futures, real estate, business debts, commodities and intellectual property;

 

·to undertake, conduct and promote research and development;

 

·to guarantee, pledge, mortgage or otherwise encumber assets as security for the obligations of the Company or third parties; and

 

·to do all that may be useful or necessary for the attainment of the above purposes.

 

2.Board of Directors.A member of the Board of Directors may vote on a proposal or transaction in which he/she has a material interest if the material facts as to the director’s self-interest are disclosed to the Board of Directors. Neither the Articles nor Curaçao law requires a majority of the disinterested directors to authorize the proposal or transaction. Members of the Board of Directors have the power to vote compensation to themselves, even if they lack an independent quorum.

2.          Board of Directors.In case of a conflict of interest between the Company and one or more directors, acting either in private or ex officio, the Company shall be represented by a person appointed thereto by the General Meeting of Shareholders or the Board of Directors. A director who knows or ought to understand that in a certain instance there is mention of a conflicting interest between the Company and him acting privately or ex officio, will timely inform the General Meeting of Shareholders or Board of Directors of such conflict of interest. No conflict of interest will be deemed to exist between the Company and one or more of its directors in case of a contract or transaction between the Company and any other corporation, partnership, association, or other organization in which one or more directors are directors or officers, or have a financial interest, solely for that reason, or solely because the director is present or participates in the meeting of the Board of Directors or Committee thereof which authorizes the contract or transaction, or solely because his or their votes are counted for such purpose if : (a) the material facts are disclosed or are known to the Board of Directors, (b) the material facts are disclosed or are known to the shareholders entitled to vote thereon, (c) the contract or transaction is fair as to the Company as of the time it is authorized, approved or ratified by the Board of Directors, a Committee thereof or the shareholders. Interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or of a Committee that authorizes the contract or transaction. The Articles provide that the directors shall receive such compensation as the Board of Directors may from time to time prescribe. Members of the Board of Directors have the power to vote compensation to themselves, even if they lack an independent quorum, subject to prior approval of the range of their compensation by the Company’s General Meeting of Shareholders.

 

The Articles do not grant borrowing powers to directors; nor do they require directors to resign at a certain age or to purchase a certain number of Common Shares.

The Articles do not grant borrowing powers to directors; nor do they require directors to resign at a certain age or to purchase a certain number of Common Shares.

 

3.Rights and Preferences.The Company has only one class of shares of common stock, the Common Shares, currently outstanding. All previous issuances of preferred shares have been converted into Common Shares. The rights and preferences of the holders of Common Shares are summarized below. The Articles authorize a class of undefined preferred shares (the “Blank Preferred Shares”). There are no rights associated with the Blank Preferred Shares and none have been issued.

3.          Rights and Preferences.The Company has only one class of shares of common stock, the Common Shares, currently outstanding. All previous issuances of preferred shares have been converted into Common Shares. The rights and preferences of the holders of Common Shares are summarized below. The Articles authorize a class of undefined preferred shares (which we refer to as the Blank Preferred Shares). There are no rights associated with the Blank Preferred Shares and none have been issued. The Board of Directors shall specify the rights that shall be associated with the Blank Preferred Shares prior to their issuance, including dividend rights and voting rights.

78

 

(a)Common Shares

 

Holders of the Common Shares are entitled to one vote for each whole share on all matters to be voted upon by shareholders, including the election of directors. Holders of the Common Shares do not have cumulative voting rights in the election of directors. All Common Shares are equal to each other with respect to liquidation and dividend rights. Holders of the Common Shares are entitled to receive dividends, subject to shareholder approval, out of funds legally available under Curaçao law. See “Dividend Policy” below. In the event of the liquidation of the Company, all assets available for distribution to the holders of the Common Shares are distributable among them according to their respective holdings, subject to the preferences of any shares having a preference upon liquidation that may be then outstanding. Holders of the Common Shares have no preemptive rights to purchase any additional, unissued Common Shares. The foregoing summary of the Common Shares does not purport to be complete and is subject to, and qualified in its entirety by, the provisions of the Articles.

 

71

(b)Dividend Policy

 

ForWe do not have a descriptiondividend policy. However, our Board of Directors will determine, on an annual basis, as to whether we will pay a dividend in the upcoming year. Such determination will be dependent upon various financial criteria, among other relevant factors. If our currentcompany continues to be profitable, our Board of Directors may decide to distribute a dividend, policy, pleaseas it has done in the recent past. Please see “Item 8. Financial Information—A. Consolidated Statements and Other Financial Information—Dividend Policy” above. Theabove for further information concerning the factors that help to determine whether and under what circumstances we may distribute dividends.

Our ability of the Company to pay dividends is subject to the limitations of the Curaçao Civil Code which provides, among other things, that dividends, while permittedand the Articles. In direct connection with the approval of our annual accounts, the general meeting of our shareholders shall decide on the distribution of the profits. Profits can either be reserved or distributed to be paid periodically duringthe shareholders in accordance with the Articles. Our Board of Directors has the right to reserve the profits at its discretion. If such reservation has been made by our Board of Directors, the general meeting of shareholders is not authorized to make a fiscal year, are subject to being proposed bydistribution out of the reserved part of the profits, unless the Board of Directors has first recommended in writing to the general meeting that such distribution out of the Companyreserved profits can be made and approved thereafterthe general meeting has adopted a resolution to that effect. Our Board of Directors may at any time resolve to make any interim distributions, if justified by the General Meetinganticipated profits of Shareholders.our company as an advanced payment of the dividend expected to be declared by the general meeting. The Curaçao Civil Code also providesand the Articles further provide that a (interim) distribution of dividends can only occur if, at the moment of distribution, the equity of the Companyour company equals at least the nominal capital of the Companyour company and, as a result of the distribution, it will not fall below the nominal capital.  Nominal capital is the sum of the par values of all of the issued shares of the Company’sour company’s capital stock at any moment in time.

 

(c)The Blank Preferred Shares

 

There are no preferences or any rights whatsoever associated with the Blank Preferred Shares. These shares are unissued and are not owned by any of the current shareholders of the Company. Any issuance of these preferred shares is solely within the discretion of the Company’s Board of Directors. The Company has undertaken toward the TASE that so long as its Common Shares are listed for trading on the TASE, the Company shall not issue or grant any shares of a different class of shares than those that are listed for trading on the TASE. This undertaking does not apply to Preferred Shares as defined in Section 46B(b) of the Israel Securities Law, on the condition that such Preferred Shares are issued in accordance with the conditions set forth in Section 46A(1) therein.

 

4.Changing the Rights of the Shareholders. The general meeting of shareholders decides upon any change in the Articles. A resolution to amend the Articles requires the approval of the absolute majority of all shares outstanding and entitled to vote.

4.          Changing the Rights of the Shareholders. The general meeting of shareholders decides upon any change in the Articles. Provided that no Blank Preferred Shares have been issued, a resolution to amend the Articles requires the approval of the absolute majority of all shares outstanding and entitled to vote.

 

5.General Meetings.At least one general meeting of shareholders must be held each year. General meetings must be held in Curaçao. Special general meetings of shareholders may be called at any time by the Chairman of the Board or by the Board of Directors upon no less than 12 nor more than 60 days’ written notice to the Company’s shareholders. Every shareholder has the right to attend any meeting of shareholders in person or by proxy and to address the meeting. No action may be taken at any meeting of shareholders unless a quorum consisting of holders of at least one-half of the shares outstanding and entitled to vote are present at the meeting in person or by proxy.

5.          General Meetings. At least one general meeting of shareholders must be held each year. Pursuant to the Articles, general meetings must be held in Curaçao. Special general meetings of shareholders may be called at any time by the Chairman of the Board or by the Board of Directors upon no less than 12 nor more than 60 days’ written notice to the Company’s shareholders. Every shareholder has the right to attend any meeting of shareholders in person or by proxy and to address the meeting. No action may be taken at any meeting of shareholders unless a quorum consisting of holders of at least one-half of the shares outstanding and entitled to vote are present at the meeting in person or by proxy. If a quorum is not present at the originally-called shareholder meeting, a second shareholder meeting, is held within two months. At that second meeting, valid resolutions may be adopted with respect to any matter stated in the notice of the original meeting and also in the notice of such second meeting or which by law is required to be brought before the shareholders (subject to certain exceptions), despite the absence of a quorum.

6.          Limitations to Own Securities. The Articles contain no limits on the right to own securities.

 

79
72 

 

6.Limitations to Own Securities.The Articles contain no limits on the right to own securities.

 

7.Change of Control. The Articles contain no provisions that would prevent or delay a change of control of the Company.

7.          Change of Control. The Articles contain no provisions that would prevent or delay a change of control of the Company.

 

8.Disclosure of Ownership.By-laws do not exist under Curaçao law. The Articles contain no provisions requiring a shareholder to disclose his or her interest at a certain time; however, holders of our shares are subject to the reporting provisions of the Securities and Exchange Commission.

8.          Disclosure of Ownership.The Articles contain no provisions requiring a shareholder to disclose his or her interest at a certain time; however, holders of our shares are subject to the reporting provisions of the SEC.

 

C.Material Contracts

 

We haveare not entered intoparty to any material contract within the two years prior to the date of this annual report, other than contracts entered into in the ordinary course of business, or as otherwise described below:

 

Share Purchase Agreement for Acquisition of StoneRiver

In the first quarter of 2017, our company entered into a share purchase agreement with StoneRiver Group L.P., or the Seller, and StoneRiver, Inc., or StoneRiver, for the acquisition of all of the issued and outstanding share capital of StoneRiver. We consummated the acquisition later in the first quarter of 2017. StoneRiver is a Denver, Colorado- based provider of technology solutions and services to the insurance industry.

The acquisition consideration is approximately $100 million in cash, subject to certain adjustments based on working capital, transaction expenses, unpaid debt and certain litigation matters.

Immediately prior to closing, we purchased a representations and warranties insurance policy covering certain indemnifiable damages under the agreement, which we refer to as the Insurance. The Insurance provides for coverage of $12,500,000 in the aggregate and its term is in general three years (except with respect to certain fundamental representations and warranties, as to which the term of the Insurance is six years).  In addition, two escrow funds were established by StoneRiver, for the purpose of enabling the indemnification of our company for certain damages that are not fully recovered under the Insurance: (i) an escrow fund in the amount of $500,000 for a period of one year and (ii) an escrow fund in the amount of $2,000,000 for a period of 18 months.

HSBC Term Loan Credit Agreement

In the first quarter of 2017, we (via our wholly-owned subsidiary, Sapiens Americas Corporation, or the Borrower) entered into a secured credit agreement, or the Credit Agreement, with HSBC Bank USA, National Association, or the Lender, in connection with, and as financing for, our acquisition of StoneRiver. Pursuant to the Credit Agreement, our company borrowed $40 million, or the Bank Loan, for a five-year term. The Bank Loan will mature in March 2022 and is payable in equal consecutive quarterly principal installments of principal and accrued interest. The Borrower is entitled to prepay the Bank Loan at any time (on any interest payment date) without penalty upon notice to the Lender. The Bank Loan bears interest at the rate of LIBOR plus 1.85%.

The repayment of the Bank Loan is secured by first priority liens over (i) substantially all assets of the Borrower and its US subsidiaries and (ii) the shares of the Borrower held by Sapiens International Corporation B.V. Certain affiliated entities of the Borrower have guaranteed the repayment of the Bank Loan. The Credit Agreement contains customary representations and warranties, affirmative covenants and negative covenants, which include, without limitation, restrictions on indebtedness, liens, investments, and certain dispositions with respect to the property secured by the lien. The Credit Agreement also contains customary events of default that entitle the Lender to cause any or all of our company's indebtedness to become immediately due and payable and to foreclose on the lien, and includes customary grace periods before certain events are deemed events of default.

Share Purchase Agreement for Acquisition of Insseco

In the third quarter of 2015, our company (via our wholly-owned subsidiary, Sapiens Technologies (1982) Ltd.) entered into a share purchase agreement with Asseco for the acquisition of all of the issued and outstanding shares of Insseco. We consummated the acquisition later in the third quarter of 2015. Insseco is a newly established company into which Asseco had transferred all of its Polish insurance employees, certain fixed assets, certain customer contracts and certain software, including intellectual property rights. Insseco has a team of approximately 140 insurance professionals and an established presence in the Polish insurance market, and services major insurance customers in Poland, including top tier insurance carriers.

73

Pursuant to the agreement, we paid the acquisition consideration in cash, consisting of 34.3 million Polish Zloty, or approximately $9.1 million. In addition, Asseco may be entitled to upside or downside performance-based payments relating to achievements of revenue goals and profitability over the next five years. If the aggregate revenues generated by Insseco from its activity from July 1, 2015 through June 30, 2020 exceed 90.0 million Polish Zloty, or approximately $23.8 million, Asseco will be entitled to receive additional amounts ranging from 3% to 15% of the excess amount of the respective revenues. If the aggregate revenues generated by Insseco for the period from July 1, 2015 through June 30, 2018 are below 84.0 million Polish Zloty or $22.2 million, Asseco will pay us an amount equal to 35% of the deficiency below such amount. In addition, the amounts payable to Asseco may be adjusted upwards or downwards as a result of changes in the profitability of a specific account that we acquired as part of the acquisition.

The estimated fair value of the contingent payments that depend on the revenue and profitability goals pursuant to the share purchase agreement was $1.0 million as of December 31, 2016.

Registration Rights Agreement

 

In connection with our acquisitions of each of IDIT and FIS, which were consummated on August 21,in the third quarter of 2011, we granted the shareholders of IDIT (the “IDIT(or the IDIT Selling Shareholders”) andShareholders), the shareholders of FIS (the “FIS(or the FIS Selling Shareholders”, andShareholders, to which we refer, together with the IDIT Selling Shareholders, as the “Holders”)Holders) and Formula certain registration rights under a Registration Rights Agreement (the “Registration Rights Agreement”).Agreement. Under the Registration Rights Agreement, the Holders and Formula are entitled to piggyback registration rights in connection with any registration statement that we file (subject to customary exceptions). The Holders also agreed to execute a lock-up agreement if requested by the representative of the underwriters in any underwritten offering.

Underwriting Agreement for Follow-On Offering Based on information that we have received from our transfer agent, we do not believe that the IDIT Selling Shareholders and Related Lock-Up Agreements

On November 14, 2013, we entered into an underwriting agreement with Barclays Capital Inc., as representative of the underwriters for an underwritten, public offering of 5,650,000 of our Common Shares, plus an additional 847,400 Common Shares to cover over-allotments. The shares (including the over-allotment shares) were sold atFIS Selling Shareholders still hold a price to the public of $6.25 per share, from which we realized net proceeds of approximately $38.2 million. The closing of the offering took place on November 19, 2013.

In connection with the offering, we, all of our directors and executive officers, and Formula agreed that, subject to certain exceptions, without the prior written consent of Barclays Capital Inc., we and they would not directly or indirectly sell or otherwise dispose of or transfer any Common Shares, exercise any right with respect to the registration of any Common Shares under the Securities Act, or enter into any swap or any other agreement or any transaction that would transfer, in whole or in part, the economic consequence of ownershipsignificant number of Common Shares for a period of 90 days afterthat are entitled to the dateforegoing registration rights under the Registration Rights Agreement as of the prospectus supplement for the Offering. That lock-up period expired in February 2014.current time.

D.Exchange Controls

 

Although there are Curaçao laws which may impose foreign exchange controls on the Company and may affect the payment of dividends, interest or other payments to non-resident holders of the Company’s securities, including the Common Shares, the Company has been granted an exemption from such foreign exchange control regulations by the Central Bank of Curaçao. Other jurisdictions in which the Company conducts operations may have various currency or exchange controls. In addition, the Company is subject to the risk of changes in political conditions or economic policies which could result in new or additional currency or exchange controls or other restrictions being imposed on the operations of the Company. As to the Company’s securities, Curaçao law and the Articles impose no limitations on the right of non-resident or foreign owners to hold or vote such securities.

 

E.Taxation

Israeli Tax Considerations and Government Programs

Tax regulations have a material impact on our business, particularly in Israel where we have our headquarters. The following summary describes the current tax structure applicable to companies in Israel, with special reference to its effect on us. The following also contains a discussion of the material Israeli tax consequences to holders of our Common Shares.

General Corporate Tax Structure

 

Generally, in 2013, Israeli companies were subject to a corporate tax at the rate of 25% on their taxable income for such year. The corporate tax rate was increased to 26.5% for 2014 and thereafter. However, the effective tax rate payable by a company that derives income from an Approved Enterprise, a Benefited Enterprise or a Preferred Enterprise, as further discussed below, may be considerably lower. See “Law for the Encouragement of Capital Investments” in this Item 10.E below. In addition, Israeli companies are currently subject to regular corporate tax rate on their capital gains.

Besides being subject to the general corporate tax rules in Israel, certain of our Israeli subsidiaries have also, from time to time, applied for and received certain grants and tax benefits from, and participate in, programs sponsored by the Government of Israel, as described below.

Law for the Encouragement of Industry (Taxes), 1969

The Law for the Encouragement of Industry (Taxes), 5729-1969 (the “Industry Encouragement Law”) provides several tax benefits for an “Industrial Company”. Pursuant to the Industry Encouragement Law, a company qualifies as an Industrial Company if it is an Israeli resident company which was incorporated in Israel and at least 90% of its income in any tax year (other than income from certain government loans) is generated from an “Industrial Enterprise” that it owns and located in Israel. An “Industrial Enterprise” is defined as an enterprise whose major activity, in a given tax year, is industrial production.

An Industrial Company is entitled to certain tax benefits, including:

§Deduction of the cost of the purchases of patents, or the right to use a patent or know-how used for the development or promotion of the Industrial Enterprise, over an eight year period commencing on the year in which such rights were first exercised;

§The right to elect, under certain conditions, to file a consolidated tax return together with Israeli Industrial Companies controlled by it; and

§Accelerated depreciation rates on equipment and buildings.

Eligibility for benefits under the Industry Encouragement Law is not subject to receipt of prior approval from any governmental authority.

We believe that certain of our Israeli subsidiaries currently qualify as Industrial Companies within the definition under the Industry Encouragement Law. We cannot assure you that we will continue to qualify as Industrial Companies or that the benefits described above will be available in the future.

Law for the Encouragement of Capital Investments, 5719-1959

The Law for the Encouragement of Capital Investments, 5719-1959 (the “Investment Law”), provides certain incentives for capital investments in a production facility (or other eligible assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, referred to as an Approved Enterprise, a Benefited Enterprise or a Preferred Enterprise, is entitled to benefits as discussed below. These benefits may include cash grants from the Israeli government and tax benefits, based upon, among other things, the location of the facility in which the investment is made. In order to qualify for these incentives, an Approved Enterprise, a Benefited Enterprise or a Preferred Enterprise is required to comply with the requirements of the Investment Law.

The Investment Law has been amended several times over the last years, with the two most significant changes effective as of April 1, 2005 (the “2005 Amendment”), and as of January 1, 2011 (the “2011 Amendment”). Pursuant to the 2005 Amendment, tax benefits granted in accordance with the provisions of the Investment Law prior to its revision by the 2005 Amendment remain in force but any benefits granted subsequently are subject to the provisions of the amended Investment Law. Similarly, the 2011 Amendment introduced new benefits instead of the benefits granted in accordance with the provisions of the Investment Law prior to the 2011 Amendment, yet companies entitled to benefits under the Investment Law as in effect up to January 1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and elect the benefits of the 2011 Amendment.

The following discussion is a summary of the Investment Law prior to its amendments as well as the relevant changes contained in the new legislation.

Tax benefits for Approved Enterprises approved before April 1, 2005.

Under the Investment Law prior to the 2005 Amendment, a company that wished to receive benefits on its investment program that is implemented in accordance with the provisions of the Investment Law (an “Approved Enterprise”), had to receive an approval from the Investment Center of the Israeli Ministry of Economy (formerly the Ministry of Industry, Trade and Labor (the “Investment Center”). Each certificate of approval for an Approved Enterprise relates to a specific investment program in the Approved Enterprise, delineated both by the financial scope of the investment and by the physical characteristics of the facility or the asset.

An Approved Enterprise may elect to forego any entitlement to the grants otherwise available under the Investment Law and, instead, participate in an alternative benefits program. Certain of our Israeli subsidiaries may choose to receive the benefits through the alternative benefits program. Under the alternative benefits program, a company’s undistributed income derived from an Approved Enterprise will be exempt from corporate tax for a period of between two and ten years from the first year of taxable income, depending upon the geographic location in Israel of the Approved Enterprise, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year, as detailed below. The benefits commence on the date in which that taxable income is first earned. The benefits period under Approved Enterprise status is limited to 12 years from the year the enterprise commences its operations, or 14 years from the year of the approval as an Approved Enterprise, whichever ends earlier. If a company has more than one Approved Enterprise program or if only a portion of its capital investments are approved, its effective tax rate is the result of a weighted combination of the applicable rates. The tax benefits from any certificate of approval relate only to taxable income attributable to the specific Approved Enterprise. Income derived from activity that is not integral to the activity of the Approved Enterprise will not enjoy tax benefits.

A company that has an Approved Enterprise program is eligible for further tax benefits, if it qualifies as a Foreign Investors’ Company, or FIC. An FIC eligible for benefits is essentially a company with a level of foreign investment, as defined in the Investment Law, of more than 25%. The level of foreign investment is measured as the percentage of rights in the company (in terms of shares, rights to profits, voting and appointment of directors), and of combined share and loan capital, that are owned, directly or indirectly, by persons who are not residents of Israel. The determination as to whether or not a company qualifies as an FIC is made on an annual basis. An FIC that has an Approved Enterprise program will be eligible for an extension of the period during which it is entitled to tax benefits under its Approved Enterprise status (so that the benefits period may be up to ten years) and for further tax benefits if the level of foreign investment exceeds 49%. If a company that has an Approved Enterprise program is a wholly owned subsidiary of another company, then the percentage of foreign investment is determined based on the percentage of foreign investment in the parent company.

The corporate tax rates and related levels of foreign investments with respect to an FIC that has an Approved Enterprise program are set forth in the following table:

Percentage of non-Israeli ownershipCorporate Tax Rate
Over 25% but less than 49%25%
49% or more but less than 74%20%
74% or more but less than 90%15%
90% or more10%

A company that has elected to participate in the alternative benefits program and that subsequently pays a dividend out of the income derived from the portion of its facilities that have been granted Approved Enterprise status during the tax exemption period will be subject to tax in respect of the amount of dividend distributed (grossed up to reflect such pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate that would have been otherwise applicable if such income had not been tax-exempted under the alternative benefits program. This rate generally ranges from 10% to 25%, depending on the extent to which non-Israeli shareholders hold such company’s shares.

In addition, dividends paid out of income attributed to an Approved Enterprise (or out of dividends received from a company whose income is attributed to an Approved Enterprise) are generally subject to withholding tax at the rate of 15%, or at a lower rate provided under an applicable tax treaty. The 15% tax rate is limited to dividends and distributions out of income derived during the benefits period and actually paid at any time up to 12 years thereafter. After this period, the withholding tax is applied at a rate of up to 30%, or at a lower rate under an applicable tax treaty. In the case of an FIC, the 12-year limitation on reduced withholding tax on dividends does not apply.

The Investment Law also provides that an Approved Enterprise is entitled to accelerated depreciation on its property and equipment that are included in an approved investment program. This benefit is an incentive granted by the Israeli government regardless of whether the alternative benefits program is elected.

The benefits available to an Approved Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations and the criteria in the specific certificate of approval with respect thereto, as described above. If a company does not meet these conditions, it would be required to refund the amount of tax benefits, adjusted to the Israeli consumer price index and interest.

In our case, subject to compliance with applicable requirements stipulated in the Investment Law and its regulations and in the specific certificate of approval, as described above, the portion of undistributed income derived from Approved Enterprise programs of certain of our Israeli subsidiaries will be exempt from corporate tax for a period of two to four years, followed by five to eight years with reduced tax rate of 25% on income derived from Approved Enterprise investment programs.

Tax benefits under the 2005 Amendment that became effective on April 1, 2005.

The 2005 Amendment applies to new investment programs and investment programs commencing after 2004, and does not apply to investment programs approved prior to April 1, 2005. The 2005 Amendment provides that terms and benefits included in any certificate of approval that was granted before the 2005 Amendment became effective (April 1, 2005) will remain subject to the provisions of the Investment Law as in effect on the date of such approval. Pursuant to the 2005 Amendment, the Investment Center will continue to grant Approved Enterprise status to qualifying investments. The 2005 Amendment, however, limits the scope of enterprises that may be approved by the Investment Center by setting criteria for the approval of a facility as an Approved Enterprise, such as provisions generally requiring that at least 25% of the Approved Enterprise’s income is derived from export.

An enterprise that qualifies under the new provisions is referred to as a Benefited Enterprise, rather than Approved Enterprise.The 2005 Amendment provides that the approval of the Investment Center is required only for Approved Enterprises that receive cash grants. As a result, a company is no longer required to obtain the advance approval of the Investment Center in order to receive the tax benefits previously available under the alternative benefits program. Rather, a company may claim the tax benefits offered by the Investment Law directly in its tax returns, provided that its facilities meet the criteria for tax benefits set forth in the 2005 Amendment. A company that has a Benefited Enterprise may, at its discretion, approach the Israel Tax Authority for a pre-ruling confirming that it is in compliance with the provisions of the Investment Law.

In order to receive the tax benefits, the 2005 Amendment states that a company must make an investment which meets all the conditions set forth in the amendment for tax benefits and which exceeds a minimum amount specified in the Investment Law. Such investment entitles a company to a Benefited Enterprise status with respect to the investment, and may be made over a period of no more than three years from the end of the year in which the company requested to have the tax benefits apply to the Benefited Enterprise. Where a company requests to have the tax benefits apply to an expansion of existing facilities, only the expansion will be considered to be a Benefited Enterprise, and the company’s effective tax rate will be the weighted average of the applicable rates. In such case, the minimum investment required in order to qualify as a Benefited Enterprise must exceed a certain percentage of the value of the company’s production assets before the expansion.

The extent of the tax benefits available under the 2005 Amendment to qualifying income of a Benefited Enterprise depends on, among other things, the geographic location of the Benefited Enterprise. Such tax benefits include an exemption from corporate tax on undistributed income for a period of between two to ten years, depending on the geographic location of the Benefited Enterprise in Israel, and a reduced corporate tax rate of between 10% to 25% for the remainder of the benefits period, depending on the level of foreign investment in the company in each year, as explained above.

Dividends paid out of income attributed to a Benefited Enterprise (or out of dividends received from a company whose income is attributed to a Benefited Enterprise) are generally subject to withholding tax at the rate of 15% or such lower rate as may be provided in an applicable tax treaty. The reduced rate of 15% is limited to dividends and distributions out of income attributed to a Benefited Enterprise during the benefits period and actually paid at any time up to 12 years thereafter, except with respect to an FIC, in which case the 12-year limit does not apply. Furthermore, a company qualifying for tax benefits under the 2005 Amendment which pays a dividend out of income attributed to its Benefited Enterprise during the tax exemption period will be subject to tax in respect of the amount of the dividend distributed (grossed-up to reflect the pre-tax income that it would have had to earn in order to distribute the dividend) at the corporate tax rate that would have otherwise been applicable

The benefits available to a Benefited Enterprise are subject to the fulfillment of conditions stipulated in the Investment Law and its regulations. If a company does not meet these conditions, it would be required to refund the amount of tax benefits, adjusted to the consumer price index and interest, or other monetary penalty.

As of December 31, 2013, we had not generated any income that was subject to the benefits under the 2005 Amendment.

Tax benefits under the 2011 Amendment that became effective on January 1, 2011.

The 2011 Amendment canceled the availability of the benefits granted in accordance with the provisions of the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a “Preferred Company” through its Preferred Enterprise (as such terms are defined in the Investment Law) as of January 1, 2011. A Preferred Company is defined as either (i) a company incorporated in Israel which is not wholly owned by a governmental entity or (ii) a limited partnership that (a) was registered under the Israeli Partnerships Ordinance and (b) all of its limited partners are companies incorporated in Israel, but not all of them are governmental entities; which has, among other things, Preferred Enterprise status and is controlled and managed from Israel. Pursuant to the 2011 Amendment, a Preferred Company is entitled to a reduced corporate tax rate of 15% with respect to its preferred income attributed to its Preferred Enterprise in 2011 and 2012, unless the Preferred Enterprise is located in a certain development zone, in which case the rate will be 10%. Such corporate tax rate was reduced to 12.5% and 7%, respectively, in 2013 and is increased to 16% and 9%, respectively, in 2014 and thereafter. Income derived by a Preferred Company from a ‘Special Preferred Enterprise’ (as such term is defined in the Investment Law) would be entitled, during a benefits period of 10 years, to further reduced tax rates of 8%, or to 5% if the Special Preferred Enterprise is located in a certain development zone.

Dividends paid out of income attributed to a Preferred Enterprise are generally subject to withholding tax at source at the rate of 15% (20% with respect to dividends to be distributed on or after January 1, 2014) or such lower rate as may be provided in an applicable tax treaty. However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 15% (20% with respect to dividends to be distributed on or after January 1, 2014) or such lower rate as may be provided in an applicable tax treaty will apply).

The 2011 Amendment also provided transitional provisions to address companies already enjoying current benefits under the Investment Law. These transitional provisions provide, among other things, that unless an irrevocable request is made to apply the provisions of the Investment Law as amended in 2011 with respect to income to be derived as of January 1, 2011: (i) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, which chose to receive grants, before the 2011 Amendment became effective, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, and subject to certain conditions; (ii) the terms and benefits included in any certificate of approval that was granted to an Approved Enterprise, that had participated in an alternative benefits program, before the 2011 Amendment became effective, will remain subject to the provisions of the Investment Law as in effect on the date of such approval, provided that certain conditions are met ; and (iii) a Benefited Enterprise can elect to continue to benefit from the benefits provided to it before the 2011 Amendment came into effect, provided that certain conditions are met. As of December 31, 2013, our Israeli subsidiaries had not filed a request to apply the new benefits under the 2011 Amendment.

Special Provisions Relating to Taxation under Inflationary Conditions

[As of tax-year 2005, our Israeli subsidiaries elected to measure their taxable income and file their tax returns under the Israeli Income Tax Regulations (Principles Regarding the Management of Books of Account of Foreign Invested Companies and Certain Partnerships and the Determination of Their Taxable Income), 1986. Therefore, as of tax-year 2005, taxable income of each of our Israeli subsidiaries is measured in terms of dollar. Each year we submit a request to the Israel Tax Authority to extend the effect of the above tax regulations on our company for an additional year.

Tax Benefits for Research and Development

Israeli tax law allows, under certain conditions, a tax deduction for research and development expenditures, including capital expenditures, for the year in which they are incurred.  Such expenditures must relate to scientific research and development projects, and must be approved by the relevant Israeli government ministry, determined by the field of research.  Furthermore, the research and development must be for the promotion of the company’s business and carried out by or on behalf of the company seeking such tax deduction.  However, the amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects.  Expenditures not so approved by the relevant Israeli government ministry, but otherwise qualifying for deduction, are deductible over a three-year period.

Transfer Pricing

As part of the Israeli 2003 tax reform, the Israeli Income Tax Ordinance (New Version), 1961 (the “Ordinance”) was amended to include section 85A, dealing with international transactions transfer pricing. Section 85A of the Ordinance provides that regardless of the actual conditions of an international transaction between related parties, the transaction shall be reported and taxed, based on the arm’s length standard,i.e., based on market conditions in similar transactions between unrelated parties. On October 30, 2006, the Income Tax Regulations (Determination of Market Conditions) (the “Regulations”), which provide instructions for the implementation of Section 85A, came into effect.

In accordance with the Regulations, a transaction shall be considered an international transaction if (i) one of the parties is a “foreign resident” as defined thereunder or if the income generated from such transaction, in all or in part, is taxed both in and outside of Israel; and (ii) there are special relations between the parties of the transaction. The Regulations establish acceptable methods for comparison between transactions, and methods for calculating the price range against which the transaction is measured.

Taxpayers are required to include in their yearly income tax returns a report declaring that their international transactions are at arm’s length. The Regulations have not had a material effect on the Company.

Israeli Taxation Considerations for Our Shareholders

 

The following is a short summary of the material provisions of the tax environment to which shareholders may be subject. This summary is based on the current provisions of tax law. To the extent that the discussion is based on new tax legislation that has not been subject to judicial or administrative interpretation, we cannot assure you that the views expressed in the discussion will be accepted by the appropriate tax authorities or the courts.

 

The summary does not address all of the tax consequences that may be relevant to all purchasers of our Common Shares in light of each purchaser’s particular circumstances and specific tax treatment. For example, the summary below does not address the tax treatment of residents of Israel and traders in securities who are subject to specific tax regimes. As individual circumstances may differ, holders of our Common Shares should consult their own tax adviser as to the United States, Israeli or other tax consequences of the purchase, ownership and disposition of Common Shares. The following is not intended, and should not be construed, as legal or professional tax advice and is not exhaustive of all possible tax considerations. Each individual should consult his or her own tax or legal adviser.

 

74

Tax Consequences Regarding Disposition of Our Common Shares

 

Overview

Israeli law generally imposes a capital gain tax on the sale of capital assets by residents of Israel, as defined for Israeli tax purposes, and on the sale of assets located in Israel, including shares of Israeli companies, by both residents and non-residents of Israel, unless a specific exemption is available or unless a tax treaty between Israel and the seller’s country of residence provides otherwise. The Ordinance distinguishes between “Real Capital Gain” and “Inflationary Surplus”. The Inflationary Surplus is a portion of the total capital gain which is equivalent to the increase of the relevant asset’s purchase price which is attributable to the increase in the Israeli consumer price index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of sale. The Real Capital Gain is the excess of the total capital gain over the Inflationary Surplus.

Capital gain

 

Israeli Resident Shareholders

 

As of January 1, 2006, the tax rate applicable to Real Capital Gain derived by Israeli individuals from the sale of shares which had been purchased on or after January 1, 2003, whether or not listed on a stock exchange, is 20%, unless such shareholder claims a deduction for interest and linkage differences expenses in connection with the purchase and holding of such shares, in which case the gain will generally be taxed at a rate of 25%. Additionally, if such shareholder is considered a Substantial Shareholder (i.e., a person who holds, directly or indirectly, alone or together with another person who collaborates with such person on a permanent basis, 10% or more of any of the company’s “means of control” (including, among other things, the right to receive profits of the company, voting rights, the right to receive the company’s liquidation proceeds and the right to appoint a director)) at the time of sale or at any time during the preceding 12-month period, such gain will be taxed at the rate of 25%. Individual shareholders dealing in securities in Israel are taxed at their marginal tax rates applicable to business income (up to 48% in 2013)2016).

 

Notwithstanding the foregoing, pursuant to the Law for Change in the Tax Burden (Legislative Amendments) (Taxes), 2011, the capital gain tax rate applicable to individuals was raised from 20% to 25% from 2012 and onwards (or from 25% to 30% if the selling individual shareholder is a Substantial Shareholder at any time during the 12-month period preceding the sale and/or claims a deduction for interest and linkage differences expenses in connection with the purchase and holding of such shares). With respect to assets (not shares that are listed on a stock exchange) purchased on or after January 1, 2003, the portion of the gain generated from the date of acquisition until December 31, 2011 will be subject to the previous capital gain tax rates (20% or 25%) and the portion of the gain generated from January 1, 2012 until the date of sale will be subject to the new tax rates (25% or 30%).

 

Under current Israeli tax legislation, the tax rate applicable to Real Capital Gain derived by Israeli resident corporations from the sale of shares of an Israeli company is the general corporate tax rate. As described above, the corporate tax rate was 25% in2016, in 20132017 the corporate tax rate is 24%, and from 2014 and onwards is 26.5%as of 2018 the corporate tax rate will be 23%.

75

 

Non-Israeli Residents Shareholders

 

Israeli capital gain tax is imposed on the disposal of capital assets by a non-Israeli resident if such assets are either (i) located in Israel; (ii) shares or rights to shares in an Israeli resident company; or (iii) represent, directly or indirectly, rights to assets located in Israel, unless a tax treaty between Israel and the seller’s country of residence provides otherwise. As mentioned above, Real Capital Gain is generally subject to tax at the corporate tax rate (25% in 20132016, 24% in 2017 and 26.5% as of 2014)23% in 2018 and thereafter) if generated by a company, or at the rate of 25% (for assets other than shares that are listed on stock exchange – 20% for the portion of the gain generated up to December 31, 2011) or 30% (for any asset other than shares that are listed on stock exchange – 25% with respect to the portion of the gain generated up to December 31, 2011), if generated by an individual from the sale of an asset purchased on or after January 1, 2003. Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income (a corporate tax rate for a corporation and a marginal tax rate of up to 48% for an individual in 2013)2016).

Notwithstanding the foregoing, shareholders who are non-Israeli residents (individuals and corporations) are generally exempt from Israeli capital gain tax on any gains derived from the sale, exchange or disposition of shares publicly traded on the Tel Aviv Stock Exchange or on a recognized stock exchange outside of Israel, provided, among other things, that (i) such gains are not generated through a permanent establishment that the non-Israeli resident maintains in Israel, (ii) the shares were purchased after being listed on a recognized stock exchange, and (iii) with respect to shares listed on a recognized stock exchange outside of Israel, such shareholders are not subject to the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985. However, non-Israeli corporations will not be entitled to the foregoing exemptions if Israeli residents (a) have a controlling interest of more than 25% or more in such non-Israeli corporation, or (b) are the beneficiaries of or are entitled to 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly. Such exemption is not applicable to a person whose gains from selling or otherwise disposing of the shares are deemed to be business income.

 

In addition, a sale of shares may be exempt from Israeli capital gain tax under the provisions of an applicable tax treaty. For example, under the U.S.-Israel Tax Treaty, (the “or the U.S-Israel Treaty,”), the sale, exchange or disposition of shares of an Israeli company by a shareholder who is a U.S. resident (for purposes of the U.S.-Israel Treaty) holding the shares as a capital asset is exempt from Israeli capital gain tax unless either (i) the shareholder holds, directly or indirectly, shares representing 10% or more of the voting rights during any part of the 12-month period preceding such sale, exchange or disposition; (ii) the shareholder, if an individual, has been present in Israel for a period or periods of 183 days or more in the aggregate during the applicable taxable year; or (iii) the capital gain arising from such sale are attributable to a permanent establishment of the shareholder which is maintained in Israel. In each case, the sale, exchange or disposition of such shares would be subject to Israeli tax, to the extent applicable; however, under the U.S.-Israel Treaty, a U.S. resident would be permitted to claim a credit for the Israeli tax against the U.S. federal income tax imposed with respect to the sale, exchange or disposition, subject to the limitations in U.S. laws applicable to foreign tax credits. The U.S-Israel Treaty does not provide such credit against any U.S. state or local taxes.

 

Payors of considerationIn some instances where our shareholders may be liable for traded shares, like our common shares, including the purchaser, the Israeli stockbroker effectuating the transaction, or the financial institution through which the sold shares are held, are required, subject to any of the foregoing exemptions and the demonstration of a shareholder regarding his, her or its foreign residency, to withhold tax uponon the sale of publicly tradedtheir ordinary shares, the payment of the consideration may be subject to the withholding of Israeli tax at source. Shareholders may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the Israel Tax Authority may require from shareholders who are not liable for Israeli tax to sign declarations in forms specified by this authority or obtain a specific exemption from the considerationIsrael Tax Authority to confirm their status as non-Israeli resident, and, in the absence of such declarations or fromexemptions, may require the Real Capital Gain generated from such sale, as applicable,purchaser of the shares to withhold taxes at the rate of 25%.source.

Taxes Applicable to Dividends

 

Israeli Resident Shareholders

 

Israeli residents who are individuals are generally subject to Israeli income tax for dividends paid on our common shares (other than bonus shares or share dividends) at 25%, or 30% if the recipient of such dividend is a Substantial Shareholder at the time of distribution or at any time during the preceding 12-month period. However, dividends distributed from taxable income accrued during the benefits period of an Approved Enterprise or Benefited Enterprise are subject to withholding tax at the rate of 15% (and 20% with respect to Preferred Enterprise),Enterprise, if the dividend is distributed during the tax benefits period under the Investment Law or within 12 years after such period. An average rate will be set in case the dividend is distributed from mixed types of income (regular and Approved/ Benefited/ Preferred income).

76

 

Israeli resident corporations are generally exempt from Israeli corporate tax for dividends paid on shares of Israeli resident corporations (like our common shares). However, dividends distributed from taxable income accrued during the benefits period of an Approved Enterprise or Benefited Enterprise are subject to withholding tax at the rate of 15%, if the dividend is distributed during the tax benefits period under the Investment Law or within 12 years after such period.

 

Non-Israeli Resident Shareholders

 

Non-Israeli residents (whether individuals or corporations) are generally subject to Israeli income tax on the receipt of dividends paid on ordinary shares, like our common shares, at the rate of 25% or 30% (if the dividend recipient is a Substantial Shareholder at the time of distribution or at any time during the preceding 12-month period) or 15% if the dividend is distributed from income attributed to our Approved Enterprise or Benefited Enterprise (and 20% with respect to Preferred Enterprise).Enterprise. Such dividends are generally subject to Israeli withholding tax at a rate of 25% so long as the shares are registered with a Nominee Company (whether the recipient is a Substantial Shareholder or not), and 15% if the dividend is distributed from income attributed to an Approved Enterprise or 20% if the dividend is distributed from income attributed to a Preferred Enterprise, unless a reduced rate is provided under an applicable tax treaty.treaty(subject to the receipt in advance of a valid certificate from the Israel Tax Authority allowing for a reduced tax rate). For example, under the U.S-Israel Treaty, the maximum rate of tax withheld in Israel on dividends paid to a holder of our common shares who is a U.S. resident (for purposes of the U.S.-Israel Treaty) is 25%. However, generally, the maximum rate of withholding tax on dividends, not generated by our Approved Enterprise, or Benefited Enterprises, that are paid to a U.S. corporation holding at least 10% or more of our outstanding voting capital from the start of the tax year preceding the distribution of the dividend through (and including) the distribution of the dividend, is 12.5%, provided that no more than 25% of our gross income for such preceding year consists of certain types of dividends and interest. Notwithstanding the foregoing, dividends distributed from income attributed to an Approved Enterprise a Benefited Enterprise or a Preferred Enterprise are subject to a withholding tax rate of 15% for such a U.S. corporation shareholder, provided that the condition related to our gross income for the previous year (as set forth in the previous sentence) is met. If the dividend is attributable partly to income derived from an Approved Enterprise, a Benefitted Enterprise, or a Preferred Enterprise, and partly to other sources of income, the withholding rate will be a blended rate reflecting the relative portions of the two types of income. U.S residents who are subject to Israeli withholding tax on a dividend may be entitled to a credit or deduction for U.S. federal income tax purposes in the amount of the taxes withheld, subject to detailed rules contained in United States tax legislation.

A non-Israeli resident who receives dividends from which tax was withheld is generally exempt from the obligation to file tax returns in Israel with respect to such income, provided that (i) such income was not generated from business conducted in Israel by the taxpayer, and (ii) the taxpayer has no other taxable sources of income in Israel with respect to which a tax return is required to be filed.

 

Payors of dividend on our common shares, including the Israeli stockbroker effectuating the transaction, or the financial institution through which the shares are held, are required, subject to any of the foregoing exemptions and the demonstration of a shareholder regarding his, her or its foreign residency, to withhold tax upon the distribution of dividend at the rate of 25%, so long as the shares are registered with a Nominee Company (for corporations and individuals).

Excess Tax

 

Individuals who are subject to tax in Israel are also subject to an additional tax at a rate of 2% on annual income exceeding NIS 811,560803,520 for 2014,2016 (and as of 2017, the additional tax will be at a rate of 3% on annual income exceeding NIS 640,000), which amount is linked to the annual change in the Israeli consumer price index, including, but not limited to, dividends, interest and capital gain, subject to the provisions of an applicable tax treaty.gain.

 

Taxation of Investments

 

The following discussion is a summary of certain anticipated tax consequences of an investment in the Common Shares under Curaçao tax laws, US federal income tax laws and Israeli laws. The discussion does not deal with all possible tax consequences relating to an investment in the Common Shares. In particular, the discussion does not address the tax consequences under state, local and other (e.g., non-US, non- Curaçao, non-Israel) tax laws. Accordingly, each prospective investor should consult its tax advisor regarding the tax consequences of an investment in the Common Shares. The discussion is based upon laws and relevant interpretations thereof in effect as of the date of this annual report on Form 20-F, all of which are subject to change.

 

77

Curaçao Taxation

 

Under the laws of Curaçao as currently in effect, a holder of Common Shares who is not a resident of, and during the taxable year has not engaged in trade or business through a permanent establishment in, Curaçao, willshould not be subject to Curaçao income tax on dividends paid with respect to the Common Shares or on gains realized during that year on sale or disposal of such shares;shares, unless the holder of Common Shares has been a resident of Curaçao in the preceding ten years and the holder of Common Shares has a qualifying interest of at least 5% of the total issued share capital; Curaçao does not impose a withholding tax on dividends paid by the Company. Under Curaçao law, no gift or inheritance taxes areshould be levied if, at the time of such gift or at the time of death, the relevant holder of Common Shares was not domiciled in Curaçao.

 

U.S. Federal Income Tax Considerations

 

Subject to the limitations described herein, this discussion summarizes certain U.S. federal income tax consequences of the purchase, ownership and disposition of our Common Shares to a U.S. holder. A U.S. holder is a holder of our Common Shares who is:

·an individual who is a citizen or resident of the U.S. for U.S. federal income tax purposes;

 

·a corporation (or another entity taxable as a corporation for U.S. federal income tax purposes) created or organized under the laws of the United States, any political subdivision thereof, or the District of Columbia;

 

·an estate, the income of which may be included in gross income for U.S. federal income tax purposes regardless of its source; or

 

·a trust (i) if, in general, a U.S. court is able to exercise primary supervision over its administration and one or more U.S. persons have the authority to control all of its substantial decisions or (ii) an electing trust that was in existence on August 19, 1996 and was treated as a domestic trust on that date.

 

Unless otherwise specifically indicated, this discussion does not consider the U.S. tax consequences to a person that is not a U.S. holder (a “non-U.S. holder”)(which we refer to as a non-U.S. holder) and considers only U.S. holders that will own our Common Shares as capital assets (generally, for investment).

 

This discussion is based on current provisions of the Internal Revenue Code of 1986, as amended, (the “Code”),or the Code, current and proposed Treasury Regulations promulgated under the Code and administrative and judicial interpretations of the Code, all as currently in effect and all of which are subject to change, possibly with a retroactive effect. This discussion does not address all aspects of U.S. federal income taxation that may be relevant to any particular U.S. holder based on the U.S. holder’s particular circumstances. In particular, this discussion does not address the U.S. federal income tax consequences to U.S. holders who are broker-dealers, insurance companies, real estate investment trusts, regulated investment companies, grantor trusts, individual retirement and tax-deferred accounts, certain former citizens or long-term residents of the U.S., tax-exempt organizations, financial institutions , “financial service entities”or who own, directly, indirectly or constructively, 10% or more of our outstanding voting shares, U.S. holders holding our Common Shares as part of a hedging, straddle or conversion transaction, U.S. holders whose functional currency is not the U.S. dollar, U.S. holders that acquired our Common Shares upon the exercise of employee stock options or otherwise as compensation, and U.S holders who are persons subject to the alternative minimum tax, who may be subject to special rules not discussed below.

 

Additionally, the tax treatment of persons who are, or hold our Common Shares through a partnership or other pass-through entity is not considered, nor is the possible application of U.S. federal estate or gift taxes or any aspect of state, local or non-U.S. tax laws.

 

You are advised to consult your tax advisor with respect to the specific U.S. federal, state, local and foreign tax consequences of purchasing, holding or disposing of our Common Shares.

78

Taxation of Distributions on Common Shares

 

Subject to the discussion below under “Tax Consequences if We Are a Passive Foreign Investment Company,” a distribution paid by us with respect to our Common Shares to a U.S. holder will be treated as dividend income to the extent that the distribution does not exceed our current and accumulated earnings and profits, as determined for U.S. federal income tax purposes.

 

Dividends that are received in taxable years beginning before January 1, 2014 by U.S. holders that are individuals, estates or trusts generally will be taxed at the rate applicable to long-term capital gains, provided those dividends meet the requirements of “qualified dividend income.” Effective January 1, 2013, the American Taxpayer Relief Act raises theThe maximum long-term capital gains rate of 15% tois 20% for individuals with annual taxable income over $400,000.that exceeds certain thresholds. In addition, under the Patient Protection and Affordable Care Act, higher income taxpayers must pay an additional 3.8 percent tax on net investment income to the extent certain threshold amounts of income are exceeded. See “New Tax“Tax on Net Investment Income” in this Item below. For this purpose, qualified dividend income generally includes dividends paid by a foreign corporation if certain holding period and other requirements are met and either (a) the stock of the foreign corporation with respect to which the dividends are paid is “readily tradable” on an established securities market in the U.S. (e.g., the NASDAQ Capital Market) or (b) the foreign corporation is eligible for benefits of a comprehensive income tax treaty with the U.S. which includes an information exchange program and is determined to be satisfactory by the U.S. Secretary of the Treasury. The United States Internal Revenue Service (“IRS”) has determined that the U.S.-Netherlands Antilles income tax treaty is not a comprehensive income tax treaty for this purpose. Dividends that fail to meet such requirements and dividends received by corporate U.S. holders are taxed at ordinary income rates. No dividend received by a U.S. holder will be a qualified dividend (i) if the U.S. holder held the Common Share with respect to which the dividend was paid for less than 61 days during the 121-day period beginning on the date that is 60 days before the ex-dividend date with respect to such dividend, excluding for this purpose, under the rules of Code Section 246(c), any period during which the U.S. holder has an option to sell, is under a contractual obligation to sell, has made (and not closed) a short sale of, is the grantor of a deep-in-the-money or otherwise nonqualified option to buy, or has otherwise diminished its risk of loss by holding other positions with respect to, such Common Share (or substantially identical securities); or (ii) to the extent that the U.S. holder is under an obligation (pursuant to a short sale or otherwise) to make related payments with respect to positions in property substantially similar or related to the Common Share with respect to which the dividend is paid. If we were to be a “passive foreign investment company” (as such term is defined in the Code), or “PFIC”,PFIC, for any taxable year, dividends paid on our Common Shares in such year or in the following taxable year would not be qualified dividends. See the discussion below regarding our PFIC status under “Tax Consequences if We Are a Passive Foreign Investment Company.” In addition, a non-corporate U.S. holder will be able to take qualified dividend income into account in determining its deductible investment interest (which is generally limited to its net investment income) only if it elects to do so; in such case the dividend income will be taxed at ordinary income rates.

 

The amount of any distribution which exceeds the amount treated as a dividend will be treated first as a non-taxable return of capital, reducing the U.S. holder’s tax basis in our Common Shares to the extent thereof, and then as capital gain from the deemed disposition of the Common Shares. Corporate holders will not be allowed a deduction for dividends received in respect of the Common Shares.

Distributions of current or accumulated earnings and profits paid in foreign currency to a U.S. holder will be includible in the income of a U.S. holder in a U.S. dollar amount calculated by reference to the exchange rate on the day the distribution is received. A U.S. holder that receives a foreign currency distribution and converts the foreign currency into U.S. dollars subsequent to receipt may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the U.S. dollar, which will generally be U.S. source ordinary income or loss.

 

Taxation of the Disposition of Common Shares

 

Subject to the discussion below under “Tax Consequences if We Are a Passive Foreign Investment Company,” upon the sale, exchange or other disposition of our Common Shares, a U.S. holder will recognize capital gain or loss in an amount equal to the difference between the amount realized on the disposition and the U.S. holder’s tax basis in our Common Shares. The gain or loss recognized on the disposition of the Common Shares will be long-term capital gain or loss if the U.S. holder held the Common Shares for more than one year at the time of the disposition and would be eligible for a reduced rate of taxation for certain non-corporate U.S. holders. Effective January 1, 2013, the American Taxpayer Relief Act raises theThe maximum long-term capital gains rate of 15% tois 20% for individuals with annual taxable income over $400,000.that exceeds certain thresholds. In addition, under the Patient Protection and Affordable Care Act, higher income taxpayers must pay an additional 3.8 percent tax on net investment income to the extent certain threshold amounts of income are exceeded. See “New Tax“Tax on Net Investment Income” in this Item below. Capital gain from the sale, exchange or other disposition of Common Shares held for one year or less is short-term capital gain and taxed as ordinary income. Gain or loss recognized by a U.S. holder on a sale, exchange or other disposition of our Common Shares generally will be treated as U.S. source income or loss. The deductibility of capital losses is subject to certain limitations.

79

 

A U.S. holder that uses the cash method of accounting calculates the dollar value of the proceeds received on the sale as of the date that the sale settles. However, a U.S. holder that uses the accrual method of accounting is required to calculate the value of the proceeds of the sale as of the trade date and may therefore realize foreign currency gain or loss. A U.S. holder that uses the accrual method may avoid realizing foreign currency gain or loss by electing to use the settlement date to determine the proceeds of sale for purposes of calculating the foreign currency gain or loss. In addition, a U.S. holder that receives foreign currency upon disposition of its Common Shares and converts the foreign currency into dollars after the settlement date or trade date (whichever date the U.S. holder is required to use to calculate the value of the proceeds of sale) may have foreign exchange gain or loss based on any appreciation or depreciation in the value of the foreign currency against the dollar, which will generally be U.S. source ordinary income or loss.

Tax Consequences if We Are a Passive Foreign Investment Company

 

We would be a passive foreign investment company, or PFIC, for a taxable year if either (1) 75% or more of our gross income in the taxable year is passive income; or (2) the average percentage (by value determined on a quarterly basis) in a taxable year of our assets that produce, or are held for the production of, passive income is at least 50%. Passive income for this purpose generally includes, among other things, certain dividends, interest, royalties, rents and gains from commodities and securities transactions and from the sale or exchange of property that gives rise to passive income. If we own (directly or indirectly) at least 25% by value of the stock of another corporation, we would be treated for purposes of the foregoing tests as owning our proportionate share of the other corporation’s assets and as directly earning our proportionate share of the other corporation’s income. As discussed below, we believe that we were not a PFIC for 2012.2016.

 

If we were a PFIC, each U.S. holder would (unless it made one of the elections discussed below on a timely basis) be taxable on gain recognized from the disposition of our Common Shares (including gain deemed recognized if our Common Shares are used as security for a loan) and upon receipt of certain excess distributions (generally, distributions that exceed 125% of the average amount of distributions in respect to such shares received during the preceding three taxable years or, if shorter, during the U.S. holder’s holding period prior to the distribution year) with respect to our Common Shares as if such income had been recognized ratably over the U.S. holder’s holding period for the shares. The U.S. holder’s income for the current taxable year would include (as ordinary income) amounts allocated to the current taxable year and to any taxable year prior to the first day of the first taxable year for which we were a PFIC. Tax would also be computed at the highest ordinary income tax rate in effect for each other taxable year to which income is allocated, and an interest charge on the tax as so computed would also apply. The tax liability with respect to the amount allocated to the taxable year prior to the taxable year of the distribution or disposition cannot be offset by any net operating losses. Additionally, if we were a PFIC, U.S. holders who acquire our Common Shares from decedents (other than nonresident aliens) would be denied the normally-available step-up in basis for such shares to fair market value at the date of death and, instead, would have a tax basis in such shares equal to the lesser of the decedent’s basis or the fair market value of such shares on the decedent'sdecedent’s date of death. .

 

As an alternative to the tax treatment described above, a U.S. holder could elect to treat us as a “qualified electing fund” (a “QEF”)QEF), in which case the U.S. holder would be taxed, for each taxable year that we are a PFIC, on its pro rata share of our ordinary earnings and net capital gain (subject to a separate election to defer payment of taxes, which deferral is subject to an interest charge). Special rules apply if a U.S. holder makes a QEF election after the first taxable year in its holding period in which we are a PFIC. We have agreed to supply U.S. holders with the information needed to report income and gain under a QEF election if we were a PFIC. Amounts includable in income as a result of a QEF election will be determined without regard to our prior year losses or the amount of cash distributions, if any, received from us. A U.S. holder’s basis in its Common Shares will increase by any amount included in income and decrease by any amounts not included in income when distributed because such amounts were previously taxed under the QEF rules. So long as a U.S. holder’s QEF election is in effect with respect to the entire holding period for its Common Shares, any gain or loss realized by such holder on the disposition of its Common Shares held as a capital asset generally will be capital gain or loss. Such capital gain or loss ordinarily would be long-term if such U.S. holder had held such Common Shares for more than one year at the time of the disposition and would be eligible for a reduced rate of taxation for certain non-corporate U.S. holders. Effective January 1, 2013, the American Taxpayer Relief Act raises theThe maximum long-term capital gains rate of 15% tois 20% for individuals with annual taxable income over $400,000.that exceeds certain thresholds. The QEF election is made on a shareholder-by-shareholder basis, applies to all Common Shares held or subsequently acquired by an electing U.S. holder and can be revoked only with the consent of the IRS. The QEF election must be made on or before the U.S. holder's tax return due date, as extended, for the first taxable year to which the election will apply.

80

As an alternative to making a QEF election, a U.S. holder of PFIC stock that is “marketable stock” (e.g., “regularly traded” on the NASDAQ Capital Market) may, in certain circumstances, avoid certain of the tax consequences generally applicable to holders of stock in a PFIC by electing to mark the stock to market as of the beginning of such U.S. holder’s holding period for our Common Shares. Special rules apply if a U.S. holder makes a mark-to-market election after the first year in its holding period in which we are a PFIC. As a result of such an election, in any taxable year that we are a PFIC, a U.S. holder would generally be required to report gain or loss to the extent of the difference between the fair market value of the Common Shares at the end of the taxable year and such U.S. holder’s tax basis in such shares at that time. Any gain under this computation, and any gain on an actual disposition of our Common Shares in a taxable year in which we are PFIC, would be treated as ordinary income. Any loss under this computation, and any loss on an actual disposition of our Common Shares in a taxable year in which we are PFIC, would be treated as ordinary loss to the extent of the cumulative net-mark-to-market gain previously included. Any remaining loss from marking our Common Shares to market will not be allowed, and any remaining loss from an actual disposition of our Common Shares generally would be capital loss. A U.S. holder’s tax basis in its Common Shares is adjusted annually for any gain or loss recognized under the mark-to-market election. There can be no assurances that there will be sufficient trading volume with respect to our Common Shares for the Common Shares to be considered “regularly traded” or that our Common Shares will continue to trade on the NASDAQ Capital Market. Accordingly, there are no assurances that our Common Shares will be marketable stock for these purposes. As with a QEF election, a mark-to-market election is made on a shareholder-by-shareholder basis, applies to all Common Shares held or subsequently acquired by an electing U.S. holder and can only be revoked with consent of the IRS (except to the extent our Common Shares no longer constitute “marketable stock”).

 

Based on an analysis of our assets and income, we believe that we were not a PFIC for 2012.2016. We currently expect that we will not be a PFIC in 2013.2017. The tests for determining PFIC status are applied annually and it is difficult to make accurate predictions of future income and assets, which are relevant to this determination. Accordingly, there can be no assurance that we will not become a PFIC in any future taxable years. U.S. holders who hold our Common Shares during a period when we are a PFIC will be subject to the foregoing rules, even if we cease to be a PFIC, subject to certain exceptions for U.S. holders who made QEF, mark-to-market or certain other special elections. U.S. holders are urged to consult their tax advisors about the PFIC rules, including the consequences to them of making a mark-to-market or QEF election with respect to our Common Shares in the event that we qualify as a PFIC.

New Tax on Net Investment Income

 

For taxable years beginning after December 31, 2012, aA U.S. holder that is an individual or estate, or a trust that does not fall into a special class of trusts that is exempt from the tax, will be subject to a 3.8% tax on the lesser of (1) the U.S. holder’s “net investment income” for the relevant taxable year and (2) the excess of the U.S. holder’s modified adjusted gross income for the taxable year over a certain threshold (which in the case of individuals will be between $125,000 and $250,000, depending on the individual’s circumstances). A U.S. holder’s net investment income generally will include its dividends on our ordinary shares and net gains from dispositions of our ordinary shares, unless those dividends or gains are derived in the ordinary course of the conduct of trade or business (other than trade or business that consists of certain passive or trading activities). Net investment income, however, may be reduced by deductions properly allocable to that income. A U.S. holder that is an individual, estate or trust is urged to consult its tax adviser regarding the applicability of the Medicare tax to its income and gains in respect of its investment in the Common Shares.

81

Non-U.S. holders of Common Shares

 

Except as provided below, a non-U.S. holder of our Common Shares will not be subject to U.S. federal income or withholding tax on the receipt of dividends on, or the proceeds from the disposition of, our Common Shares, unless, in the case of U.S. federal income taxes, that item is effectively connected with the conduct by the non-U.S. holder of a trade or business in the United States and, in the case of a resident of a country which has an income tax treaty with the United States, such item is attributable to a permanent establishment in the United States or, in the case of an individual, a fixed place of business in the United States. In addition, gain recognized on the disposition of our Common Shares by an individual non-U.S. holder will be subject to tax in the United States if the non-U.S. holder is present in the United States for 183 days or more in the taxable year of the sale and certain other conditions are met.

 

Information Reporting and Backup Withholding

 

A U.S. holder generally is subject to information reporting and may be subject to backup withholding at a rate of up to 28% (through 2013) with respect to dividend payments on, or receipt of the proceeds from the disposition of, our Common Shares. Backup withholding will not apply with respect to payments made to exempt recipients, including corporations and tax-exempt organizations, or if a U.S. holder provides a correct taxpayer identification number, certifies that such holder is not subject to backup withholding or otherwise establishes an exemption. Non-U.S. holders are not subject to information reporting or backup withholding with respect to dividend payments on, or receipt of the proceeds from the disposition of, our Common Shares in the U.S., or by a U.S. payor or U.S. middleman, provided that such non-U.S. holder provides a taxpayer identification number, certifies to its foreign status, or otherwise establishes an exemption. Backup withholding is not an additional tax and may be claimed as a credit against the U.S. federal income tax liability of a holder, or alternatively, the holder may be eligible for a refund of any excess amounts withheld under the backup withholding rules, in either case, provided that the required information is furnished to the IRS.

 

New Information Reporting by Certain U.S. Holders

 

Under recently enacted legislation, U.S. citizens and individuals taxable as resident aliens of the United States that own “specified foreign financial assets” with an aggregate value in a taxable year in excess of $50,000certain threshold (as determined under rules in new temporary Treasury regulations) and that are required to file a U.S. federal income tax return generally will be required to file an information report with respect to those assets with their tax returns. IRS Form 8938 has been issued for that purpose. “Specified foreign financial assets” include any financial accounts maintained by foreign financial institutions, foreign stocks held directly, and interests in foreign estates, foreign pension plans or foreign deferred compensation plans. Under those rules, our ordinary shares, whether owned directly or through a financial institution, estate or pension or deferred compensation plan, would be “specified foreign financial assets”. Under proposed Treasury regulations, the reporting obligation applies to certain U.S. entities that hold, directly or indirectly, specified foreign financial assets. Penalties can apply if there is a failure to satisfy this reporting obligation. A U.S. Holder is urged to consult his tax adviser regarding his reporting obligation.

 

F.           Dividends and Paying Agents.

F.Dividends and Paying Agents.

 

Not applicable.

 

G.           Statement by Experts.

G.Statement by Experts.

 

Not applicable.

 

82

H.           Documents on Display.

H.Documents on Display.

 

We are currently subject to the information and periodic reporting requirements of the Exchange Act that are applicable to foreign private issuers. Although as a foreign private issuer we are not required to file periodic information as frequently or as promptly as United States companies, we generally do publicly announce our quarterly and year-end results promptly and file periodic information with the United States Securities and Exchange Commission under cover of Form 6-K. As a foreign private issuer, we are also exempt from the rules under the Exchange Act prescribing the furnishing and content of proxy statements and our officers, directors and principal shareholders are exempt from the reporting and other provisions in Section 16 of the Exchange Act. Our SEC filings are filed electronically on the EDGAR reporting system and may be obtained through that medium. You may inspect without charge and copy at prescribed rates such filings, including any exhibits and schedules, at the public reference facilities maintained by the SEC, 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of such materials from the SEC at prescribed rates. The SEC also maintains a web site that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. The address of this web site is http://www.sec.gov. You may call the SEC at 1-800-SEC-0330 for further information on the public reference rooms. The Exchange Act file number for our Securities and Exchange Commission filings is 000-20181.

 

Information about Sapiens is also available on our website at http://www.sapiens.com. Such information on our website is not part of this annual report.

I.           Subsidiary Information.

I.Subsidiary Information.

 

Not applicable.

Item 11.         Quantitative and Qualitative Disclosure about Market Risk.

Item 11.Quantitative and Qualitative Disclosure about Market Risk.

 

Market risks relating to our operations result primarily from changes in exchange rates, interest rates or weak economic conditions in the markets in which we sell our products and services. We have been and we are actively monitoring these potential exposures. To manage the volatility relating to these exposures, we may enter into various forward contracts or other hedging instruments. Our objective is to reduce, where it is deemed appropriate to do so, fluctuations in earnings and cash flows associated with changes in foreign currency rates and interest rates.

Foreign Currency Risk.We conduct our business in various foreign currencies, primarily those of Israel and the United Kingdom, and to a lesser extent of Japan, Europe and Canada. A devaluation of the NIS, GBP, Euro and the Japanese Yen in relation to the US Dollar has the effect of reducing the US Dollar amount of any of our expenses or liabilities which are payable in those currencies (unless such expenses or payables are linked to the US dollar) while reducing the US Dollar amount of any of our revenues which are payable to us in those currencies.

 

Because exchange rates between the NIS, GBP, Euro and the Japanese Yen against the US dollar fluctuate continuously, exchange rate fluctuations and especially larger periodic devaluations will have an impact on our revenue and profitability and period-to-period comparisons of our results. The effects of foreign currency re-measurements are reflected as financial expenses in our consolidated financial statements. A hypothetical 10% movement in foreign currency rates (primarily the NIS, GBP, Euro, Japanese Yen, PLN and Japanese Yen)INR) against the US dollar, with all other variables held constant on the expected sales, would have resulted in a decrease or increase in 20132016 sales revenues of approximately $9$13.6 million.

 

We monitor our foreign currency exposure and, from time to time, may enter into currency forward contracts or put/call currency options to hedge balance sheet exposure. We may use such contracts to hedge exposure to changes in foreign currency exchange rates associated with balance sheet balances denominated in a foreign currency and anticipated costs to be incurred in a foreign currency.

 

Market Risk.We currently do not invest in, or otherwise hold, for trading or other purposes, any financial instruments subject to market risk.

 

Interest Rate Risk. We pay interest on our credit facilities based on the prime interest rate in Israel for some of our NIS-denominated loans. As a result, changes in the general level of interest rates directly affect the amount of interest payable by us under these facilities. However, we expect our exposure to risk from changes in interest rates to be minimal and not material. Therefore, no quantitative tabular disclosures are required.

Item 12.       Description of Securities Other than Equity Securities.

Item 12.Description of Securities Other than Equity Securities.

 

Not applicable.

 

83

PART II

Item 13.       Defaults, Dividend Arrearages and Delinquencies.

Item 13.Defaults, Dividend Arrearages and Delinquencies.

 

Not applicable.

Item 14.       Material Modifications to the Rights of Security Holders and Use of Proceeds.

Item 14.Material Modifications to the Rights of Security Holders and Use of Proceeds.

 

None.

Item 15.Controls and Procedures

 

Item 15.       Controls and Procedures

A.A.           Disclosure Controls and Procedures.

Our management, including our President and Chief Executive Officer, and Chief Financial Officer, havehas evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of the end of the period covered by this annual report (the “Evaluation Date”).December 31, 2016. Based on such evaluation, the President and Chief Executive Officer, and the Chief Financial Officer, have concluded that, as of the Evaluation Date,December 31, 2016, the Company’s disclosure controls and procedures are effective.

 

B.           Management's
B.Management’s Annual Report on Internal Control Over Financial Reporting.

Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Our management, including our President and Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework and criteria established in Internal Control Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as of the end of the period covered by this report.

Based on that evaluation, our management has concluded that our internal control over financial reporting was effective as of December 31, 2013.2016. Notwithstanding the foregoing, there can be no assurance that our internal control over financial reporting will detect or uncover all failures of persons within the Company to comply with our internal procedures, as all internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective may not prevent or detect misstatements.

 

C.Attestation Report of Registered Public Accounting Firm.

C.Attestation Report of Registered Public Accounting Firm.

 

The attestation report of Kost Forer Gabbay & Kasierer, a member of EY Global, an independent registered public accounting firm in Israel, on our management’s assessment of our internal control over financial reporting as of December 31, 20132016 is provided on page F-3, as included under Item 18 of this annual report.

 

101

D.           Changes in Internal Control Over Financial Reporting.

Based on the evaluation conducted by our President and Chief Executive Officer and our Chief Financial Officer pursuant to Rules 13a-15(d) and 15d-15(d) under the Exchange Act, our management has concluded that there was no change in our internal control over financial reporting that occurred during the year ended December 31, 20132016 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

ITEM 16.RESERVED

ITEM 16.         RESERVED

84

Item 16A.           Audit Committee Financial Expert.

Item 16A.Audit Committee Financial Expert.

 

Our Board of Directors has determined that Mr. Yacov Elinav, a member of our Audit Committee, meets the definition of an “audit committee financial expert,” as defined under the applicable rules promulgated by the SEC. All members of our Audit Committee, including Mr. Elinav, are “independent”, as defined under the NASDAQ Listing Rules.

 

Item 16B.            Code of Ethics.

Item 16B.Code of Ethics.

 

We have adopted a Code of Ethics that applies to our principal executive officer, principal financial officer and corporate controller, as well as to our directors and other employees. The Code of Ethics is publicly available on our website at www.sapiens.com. Written copies are available upon request. If we make any substantive amendments to the Code of Ethics or grant any waivers, including any implicit waiver, from a provision of such Code to our principal executive officer, principal financial officer or corporate controller, we will disclose the nature of such amendment or waiver on our website.

 

ITEM 16C.           PRINCIPAL ACCOUNTANT FEES AND SERVICES.

ITEM 16C.PRINCIPAL ACCOUNTANT FEES AND SERVICES.

 

Policies and Procedures

 

Our Audit Committee has adopted policies and procedures for the pre-approval of audit and non-audit services rendered by our independent auditors, Kost Forer Gabbay & Kasierer, a member of EY Global. The policies generally require the Audit Committee’s pre-approval of the scope of the engagement of our independent auditors or additional work performed on an individual basis. The policy prohibits retention of the independent auditors to perform the prohibited non-audit functions defined in Section 201 of the Sarbanes-Oxley Act of 2002 or the rules of the SEC and also provides that the Audit Committee consider whether proposed services are compatible with the independence of the public auditors.

 

Fees Paid to Independent Auditors

 

Fees billed or expected to be billed by Kost Forer Gabbay & Kasierer, a member of EY Global and other members of EY Global for professional services for each of the last two fiscal years were as followsfollows:

  Year ended December 31, 
  2012  2013 
  (in thousands) 
Audit Fees $264  $363 
Tax Fees $160  $77 
         
Total $424  $440 

  Year ended December 31, 
  2015  2016 
  (in thousands) 
Audit Fees $415  $400 
Tax Fees $108  $195 
Total $523  $595 

 

(1)Audit Fees consist of fees billed for the annual audit and the quarterly reviews of the Company’s consolidated financial statements and consist of services that would normally be provided in connection with statutory and regulatory filings or engagements, including services that generally only the independent auditors can reasonably provide.

 

(2)Tax Fees are for professional services rendered by our auditors for tax compliance, tax advice on actual or contemplated transactions, tax consulting associated with international transfer prices and global mobility.

 

Item 16D.           Exemptions from the Listing Standards for Audit Committees

Item 16D.Exemptions from the Listing Standards for Audit Committees

 

Not applicable.

 

Item 16E.           Purchase of Equity Securities by the Issuer and Affiliated Purchasers

Item 16E.Purchase of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

85

ITEM 16F.           CHANGE IN REGISTRANT'S CERTIFYING ACCOUNTANT.

ITEM 16F.CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT.

 

Not applicable.

 

ITEM 16G.           CORPORATE GOVERNANCE.

ITEM 16G.CORPORATE GOVERNANCE.

 

We are exempt from a number of the requirements under the NasdaqNASDAQ Listing Rules based on our status as a “foreign private issuer.” See Item 6.C above “Board Practices— NASDAQ Opt-Outs for a Foreign Private Issuer.”

 

We have elected to follow our home country practice in lieu of the requirements set forth in NASDAQ Listing Rule 5250(d)(1), which require a domestic United States company to make available to its shareholders a copy of its annual report containing its audited financial statements in one of three specific ways. Instead of distributing copies of our annual report by mail, furnishing an annual report in accordance with Rule 14a-16 under the Exchange Act or posting our annual report on our website and undertaking to provide a hard copy thereof free of charge upon request, we simply make our annual report available to shareholders via our website (http://www.sapiens.com/Annual-Reports/).

 

We have also elected to follow our home country practice in lieu of the requirements of NASDAQ Listing Rules 5605(b), (d) and (e) which require:

The majority of the company’s board of directors must qualify as independent directors, as defined under NASDAQ Listing Rule 5605(a)(2) and that the independent directors have regularly scheduled meetings at which only independent directors are present.

 

The compensation of the chief executive officer and all other executive officers must be determined, or recommended to the board of directors for determination, either by (i) a majority of the independent directors or (ii) a compensation committee comprised solely of independent directors (subject to limited exceptions).

 

Director nominees must either be selected or recommended for the board of directors’ selection, either by (a) a majority of independent directors or (b) a nominations committee comprised solely of independent directors (subject to limited exceptions).

 

The company must certify that it has adopted a formal written charter or board resolution, as applicable, addressing the nominations process and such related matters as may be required under US federal securities laws.

 

We have also elected to follow our home country practice in lieu of the requirements set forth in of NASDAQ Listing Rule 5635, which require a domestic United States Companycompany to obtain shareholder approval for certain dilutive events, such as for the establishment or amendment of certain equity based compensation plans and arrangements, an issuance that will result in a change of control of the company, certain transactions other than a public offering involving issuances of a 20% or more interest in the company and certain acquisitions of the stock or assets of another company.as:

·the establishment or amendment of certain equity based compensation plans and arrangements;

·an issuance that will result in a change of control of the company;

·certain transactions other than a public offering involving issuances of a 20% or more interest in the company; and

·certain acquisitions of the stock or assets of another company.

 

We have submitted to NASDAQ a written statement from our independent Curaçao counsel whichthat certified that our practice of not making the annual report available in accordance with NASDAQ rules, but rather making it available on our website, our not complying with the requirements of NASDAQ Listing Rules 5605(b), (d) and (e) and not obtaining the shareholder approvals required under NASDAQ Listing Rule 5635 are not prohibited by Curaçao law.

 

86

ITEM 16H.           MINE SAFETY DISCLOSURE.

ITEM 16H.MINE SAFETY DISCLOSURE.

 

Not applicable.

 

PART III

Item 17.         Financial Statements.

Item 17.Financial Statements.

 

We have elected to provide financial statements and related information pursuant to Item 18.

Item 18.         Financial Statements.

Item 18.Financial Statements.

 

The Consolidated Financial Statements and related notes required by this Item are contained on pages F-1 through F-40F-41 hereof.

87

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED FINANCIAL STATEMENTS

 

AS OF DECEMBER 31, 20132016

 

IN U.S. DOLLARS

 

INDEX

 

 Page
  
Reports of Independent Registered Public Accounting FirmF-2 - F-4F-3
  
Consolidated Balance SheetsF - 54 - F - 5
Consolidated Statements of IncomeF - 6
  
Consolidated Statements of Comprehensive IncomeF - 7
  
Consolidated Statements of Comprehensive IncomeChanges in EquityF - 8
  
Consolidated Statements of Changes in EquityCash FlowsF - 9 - F - 10
  
Consolidated Statements of Cash FlowsF – 10 - F – 11
Notes to the Consolidated Financial StatementsF - 1211 - F – 42- 41

 

- - - - - - - -

 

 

 

Kost Forer Gabbay & Kasierer

3 Aminadav St.

Tel-Aviv 6706703, Israel

 

Tel: +972-3-6232525

Fax: +972-3-5622555

ey.com

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and Shareholders of

 

SAPIENS INTERNATIONAL CORPORATION N.V.

 

We have audited the accompanying consolidated balance sheets of Sapiens International Corporation N.V. ("the Company") and its subsidiaries as of December 31, 20122015 and 2013,2016, and the related consolidated statements of income, statements of comprehensive income, changes in equity, and cash flows for each of the three years in the period ended December 31, 2013.2016. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements,statements. An audit also includes assessing the accounting principles used and significant estimates made by management, andas well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the Company and its subsidiaries as of December 31, 20122015 and 2013,2016 and the consolidated results of theirits operations and theirits cash flows for each of the three years in the period ended December 31, 2013,2016, in conformity with U.S.accounting principles generally accepted accounting principles.in the United States.

 

We also have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the Company's internal control over financial reporting as of December 31, 2013,2016, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission - 1992 framework(2013 framework) and our report dated April 23, 2014,27, 2017, expressed an unqualified opinion thereon.

 

Tel-Aviv, Israel/s/KOST FORER GABBAY & KASIERER
April 23, 201427, 2017A memberMember of EYErnst & Young Global

F - 2

 

Kost Forer Gabbay & Kasierer

3 Aminadav St.

Tel-Aviv 6706703, Israel

 

Tel: +972-3-6232525

Fax: +972-3-5622555

ey.com

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

ON INTERNAL CONTROL OVER FINANCIAL REPORTING

 

To the Shareholders and Board of Directors of

 

SAPIENS INTERNATIONAL CORPORATION N.V.

 

We have audited Sapiens International Corporation N.V. ("the Company") internal control over financial reporting as of December 31, 2013,2016, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission - 1992 framework(the "COSO criteria")(2013 framework) (the COSO criteria). The Company's management is responsible for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying management's reportManagement's Report on internal controlInternal Control over financial reporting.Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit.

 

We conducted our audit in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the company's assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2013,2016, based on the COSO criteria.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheets of Sapiens International Corporation N.V. and its subsidiaries as of December 31, 20122015 and 2013,2016, and the related consolidated statements of income, comprehensive income, changes in shareholders' equity and cash flows for each of the three years in the period ended December 31, 2013,2016 and our report dated April 23, 2014,27, 2017 expressed an unqualified opinion thereon.

 

Tel-Aviv, Israel/s/ KOST FORER GABBAY & KASIERER
April 23, 201427, 2017A Member of EYErnst & Young Global

 

F-4
F - 3 

 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands

 

 December 31,  December 31, 
 2012  2013  2015  2016 
          
ASSETS                
                
CURRENT ASSETS:                
Cash and cash equivalents $29,050  $70,313  $54,351  $60,908 
Trade receivables (net of allowance for doubtful accounts of $ 165 and $ 293 at December 31, 2012 and 2013, respectively)  16,299   23,669 
Marketable securities  8,776   18,220 
Trade receivables (net of allowance for doubtful accounts of $ 199 and $ 623 at December 31, 2015 and 2016, respectively)  29,761   34,684 
Other receivables and prepaid expenses  

2,321

   4,126   5,455   6,389 
Deferred tax assets  2,750   2,420 
                
Total current assets  50,420   100,528   98,343   120,201 
                
LONG-TERM ASSETS:                
Marketable securities  30,875   17,228 
Capitalized software development costs, net  19,856   20,755 
Other intangible assets, net  7,684   7,599 
Property and equipment, net  5,675   9,807 
Goodwill  70,035   73,597 
Other long-term assets  2,316   2,957   4,252   4,623 
Severance pay fund  10,306   11,228   5,551   4,041 
Capitalized software development costs, net  17,494   19,704 
Other intangible assets, net  11,718   10,310 
Goodwill  68,087   72,438 
Property and equipment, net  2,243   5,263 
                
Total long-term assets  112,164   121,900   143,928   137,650 
                
Total assets $162,584  $222,428  $242,271  $257,851 

 

The accompanying notes are an integral part of the consolidated financial statements.

F - 4

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS
U.S. dollars in thousands (except share data)

 

 December 31,  December 31, 
 2012  2013  2015  2016 
          
LIABILITIES AND EQUITY                
                
CURRENT LIABILITIES:                
Trade payables $4,382  $6,517  $4,721  $6,562
Employees and payroll accruals  12,496   13,577   17,119   18,143 
Accrued expenses and other liabilities  7,518   7,671   14,893   13,906 
Deferred revenues and customer advances  7,301   9,928   10,268   9,137 
                
Total current liabilities  31,697   37,693   47,001   47,748 
                
LONG-TERM LIABILITIES:                
Other long-term liabilities  803   1,712   6,414   9,864 
Accrued severance pay  11,645   12,615   6,662   4,940 
                
Total long-term liabilities  12,448   14,327   13,076   14,804 
                
COMMITMENTS AND CONTINGENT LIABILITIES                
                
REDEEMABLE NON-CONTROLLING INTEREST  385   908 
        
EQUITY:                
Sapiens International Corporation N.V. Shareholders' equity:                
Share capital:                
Preferred shares of € 0.01 par value:        
Authorized - 1,000,000 shares at December 31, 2012 and 2013;        
Issued and outstanding: None at December 31, 2012 and 2013        
Common shares of € 0.01 par value:        
Authorized: 54,000,000 shares at December 31, 2012 and 2013;        
Issued: 41,007,801 and 48,343,278 shares at December 31, 2012 and 2013, respectively;        
Outstanding: 38,679,505 and 46,014,982 shares at December 31, 2012 and 2013, respectively  547   645 
Common shares of € 0.01 par value:
Authorized: 70,000,000 shares at December 31, 2015 and 2016, respectively; Issued: 51,088,077 and 51,364,247 shares at December 31, 2015 and 2016, respectively; Outstanding: 48,759,781 and 49,035,951 shares at December 31, 2015 and 2016, respectively
  678   681 
Additional paid-in capital  210,047   244,560   233,980   226,782 
Treasury shares, at cost - 2,328,296 Common shares at December 31, 2012 and 2013, respectively  (9,423)  (9,423)
Foreign currency translation adjustments  (4,870)  1,082 
Treasury shares, at cost - 2,328,296 Common shares at December 31, 2015 and 2016  (9,423)  (9,423)
Accumulated other comprehensive loss  (11,679)  (11,167)
Accumulated deficit  (78,697)  (67,093)  (32,614)  (13,278)
                
Total Sapiens International Corporation N.V. shareholders' equity  117,604   169,771   180,942   193,595 
Non-controlling interests  835   637   867   796 
                
Total equity  118,439   170,408   181,809   194,391 
                
Total liabilities and equity $162,584  $222,428  $242,271  $257,851 

 

The accompanying notes are an integral part of the consolidated financial statements.

F - 5

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF INCOME
U.S. dollars in thousands (except per share data)

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Revenues:            
License $5,282  $10,025  $15,164 
Services  64,645   103,884   120,213 
Total Revenues  69,927   113,909   135,377 
Cost of revenues:            
License  591   624   953 
Services  39,476   65,835   84,018 
Total cost of revenues  40,067   66,459   84,971 
Revenues $157,450  $185,636  $216,190 
            
Cost of revenues  99,095   111,192   130,402 
                        
Gross profit  29,860   47,450   50,406   58,355   74,444   85,788 
                        
Operating expenses:                        
Research and development, net  5,008   10,169   11,846 
Research and development  11,352   10,235   16,488 
Selling, marketing, general and administrative  18,113   25,236   26,677   32,097   39,859   44,460 
Acquisitions-related and restructuring costs  1,115   -   - 
                        
Total operating expenses  24,236   35,405   38,523   43,449   50,094   60,948 
                        
Operating income  5,624   12,045   11,883   14,906   24,350   24,840 
Financial income, net  104   193   520   124   163   533 
                        
Income before taxes on income  5,728   12,238   12,403   15,030   24,513   25,373 
Tax benefit (taxes on income)  230  (435)  (811)
Taxes on income  (454)  (4,213)  (5,772)
                        
Net income  5,958   11,803   11,592   14,576   20,300   19,601 
                        
Attributable to non-controlling interests  61   23   (12)
Attributed to non-controlling interests  131   59   (43)
Attributed to redeemable non-controlling interest  (18)  1   (135)
Adjustment to redeemable non-controlling interest  -   224   443 
                        
Net income attributable to Sapiens' shareholders $5,897  $11,780  $11,604  $14,463  $20,016  $19,336 
                        
Net earnings per share attributable to Sapiens' shareholders                        
                        
Basic $0.21  $0.29  $0.29  $0.31  $0.42  $0.40 
                        
Diluted $0.19  $0.28  $0.27  $0.30  $0.41  $0.40 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

F-7
F - 6 

 

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
U.S. dollars in thousands

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Net income $5,958  $11,803  $11,592  $14,576  $20,300  $19,601 
                        
Other comprehensive income (loss):            
            
Foreign currency translation adjustments  (5,623)  1,441   5,923   (11,181)  (1,367)  476 
Unrealized gains (losses) arising from marketable securities during the period, net of tax  (158)  (37)  41 
Losses reclassified into earnings from marketable securities, net of tax  3   5   - 
                        
Comprehensive income  335   13,244   17,515 
              (11,336)  (1,399)  517 
Comprehensive income attributable to non-controlling interests  58   57   (41)
            
Total comprehensive income  3,240   18,901   20,118 
            
Comprehensive income (loss) attributed to non-controlling interests  158   59   (38)
Comprehensive income (loss) attributed to redeemable non-controlling interest  (18)  1   (135)
Comprehensive income adjustment to redeemable non-controlling interest  -   224   443 
                        
Comprehensive income attributable to Sapiens' shareholders $277  $13,187  $

17,556

  $3,100  $18,617  $19,848 

 

The accompanying notes are an integral part of the consolidated financial statements.

F - 7

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
U.S. dollars in thousands(except of share data)

 

  Common stock  Additional
paid-in
  Treasury  Other
Comprehensive
  Accumulated  Non-controlling  Total 
  Shares  Amount  capital  shares  Income  deficit  interests  equity 
                         
Balance as of January 1, 2011  22,044,834  $282  $133,136  $(2,423) $(657) $(96,374) $154  $34,118 
                                 
Stock-based compensation  -   -   336   -   -   -   -   336 
Stock-based compensation with respect to Harcase acquisition  -   -   240   -   -   -   -   240 
Issuance of shares and options  upon the acquisition of IDIT  7,483,125   108   31,336   -   -   -   -   31,444 
Issuance of shares, options and assumption of non-controlling interest upon the acquisition of FIS  10,016,875   143   42,778   -   -   -   882   43,803 
Issuance expenses relating to FIS and IDIT acquisition          (102)                  (102)
Employee stock options exercised  135,796   1   206   -   -   -   -   207 
Dividend to non-controlling interests  -   -   -   -   -   -   (134)  (134)
Foreign currency translation adjustments  -   -   -   -   (5,620)  -   (3)  (5,623)
Net income  -   -   -   -   -   5,897   61   5,958 
                                 
Balance as of December 31, 2011  39,680,630   534   207,930   (2,423)  (6,277)  (90,477)  960   110,247 
                                 
Stock-based compensation  -   -   690   -   -   -   -   690 
Stock-based compensation with respect to Harcase acquisition  -   -   241   -   -   -   -   241 
Repurchase of shares  (2,000,000)  -   -   (7,000)  -   -   -   (7,000)
Employee stock options exercised  998,875   13   1,186   -   -   -   -   1,199 
Dividend to non-controlling interests  -   -   -   -   -   -   (182)  (182)
Foreign currency translation adjustments  -   -   -   -   1,407   -   34   1,441 
Net income  -   -   -   -   -   11,780   23   11,803 
                                 
Balance as of December 31, 2012  38,679,505   547   210,047   (9,423)  (4,870)  (78,697)  835   118,439 
                                 
Stock-based compensation  -   -   933   -   -   -   -   933 
Issuance of shares upon public offering, net  6,497,400   87   37,704   -   -   -   -   37,791 
Distribution of dividend  -   -   (5,802)  -   -   -   -   (5,802)
Employee stock options exercised  815,564   11   1,678   -   -   -   -   1,689 
Warrants exercised (cashless)  22,513   -   -   -   -   -   -  -
Dividend to non-controlling interests  -   -   -   -   -   -   (157  (157
Foreign currency translation adjustments  -   -   -   -   5,952   -   (29)  5,923 
Net income  -   -   -   -   -   11,604   (12)  11,592 
                                 
Balance as of December 31, 2013  46,014,982  $645  $244,560  $(9,423) $1,082  $(67,093) $637  $170,408 
  Common stock  Additional
paid-in
  Treasury  Accumulated
other
comprehensive
  Accumulated  Non-controlling  Total 
  Shares  Amount  capital  shares  income (loss)  deficit  interests  equity 
                         
Balance as of January 1, 2014  46,014,982  $645  $244,560  $(9,423) $1,082  $(67,093) $637  $170,408 
                                 
Stock-based compensation  -   -   1,067   -   -   -   -   1,067 
Employee stock options exercised (cash and cashless)  1,225,368   17   1,552   -   -   -   -   1,569 
Warrants exercised (cashless)  438,961   5   (5)  -   -   -   -   - 
Dividend to non-controlling interests  -   -   -   -   -   -   (106)  (106)
Other comprehensive loss  -   -   -   -   (11,363)  -   27   (11,336)
Net income  -   -   -   -   -   14,463   131   14,594 
                                 
Balance as of December 31, 2014  47,679,311  $667  $247,174  $(9,423) $(10,281) $(52,630) $689  $176,196 
                                 
Adjustment for acquisition under common control  -   -   2,097   -   -   -   -   2,097 
                                 
Balance as of December 31, 2014 *)  47,679,311  $667  $249,271  $(9,423) $(10,281) $(52,630) $689  $178,293 
                                 
Stock-based compensation  -   -   1,153   -   -   -   196   1,349 
Employee stock options exercised (cash and cashless)  1,080,470   11   1,557   -   -   -   -   1,568 
Distribution of dividend  -   -   (7,186)  -   -   -   -   (7,186)
Dividend to non-controlling interests  -   -   -   -   -   -   (77)  (77)
Other comprehensive loss  -   -   -   -   (1,398)  -   (1)  (1,399)
Adjustment to redeemable non-controlling interest  -   -   -   -   -   (224)  -   (224)
Distribution to ultimate parent for a business acquisition under common control  -   -   (10,815)  -   -   -   -   (10,815)
Net income  -   -   -   -   -   20,240   60   20,300 
                                 
Balance as of December 31, 2015  48,759,781  $678  $233,980  $(9,423) $(11,679) $(32,614) $867  $181,809 
                                 
Stock-based compensation  -   -   1,701   -   -       40   1,741 
Employee stock options exercised (cash and cashless)  276,170   3   887   -   -   -   -   890 
Distribution of dividend  -   -   (9,786)  -   -   -   (73)  (9,859)
Other comprehensive income  -   -   -   -   512   -   5   517 
Redeemable non-controlling interest  -   -   -   -   -   (308)  -   (308)
Net income  -   -   -   -   -   19,644   (43)  19,601 
                                 
Balance as of December 31, 2016  49,035,951  $681  $226,782  $(9,423) $(11,167) $(13,278) $796  $194,391 

 

*) Derived from the audited financial statements of the Company as of December 31, 2014, adjusted for the acquisition of Insseco (see note 1(d)(2)).

The accompanying notes are an integral part of the consolidated financial statements.

F - 8

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
Cash flows from operating activities:                        
                        
Net income $5,958  $11,803  $11,592  $14,576  $20,300  $19,601 
Reconciliation of net income to net cash provided by operating activities:                        
Depreciation and amortization  6,748   7,393   7,887   8,717   9,625   10,021 
Stock-based compensation  336   690   933   1,067   1,349   1,955 
Compensation associated with acquisition of subsidiary  755   128   - 
Amortization of premium and accrued interest on marketable securities  (225)  (453)  (516)
                        
Net changes in operating assets and liabilities, net of amount acquired:            
Net changes in operating assets and liabilities            
Trade receivables, net  (3,333)  (1,649)  (6,677)  (6,637)  1,893   (5,435)
Other operating assets  (480)  152   (2,317)  127   (1,229)  (3,309)
Deferred tax assets, net  222   (194)  1,133   (1,020)  2,169   1,664 
Trade payables  (1,279)  1,746   1,874   (3,297)  1,511   1,101 
Other operating liabilities  (804)  

333

   383   8,469   4,134   2,223 
Deferred revenues and customer advances  (408)  (2,372)  2,508   (223)  1,300   (1,035)
Accrued severance pay, net  698   762   (50)  7   (159)  (231)
                        
Net cash provided by operating activities  8,413   18,792   17,266   21,561   40,440   26,039 
                        
Cash flows from investing activities:                        
                        
Purchase of property and equipment  (482)  (1,327)  (4,129)  (1,468)  (2,815)  (4,664)
Capitalized software development costs  (4,735)  (3,464)  (5,392)  (6,094)  (6,032)  (5,545)
Issuance expenses relating to FIS and IDIT acquisition  (102)  -   - 
Earn-out payment with respect to Harcase acquisition  (952)  -   - 
Cash acquired, net of payments for business acquisitions  3,741   -   - 
Restricted cash  -   (68)  (210)
Net cash paid for acquisitions (b)  (2,064)  (2,934)  (4,382)
Investment in marketable securities  (34,906)  (7,678)  (9,017)
Proceeds from sales of marketable securities  1,543   1,499   13,898 
Restricted cash, net  239   (893)  1,393 
                        
Net cash used in investing activities $(2,530) $(4,859)  (9,731) $(42,750) $(18,853) $(8,317)

 

The accompanying notes are an integral part of the consolidated financial statements.

F - 9

SAPIENS INTERNATIONAL CORPORATION N.V.

AND ITS SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS
U.S. dollars in thousands

 

 Year ended December 31, 
 2011  2012  2013  Year ended December 31, 
        2014  2015  2016 
Cash flows from financing activities:                        
                        
Proceeds from employee stock options exercised $207  $1,199   1,689  $1,569  $1,568  $890 
Repurchase of shares  -   (7,000)  - 
Issuance of shares upon public offering, net  -   -   37,791 
Distribution to ultimate parent for a business acquisition under common control (c)  -   (8,482)  (1,440)
Repayment of loan  -   -   (824)
Distribution of dividend  -   -   (5,802)  -   (7,186)  (9,786)
Dividend to non-controlling interests  (134)  (182)  (157)
Dividend to non-controlling interest  (106)  (77)  (73)
                        
Net cash provided by (used in) financing activities  73   (5,983)  33,521   1,463   (14,177)  (11,233)
                        
Effect of exchange rate changes on cash  (678)  (360)  207   (3,187)  (459)  68 
                        
Increase in cash and cash equivalents  5,278   7,590   41,263 
Increase (decrease) in cash and cash equivalents  (22,913)  6,951   6,557 
Cash and cash equivalents at beginning of year  16,182   21,460   29,050   70,313   47,400   54,351 
                        
Cash and cash equivalents at end of year $21,460  $29,050  $70,313  $47,400  $54,351  $60,908 
                        
(a) Supplemental cash flow activities:            
Supplemental cash flow activities:            
                        
Cash paid during the year for:            
Interest $16  $2  $7 
(a) Cash paid (received) during the year for:            
            
Interest paid $5  $6  $48 
            
Interest received $(604) $(1,199) $(1,321)
                        
Income taxes $162  $1,752  $739  $665  $2,234  $1,196 
            
(b) Net cash paid for acquisitions:            
            
Fair value of assets acquired and liabilities assumed at the date of acquisition:            
Working capital, net (excluding cash and cash equivalents) $(228) $(1,221) $1,547 
Other long term assets  -   (183)  (2,089)
Other long term liabilities  -   1,424   1,420 
Goodwill and other intangible assets  (2,013)  (3,903)  (5,260)
Contingent payments  -   949   - 
Redeemable non-controlling interest  177   -   - 
            
 $(2,064) $(2,934) $(4,382)
            
(c) Non-cash transactions:            
            
Loan and contingent payments to ultimate parent  -   (2,333)  - 

 

The accompanying notes are an integral part of the consolidated financial statements.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
 F - 10

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 1:      GENERAL

NOTE 1:GENERAL

 

a.General:

 

Sapiens International Corporation N.V. (“Sapiens”) and its subsidiaries (collectively, the “Company”), a member of the Formula Systems (1985) Ltd. Group, is a global provider of software solutions for the insurance industry, with an emerging focus on the broader financial services sector. The Company's offerings include a broad range of software solutions and services, comprised ofof: (i) core software solutions for the insurance industry, including Property & Casualty/General Insurance (“P&C”) and Life, Annuities and Pensions (“L&P”) products, and record keeping software solutions for providers of Retirement ServicesServices; (ii) variety of technology based solutionsolutions including business decision management solutions for the financial services industry, including insurance, banking and capital marketsmarkets; and (iii) global Servicesservices including project delivery and implementation of the Company’ software solutions.

On August 21, 2011 Sapiens completed the acquisition of FIS Software Ltd. ("FIS") and IDIT I.D.I. Technologies Ltd. ("IDIT") (See note 1(b) and 1(c) for further information).

The Company's target markets areCompany operates primarily in North America, United Kingdom, Europe, Israel, Europe, and Asia Pacific.

 

b.Acquisition of FIS:Maximum Processing:

 

On August 21, 2011,May 26, 2016, Sapiens entered into an agreement to purchase 100% of Maximum Processing Inc.’s (MaxPro) total shares outstanding. MaxPro specializes in providing business and technology solutions across the Company completedinsurance industry.

Sapiens paid the acquisition consideration in cash, consisting of all$4,278 (of which $1,490 was deposited at closing in escrow). In addition, the seller has performance based payments relating to achievements of revenue and profitability targets over three years (2016-2018) of up to $3,126 that are subject to continued employment and therefore, not part of the outstanding shares of FIS, a provider of insurance software solutions for L&P, in consideration for $ 49,671, composed of the following:purchase price.

Sapiens' common shares $38,987 
Cash paid  6,750 
Warrants (i)  2,031 
Options (ii)  1,903 
     
Total purchase price $49,671 

 

(i)c.Sapiens issued 1,000,000 warrants (See Note 11(d)).Acquisition of 4Sight business intelligence:

On June 7, 2016, Sapiens entered into an agreement to purchase 100% of 4Sight Business Intelligence Inc.’s (4Sight) total shares outstanding. 4sight's system provides analytics software for the insurance industry.

Sapiens paid the acquisition consideration of $330. In addition, the seller has performance based payments relating to achievements of revenue and profitability targets over three years (2016-2018) of up to $2,600. Such payments are also subject to continued employment and therefore, are not part of the purchase price.

SAPIENS INTERNATIONAL CORPORATION N.V.d.Acquisitions in previous years:

AND ITS SUBSIDIARIES1.On May 6, 2015, the Company completed the agreement to acquire all of the outstanding shares of Ibexi Solution Private Limited (Ibexi), an India-based provider of insurance business and technology solutions, in total consideration of $4,764 including a contingent obligation valued at $949 at the acquisition date. As of December 31, 2016, the estimated fair value of the contingent payment is $1,680.

 F - 11

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 1:      
NOTE 1:GENERAL (Cont.)

In addition, an amount of approximately $1,900 is subject to continued employment and therefore not part of the purchase price, but is recognized over the service period.

 

(ii)2.RepresentsOn August 18, 2015 (the “acquisition date”), Sapiens completed the fair valueacquisition from Asseco Poland S.A. (“Asseco” or the “Seller”) of all issued and outstanding shares of Insseco. Asseco is the vested portion of 934,970 optionsultimate parent company of Sapiens, granted upon consummationthrough holding in Formula Systems, which has been lastly effective as of December 23, 2014 and thereafter, the acquisition todirect parent company of Sapiens. Insseco is a newly established company into which Asseco transferred all of its Polish insurance employees, certain fixed assets, certain customer contracts and certain software including intellectual property rights. Insseco has an established presence in the holders of partially vested options of FIS originally granted under the FIS Employee Share Option Plan. The fair value of these options was determined using a Binomial valuation model with the following assumptions: stock price of $ 4.1, early exercise of 1.5-11, risk-free interest rate of 0.10%-2.07%, expected volatility of 70%Polish insurance market, and no dividend yield.services major insurance customers in Poland, including top tier insurance carriers.

Sapiens paid the acquisition consideration in cash, consisting of 34.3 million Polish Zloty or approximately $9,100. In addition, the seller has upside or downside performance based payments relating to achievements of revenue goals and profitability over the next five years. If the aggregate revenues generated by Insseco from its activity from July 1, 2015 through June 30, 2020 exceed 90 million Polish Zloty or approximately $23,800, the Seller shall be entitled to receive additional amounts ranging from 3% to 15% of the excess amount of the respective revenues. If the aggregate revenues generated by Insseco for the period from July 1, 2015 through June 30, 2018 are below 84 million Polish Zloty or $22,200, the seller shall pay Sapiens an amount equal to 35% of the deficiency below such amount. In addition, the amounts payable to the seller may be adjusted upwards or downwards as a result of changes in the profitability of a specific account that Sapiens acquired as part of the acquisition. The estimated fair value of the contingent payments as of December 31, 2016 is $1,000.

 

The acquisition of FIS allowsInsseco from Asseco, which is the ultimate parent company of Sapiens is a transaction between entities under common control, and therefore accounted for under the pooling of interest method in accordance with ASC 805, Business Combinations. Under the pooling-of-interests method, combination between two businesses under common control is accounted for at carrying amounts with retrospective adjustment of prior period financial statements. As the common control achieved on December 23, 2014, the balance sheet as of December 31, 2014 of Sapiens was adjusted to offer an enhanced solution forreflect the L&P market. In addition, the acquisition of FIS has grown Sapiens' customer base in the insurance market world-wide. The value of goodwill is attributed to synergiescarrying amounts combination between Sapiens solutions and services and FIS’s solutions and services which strengthen the Company's position in the market as a leading provider of L&P core software solutions.Insseco.

 

The acquisition was accountedresults of Sapiens for by the acquisitiontwelve-month period ended December 31, 2015 were also adjusted to reflect the combination with Insseco, accordingly.

Under the pooling-of-interest method, and accordingly, the purchase price has been allocated according to the fair valueequity accounts of the combining entities are combined and the difference between the consideration paid and the net assets acquired and liabilities assumed of FIS. The results of FIS operations have been included in the consolidated financial statements since August 21, 2011.is reflected as an equity transaction (i.e., distribution to parent company).

 

F - 12

The following table summarizes the fair values of the assets acquired and liabilities assumed based on management's assessment with the assistance of a third party valuation:

SAPIENS INTERNATIONAL CORPORATION N.V.

 

Cash and cash equivalents $8,349 
Restricted cash  239 
Trade receivables  5,152 
Other receivables and prepaid expenses  632 
Property and equipment  451 
Severance pay fund  4,182 
Other intangible assets  11,724 
Goodwill  35,523 
     
Total assets acquired  66,252 
     
Trade payables  (1,486)
Employees and payroll accruals  (3,461)
Accrued expenses and other liabilities  (1,914)
Deferred revenues  (1,706)
Deferred tax liabilities  (406)
Accrued severance pay  (4,487)
Long-term contracts  (2,239)
Non-controlling interest  (882)
     
Total liabilities assumed  (16,581)
     
Total assets acquired, net $49,671 
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 1:        GENERAL (Cont.)

NOTE 1:GENERAL (Cont.)

 

In performingAs opposed to the purchase price allocation, management considered, amongmethod of accounting, no intangible assets are recognized in the transaction, other factors, analyses of historical financial performance, highestthan those existed in the combining entities and best useno goodwill is recognized as a result of the acquired assets and estimates of future performance of FIS's business. In performing the purchase price allocation the fair value of intangible assets such as customer relationship was based on the income approach, core technology was valuated using the relief from royalty method and long-term contracts were valuated based on an exit price that would be paid or received in a transfer of all the rights and obligations of the contractor to a market participant.combination.

 

The following table sets forthapplication of the components of intangible assets and liabilities associatedpooling-of-interest method with respect to the acquisition of Insseco increased the total assets, liabilities and their annual amortization rates:

  Fair value  Weighted
average rate
 
       
Core technology $4,206   13%
Customer relationships  7,518   14%
Long-term contracts  (2,239)  67%
         
Total $9,485   22%

equity as of December 31, 2014 by $4,387, $2,290, and $2,097, respectively. Revenues, pretax income and net income of FISInsseco for the twelve-month period since the acquisition date throughended December 31, 2011,2015, which are included in the consolidated financial statements of income amounted to $ 11,207.$10,516, $1,324 and $1,165, respectively.

 

c.3.AcquisitionOn August 1, 2014, the Company completed the acquisition of IDIT:all of the outstanding shares of Knowledge Partners International (KPI), a pioneer and recognized leader in decision management consultancy, services and training, in consideration of $ 2,380, composed of the following:

 

On August 21, 2011, the Company completed the acquisition of all of the outstanding shares of IDIT, a provider of insurance software solutions which focuses on the P&C market in consideration for $ 31,444, composed as follows:

Sapiens' common shares $29,052 
Options (i)  2,392 
     
Total purchase price $31,444 
Cash $2,203 
Share consideration *  177 
     
Total purchase price $2,380 

 

(i)*)Represents the fair valueSapiens issued 57,000 shares of its subsidiary, Sapiens Software Solution (Decision) Ltd, reflecting 3% of the vested portion of 1,003,874 options of Sapiens granted upon consummation ofsubsidiary's outstanding shares. According to the agreement, the sellers will have the right to sell their minority interests to the Company during the period commencing on the date that is 48 months following the acquisition todate, and the holders of partially vested options of IDIT originally granted under the IDIT Employee Share Option Scheme. The fair value of these options was determined usingCompany will have a Binomial valuation model with the following assumptions: stock price of $ 4.1, early exercise factor of 1.5-11, risk-free interest rate of 0.10%-2.07%, expected volatility of 70% and no dividend yield.
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)corresponding call option.

 

NOTE 1:      GENERAL (Cont.)Sapiens issued additional 88,500 restricted shares of its subsidiary, Sapiens Software Solution (Decision) Ltd, expensed over a vesting period of three years commencing on the acquisition date.

 

The acquisition of IDIT allows the Company to offer its customers and partners a more extensive product portfolio in the industry. Acquiring IDIT has strengthened Sapiens' presence in the P&C insurance market by increasing its customer base. IDIT is considered as a separate reporting unit.

The acquisition was accounted for by the acquisition method and accordingly, the purchase price has been allocated according to the fair value of the assets acquired and liabilities assumed of IDIT. The results of IDIT's operations have been included in the consolidated financial statements since August 21, 2011.

The following table summarizes the fair values of the assets acquired and liabilities assumed based on management's assessment with the assistance of a third party valuation:

Cash and cash equivalents $2,143 
Restricted cash  216 
Trade receivables  1,194 
Other receivables and prepaid expenses  302 
Other long term assets  90 
Property and equipment  482 
Severance pay fund  1,800 
Other intangible assets  7,918 
Goodwill  25,355 
     
Total assets acquired  39,500 
     
Trade payables  (807)
Employees and payroll accruals  (2,328)
Accrued expenses and other liabilities  (1,012)
Deferred revenues  (1,769)
Accrued severance pay  (2,140)
     
Total liabilities assumed  (8,056)
     
Total purchase price $31,444 

In performing the purchase price allocation, management considered, among other factors, analyses of historical financial performance, highest and best use of the acquired assets and estimates of future performance of IDIT's business. In performing the purchase price allocation the fair value of intangible assets such as customer relationship was determined based on the income approach, core technology was valued using the relief from royalty method and long-term contracts were valued based on an exit price that would be paid or received in a transfer of all the rights and obligations of the contractor to a market participant.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 1:       GENERAL (Cont.)

The following table sets forth the components of intangible assets associated with the acquisition and their annual amortization rates:

  Fair value  Weighted
average rate
 
       
Core technology $5,548   14%
Customer relationships  1,389   16%
Long-term contracts  981   74%
         
Total intangible assets $7,918   22%

Revenues of IDIT for the period since the acquisition date through December 31, 2011, which are included in the consolidated financial statements, amounted to $ 5,105.

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES

 

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in United States ("U.S. GAAP").

 

a.Use of estimates:

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions. The Company's management believes that the estimates, judgments and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.

 

F - 13

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

b.Financial statements in United States dollars:

 

The currency of the primary economic environment in which the operations of Sapiens and certain subsidiaries are conducted is the U.S. dollar ("dollar"); thus, the dollar is the functional currency of Sapiens and certain subsidiaries.

 

Sapiens and certain subsidiaries' transactions and balances denominated in dollars are presented at their original amounts. Non-dollar transactions and balances have been remeasured to dollars in accordance with ASC 830, "Foreign Currency Matters". All transaction gains and losses from remeasurement of monetary balance sheet items denominated in non-dollar currencies are reflected in the statements of income as financial income or expenses, as appropriate.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:       SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

For those subsidiaries, whose functional currency has been determined to be their local currency, assets and liabilities are translated at year-end exchange rates and statement of income items are translated at average exchange rates prevailing during the year. Such translation adjustments are recorded as a separate component of accumulated other comprehensive income (loss) in shareholders' equity.

 

c.Principles of consolidation:

 

The consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. All intercompany balances and transactions have been eliminated upon consolidation.

Non-controlling interests of subsidiaries represent the non-controlling shareholders' share of the total comprehensive income (loss) of the subsidiaries and fair value of the net assets upon the acquisition of the subsidiaries. The non-controlling interests are presented in equity separately from the equity attributable to the equity holders of the Company.

Redeemable non-controlling interests are classified as mezzanine equity, separate from permanent equity, on the consolidated balance sheets and measured at each reporting period at the higher of their redemption amount or the non-controlling interest book value, in accordance with the requirements ofAccounting Standards Codification(“ASC”) 810 “Consolidation” and ASC 480-10-S99-3A, “Distinguishing Liabilities from Equity”.

 

d.Cash equivalents:

 

Cash equivalents are short-term highly liquid investments that are readily convertible to cash, with original maturities of three months or less at acquisition.

 

e.Restricted cash:

 

The Company maintains certain cash amounts restricted as to withdrawal or use. OnAs of December 31, 2013,2015, the Company maintained a restricted cash balance of $ 782$1,370 that representsrepresented security deposits with respect to lease agreements, hedging transactions and credit lines from banks. The restricted cash balance was released during 2016. Restricted cash is included withinin other receivables and prepaid expenses.

 

F - 14

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

f.Marketable securities:

The Company accounts for all its investments in debt securities, in accordance with ASC 320, “Investments - Debt and Equity Securities”. The Company classifies all debt securities as “available-for-sale”. All of the Company’s investments in available-for-sale securities are reported at fair value. Unrealized gains and losses are comprised of the difference between fair value and the amortized cost of such securities and are recognized, net of tax, in accumulated other comprehensive income (loss).

The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization together with interest on securities is included in “financial income, net”.

The Company recognizes an impairment charge when a decline in the fair value of its investments in debt securities below the cost basis of such securities is judged to be other-than-temporary. Factors considered in making such a determination include the duration and severity of the impairment, the reason for the decline in value, the potential recovery period and the Company’s intent to sell, including whether it is more likely than not that the Company will be required to sell the investment before recovery of cost basis. Securities that are deemed other-than-temporarily impaired, the amount of impairment is recognized in “net gain on sale of marketable securities previously impaired” in the statements of income and is limited to the amount related to credit losses, while impairment related to other factors is recognized in other comprehensive income. During 2014, 2015 and 2016, the Company did not recognize an impairment charge as the decline in fair value of its investment in marketable securities is not judged to be other-than-temporary.

g.Property and equipment, net:

 

Property and equipment are stated at cost, net of accumulated depreciation using the straight-line method over the estimated useful lives of the assets, at the following annual rates:

 

  %
   
Computers and peripheral equipment 33
Office furniture and equipment 6 - 1520
Buildings 2.5

 

Leasehold improvements are amortized byusing the straight-line method over the term of the lease (including option terms that are deemed to be reasonably assured) or the estimated useful life of the improvements, whichever is shorter.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
 F - 15

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

g.h.Research and development costs:

 

Research and development costs incurred in the process of software production before establishment of technological feasibility are charged to expenses as incurred. Costs incurred to develop software to be sold are capitalized after technological feasibility is established in accordance with ASC 985-20, "Software“Software - Costs of Software to be Sold, Leased, or Marketed"Marketed”. Based on the Company'sCompany’s product development process, technological feasibility is established upon completion of a detailed program design.

 

Costs incurred by the Company between completion of the detailed program design and the point at which the product is ready for general release, have been capitalized.

 

Capitalized software development costs are amortized commencing with general product release by the straight-line method over the estimated useful life of the software product (between 5-7 years).

 

h.i.Other intangible assets, net:

 

Technology isand patents acquired are amortized over itstheir estimated useful life on a straight-line basis. The acquired customer relationships are amortized over their estimated useful lives in proportion to the economic benefits realized or the straight-linemethod. The weighted averageannual rates for other intangible assets are as follows:

 

  %
   
Technology 15%13 - 25
Customer relationships 10 - 17
Patent14%10

 

i.j.Impairment of long-lived assets:

 

The Company's long-lived assets and identifiable intangibles that are subject to amortization are reviewed for impairment in accordance with ASC 360 "Property, Plant, and Equipment", whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the assets. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. During 2011, 20122014, 2015 and 2013,2016, no impairment losses have been identified.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

j.k.Goodwill:

 

Goodwill represents the excess of the purchase price in a business combination over the fair value of the net tangible and intangible assets acquired. Under ASC 350," Intangibles—Intangibles- Goodwill and Other" ("ASC 350"), goodwill is subject to an annual impairment test or more frequently if impairment indicators are present. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. Previously theThe Company operatedoperates in twofour reporting units: Sapiens and IDIT. Following reorganization in 2013 Sapiens was divided to three reporting units: Sapiens, FIS and Decision. The goodwill was allocated based on the relative fair value of these three reporting units. Therefore the Company has four operating units: Sapiens, FIS,Emerge, L&P, Decision and IDIT.P&C.

F - 16

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The Company applied the provisions of ASC 360350 for the Company's annual impairment test. Under the provisions, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If after assessing the totality of events or circumstances, an entity determines it isqualitative assessment does not result in a more likely than not that the fair valueindication of a reporting unitimpairment, no further impairment testing is less than its carrying amount, then performing the two-step impairment test is unnecessary.required.

 

The Company performed annual impairment testsa qualitative assessment during the fourth quarter of each of 2011, 20122014, 2015 and 2013. This analysis determined2016 and concluded that no indicatorsthe qualitative assessment did not result in a more likely than not indication of impairment, existed primarily because (1) The fair value of the reporting units as of December 31, 2013 increased compared to the fair value estimated as of the acquisition date (2) the Company's reporting units overall financial performance has been growing since the acquisition, and (3) forecasts of operating income and cash flows generated by the Company's reporting units appear sufficient to support the book values of the net assets of each reporting unit.therefore no further impairment testing was required.

 

k.l.Revenue recognition:

 

The Company generates revenues from sales of software licenses which normally include significant implementation services that are considered essential to the functionality of the software license. In addition, the Company generates revenues from post implementation consulting services and maintenance services.

 

Revenues are recognized when persuasive evidence of an agreement exists, delivery of the product has occurred, the fee is fixed or determinable, and collectability is probable. The Company considers all arrangements with payment terms extending beyond six months from the delivery of the elements not to be fixed or determinable. If the fee is not fixed or determinable, revenue is recognized as payments become due from the customer, provided that all other revenue recognition criteria have been met.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company usually sells its software licenses as part of an overall solution offered to a customer that combines the sale of software licenses which normally include significant implementation that is considered essential to the functionality of the license. The Company accounts for revenues from theits services (either fixed price or Time and Materials (T&M)) together with the softwarethat require significant customization, integration and installation under contract accounting using the percentage-of-completion method in accordance with ASC 605-35, "Construction-Type and Production-Type Contracts". The percentage, using the percentage-of-completion ("POC") method of completion method is used when the required services are quantifiable,accounting based on the ratio of costs related to contract performance incurred to date to the total estimated numberamount of labor hours necessarysuch project costs. The revenues recognized are limited to completerevenues derived from the project, and under that method revenues are recognized using labor hours incurred as the measure of progress towards completion. Company's enforceable right to receive payment for services provided by it in accordance with its contracts with its customers.

 

In accordance with ASC 985-605, the Company establishes Vendor Specific Objective Evidence ("VSOE") of fair value of maintenance services (PCS) based on the Bell-Shaped approach and determined. The Company's policy for establishing VSOE for PCS,of fair value of maintenance services is based on the price charged when the elementmaintenance is sold separately (that is, the actual renewal rate). The Company's process for establishing VSOE of fair value of PCS is through performance of VSOE compliance test which is an analysis of the entire population of PCS renewal activity for its installed base of customers.renewed separately.

 

Provisions for estimated losses on contracts in progress are made in the period in which they are first determined, in the amount of the estimated loss on the entire contact. Provisions for estimated losses are presented in accrued expenses and other liabilities. 

 

Maintenance revenue is recognized ratably over the term of the maintenance agreement.

Deferred revenues and customer advances include unearned amounts received under maintenance and support agreements and amounts received from customers, for which revenues have not yet been recognized.

F - 17

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

In addition, the Company derives a significant portion of its revenues from post implementation consulting services provided on a "Time and Materials" ("T&M") basis which are recognized as services are performed.

 

l.m.Income taxes:

 

The Company accounts for income taxes in accordance with ASC 740, "Income Taxes". This topic prescribes the use of the asset and liability method, whereby deferred tax asset and liability account balances are determined based on the differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company provides a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The Company implements a two-step approach to recognize and measure uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative basis) likely to be realized upon ultimate settlement.

 

The Company classifies interest as financial expenses and penalties as selling, marketing, general and administration expenses.

 

m.n.Concentrations of credit risk:risks:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, trade receivables, marketable securities and foreign currency derivative contracts.

 

The Company's cash and cash equivalents and restricted cash are invested in bank deposits mainly in dollars, with a significant portion also invested in NIS. Deposits in the U.S. may be in excess of insured limits and are not insured in other jurisdictions. Generally, these banks deposits may be redeemed upon demand and therefore bear minimal risk.

 

The Company's trade receivables are generally derived from sales to large and solid organizations located mainly in North America, Israel, United Kingdom, Rest of Europe and Asia Pacific. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. In certain circumstances, the Company may require prepayment. An allowance for doubtful accounts is determined with respect to those amounts that the Company has determined to be doubtful of collection. Provisions for doubtful accounts wereare recorded in selling, marketing, general and administrative expenses.

F - 18

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

The Company's marketable securities include investment in corporate and government debentures. The Company's investment policy limits the amount that the Company may invest in any one type of investment or issuer, thereby reducing credit risk concentrations.

 

The Company entered into forward contracts, and option contracts intended to protect against the increase in value of forecasted non-dollar currency cash flows. The derivative instruments hedge a portion of the Company's non-dollar currency exposure.

 

No off-balance sheet concentrations of credit risk exist.

 

n.o.Accrued severance pay:

 

The Company's liability for severance pay for its Israeli employees is calculated pursuant to Israel's Severance Pay Law based on the most recent monthly salary of the employees multiplied by the number of years of employment as of the balance sheet date. Employees are entitled to one month's salary for each year of employment, or a portion thereof. The Company's liability is fully provided by monthly deposits with insurance policies and severance pay funds and by an accrual.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The deposited funds include profits (losses) accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligation pursuant to Israel's Severance Pay Law or employment agreements. The value of the deposited funds is based on the cash surrendered value of these policies and recorded as an asset in the Company's consolidated balance sheetsheets.

 

In addition, the Company signed on a collective agreement with certain employees, according to which the Company's contributions for severance pay shall be insteadin lieu of severance compensation and that upon release of the policy to the employee, no additional payments shall be made by the Company to the employee. Generally, the Company, under its sole discretion, pays to these employees the entire liability, irrespective of the collective agreement described per above. Therefore, the net obligation related to those employees is stated on the balance sheet as accrued severance pay.

 

The Company's agreements with certain employees in Israel are in accordance with Section 14 of the Severance Pay Law, 1963, whereas, the Company's contributions for severance pay shall be insteadin lieu of its severance liability. Upon contribution of the full amount of the employee's monthly salary, and release of the policy to the employee, no additional calculations shall be conducted between the parties regarding the matter ofo severance pay and no additional payments shall be made by the Company to the employee. Further, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as they are legally released from obligation to employees once the deposit amounts have been paid.

 

Severance expense for the years 2011, 20122014, 2015 and 20132016 amounted to $ 1,514, $ 2,217$3,022, $3,518 and $ 2,909,$4,094, respectively.

F - 19

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

o.NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

p.Basic and diluted net earnings per share:

 

Basic net earnings per share are computed based on the weighted average number of common shares outstanding during each year. Diluted net earnings per share are computed based on the weighted average number of common shares outstanding during each year plus dilutive potential equivalent common shares considered outstanding during the year, in accordance with ASC 260, "Earnings Per Share".

 

p.q.Stock-based compensation:

 

The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation - Stock Compensation" ("ASC 718"), which requires the measurement and recognition of compensation expense based on estimated fair values for all share-based payment awards made. ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model. The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of income.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The Company uses the Binomial Lattice ("Binomial model") option-pricing model to estimate the fair value for any options granted. The Binomial model takes into account variables such as volatility, dividend yield rate, and risk free interest rate and also allows for the use of dynamic assumptions and considers the contractual term of the option, the probability that the option will be exercised prior to the end of its contractual life, and the probability of termination or retirement of the option holder in computing the value of the option.

 

Stock-based compensation cost is measured at the grant date, based on the fair value of the award. The Company recognizes compensation expensesexpense for the value of its awards, which have graded vesting, based on the straight-line basis over the requisite service period of the award, net of estimated forfeitures. Estimated forfeitures are based on actual historical pre-vesting forfeitures.

 

The fair value of each option granted in 2011, 20122014, 2015 and 20132016 using the Binomial model, iswas estimated on the date of grant with the following assumptions:

 

 Year ended December 31, Year ended December 31,
 2011 2012 2013  2014 2015 2016
           
Contractual lifeContractual life6 years 6 years 6 years 6 years 6 years 6 years
Expected exercise factor (weighted average)2.5 2.8 1.5-2
Expected exercise factor 1.5-2 1.5-2.5 2-2.8
Dividend yieldDividend yield0% 0% 0% 0% 0% 0%
Expected volatility (weighted average)Expected volatility (weighted average)70% 60% 54.29% 48.9% 43.0%-44.1% 34.9%-42.4%
Risk-free interest rateRisk-free interest rate0.1%-1.2% 0.2%-1.0% 1.52% 1.8%-1.9% 1.6%-1.8% 1.3%-1.7%

F - 20

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The risk-free interest rate assumption is based on the yield from U.S. Treasury zero-coupon bonds with an equivalent term as of the Company's employee stock options. Since dividend payment is applied to reduce the exercise price of the option, the effect of the dividend protection is reflected by using an expected dividend assumption of zero. The expected life of options granted is derived from the output of the option valuation model and represents the period of time the options are expected to be outstanding. The expected exercise factor is based on industry acceptable rates since no actual historical behavior by option holders exists. Expected volatility is based on the historical volatility of the Company.

 

Stock-based compensation cost is measured at the grant date, based on the fair value of the award, and is recognized as an expense on a straight-line basis over the requisite service period for each of the awards.

q.r.Fair value of financial instruments:

 

ASC 820, "Fair Value Measurements and Disclosures" ("ASC 820"), defines fair value as the price that would be received to sell an asset or paid to transfer a liability (i.e., the "exit price") in an orderly transaction between market participants at the measurement date.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

In determining fair value, the Company uses various valuation approaches. ASC 820 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances.

 

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

 

As a basis for considering such assumptions, ASC 820 establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

 

Level 1 -QuotedValuations based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company can access athas the measurement date.ability to access. Valuation adjustments and block discounts are not applied to Level 1 instruments. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2 -Inputs other thanValuations based on one or more quoted prices included within Level 1in markets that are observablenot active or for the asset or liability,which all significant inputs are observable, either directly or indirectly.

Level 3 -UnobservableValuations based on inputs forthat are unobservable and significant to the asset or liability.overall fair value measurement.

 

The Company measures its marketable debt securities and foreign currency derivative instruments at fair value. The Company's marketable debts securities are traded in markets that are not considered to be active, but are valued based on quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency and accordingly are categorized as Level 2.

Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.

Foreign currency derivative contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments.

F - 21

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

The carrying amounts of cash and cash equivalents, restricted cash, accounts receivable, and accounts payable approximate fair value due to the short-term maturities of such instruments.

 

r.s.Derivatives and hedging:

 

The Company enters into option contracts and forward contracts to hedge certain transactions denominated in foreign currencies. The purpose of the Company's foreign currency hedging activities is to protect the Company from risk that the eventual dollar cash flows from international activities will be adversely affected by changes in the exchange rates. The Company's option and forward contracts do not qualify as hedging instruments under ASC 815.815, "Derivatives and hedging". Changes in the fair value of option strategies are reflected in the consolidated statements of income as financial income or expense.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

In 2011, 20122014, 2015 and 2013,2016, the Company entered into option strategies contracts in the notional amounts of $ 1,979, $ 10,408$33,270, $9,250 and $ 9,868,$26,336, respectively, and in 20122014, 2015 and 20132016 the Company entered into forward contracts in the notional amounts of $ 1,734$7,383, $42,770 and $ 299,$17,668, respectively, that converted a portion of its floatingin order to protect against foreign currency liabilities to a fixed rate basis for a twelve-month period, thus reducing the impact of the currency changes on the Company's cash flow.fluctuations.

 

As of December 31, 20122014, 2015 and 2013,2016, the Company had outstanding options and forward contracts, in the notional amount of $7,520$25,772, $21,876 and $ 2,982,$0, respectively.

 

In 2011, 20122014, 2015 and 2013,2016, the Company recorded an income (expenses) of $ 27, $ 97$(397), $230 and $387,$849, respectively, with respect to the above transactions, presented in the statements of income as financial income.income (expenses).

 

s.t.Treasury shares:

 

Repurchased common shares are held as treasury shares. The Company presents the cost to repurchase treasury stock as a reduction of shareholders’ equity.

 

t.u.Comprehensive income:income (loss):

 

The Company accounts for comprehensive income (loss) in accordance with ASC No. 220, "Comprehensive Income". Comprehensive income generally represents all changes in shareholders' equity during the period except those resulting from investments by, or distributions to, shareholders.

The Company determined that its itemscomponents of accumulated other comprehensive income relate to foreign currency translation adjustments.loss, in the amount of $11,679 and $11,167 at December 31, 2015 and 2016, respectively, were as follows:

F - 22

SAPIENS INTERNATIONAL CORPORATION N.V.

 

u.Impact of recently issued accounting standards:

In July 2013, the Financial Accounting Standards Board (“FASB”) issued guidance that requires that a nonrecognized tax benefit be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. This net presentation is required unless a net operating loss carryforward, a similar tax loss, or a tax credit carryforward is not available at the reporting date or the tax law of the jurisdiction does not require, and the entity does not intend to use, the deferred tax asset to settle any additional income tax that would result from the disallowance of the unrecognized tax benefit. This guidance is effective for fiscal year beginning after December 15, 2013, with early adoption permitted. The Company believes that the adoption of this standard will not have a material impact on its consolidated financial statements.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 2:      SIGNIFICANT ACCOUNTING POLICIES (Cont.)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

 

In March 2013, the FASB issued further guidance on accounting for the release of a cumulative translation adjustment into net income when a parent company either sells a part or all of its investment in a foreign entity or no longer holds a controlling financial interest in a subsidiary or group of assets and provides guidance for the acquisition in stages of a controlling interest in a foreign entity. This guidance is effective for fiscal years beginning after December 15, 2013, with early adoption permitted. The Company believes that the adoption of this standard will not have a material impact on its consolidated financial statements.

  December 31, 
  2015  2016 
       
Foreign currency translation differences $11,492  $11,021 
Unrealized losses on available-for-sale marketable securities, net of tax  187   146 
         
  $(11,679) $(11,167)

 

NOTE 3:      OTHER LONG TERM ASSETS

v.Impact of recently issued accounting standards:

 

  December 31, 
  2012  2013 
       
Deferred tax assets $608  $396 
Government authorities  1,208   1,917 
Other  500   644 
         
  $2,316  $2,957 
In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) (ASU 2014-09), which amends the existing accounting standards for revenue recognition. In August 2015, the FASB issued ASU No. 2015-14, Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date, which delays the effective date of ASU 2014-09 by one year. The FASB also agreed to allow entities to choose to adopt the standard as of the original effective date.  The new revenue recognition standard will be effective in the first quarter of 2018, with the option to adopt it in the first quarter of 2017. The Company currently anticipates adopting the new standard effective January 1, 2018. The new standard also permits two methods of adoption: retrospectively to each prior reporting period presented (full retrospective method), or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application (the modified retrospective method). The Company preliminarily anticipates adopting the standard using the modified retrospective method. However, the Company is continuing to evaluate the impact of the standard on its consolidated financial statements and related disclosures and the adoption method is subject to change.

In February 2016, the FASB issued ASU 2016-02, “Leases” (Topic 842), whereby, lessees will be required to recognize for all leases at the commencement date a lease liability, which is a lessee‘s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. A modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements must be applied. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. Companies may not apply a full retrospective transition approach. ASU 2016-02 is effective for annual and interim periods beginning after December 15, 2018. Early application is permitted. The Company is evaluating the potential impact of this pronouncement.

 

F-26
F - 23 

SAPIENS INTERNATIONAL CORPORATION N.V.

 

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 2:SIGNIFICANT ACCOUNTING POLICIES (Cont.)

In March 2016, the FASB issued ASU 2016-09, which provides for improvements to employee share-based payment accounting. ASU 2016-09 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. ASU 2016-09 simplifies several aspects of the accounting for employee share-based payment transactions, including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification in the statement of cash flows. The Company does not expect that this new guidance will have a material impact on the Company’s consolidated financial statements.

In April 2016, the FASB issued ASU 2016-10, “Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing” (“ASU 2016-10”), which clarifies the following two aspects of Topic 606: (a) identifying performance obligations; and (b) the licensing implementation guidance. The amendments do not change the core principle of the guidance in Topic 606. The new guidance is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods, which will be our interim period beginning January 1, 2018. Early adoption is permitted only as of annual reporting periods beginning after December 15, 2016, including interim reporting periods with that reporting period. We are evaluating the impact of this standard.

In November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (ASU 2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash flows. This guidance will be effective for us in the first quarter of 2018 and early adoption is permitted. The Company is still evaluating the effect that this guidance will have on its consolidated financial statements and related disclosures

NOTE 3:MARKETABLE SECURITIES

As of December 31, 2015 and 2016, the fair value, amortized cost and gross unrealized holding gains and losses of available-for-sale marketable securities were as follows:

  December 31, 2016 
  

Amortized

cost

  

Gross
unrealized

gains

  

Gross

unrealized
losses

  

Fair

value

 
             
Government debentures – fixed interest rate $3,167   -  $(3) $3,164 
Corporate debentures – fixed interest rate  32,473   -   (189)  32,284 
                 
  $35,640   -  $(192) $35,448 

F - 24

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 3:MARKETABLE SECURITIES (Cont.)

  December 31, 2015 
  

Amortized

cost

  

Gross
unrealized

gains

  

Gross

unrealized
losses

  

Fair

value

 
             
Government debentures – fixed interest rate $5,242   -  $(19) $5,223 
Corporate debentures – fixed interest rate  34,663   -   (235)  34,428 
                 
  $39,905   -  $(254) $39,651 

As of December 31, 2016, the contractual maturities of available-for-sale marketable securities are up to three years. $18,220 were classified as short-term marketable securities as part of the current assets due to contractual maturity of up to one year. Interest receivable included in other receivables and prepaid expenses amounted to $334 and $226 as of December 31, 2015 and 2016, respectively.

NOTE 4:OTHER LONG-TERM ASSETS

  December 31, 
  2015  2016 
       
Deferred tax assets $2,779  $2,261 
Other  1,473   2,362 
         
  $4,252  $4,623 

NOTE 5:PROPERTY AND EQUIPMENT, NET

 

NOTE 4:      PROPERTY AND EQUIPMENT, NET

 December 31,  December 31, 
 2012  2013  2015  2016 
          
Cost:                
Computers and peripheral equipment $8,600  $12,190  $15,477  $18,503 
Office furniture and equipment  2,909   4,183 
Leasehold improvements  1,581   2,959 
Office furniture, equipment and other  4,228   4,309 
Buildings and Leasehold improvements  2,780   6,051 
                
  13,090   19,332   22,485   28,863 
Accumulated depreciation:                
Computers and peripheral equipment  7,279   9,964   12,712   14,737 
Office furniture and equipment  2,261   2,609 
Office furniture, equipment and other  2,607   2,682 
Leasehold improvements  1,307   1,496   1,491   1,637 
                
  10,847   14,069   16,810   19,056 
                
Depreciated cost $2,243  $5,263  $5,675  $9,807 

 

Depreciation expense totaled $ 755, $ 903$1,582, $2,080 and $ 1,260$2,835 for the years 2011, 20122014, 2015 and 2013, respectively 2016, respectively.

F - 25

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 5:      CAPITALIZED SOFTWARE DEVELOPMENT COSTS, NET

NOTE 6:CAPITALIZED SOFTWARE DEVELOPMENT COSTS, NET

 

The changes in capitalized software development costs during the yearyears ended December 31, 20122015 and 20132016 were as follows:

 

 Year ended December 31,  Year ended December 31, 
 2012  2013  2015  2016 
          
Balance at the beginning of the year $17,399  $17,494  $19,243  $19,856 
                
Capitalization  3,464   5,392   6,032   5,545 
Amortization  (3,758)  (4,500)  (5,439)  (4,929)
Functional currency translation adjustments  389   1,318   20   283 
                
Balance at the year end $17,494  $19,704  $19,856  $20,755 

 

Amortization of capitalized software development costs for 2011, 20122014, 2015 and 2013,2016, was $ 4,544, $ 3,758$4,926, $5,439 and $ 4,500,$4,929, respectively. Amortization expense is included in cost of revenues.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 6:      OTHER INTANGIBLE ASSETS, NET

NOTE 7:OTHER INTANGIBLE ASSETS, NET

 

a.Other intangible assets, net, are comprised of the following:

 

 December 31, 
 2012  2013  weighted average
remaining useful life
(years)
 December 31, 
        2015  2016 
Original amounts:                  
                  
Customer relationship $9,335  $9,929 
Customer relationships 3.92 $10,853  $11,804 
Technology  5,842   6,151  4.47  6,717   8,080 
Patent 7.5  1,230   1,248 
                  
  15,177   16,080     18,800   21,132 
                  
Accumulated amortization:                  
                  
Customer relationship  2,058   3,418 
Customer relationships    6,361   7,756 
Technology  1,401   2,352     4,581   5,475 
Patent    174   302 
                  
  3,459   5,770     11,116   13,533 
                  
Other intangible assets, net $11,718  $10,310    $7,684  $7,599 

 

b.Amortization of other intangible assets was $ 1,449, $ 2,732$2,209, $2,106 and $ 2,127$2,257 for 2011, 20122014, 2015 and 2013,2016, respectively.

 

F - 26

NOTE 6:      OTHER INTANGIBLE ASSETS, NET (Cont.)

SAPIENS INTERNATIONAL CORPORATION N.V.

 

c.Estimated amortization expense for future periods:

For the year ended December 31,   
    
2014 $2,260 
2015  2,123 
2016  1,768 
2017  1,636 
2018  1,245 
2019 and thereafter  1,278 
     
  $10,310 
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 7:OTHER INTANGIBLE ASSETS, NET (Cont.)

NOTE 7:-     GOODWILL 

c.Estimated amortization expense for future periods:

For the year ended December 31,   
    
2017 $2,294 
2018  1,951 
2019  1,323 
2020  524 
2021 and thereafter  1,507 
     
  $7,599 

NOTE 8:GOODWILL

 

The changes in the carrying amount of goodwill for each reporting unit for the years ended December 31, 20122015 and 20132016 are as follows:

 

  Year ended December 31, 
  2015  2016 
       
Balance at the beginning of the year $67,698  $70,035 
         
Acquisition of subsidiaries  2,588   2,967 
Functional currency translation adjustments  (251)  595 
         
Balance at year- end $70,035  $73,597 

  Year ended December 31, 
  2012  2013 
       
Balance at the beginning of the year $66,715  $68,087 
         
Functional currency translation adjustments  1,372   4,351 
         
Balance at the year end $68,087  $72,438 

NOTE 9:ACCRUED EXPENSES AND OTHER LIABILITIES

 

NOTE 8:       ACCRUED EXPENSES AND OTHER LIABILITIES

  December 31, 
  2015  2016 
       
Government authorities $3,419  $5,009 
Accrued royalties to the IIA (Note 10a)  251   259 
Accrued expenses  11,223   8,638 
         
  $14,893  $13,906 

 

  December 31, 
  2012  2013 
       
Government authorities $1,668  $3,084 
Accrued royalties to the OCS (Note 9a)  596   269 
Accrued contract costs  563   37 
Accrued expenses  4,691   4,281 
         
  $7,518  $7,671 
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 9:      COMMITMENTS AND CONTINGENT LIABILITIES

NOTE 10:COMMITMENTS AND CONTINGENT LIABILITIES

 

a.Sapiens Technologies (1982) Ltd. ("Sapiens Technologies"), a subsidiary incorporated in Israel, was partially financed under programs sponsored by the Israel Innovation Authority ("IIA"), formerly the Office of the Chief Scientist, ("OCS") for the support of certain research and development activities conducted in Israel.

 

F - 27

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 10:COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

In exchange for participation in the programs by the OCS,IIA, the Company agreed to pay 3%-3.5%3.5% of total net consolidated license and maintenance revenue and 0.35% of the net consolidated consulting services revenue related to the software developed within the framework of these programs based on an understanding with the OCSIIA reached in January 2012. The understanding reached with the OCS resulted in a reversal of an accrual in the amount of $ 922 which was recorded as a reduction of cost of revenues in 2011.

 

The royalties will be paid up to a maximum amount equaling 100%-150% of the grants provided by the OCS,IIA, linked to the dollar, and for grants received after January 1, 1999, bear annual interest at a rate based on LIBOR.

 

Royalties' expensesRoyalty expense amounted to $ 510, $574$618, $505 and $514$503 in 2011, 20122014, 2015 and 2013,2016, respectively, and are included in cost of revenues.

 

As of December 31, 2013,2016, the Company had a contingent liability to pay royalties of approximately $ 7,608.$7,119.

 

b.Lease commitments:

 

The Company leases office space, office equipment and various motor vehicles under operating leases.

 

1.The Company's office space and office equipment are rented under several operating leases. Future minimum lease commitments under non-cancelable operating leases for the years ended December 31, were as follows:

 

2014 $2,718 
2015  2,875 
2016  2,769 
2017  2,562 
2018  2,552 
2019 and thereafter  3,828 
     
  $17,304 
2017 $4,050 
2018  3,426 
2019  2,974 
2020  1,085 
2021 and thereafter  83 
     
  $11,618 

 

Rent expense for the years ended December 31, 2011, 20122014, 2015 and 20132016 was $ 2,399, $ 3,051$3,782, $4,418 and $ 3,370,$6,284, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 9: COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

 

2.The Company leases its motor vehicles under cancelable operating lease agreements.

 

The minimum payment under these operating leases, upon cancellation of these lease agreements was $ 314$168 as of December 31, 2013.2016.

 

c.The Company has provided bank guarantees in the amount of $ 1,183$827 as security for the rent to be paid for its leased offices. The lease isbank guarantees are valid forthrough February 2017 and thereafter will be renewed in an amount of approximately three years ending in October 2015.

$850 which will be valid through February 2018. As of December 31, 2013,2016, the Company has provided bank guarantees in the amount of $ 173$426 as security for the performance of various contracts with customers and suppliers.

 

F - 28

NOTE 10:   TAXES ON INCOME

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 10:COMMITMENTS AND CONTINGENT LIABILITIES (Cont.)

As of December 31, 2016, the Company had no restricted bank deposits in favor of the bank guarantees.

 

a.d.Parent taxation:On August 27, 2015, the Company's wholly-owned subsidiary was summoned to a hearing at a court in Amsterdam in connection with a claim initiated against it by one of its customers.

 

Sapiens is governedAlthough the software system provided by the Company's subsidiary has been used by the customer since 2008, the customer claims that the software system furnished it did not comply with its requirements and that the subsidiary failed to correct errors in the software systems in accordance with the service level agreement between the parties. The remedies sought by the customer are: (i) termination of all contracts with the subsidiary; and (ii) refund of all amounts paid by the customer to the subsidiary under the lawsforegoing contracts plus damages in an aggregate amount of Curaçao. In addition, Sapiens is registered as an Israeli corporation for tax purposes only.approximately €21.5 million.

As of the date of publication of these financial statements, the legal proceedings are at its early stage and the Company has included in these financial statements a provision which reflects the Company’s current estimate of the potential outcome of the foregoing claim.

 

b.NOTE 11:TAXES ON INCOME

a.Israeli taxation:

 

1.Corporate tax rates in Israel:

 

TaxableThe Israeli corporate income of Israeli companies is subject to tax at the rate of 24% in 2011, andwas 25% in 20122016 and 2013.26.5% in 2015 and 2014.

 

On July 30, 2013,In January 2016, the Israeli Parliament (the Knesset)Law for Amending the Income Tax Ordinance (No. 216) (Reduction of Corporate Tax Rate), 2016 was approved, the second and third readingswhich includes a reduction of the Economic Plan for 2013-2014 ("Amended Budget Law") which consists, among others, raising the Israeli corporate tax rate from 25%26.5% to 26.5% commencing25%, effective from January 1, 2014.2016.

In December 2016, the Israeli Parliament approved the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016 which reduces the corporate income tax rate to 24% (instead of 25%) effective from January 1, 2017 and to 23% effective from January 1, 2018.

 

2.Tax benefits under the Israel Law for the Encouragement of Capital Investments, 1959 ("the Law"):

 

Certain of the Company's Israeli subsidiaries have been granted "Approved Enterprise" and "Privileged"Preferred Enterprise" status, which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Approved Enterprise and PrivilegedPreferred Enterprise benefits is taxedsubject to corporate tax at regular rates.the rate that would have otherwise been applicable on the Approved or Preferred Enterprise’s income.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
 F - 29

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 10:    TAXES ON INCOME (Cont.)

NOTE 11:TAXES ON INCOME (Cont.)

 

The entitlement to the above benefits is conditional upon the fulfilling of the conditions stipulated by the Laws and regulations. Should the certain Israeli subsidiaries fail to meet such requirements in the future, income attributable to their Approved Enterprise and PrivilegedPreferred Enterprise programs could be subject to the statutory Israeli corporate tax rate and they could be required to refund a portion of the tax benefits already received, with respect to such programs. As of December 31, 2013,2016, management believes that these subsidiaries are in compliance withfollowing all the conditions required by the Law.

 

Effective January 1, 2011,Approved enterprise tax regime

Under Approved Enterprise track, the Knesset enactedCompany is tax exempt in the first two years/six years/ten years of the benefit period (dependent on the development area) and subject to tax at the reduced rate of 10%-25% for a period of five/eight years (if the benefit period qualifying for tax exemption is two years) or one year/four years (if the benefit period qualifying for tax exemption is six years)/for the remaining benefit period (dependent on the level of foreign investment). Under the terms of the Approved Enterprise program, income that is attributable to one of the Company's Israeli subsidiaries was exempt from income tax for a period of two years commencing 2014.

If a dividend is distributed out of tax exempt profits, as above, the Company will become liable for tax at the rate applicable to its profits from the approved enterprise in the year in which the income was earned, as if it was not under the Approved Enterprise track. The Company's policy is not to distribute such a dividend.

Preferred enterprise tax regime

In August 2013, the Law for Economic PolicyChanging National Priorities (Legislative Amendments for 2011Achieving Budget Targets for 2013 and 2012 (Amended Legislation)2014), and among other things, amended2013 which includes Amendment 71 to the Law for the Encouragement of Capital Investments ("the Amendment"). According to was enacted. Per the Amendment, the benefit tracks in the Investment Law were modified and a flat tax rate applieson preferred income from a preferred enterprise in 2014 and thereafter will be 16% (in development area A - 9%). As for changes in tax rates resulting from the enactment of Amendment 73 to the Company's entire preferred income. TheLaw, see below. As of December 31, 2015, some of the Company will be able to optIsraeli subsidiaries had filed a request to apply (the waiver is non-recourse) the new benefits under the 2011 Amendment and from then on it will be subjecttherefore subjected to the amended tax rate of 16%.

 

The Amendment also prescribes that any dividends distributed to individuals or foreign residents from the preferred enterprise's earnings as above will be subject to tax at a rate of 20%.

F - 30

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

3.NOTE 11:Tax benefits under the Law for the Encouragement of Industry (Taxation), 1969:TAXES ON INCOME (Cont.)

 

New Amendment- Technological preferred enterprise

Management believes

In December 2016, the Economic Efficiency Law (Legislative Amendments for Applying the Economic Policy for the 2017 and 2018 Budget Years), 2016, which includes Amendment 73 to the Law for the Encouragement of Capital Investments ("the Amendment"), was published.

The Amendment prescribes special tax tracks for technological enterprises, which are subject to rules that are to be issued by the Minister of Finance by March 31, 2017.

The new tax track that may be relevant to certain of the Company's IsraeliCompany's subsidiaries are currently qualifiesin Israel is the technological preferred enterprise. A technological preferred enterprise, as an "industrial company" underdefined in the Law, will be subject to tax at a rate of 12% on profits deriving from intellectual property

Since as of December 31, 2016 definitive criteria to determine the tax benefits has not yet been established, it cannot be concluded that the legislation in respect of technological enterprises had been enacted or substantively enacted as of that date. Accordingly, the above law andchanges in the tax rates relating to technological enterprises were not taken into account in the computation of deferred taxes as such, is entitled to certain tax benefits including accelerated depreciation and amortization of intangible property rights for tax purposes.December 31, 2016.

 

4.3.Foreign Exchange Regulations:

 

Under the Foreign Exchange Regulations, some of the Company's Israeli subsidiaries calculate their tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into NIS according to the exchange rate as of December 31st of each year.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 10: TAXES ON INCOME (Cont.)

 

c.Income taxes on non-Israeli subsidiaries:

 

Non-Israeli subsidiaries are taxed according to the tax laws in their respective country of residence. Neither Israeli income taxes, foreign withholding taxes nor deferred income taxes were provided in relation to undistributed earnings of the non-Israelisnon-Israeli subsidiaries.

This is because the Company intends to permanently reinvest undistributed earnings in the foreign subsidiaries in which those earnings arose. If these earnings were distributed in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and non-Israeli withholding taxes.

 

The amount of undistributed earnings of foreign subsidiaries that are considered to be reinvested as of December 31, 20132016 was $8,403$23,495 and the amount of the unrecognized deferred tax liability for temporary differences related to investments in foreign subsidiaries that were essentially permanent in duration as of December 31, 20132016 was $125.$1,665.

F - 31

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 11:TAXES ON INCOME (Cont.)

  

d.Net operating losses carryforward:carry forward:

 

As of December 31, 2013,2016, certain subsidiaries had tax loss carry-forwards totaling approximately $ 45,912.$24,177 Most of these carry-forward tax losses have no expiration date.

 

e.Deferred tax assets and liabilities:

 

Deferred taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. Significant components of the Company deferred tax assets are as follows:

  December 31, 
  2015  2016 
       
Deferred tax assets:        
Net operating losses carry forward $7,275  $6,515 
Research and development  2,123   1,619 
Other  3,188   3,155 
         
Deferred tax assets before valuation allowance  12,586   11,289 
Valuation allowance  (6,212)  (6,589)
         
Deferred tax assets  6,374   4,700 
         
Deferred tax liabilities:        
Capitalized software development costs  (2,804)  (3,011)
Acquired intangibles  (1,472)  (1,202)
Property and equipment  (53)  (369)
Other  (163)  (24)
         
Deferred tax liabilities  (4,492)  (4,606)
         
Deferred tax assets, net $1,882  $94 

  December 31, 
  2015  2016 
       
Long-term deferred tax assets, net  2,779   2,261 
Long-term deferred tax liabilities, net  (897)  (2,167)
         
Deferred tax assets, net $1,882  $94 

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
 F - 32

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 10: TAXES ON INCOME (Cont.)

  December 31, 
  2012  2013 
       
Deferred tax assets:        
Net operating losses carryforward $14,351  $12,080 
Research and development  3,013   2,592 
Other  1,016   1,132 
         
Deferred tax assets before valuation allowance  18,380   15,804 
Valuation allowance  (8,263)  (8,324)
         
Deferred tax assets  10,117   7,480 
         
Deferred tax liabilities:        

Capitalized software development costs

  (3,705)  (3,203)
Acquired intangibles  (3,905)  (2,854)
         

Deferred tax liabilities

  

(7,610

)  

(6,057

)
         
Deferred tax assets, net $2,507  $1,423 

  December 31, 
  2012  2013 
       
Current deferred tax assets $2,750  $2,420 
Long-term deferred tax assets  608   396 
Current deferred tax liabilities  (121)  - 
 Long-term deferred tax liabilities  (730)  (1,393)
         
Deferred tax assets, net $2,507  $1,423 
NOTE 11:TAXES ON INCOME (Cont.)

 

Long-term deferred tax assets are included withinin other long term assets. Current and long-term assets in the balance sheets. Long-term deferred tax liabilities are included within other liabilities andin other long-term liabilities respectively, in the balance sheets.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 10:   TAXES ON INCOME (Cont.)

 

The Company has provided valuation allowances in respect of certain deferred tax assets resulting from tax lossoperating losses carry forwards and other reserves and allowances due to uncertainty concerning realization of these deferred tax assets.

 

f.Income before taxes on income is comprised as follows:

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Domestic (Curaçao) $(236) $(745) $(875)
Domestic (Israel) $11,281  $19,478  $13,701 
Foreign  5,964   12,983   13,278   3,749   5,035   11,672 
                        
 $5,728  $12,238  $12,403  $15,030  $24,513  $25,373 

 

g.A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income for an Israeli company, and the actual tax expense as reported in the statements of income is as follows:

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Income before taxes on income, as reported in the statements of income $5,728  $12,238  $12,403  $15,030  $24,513  $25,373 
                        
Statutory tax rate in Israel  24%  25%  25%  26.5%  26.5%  25%
                        
Theoretical taxes on income $1,375  $3,018  $3,097  $3,983  $6,496  $6,343 
Increase (decrease) in taxes resulting from:                        
Effect of different tax rates  75   120   158   362   117   (382)
Utilization of carryforward tax losses for which valuation allowance was provided  (66)  (2,690)  (1,162)
Non-deductible expenses and tax exempt income  68   82   9 
Effect of “Approved, Beneficiary or Preferred Enterprise” status  (2,323)  (2,406)  (1,338)
Utilization of carry forward tax losses for which valuation allowance was provided  (1,177)  (195)  - 
Non-deductible expenses  80   569   584 
Recognition of deferred taxes during the year for which valuation allowance was provided in prior years  (2,040)  (1,206)  (971)  (1,496)  -   - 
Losses and temporary differences for which valuation allowance was provided  244   421   222   580   127   377 
Others  114   690   

(542

)  445   (495)  188 
                        
Taxes on income, as reported in the statements of income $(230) $435  $811  $454  $4,213  $5,772 

 

F-35
F - 33 

SAPIENS INTERNATIONAL CORPORATION N.V.

 

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 10:    TAXES ON INCOME (Cont.)

NOTE 11:TAXES ON INCOME (Cont.)

 

h.Taxes on income (benefit) are comprised as follows:

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Current $470  $738  $400  $1,474  $2,627  $4,122 
Deferred  (700)  (303)  411   (1,020)  1,586   1,650 
                        
 $(230) $435  $811  $454  $4,213  $5,772 

 

The Company's entire provision for taxes on income relates to operations in jurisdictions other than Curaçao.

  Year ended December 31, 
  2014  2015  2016 
          
Domestic (Israel) $(443) $2,684  $2,824 
Foreign  897   1,529   2,948 
             
  $454  $4,213  $5,772 

 

i.Uncertain tax positions:

 

A reconciliation of the beginning and ending balances of the total amounts of unrecognized tax benefits is as follows:

 

 December 31,  December 31, 
 2012  2013  2015  2016 
          
Balance at the beginning of the year $1,566  $510  $705  $1,365 
Settlement with tax authorities  (925)  - 
Increase in tax positions  66   199   570   688 
Decrease in tax positions  (197)  (57)  (64)  (293)
Acquisition of subsidiary (*)  154   227 
                
Balance at the end of the year $510  $652  $1,365  $1,987 

(*) The amount initially consolidated as part of the acquisition of subsidiary in 2015 was net of Withholding taxes assets of $635.

 

The entire balance of unrecognized tax benefits, if recognized, would reduce the Company's annual effective tax rate.

 

As of December 31, 20122015 and 20132016, accrued interest related to uncertain tax positions amounted to $ 184$422 and $ 200,$490, respectively.

 

As of December 31, 2013, mostTax assessments filed by Part of the Company's Israeli subsidiaries through the year ended December 31, 2011 are subjectconsidered to Israeli income tax audits for the tax years 2009 through 2013, to U.S. federal income tax audits for the tax years of 2009 through 2013 and to other for the tax years of 2006 through 2013.be final.

 

F-36
F - 34 

SAPIENS INTERNATIONAL CORPORATION N.V.

 

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 11:   EQUITY

NOTE 12:EQUITY

 

a.The common shares of the Company are traded on the Tel-Aviv Stock ExchangeNASDAQ and on the NASDAQ.Tel-Aviv Stock Exchange.

 

Common shares confer upon their holders voting rights, the right to receive cash dividends and the right to share in excess assets upon liquidation of the Company.

 

On November 14, 2013 the Company completed a secondary public offering of its ordinary shares on the NASDAQ. The Company issued 6,497,400 shares at a price of $ 6.25 per share before issuance expenses. Total net proceeds from the issuance amounted to $ 37,791.

b.Stock option plans:

 

In 2011, in connection with the acquisition of IDIT and FIS, the Company's board of directors approved its 2011 Share Incentive Plan (the “2011 Plan”) pursuant to which the Company's employees, directors, officers, consultants, advisors, suppliers, business partner, customer and any other person or entity whose services are considered valuable are eligible to receive awards of share options, restricted shares, restricted share units and other share-based awards. Options granted under the 2011 Plan may be exercised for a period of up to 6six years from the date of grant and become exercisable in four equal, annual installments, beginning with the first anniversary of the date of the grant, or pursuant to such other schedule as may provide in the option agreement.

 

The total number of Common Shares available under the 2011 Plan was set at 4,000,000. Upon the approval of the 2011 Plan, the board of directors determined that no further awards would be issued under the Company's previously existing share incentive plans.

 

Pursuant toIn February 2016, our Board of Directors approved the termsreservation of an additional 4,000,000 Common Shares for issuance under the acquisitions of IDIT and FIS, the Company replaced unvested options with Sapiens options, based on the agreed exchange ratio applicable to the purchase of the outstanding shares of IDIT and FIS, respectively. Each replaced option is subject to the same terms and conditions, including vesting and timing of exercisability, as applied to any such option immediately prior to the acquisition.2011 Plan.

 

As of December 31, 2013 839,9842016, 3,900,284 common shares of the Company were available for future grant under the 2011 Plan. Any optionoptions granted under the 2011 Plan which are forfeited, cancelled, terminated or cancelled before expiration,expired, will become available for future grant under the 2011 Plan.

A summary of the stock option activities in 2016 is as follows:

  Year ended December 31, 2016 
  Amount of
options
  

Weighted

average

exercise
price

  Weighted average
remaining
contractual life
(in years)
  Aggregate
intrinsic value
 
             
Outstanding at January 1, 2016  2,175,488   5.36   3.49  $9,274 
Granted  310,000   11.63         
Exercised  (276,170)  3.52         
Expired and forfeited  (71,535)  6.17         
                 
Outstanding at December 31, 2016  2,137,783   6.91   3.43   15,171 
                 
Vested and expected to vest  2,085,779   6.85   3.41   14,927 
                 
Exercisable at December 31, 2016  1,172,950   4.84   2.56  $10,646 

In 2014, 2015 and 2016, the Company granted 340,000, 673,408 and 310,000 stock options to employees and directors, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
 F - 35

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 11:    EQUITY (Cont.)

A summary of the stock option activities in 2013 is as follows:

  Year ended December 31, 2013 
  Amount of
options
  Weighted
average
exercise
price
  Weighted
average
remaining
contractual
life (in years)
  Aggregate
intrinsic value
 
             
Outstanding at January 1, 2013  4,220,809   2.21   3.91   7,562 
Granted  595,000   5.39         
Exercised  (815,564)  2.07         
Expired and forfeited  (121,750)  2.28         
                 
Outstanding at December 31, 2013  3,878,495   2.57   3.38   19,949 
                 
Exercisable at December 31, 2013  2,649,307   1.79   2.61   15,692 

In 2011, 2012 and 2013, the Company granted 2,429,844, 432,805 and 595,000 stock options to employees and directors, respectively.

NOTE 12:EQUITY (Cont.)

 

The weighted average grant date fair values of the options granted during the years ended December 31, 2011, 20122014, 2015 and 20132016 were $ 2.25,3.19, $ 1.963.79 and $ 2.51,4.30, respectively.

All outstanding options are in the money as of December 31, 2016.

 

The total intrinsic value of options exercised during the years ended December 31, 2011, 20122014, 2015 and 20132016 was $ 253, $ 2,668$7,446, $10,294 and $ 2,839,$2,304, respectively.

 

The options outstanding under the Company's stock option plans as of December 31, 20132016 have been separated into ranges of exercise price as follows:

 

              Weighted 
  Options  Weighted     Options  Average 
  outstanding  average  Weighted  Exercisable  Exercise 
  as of  remaining  average  as of  price of 
Ranges of December 31,  contractual  exercise  December 31,  Options 
exercise price 2013  Term  price  2013  Exercisable 
     (Years)  $     $ 
                     
0.85-1.45  1,849,921   1.68   1.34   1,787,421   1.34 
1.63  199,745   4.42   1.63   191,968   1.63 
2.09-2.48  266,608   6.30   2.33   212,801   2.30 
2.85  300,000   3.97   2.85   200,000   2.85 
3.60-3.69  615,055   4.64   3.66   194,951   3.65 
3.92-4.50  62,166   2.57   4.08   62,166   4.08 
4.87-5.00  343,000   5.36   4.91   -   - 
5.40-5.68  115,000   5.57   5.46   -   - 
6.42  100,000   5.85   6.42   -   - 
7.66  27,000   6.00   7.66   -   - 
                     
   3,878,495   3.38   2.57   2,649,307   1.79 
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)
              Weighted 
  Options  Weighted     Options  Average 
  outstanding  Average  Weighted  Exercisable  Exercise 
  as of  remaining  average  as of  price of 
Ranges of December 31,  contractual  exercise  December 31,  Options 
exercise price 2016  Term  price  2016  Exercisable 
     (Years)  $     $ 
                
1.28-1.88  64,590   2.87   1.44   64,590   1.44 
2.06-2.50  273,972   1.69   2.40   273,972   2.40 
3.25-3.57  288,221   1.53   3.37   288,221   3.37 
4.52  74,000   2.40   4.52   43,000   4.52 
5.05-5.33  67,500   2.60   5.08   48,750   5.07 
6.07-6.81  230,000   3.15   6.48   174,167   6.38 
7.21-7.48  209,500   3.21   7.44   90,250   7.42 
8.22-9.73  500,000   4.63   8.80   140,000   8.65 
10.58-11.21  280,000   4.78   10.76   50,000   10.58 
12.43-13.02  150,000   5.69   12.73   -   - 
                     
   2,137,783   3.43   6.91   1,172,950   4.84 

 

NOTE 11:    EQUITY (Cont.)The total equity-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2014, 2015 and 2016, was $1,067, $1,349 and $1,955, respectively.

 

c.As of December 31, 2013,2016, there was $ 2,166$3,288 of total unrecognized compensation cost related to non-vested options, which is expected to be recognized over a period of up to four years.

 

d.Warrants:During 2016, 29,500 of the 88,500 restricted shares of Sapiens Decision, the Company's majority-owned subsidiary that were granted to one of the former shareholders of KPI in 2014 (as described in note 1(d)(3)) vested, thereby reducing the Company's percentage ownership of Sapiens Decision from 95.7% to 94.25%. During 2016, Sapiens Decision granted 10,000 options to certain of its employees to purchase shares of Sapiens Decision.

 

F - 36

The following table summarizes information regarding outstanding warrants to purchase Common shares of the Company as of December 31, 2013:

SAPIENS INTERNATIONAL CORPORATION N.V.

 

Warrants to
Common
shares
  Weighted average
exercise price per
share
  Warrants
exercisable
  Exercisable through
          
 950,102  $3.82   950,102  August 2014
 11,000  $2.00   11,000  May 2015
 17,000  $2.24   17,000  February 2015
             
 978,102  $3.77   978,102   

e.Repurchase of shares:

On November 29, 2012, the Company repurchased from one of its shareholders 2,000,000 common shares, representing approximately 5% of the total number of issued and outstanding common shares, at a price of $ 3.50 per share, for a total consideration of $7,000. The repurchased shares are held as treasury shares.

f.Dividend:

On February 20, 2013, the Company's extraordinary general meeting of shareholders approved the distribution of cash dividend of $ 0.15 per common share for a total amount of $ 5,802 which was paid on February 22, 2013.
SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

 

NOTE 12:EQUITY (Cont.)

NOTE 12:-   BASIC AND DILUTED NET EARNINGS PER SHARE

e.Dividend:

On April 7, 2016, the Company's extraordinary general meeting of shareholders approved the distribution of a cash dividend of $0.20 per common share for a total amount of $9,786 that was paid during June 2016.

 

  Year ended December 31, 
  2011  2012  2013 
          
Numerator:            
             
Net income attributed to Sapiens shareholders $5,897  $11,780  $11,604 
             
Denominator (thousands):            
             
Denominator for basic earnings per share - weighted average number of common shares, net of treasury stock  28,460   39,953   40,024 
Shares and related put options issued in Harcase acquisition  298   114   - 
Stock options and warrants  2,006   1,604   2,292 
             
Denominator for diluted net earnings per share - adjusted weighted average number of shares  30,764   41,671   42,316 
On April 22, 2015, the Company's extraordinary general meeting of shareholders approved the distribution of a cash dividend of $0.15 per common share for a total amount of $7,186 that was paid during June and July 2015.

NOTE 13:RELATED PARTIES TRANSACTIONS

Agreements with controlling shareholder and its affiliates:

The Company has in effect services agreements with certain companies that are affiliated with Formula Systems (1985) Ltd. (“Formula”), Sapiens' parent company (most recently since December 23, 2014 and thereafter), pursuant to which the Company has received services amounting to approximately $1,100, $2,600 and $6,100, in aggregate for the years ended December 31, 2014, 2015 and 2016. In addition, during the years ended December 31, 2014, 2015 and 2016, the Company purchased from those affiliated companies an aggregate of approximately $200, $1,100 and $1,000 of hardware and software. Furthermore, the Company paid to Formula $131 for the year ended December 31, 2016 in respect of the Company’s portion of the directors' fees payable to the Company’s Chairman of the Board, who serves as Chief Executive Officer of Formula.

On August 18, 2015, Sapiens completed the acquisition from Asseco Poland S.A. (“Asseco”) of all issued and outstanding shares of Insseco. Asseco is the ultimate parent company of Sapiens, through its holdings in Formula. Please see note 1(d)(2) above for further information concerning this acquisition.

Under the share purchase agreement for that acquisition, Asseco committed to assign all customer contracts to Insseco that relate to the intellectual property that the Company acquired as part of the acquisition. In the event that Asseco cannot obtain the consent of any customer to the assignment of its contract to Insseco, Asseco will hold that customer's contract in trust for the benefit of Insseco. Under that arrangement, in 2016, Insseco invoiced Asseco in a back-to-back manner for all invoices issued by Asseco on Insseco's behalf to customers under those contracts that were not yet assigned by Asseco to Insseco.

During the years ended December 31, 2014, 2015 and 2016, Asseco provided back office and professional services and fixed assets to Insseco in an amount totaling approximately $200, $1,700 and $1,900, respectively.

As of December 31, 2015 and 2016, the Company had trade payables balances due to its related parties in amount of approximately $2,700 and $1,300, respectively. In addition, as of December 31, 2015 and 2016, the Company had trade receivables balances due from its related parties in amount of approximately $3,200 and $1,400, respectively.

F - 37

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 14:BASIC AND DILUTED NET EARNINGS PER SHARE

  Year ended December 31, 
  2014  2015  2016 
          
Numerator:            
             
Net income attributed to Sapiens shareholders $14,463  $20,016  $19,336 
Adjustment to redeemable non-controlling interest  -   224   443 
             
Net income used for earnings per share $14,463  $20,240  $19,779 
             
Denominator (thousands):            
             
Denominator for basic earnings per share - weighted average number of common shares, net of treasury stock  47,210   48,121   48,947 
Stock options and warrants  1,427   1,206   833 
             
Denominator for diluted net earnings per share - adjusted weighted average number of shares  48,637   49,327   49,780 

 

The weighted average number of shares related to outstanding anti-dilutive options and warrants excluded from the calculations of diluted net earnings per share was 1,308,212, 1,675,521599,287, 582,570 and 466,534250,809 for the years 2011, 20122014, 2015 and 2013,2016, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 13:   GEOGRAPHIC INFORMATION

NOTE 15:GEOGRAPHIC INFORMATION

 

a.The Company operates in a single reportable segment as a provider of software solutions. See Note 1 for a brief description of the Company's business. The data below is presented in accordance with ASC 280, "Segment Reporting".

 

b.Geographic information:

 

The following table sets forth revenues by country based on the billing address of the customer. Other than as shown below, no other country accounted for more than 10% of the Company’sCompany's revenues during the years ended December 31, 2011, 20122014, 2015 and 2013.2016.

 

   Year ended December 31, 
   2011  2012  2013 
1.Revenues:            
              
 North America* $20,889  $35,519  $44,237 
 United Kingdom  14,672   26,630   31,115 
 Israel  21,470   23,100   23,009 
 Rest of Europe  4,870   16,140   24,862 
 Asia Pacific  8,026   12,520   12,154 
              
   $69,927  $113,909  $135,377 
    Year ended December 31, 
    2014  2015  2016 
1. Revenues:            
               
  North America* $49,585  $61,332  $74,455 
  United Kingdom  34,961   42,580   46,892 
  Rest of Europe  28,351   32,897   35,535 
  Israel  28,821   28,315   29,085 
  Asia Pacific  15,732   20,512   30,223 
               
    $157,450  $185,636  $216,190 

F - 38

 

*Revenue amounts for North America that are shown in the above table consist primarily of revenues from the United States, except for approximately $1,200, $1,900 and $1,100 of revenues derived from Canada in the years ended December 31, 2011, 2012 and 2013, respectively.SAPIENS INTERNATIONAL CORPORATION N.V.

 

   December 31, 
   2012  2013 
2.Property and equipment:        
          
 Israel $1,422  $4,180 
 North America  266   231 
 Rest of the world  555   852 
          
   $2,243  $5,263 

c.Major customer data:

Revenues from a major customer accounted for 20%, 12% and 9% of total revenues for the years ended December 31, 2011, 2012 and 2013, respectively.

SAPIENS INTERNATIONAL CORPORATION N.V.
AND ITS SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 15:GEOGRAPHIC INFORMATION (Cont.)

* Revenue amounts for North America that are shown in the above table consist primarily of revenues from the United States, except for approximately $558, $471 and $854 of revenues derived from Canada in the years ended December 31, 2014, 2015 and 2016, respectively.

    December 31, 
    2015  2016 
2. Property and equipment:        
           
  Israel $4,224  $5,987 
  North America  147   2,136 
  Others  1,304   1,684 
           
    $5,675  $9,807 

c.Major customer data:

The following table sets forth revenues from major customers during the years ended December 31, 2014, 2015 and 2016. 

  Year ended December 31, 
  2014  2015  2016 
          
Customer A  11%  12%  14%

NOTE 14:   SELECTED STATEMENTS OF OPERATIONS DATA

NOTE 16:SELECTED STATEMENTS OF OPERATIONS DATA

 

a.Research and development expenses, net:expenses:

 

 Year ended December 31,  Year ended December 31, 
 2011  2012  2013  2014  2015  2016 
              
Total costs $9,743  $13,633  $17,238  $17,446  $16,267  $22,033 
Less - capitalized software development costs  (4,735)  (3,464)  (5,392)  (6,094)  (6,032)  (5,545)
                        
Research and development expenses, net $5,008  $10,169  $11,846  $11,352  $10,235  $16,488 

F - 39

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 16:SELECTED STATEMENTS OF OPERATIONS DATA (Cont.)

 

b.Financial income, net:

 

Financial income:                        
Interest $160  $201  $188  $356  $657  $784 
Derivatives gains  -   230   849 
Foreign currency translation  530   501   644   883   556   191 
                        
  690   702   832   1,239   1,443   1,824 
Financial expenses:                        
Interest  189   169   87 
Derivatives losses  397   -   - 
Foreign currency translation  341   284   155   586   981   735 
Bank charges and other  56   56   70   132   299   556 
                        
  (586)  (509)  (312)  (1,115)  (1,280)  (1,291)
                        
Financial income, net $104  $193  $520  $124  $163  $533 

NOTE 17:SUBSEQUENT EVENTS

a.Share Purchase Agreement for Acquisition of StoneRiver

On February 14, 2017, the Company entered into a share purchase agreement with StoneRiver Group L.P. (or the "Seller") and StoneRiver, Inc. (or "StoneRiver"), for the acquisition of all of the issued and outstanding share capital of StoneRiver. The Company consummated the acquisition in the first quarter in 2017. StoneRiver is a Denver, Colorado- based provider of technology solutions and services to the insurance industry.

The acquisition consideration is approximately $100 million in cash, subject to certain adjustments based on working capital, transaction expenses, unpaid debt and certain litigation matters.

Immediately prior to closing, the Company purchased a representations and warranties insurance policy covering certain indemnifiable damages under the agreement (which is referred to as the "Insurance"). The Insurance provides for coverage of $12,500 in the aggregate and its term is in general three years (except with respect to certain fundamental representations and warranties, as to which the term of the Insurance is six years).  In addition, two escrow funds were established by StoneRiver, for the purpose of enabling the indemnification of the Company for certain damages that are not fully recovered under the Insurance: (i) an escrow fund of $500 for a period of one year and (ii) an escrow fund of $2,000 for a period of 18 months.

F - 40

SAPIENS INTERNATIONAL CORPORATION N.V.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
U.S. dollars in thousands (except share and per share data)

NOTE 17:SUBSEQUENT EVENTS (Cont.)

b.HSBC Term Loan Credit Agreement

On February 28, 2017, the Company (via our wholly-owned subsidiary, Sapiens Americas Corporation, or the Borrower) entered into a secured credit agreement, or the Credit Agreement, with HSBC Bank USA, National Association, (or the "Lender") as financing for, the acquisition of StoneRiver. Pursuant to the Credit Agreement, Company borrowed $40 million, or the Bank Loan, for a five-year term. The Bank Loan will mature in February 2022 and is payable in equal consecutive quarterly principal installments of principal and accrued interest. The Borrower is entitled to prepay the Bank Loan at any time (on any interest payment date) without penalty upon notice to the Lender. The Bank Loan bears interest at the rate of LIBOR plus 1.85%.

The repayment of the Bank Loan is secured by first priority liens over: (i) substantially all assets of the Borrower and its US subsidiaries; and (ii) the shares of the Borrower held by Sapiens International Corporation B.V. Certain affiliated entities of the Borrower have guaranteed the repayment of the Bank Loan. The Credit Agreement contains customary representations and warranties, affirmative covenants and negative covenants, which include, without limitation, restrictions on indebtedness, liens, investments, and certain dispositions with respect to the property secured by the lien. The Credit Agreement also contains customary events of default that entitle the Lender to cause any or all of the Company's indebtedness to become immediately due and payable and to foreclose on the lien, and includes customary grace periods before certain events are deemed events of default.

c.Dispute with Customer

Subsequent to the balance sheet date, the Company received a letter from one of its significant customers, in which the customer alleged that the Company has materially breached a software development project agreement between them. The Company informed the customer that it has not materially breached any of its obligations under the agreement and that the customer itself has materially breached the agreement. Work on the project has been halted due to the dispute. The Company believes that this does not have an impact on its financial statements for the year ended December 31, 2016.

 

- - - - - - - -

F - 41

Item 19.Exhibits

Item 19.         Exhibits

Please see the exhibit index incorporated herein by reference.

88

SIGNATURE

 

The exhibits filed with or incorporated intoregistrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report are listed immediately below.on its behalf.

 

ExhibitNo.SAPIENS INTERNATIONAL CORPORATION N.V.
 
By:/s/ Roni Al Dor
Roni Al Dor
President & Chief Executive Officer

Date: April 27, 2017

89

EXHIBIT INDEX

Exhibit
No.
Exhibit Description
   
1.1 Articles of Association of Sapiens International Corporation N.V., as amended*amended (incorporated by reference to Exhibit 1.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2015, filed with the SEC on March 29, 2016)
   
4.1 Sapiens International Corporation N.V. 1992 Stock Option and Incentive Plan, as amended and restated (incorporated by reference to Exhibit 28.1 to the Company’s Registration Statement on Form S-8 (SEC File No. 333-64208), filed with the SEC on June 9, 1993, and to the Company'sCompany’s Registration Statement on Form S-8 (SEC File No. 333-10622), filed with the SEC on July 22, 1999)
   
4.2 Sapiens International Corporation N.V. 2003 Share Option Plan (incorporated by reference to Exhibit 4(c)2 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2006, filed with the SEC on June 28, 2007)
   
4.3 Sapiens International Corporation N.V. 2005 Special Incentive Share Option Plan (incorporated by reference to Exhibit 4(c)3 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2006, filed with the SEC on June 28, 2007)
   
4.4 Sapiens International Corporation N.V. 2011 Share Incentive Plan (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-8 (SEC File No. 333-177834), filed with the SEC on November 9, 2011)
   
4.5Form of Registration Rights Agreement, dated August 21, 2011, by and among Sapiens International Corporation N.V. and certain of its shareholders (incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form F-3 (SEC File No. 333-187185), filed with the SEC on March 11, 2013)
8.1��List of Subsidiaries*

12.1 Certification by Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act*
   
12.2 Certification by Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act*
   
13.1 Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b)/Rule 15d-14(b) under the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
   
15.1 Consent of Kost Forer Gabbay & Kasierer, a member of EY Global, independent registered public accounting firm*
   
101 The following financial information from Sapiens International Corporation N.V.’s Annual Report on Form 20-F for the year ended December 31, 20132016 formatted in XBRL (eXtensible Business Reporting Language):
(i) Consolidated Balance Sheets at December 31, 20122015 and 2013; 2016;
(ii) Consolidated Statements of Income for the years ended December 31, 2011, 20122014, 2015 and 2013; 2016;
(iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2011, 20122014, 2015 and 2013; 2016;

(iv) Consolidated Statements of Changes in Equity for the years ended December 31, 2011, 20122014, 2015 and 2013; 2016;

(v) Consolidated Statements of Cash Flows for the years ended December 31, 2011, 20122014, 2015 and 2013;2016; and

(vi) Notes to the Consolidated Financial Statements, tagged as blocks of text. Users of this data are advised, in accordance with Rule 406T of Regulation S-T promulgated by the SEC, that this Interactive Data File is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under those sections.*

 

* Filed herewith

SIGNATURE

The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.

SAPIENS INTERNATIONAL CORPORATION N.V.
By:/s/ Roni Al Dor
Roni Al Dor
President & Chief Executive Officer

Date: April 23, 2014

EXHIBIT INDEX

Exhibit No.Exhibit Description
1.1Articles of Association of Sapiens International Corporation N.V., as amended*
4.1Sapiens International Corporation N.V. 1992 Stock Option and Incentive Plan, as amended and restated (incorporated by reference to Exhibit 28.1 to the Company’s Registration Statement on Form S-8 (SEC File No. 333-64208), filed with the SEC on June 9, 1993, and to the Company's Registration Statement on Form S-8 (SEC File No. 333-10622), filed with the SEC on July 22, 1999)
4.2Sapiens International Corporation N.V. 2003 Share Option Plan (incorporated by reference to Exhibit 4(c)2 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2006, filed with the SEC on June 28, 2007)
4.3Sapiens International Corporation N.V. 2005 Special Incentive Share Option Plan (incorporated by reference to Exhibit 4(c)3 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2006, filed with the SEC on June 28, 2007)
4.4Sapiens International Corporation N.V. 2011 Share Incentive Plan (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-8 (SEC File No. 333-177834), filed with the SEC on November 9, 2011)
8.1List of Subsidiaries*
12.1Certification by Chief Executive Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act*
12.2Certification by Chief Financial Officer pursuant to Rule 13a-14(a)/Rule 15d-14(a) under the Exchange Act*
13.1Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b)/Rule 15d-14(b) under the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
15.1Consent of Kost Forer Gabbay & Kasierer, a member of EY Global, independent registered public accounting firm*
101The following financial information from Sapiens International Corporation N.V.’s Annual Report on Form 20-F for the year ended December 31, 2013 formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheets at December 31, 2012 and 2013; (ii) Consolidated Statements of Income for the years ended December 31, 2011, 2012 and 2013; (iii) Consolidated Statements of Comprehensive Income for the years ended December 31, 2011, 2012 and 2013; (iv) Consolidated Statements of Changes in Equity for the years ended December 31, 2011, 2012 and 2013; (v) Consolidated Statements of Cash Flows for the years ended December 31, 2011, 2012 and 2013; and (vi) Notes to the Consolidated Financial Statements, tagged as blocks of text. Users of this data are advised, in accordance with Rule 406T of Regulation S-T promulgated by the SEC, that this Interactive Data File is deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under those sections.*

 

* Filed herewith

 

10890